Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:corticosteroid hormone
go back to main search page
Accession:CHEBI:36699 term browser browse the term
Definition:Any of a class of steroid hormones that are produced in the adrenal cortex.
Synonyms:related_synonym: adrenal cortex hormones;   corticosteroid hormones


show annotations for term's descendants           Sort by:
11-deoxycorticosterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acta2 actin alpha 2, smooth muscle increases expression
multiple interactions 		ISO Desoxycorticosterone results in increased expression of ACTA2 mRNA; Desoxycorticosterone results in increased expression of ACTA2 protein
Rotenone inhibits the reaction [Desoxycorticosterone results in increased expression of ACTA2 protein] 		CTD PMID:17596522 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Agt angiotensinogen increases activity EXP Desoxycorticosterone results in increased activity of AGT protein CTD PMID:9087624 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 increases metabolic processing ISO AKR1C18 protein results in increased metabolism of Desoxycorticosterone CTD PMID:17122075 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Ar androgen receptor multiple interactions ISO Desoxycorticosterone binds to and results in increased activity of AR protein mutant form CTD PMID:11956172 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of BAX protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of BAX protein]; atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of BAX protein] CTD PMID:22431579 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein]; Atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein] CTD PMID:22431579 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Cat catalase multiple interactions EXP CAT protein results in increased susceptibility to [tert-Butylhydroperoxide co-treated with Desoxycorticosterone co-treated with tempol] CTD PMID:12646410 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 mRNA; [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 protein; Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 protein] CTD PMID:21135038 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Cdh1 cadherin 1 decreases expression
multiple interactions 		ISO Desoxycorticosterone results in decreased expression of CDH1 mRNA; Desoxycorticosterone results in decreased expression of CDH1 protein
Rotenone inhibits the reaction [Desoxycorticosterone results in decreased expression of CDH1 protein] 		CTD PMID:17596522 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cyba cytochrome b-245 alpha chain increases expression
multiple interactions 		EXP Desoxycorticosterone results in increased expression of CYBA mRNA; Desoxycorticosterone results in increased expression of CYBA protein
[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of CYBA protein 		CTD PMID:16271043 PMID:22431579 NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214 		JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 affects metabolic processing
multiple interactions
increases chemical synthesis 		ISO
EXP 		CYP11B1 protein affects the metabolism of Desoxycorticosterone
Plant Extracts inhibits the reaction [Desoxycorticosterone binds to CYP11B1 protein]
CYP11B1 protein results in increased chemical synthesis of Desoxycorticosterone 		CTD PMID:15666820 PMID:16054388 PMID:19900470 NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 affects metabolic processing
multiple interactions
increases hydroxylation 		ISO CYP11B2 protein affects the metabolism of Desoxycorticosterone
[CYP11B2 protein results in increased hydroxylation of Desoxycorticosterone] which results in increased chemical synthesis of Corticosterone 		CTD PMID:15985365 PMID:21384875 NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921 		JBrowse link
G Edn1 endothelin 1 multiple interactions
increases expression 		EXP [Sodium Chloride, Dietary co-treated with Desoxycorticosterone] results in increased expression of EDN1 mRNA; [Sodium Chloride, Dietary co-treated with Desoxycorticosterone] results in increased expression of EDN1 protein; Clofibrate inhibits the reaction [Desoxycorticosterone results in increased expression of EDN1 protein]; Mibefradil inhibits the reaction [[Sodium Chloride, Dietary co-treated with Desoxycorticosterone] results in increased expression of EDN1 mRNA]
Desoxycorticosterone results in increased expression of EDN1; Desoxycorticosterone results in increased expression of EDN1 protein 		CTD PMID:1860718 PMID:8934362 PMID:12600921 PMID:16054168 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Ednra endothelin receptor type A multiple interactions
affects response to substance 		EXP [5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide binds to and results in decreased activity of EDNRA protein] inhibits the reaction [Desoxycorticosterone results in increased chemical synthesis of Reactive Oxygen Species]; [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of EDNRA protein
EDNRA protein affects the susceptibility to Desoxycorticosterone 		CTD PMID:12600921 PMID:16271043 PMID:22431579 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284 		JBrowse link
G Egf epidermal growth factor multiple interactions
increases response to substance 		EXP 4,5-dianilinophthalimide inhibits the reaction [EGF protein results in increased susceptibility to Desoxycorticosterone]; RTKI cpd inhibits the reaction [EGF protein results in increased susceptibility to Desoxycorticosterone] CTD PMID:11751714 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions EXP Desoxycorticosterone promotes the reaction [EP300 protein binds to SULT1A1 promoter]; Desoxycorticosterone promotes the reaction [EP300 protein binds to TAT promoter] CTD PMID:22465009 NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574 		JBrowse link
G Fabp3 fatty acid binding protein 3 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of FABP3 protein; Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of FABP3 protein] CTD PMID:21135038 NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881 		JBrowse link
G Gas6 growth arrest specific 6 multiple interactions EXP GAS6 protein promotes the reaction [Desoxycorticosterone results in increased expression of IL6 protein]; GAS6 protein promotes the reaction [Desoxycorticosterone results in increased expression of TNF protein] CTD PMID:19564549 NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088 		JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of GPX1 protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of GPX1 protein]; atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of GPX1 protein] CTD PMID:22431579 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of HAVCR1 mRNA CTD PMID:21135038 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of IL1B mRNA CTD PMID:21135038 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il6 interleukin 6 increases expression
multiple interactions 		EXP Desoxycorticosterone results in increased expression of IL6 protein
GAS6 protein promotes the reaction [Desoxycorticosterone results in increased expression of IL6 protein] 		CTD PMID:19564549 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Lcn2 lipocalin 2 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of LCN2 mRNA; Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of LCN2 mRNA] CTD PMID:21135038 NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842 		JBrowse link
G Ncf1 neutrophil cytosolic factor 1 affects localization EXP Desoxycorticosterone affects the localization of NCF1 protein CTD PMID:16271043 NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079 		JBrowse link
G Nos3 nitric oxide synthase 3 decreases phosphorylation
multiple interactions
increases expression 		EXP Desoxycorticosterone results in decreased phosphorylation of NOS3 protein
NOS3 protein inhibits the reaction [Desoxycorticosterone results in increased expression of VCAM1 protein]
Desoxycorticosterone results in increased expression of NOS3 protein 		CTD PMID:11834524 PMID:14993198 PMID:16271043 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664 		JBrowse link
G Nox1 NADPH oxidase 1 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of NOX1 protein CTD PMID:22431579 NCBI chr  X:101,572,338...101,625,571
Ensembl chr  X:101,572,340...101,595,520 		JBrowse link
G Nppa natriuretic peptide A increases expression EXP Desoxycorticosterone results in increased expression of NPPA protein CTD PMID:2965178 NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 increases phosphorylation
multiple interactions
decreases expression 		ISO
EXP 		Desoxycorticosterone results in increased phosphorylation of NR3C1 protein
Desoxycorticosterone promotes the reaction [NR3C1 protein binds to TAT promoter]
Desoxycorticosterone results in decreased expression of NR3C1 mRNA
Desoxycorticosterone binds to and results in increased activity of NR3C1 protein 		CTD PMID:8969928 PMID:11956172 PMID:18483179 PMID:22465009 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 decreases expression EXP Desoxycorticosterone results in decreased expression of NR3C2 mRNA CTD PMID:8969928 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Pdgfa platelet derived growth factor subunit A multiple interactions EXP [PDGFA protein binds to PDGFB protein] which results in increased susceptibility to Desoxycorticosterone CTD PMID:11751714 NCBI chr12:20,759,366...20,780,337
Ensembl chr12:20,754,208...20,780,322 		JBrowse link
G Pdgfb platelet derived growth factor subunit B multiple interactions EXP [PDGFA protein binds to PDGFB protein] which results in increased susceptibility to Desoxycorticosterone CTD PMID:11751714 NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343 		JBrowse link
G Pomc proopiomelanocortin increases abundance ISO POMC protein results in increased abundance of Desoxycorticosterone CTD PMID:3015796 NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO PPARA protein affects the susceptibility to [Sodium Chloride, Dietary co-treated with Desoxycorticosterone] CTD PMID:16054168 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha increases expression ISO Desoxycorticosterone results in increased expression of PPARGC1A mRNA CTD PMID:23056435 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression EXP Desoxycorticosterone results in increased expression of PTGS2 protein CTD PMID:15834289 PMID:16271043 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Rac1 Rac family small GTPase 1 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of RAC1 protein CTD PMID:22431579 NCBI chr12:16,150,411...16,170,864
Ensembl chr12:16,128,649...16,172,109 		JBrowse link
G Ren renin multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of REN protein CTD PMID:11039 NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions EXP Desoxycorticosterone inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:9830022 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Slc22a3 solute carrier family 22 member 3 multiple interactions EXP Desoxycorticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of Tetraethylammonium] CTD PMID:9830022 NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353 		JBrowse link
G Slco1a1 solute carrier organic anion transporter family, member 1a1 multiple interactions
decreases activity 		EXP Desoxycorticosterone inhibits the reaction [SLCO1A1 protein results in increased uptake of estradiol-17 beta-glucuronide]
Desoxycorticosterone results in decreased activity of SLCO1A1 protein 		CTD PMID:11883641 NCBI chr 4:176,606,924...176,682,027
Ensembl chr 4:176,607,687...176,681,992 		JBrowse link
G Sod1 superoxide dismutase 1 decreases expression
multiple interactions 		EXP Desoxycorticosterone results in decreased expression of SOD1 protein
[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD1 protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD1 protein]; atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD1 protein]; tempol inhibits the reaction [Desoxycorticosterone results in decreased expression of SOD1 protein] 		CTD PMID:12646410 PMID:22431579 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions
decreases expression 		EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD2 protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD2 protein]; Atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of SOD2 protein]; SOD2 protein inhibits the reaction [Desoxycorticosterone results in increased expression of VCAM1 protein]
Desoxycorticosterone results in decreased expression of SOD2 protein 		CTD PMID:11834524 PMID:22431579 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Spp1 secreted phosphoprotein 1 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of SPP1 mRNA; [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of SPP1 protein; Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of SPP1 mRNA] CTD PMID:21135038 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 multiple interactions EXP Desoxycorticosterone promotes the reaction [EP300 protein binds to SULT1A1 promoter] CTD PMID:22465009 NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131 		JBrowse link
G Tat tyrosine aminotransferase multiple interactions EXP Desoxycorticosterone promotes the reaction [EP300 protein binds to TAT promoter]; Desoxycorticosterone promotes the reaction [NR3C1 protein binds to TAT promoter] CTD PMID:22465009 NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482 		JBrowse link
G Tnc tenascin C multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of TNC mRNA; Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of TNC mRNA]; Spironolactone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of TNC mRNA] CTD PMID:21135038 NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression 		EXP GAS6 protein promotes the reaction [Desoxycorticosterone results in increased expression of TNF protein] CTD PMID:19564549 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tp53 tumor protein p53 multiple interactions EXP [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of TP53 protein; acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of TP53 protein]; atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of TP53 protein] CTD PMID:22431579 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions
increases expression 		EXP NOS3 protein inhibits the reaction [Desoxycorticosterone results in increased expression of VCAM1 protein]; SOD2 protein inhibits the reaction [Desoxycorticosterone results in increased expression of VCAM1 protein] CTD PMID:11834524 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Xdh xanthine dehydrogenase increases activity
multiple interactions 		EXP Desoxycorticosterone results in increased activity of XDH protein
Desoxycorticosterone promotes the reaction [XDH protein results in increased chemical synthesis of Reactive Oxygen Species] 		CTD PMID:16271043 NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350 		JBrowse link
11-deoxycortisol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor multiple interactions ISO Cortodoxone binds to and results in increased activity of AR protein mutant form CTD PMID:11956172 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 increases metabolic processing
affects metabolic processing 		ISO CYP11B1 protein results in increased metabolism of Cortodoxone
CYP11B1 protein affects the metabolism of Cortodoxone 		CTD PMID:15522937 PMID:15780661 PMID:15985365 PMID:16030167 PMID:16054388 More... NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 increases metabolic processing
affects metabolic processing 		ISO CYP11B2 protein results in increased metabolism of Cortodoxone
CYP11B2 protein affects the metabolism of Cortodoxone 		CTD PMID:15743198 PMID:19900470 NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 affects binding ISO Cortodoxone binds to NR3C1 protein CTD PMID:15705660 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 increases activity ISO Cortodoxone results in increased activity of NR3C2 protein CTD PMID:15780662 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
11beta,21-Dihydroxypregn-4-ene-3,20-dione 21-acetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor multiple interactions ISO corticosterone acetate inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:18324785 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
16-alpha,17-Epoxypregn-4-ene-3,20-dione term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor multiple interactions ISO 16 alpha,17-epoxyprogesterone inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:18324785 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Ephx2 epoxide hydrolase 2 multiple interactions ISO 16 alpha,17-epoxyprogesterone inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] CTD PMID:2043152 NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160 		JBrowse link
16-Hydroxyprogesterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions ISO [CYP17A1 protein results in increased hydroxylation of Progesterone] which results in increased chemical synthesis of 16-hydroxyprogesterone CTD PMID:17194026 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
18-hydroxycortisol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 affects chemical synthesis ISO CYP11B1 protein affects the chemical synthesis of 18-hydroxycortisol CTD PMID:15356073 NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 affects chemical synthesis ISO CYP11B2 protein affects the chemical synthesis of 18-hydroxycortisol CTD PMID:15356073 NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921 		JBrowse link
G Pomc proopiomelanocortin increases abundance ISO POMC protein results in increased abundance of 18-hydroxycortisol CTD PMID:3015796 NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173 		JBrowse link
18-oxocortisol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 affects chemical synthesis ISO CYP11B2 protein affects the chemical synthesis of 18-oxocortisol CTD PMID:15356073 NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921 		JBrowse link
5alpha-Pregnan-20alpha-ol-3-one term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akr1c3 aldo-keto reductase family 1, member C3 increases chemical synthesis ISO AKR1C3 protein results in increased chemical synthesis of allopregnan-20 alpha-ol-3-one CTD PMID:25463305 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Srd5a1 steroid 5 alpha-reductase 1 increases chemical synthesis ISO SRD5A1 protein results in increased chemical synthesis of allopregnan-20 alpha-ol-3-one CTD PMID:25463305 NCBI chr 1:35,514,914...35,548,898
Ensembl chr 1:35,514,846...35,548,903 		JBrowse link
alclometasone dipropionate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO alclometasone dipropionate results in decreased expression of CCL2 protein CTD PMID:20116850 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO alclometasone dipropionate results in increased expression of CCL3 protein CTD PMID:20116850 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression ISO alclometasone dipropionate results in increased expression of CCL4 protein CTD PMID:20116850 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Csf2 colony stimulating factor 2 decreases expression ISO alclometasone dipropionate results in decreased expression of CSF2 protein CTD PMID:11407316 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Ifng interferon gamma decreases expression ISO alclometasone dipropionate results in decreased expression of IFNG protein CTD PMID:11407316 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Il2 interleukin 2 decreases expression ISO alclometasone dipropionate results in decreased expression of IL2 protein CTD PMID:11407316 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Il3 interleukin 3 decreases expression ISO alclometasone dipropionate results in decreased expression of IL3 protein CTD PMID:11407316 NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,906,460...38,908,810 		JBrowse link
G Il4 interleukin 4 decreases expression ISO alclometasone dipropionate results in decreased expression of IL4 protein CTD PMID:11407316 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il5 interleukin 5 decreases expression ISO alclometasone dipropionate results in decreased expression of IL5 protein CTD PMID:11407316 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO alclometasone dipropionate results in decreased expression of VEGFA protein CTD PMID:20116850 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
aldosterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases secretion
increases expression
multiple interactions 		ISO ABCB1 protein results in increased secretion of Aldosterone
Aldosterone results in increased expression of ABCB1 mRNA
Elacridar inhibits the reaction [ABCB1 protein results in increased secretion of Aldosterone]; valspodar inhibits the reaction [ABCB1 protein results in increased secretion of Aldosterone] 		CTD PMID:12387747 PMID:22464980 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Ace angiotensin I converting enzyme increases activity
increases expression
multiple interactions 		EXP Aldosterone results in increased activity of ACE protein
Aldosterone results in increased expression of ACE mRNA
AG 1879 inhibits the reaction [Aldosterone results in increased expression of ACE mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Aldosterone results in increased expression of ACE mRNA]; Dactinomycin inhibits the reaction [Aldosterone results in increased activity of ACE protein]; Dactinomycin inhibits the reaction [Aldosterone results in increased expression of ACE mRNA]; Genistein inhibits the reaction [Aldosterone results in increased expression of ACE mRNA]; RTKI cpd inhibits the reaction [Aldosterone results in increased expression of ACE mRNA]; Spironolactone inhibits the reaction [Aldosterone results in increased activity of ACE protein]; Spironolactone inhibits the reaction [Aldosterone results in increased expression of ACE mRNA] 		CTD PMID:15932931 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942 		JBrowse link
G Acta2 actin alpha 2, smooth muscle increases expression
multiple interactions 		ISO
EXP 		Aldosterone results in increased expression of ACTA2 mRNA; Aldosterone results in increased expression of ACTA2 protein
Spironolactone inhibits the reaction [Aldosterone results in increased expression of ACTA2 protein]; tempol inhibits the reaction [Aldosterone results in increased expression of ACTA2 protein]
eplerenone inhibits the reaction [Aldosterone results in increased expression of ACTA2 mRNA]; eplerenone inhibits the reaction [Aldosterone results in increased expression of ACTA2 protein]; Rotenone inhibits the reaction [Aldosterone results in increased expression of ACTA2 mRNA]; Rotenone inhibits the reaction [Aldosterone results in increased expression of ACTA2 protein]; U 0126 inhibits the reaction [Aldosterone results in increased expression of ACTA2 mRNA]; U 0126 inhibits the reaction [Aldosterone results in increased expression of ACTA2 protein] 		CTD PMID:17596522 PMID:25204689 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Agt angiotensinogen increases abundance
multiple interactions
increases secretion
increases expression 		ISO
EXP 		AGT protein modified form results in increased abundance of Aldosterone; AGT protein results in increased abundance of Aldosterone
AGT protein affects the reaction [SLC9A3 gene mutant form results in increased abundance of Aldosterone]
AGT protein results in increased secretion of Aldosterone
Aldosterone results in increased expression of AGT protein alternative form
AGT protein affects the reaction [DAB2 protein results in increased secretion of Aldosterone]; AGT protein alternative form promotes the reaction [Aldosterone results in increased expression of IL18 mRNA]
[AGT co-treated with REN] results in increased abundance of Aldosterone; [Valsartan co-treated with benidipine] inhibits the reaction [AGT protein results in increased abundance of Aldosterone]; benidipine inhibits the reaction [AGT protein results in increased abundance of Aldosterone]; candesartan inhibits the reaction [[AGT co-treated with REN] results in increased abundance of Aldosterone]; Clozapine inhibits the reaction [Dopamine promotes the reaction [AGT protein results in increased secretion of Aldosterone]]; Clozapine promotes the reaction [Raclopride promotes the reaction [Dopamine promotes the reaction [AGT protein results in increased secretion of Aldosterone]]]; Dopamine promotes the reaction [AGT protein results in increased secretion of Aldosterone]; efonidipine inhibits the reaction [AGT protein results in increased abundance of Aldosterone]; Enalapril inhibits the reaction [[AGT co-treated with REN] results in increased abundance of Aldosterone]; KCNJ5 protein inhibits the reaction [AGT protein results in increased secretion of Aldosterone]; Losartan inhibits the reaction [AGT protein results in increased abundance of Aldosterone]; Mibefradil inhibits the reaction [AGT protein results in increased abundance of Aldosterone]; naringin inhibits the reaction [AGT protein results in increased secretion of Aldosterone]; Raclopride inhibits the reaction [Dopamine promotes the reaction [AGT protein results in increased secretion of Aldosterone]]; Raclopride promotes the reaction [Dopamine promotes the reaction [AGT protein results in increased secretion of Aldosterone]]; Valsartan inhibits the reaction [AGT protein results in increased abundance of Aldosterone] 		CTD PMID:6257467 PMID:7588239 PMID:8952583 PMID:11549694 PMID:16788141 More... NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a multiple interactions
increases expression 		ISO
EXP 		[Losartan results in decreased activity of AGTR1 protein] which results in decreased abundance of Aldosterone
Aldosterone results in increased expression of AGTR1A mRNA 		CTD PMID:9087624 PMID:9124547 PMID:15302841 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Agtr2 angiotensin II receptor, type 2 increases expression EXP Aldosterone results in increased expression of AGTR2 mRNA CTD PMID:15809360 NCBI chr  X:116,914,320...116,918,504
Ensembl chr  X:116,913,656...116,918,745 		JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 multiple interactions ISO [AKR1D1 protein co-treated with NADP] results in increased reduction of Aldosterone CTD PMID:25500266 NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540 		JBrowse link
G Alb albumin multiple interactions ISO ALB protein inhibits the reaction [Acetaminophen results in increased abundance of Aldosterone] CTD PMID:1825077 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions
increases expression 		ISO acephate inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; alachlor inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; Atrazine metabolite inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; bifenthrin inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; cypermethrin inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; DDT inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; Dimethoate inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; fenvalerate inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; fipronil inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; Methoxychlor inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; o,p'-DDT inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; Permethrin inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; Spironolactone inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; terbutylazine inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; Zineb inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] CTD PMID:29149346 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Aqp2 aquaporin 2 multiple interactions EXP [Aldosterone co-treated with Lithium] affects the expression of AQP2 protein CTD PMID:16159898 NCBI chr 7:132,590,286...132,595,321
Ensembl chr 7:132,590,225...132,595,319 		JBrowse link
G Casp3 caspase 3 multiple interactions EXP Aldosterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] CTD PMID:15755911 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Ccn2 cellular communication network factor 2 increases expression
multiple interactions 		EXP
ISO 		Aldosterone results in increased expression of CCN2 protein
Spironolactone inhibits the reaction [Aldosterone results in increased expression of CCN2 protein]
Aldosterone results in increased expression of CCN2 mRNA 		CTD PMID:17278980 PMID:30809271 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Cd80 Cd80 molecule multiple interactions EXP [Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CD80 mRNA; Eplerenone inhibits the reaction [[Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CD80 mRNA] CTD PMID:27773435 NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540 		JBrowse link
G Cdh1 cadherin 1 decreases expression
multiple interactions 		ISO Aldosterone results in decreased expression of CDH1 mRNA; Aldosterone results in decreased expression of CDH1 protein
eplerenone inhibits the reaction [Aldosterone results in decreased expression of CDH1 mRNA]; eplerenone inhibits the reaction [Aldosterone results in decreased expression of CDH1 protein]; Rotenone inhibits the reaction [Aldosterone results in decreased expression of CDH1 mRNA]; Rotenone inhibits the reaction [Aldosterone results in decreased expression of CDH1 protein]; U 0126 inhibits the reaction [Aldosterone results in decreased expression of CDH1 mRNA]; U 0126 inhibits the reaction [Aldosterone results in decreased expression of CDH1 protein] 		CTD PMID:17596522 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions EXP [Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of COL1A1 mRNA; Eplerenone inhibits the reaction [[Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of COL1A1 mRNA] CTD PMID:27773435 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain increases expression ISO Aldosterone results in increased expression of COL1A2 mRNA CTD PMID:30809271 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col3a1 collagen type III alpha 1 chain increases expression
multiple interactions 		ISO
EXP 		Aldosterone results in increased expression of COL3A1 mRNA
[Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of COL3A1 mRNA; Eplerenone inhibits the reaction [[Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of COL3A1 mRNA] 		CTD PMID:27773435 PMID:30809271 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain multiple interactions EXP [Eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; Eplerenone inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]] CTD PMID:18682491 NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482 		JBrowse link
G Crebbp CREB binding protein multiple interactions EXP Aldosterone promotes the reaction [NR3C2 protein binds to CREBBP protein]; Aldosterone results in increased expression of and results in increased localization of CREBBP protein CTD PMID:19966502 NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266 		JBrowse link
G Cs citrate synthase multiple interactions EXP [[Aldosterone co-treated with Mifepristone] results in increased abundance of Mineralocorticoids] which results in increased activity of CS protein CTD PMID:1328298 NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 increases chemical synthesis
affects chemical synthesis
multiple interactions 		ISO
EXP 		CYP11B2 protein polymorphism results in increased chemical synthesis of Aldosterone; CYP11B2 protein results in increased chemical synthesis of Aldosterone
CYP11B2 protein affects the chemical synthesis of Aldosterone
[CYP11B2 protein results in increased hydroxylation of Corticosterone] which results in increased chemical synthesis of Aldosterone 		CTD PMID:12525251 PMID:12783697 PMID:15731365 PMID:16043663 PMID:16054388 More... NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921 		JBrowse link
G Dab2 DAB adaptor protein 2 multiple interactions EXP AGT protein affects the reaction [DAB2 protein results in increased secretion of Aldosterone] CTD PMID:17303656 NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:57,242,064...57,294,888 		JBrowse link
G Dhrs3 dehydrogenase/reductase 3 multiple interactions ISO Aldosterone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein] CTD PMID:23275455 NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653 		JBrowse link
G Edn1 endothelin 1 increases expression
multiple interactions 		EXP Aldosterone results in increased expression of EDN1 protein
[EDN1 protein binds to and results in increased activity of EDNRA protein] promotes the reaction [Aldosterone results in increased expression of IL18 mRNA] 		CTD PMID:18660453 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Ednra endothelin receptor type A multiple interactions EXP [cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; [EDN1 protein binds to and results in increased activity of EDNRA protein] promotes the reaction [Aldosterone results in increased expression of IL18 mRNA] CTD PMID:18660453 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284 		JBrowse link
G Egfr epidermal growth factor receptor increases expression EXP Aldosterone results in increased expression of EGFR mRNA CTD PMID:11507004 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G F2r coagulation factor II (thrombin) receptor multiple interactions EXP [Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of F2R mRNA CTD PMID:27773435 NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579 		JBrowse link
G Faslg Fas ligand increases expression EXP Aldosterone results in increased expression of FASLG protein CTD PMID:19001025 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503 		JBrowse link
G Gas6 growth arrest specific 6 increases expression
multiple interactions 		EXP Aldosterone results in increased expression of GAS6 protein
NR3C2 protein promotes the reaction [Aldosterone results in increased expression of GAS6 protein]; Spironolactone inhibits the reaction [Aldosterone results in increased expression of GAS6 protein] 		CTD PMID:19564549 NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088 		JBrowse link
G Gata4 GATA binding protein 4 increases expression EXP Aldosterone results in increased expression of GATA4 protein CTD PMID:19966502 NCBI chr15:41,635,572...41,707,252
Ensembl chr15:41,635,572...41,681,609 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression
multiple interactions 		EXP Aldosterone results in increased expression of GCLC protein
Spironolactone inhibits the reaction [Aldosterone results in increased expression of GCLC protein]; tempol inhibits the reaction [Aldosterone results in increased expression of GCLC protein] 		CTD PMID:24512358 PMID:25204689 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 increases expression EXP Aldosterone results in increased expression of GSTP1 protein CTD PMID:25204689 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression EXP Aldosterone results in increased expression of HMOX1 protein CTD PMID:25204689 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 increases expression EXP Aldosterone results in increased expression of HNRNPA2B1 mRNA; Aldosterone results in increased expression of HNRNPA2B1 protein CTD PMID:23139218 NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:81,869,661...81,877,572 		JBrowse link
G Hpse heparanase increases expression
multiple interactions 		EXP Aldosterone results in increased expression of HPSE mRNA; Aldosterone results in increased expression of HPSE protein
Spironolactone inhibits the reaction [Aldosterone results in increased expression of HPSE mRNA]; Spironolactone inhibits the reaction [Aldosterone results in increased expression of HPSE protein] 		CTD PMID:19429930 NCBI chr14:9,200,971...9,241,377
Ensembl chr14:9,188,275...9,241,754 		JBrowse link
G Il18 interleukin 18 increases expression
multiple interactions 		EXP Aldosterone results in increased expression of IL18 mRNA; Aldosterone results in increased expression of IL18 protein
[cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; [EDN1 protein binds to and results in increased activity of EDNRA protein] promotes the reaction [Aldosterone results in increased expression of IL18 mRNA]; AGT protein alternative form promotes the reaction [Aldosterone results in increased expression of IL18 mRNA]; Bezafibrate inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; Cycloheximide inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; Eplerenone inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; exoenzyme C3, Clostridium botulinum inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; fasudil inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]]; olmesartan inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; Pioglitazone inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; prolinedithiocarbamate inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; Simvastatin inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; SN50 peptide inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; Spironolactone inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA] 		CTD PMID:18660453 NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286 		JBrowse link
G Il6 interleukin 6 increases expression ISO Aldosterone results in increased expression of IL6 protein CTD PMID:17043157 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Jak2 Janus kinase 2 increases phosphorylation
multiple interactions 		EXP Aldosterone results in increased phosphorylation of JAK2 protein
Dactinomycin inhibits the reaction [Aldosterone results in increased phosphorylation of JAK2 protein]; Spironolactone inhibits the reaction [Aldosterone results in increased phosphorylation of JAK2 protein] 		CTD PMID:15932931 NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762 		JBrowse link
G Kcnj5 potassium inwardly-rectifying channel, subfamily J, member 5 multiple interactions
decreases secretion 		ISO KCNJ5 protein inhibits the reaction [AGT protein results in increased secretion of Aldosterone]
KCNJ5 protein results in decreased secretion of Aldosterone 		CTD PMID:22798349 NCBI chr 8:38,981,598...39,011,197
Ensembl chr 8:38,983,034...39,011,101 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO Acetylcysteine inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein; eplerenone inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Rotenone inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK1 protein] CTD PMID:17596522 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 affects chemical synthesis ISO MAPK14 protein affects the chemical synthesis of Aldosterone CTD PMID:14592955 NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO Acetylcysteine inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Aldosterone results in increased phosphorylation of and results in increased activity of MAPK3 protein; eplerenone inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Rotenone inhibits the reaction [Aldosterone results in increased phosphorylation of and results in increased activity of MAPK3 protein] CTD PMID:17596522 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mt1a metallothionein 1A multiple interactions
increases expression 		EXP [Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in increased expression of MT1A protein; Amlodipine inhibits the reaction [Aldosterone results in increased expression of MT1A mRNA]; Spironolactone inhibits the reaction [[Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in increased expression of MT1A protein]; Spironolactone inhibits the reaction [Aldosterone results in increased expression of MT1A mRNA] CTD PMID:17616752 PMID:19333130 NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Mtf1 metal-regulatory transcription factor 1 increases expression
multiple interactions 		EXP Aldosterone results in increased expression of MTF1 mRNA; Aldosterone results in increased expression of MTF1 protein
Amlodipine inhibits the reaction [Aldosterone results in increased expression of MTF1 mRNA]; Amlodipine inhibits the reaction [Aldosterone results in increased expression of MTF1 protein]; Spironolactone inhibits the reaction [Aldosterone results in increased expression of MTF1 mRNA]; Spironolactone inhibits the reaction [Aldosterone results in increased expression of MTF1 protein] 		CTD PMID:19333130 NCBI chr 5:142,347,024...142,391,810
Ensembl chr 5:142,347,054...142,391,810 		JBrowse link
G Nedd4l NEDD4 like E3 ubiquitin protein ligase multiple interactions ISO Aldosterone inhibits the reaction [NEDD4L gene mutant form results in decreased cleavage of SCNN1A protein] CTD PMID:23348737 NCBI chr18:60,663,918...60,996,824
Ensembl chr18:60,663,970...60,996,824 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases activity
multiple interactions 		EXP Aldosterone results in increased activity of NFE2L2 protein
Spironolactone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein]; tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] 		CTD PMID:25204689 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nol3 nucleolar protein 3 decreases phosphorylation EXP Aldosterone results in decreased phosphorylation of NOL3 protein CTD PMID:19001025 NCBI chr19:50,066,493...50,068,175
Ensembl chr19:50,063,986...50,068,722 		JBrowse link
G Nppa natriuretic peptide A multiple interactions
decreases secretion
increases expression 		EXP
ISO 		Aldosterone promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA]; Spironolactone inhibits the reaction [Aldosterone results in increased expression of NPPA mRNA]
NPPA protein results in decreased secretion of Aldosterone 		CTD PMID:2434734 PMID:2931268 PMID:19966502 NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493 		JBrowse link
G Nppb natriuretic peptide B decreases abundance
affects abundance 		ISO NPPB protein results in decreased abundance of Aldosterone
NPPB affects the abundance of Aldosterone 		CTD PMID:16333235 PMID:20339970 NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions
affects binding
increases activity
decreases expression 		ISO
EXP 		Aldosterone binds to and results in increased activity of NR3C1 protein
NR3C1 protein binds to Aldosterone
Aldosterone promotes the reaction [[NR3C1 protein binds to TAT promoter] which results in increased expression of TAT mRNA]
Aldosterone results in increased activity of NR3C1 protein
Aldosterone results in decreased expression of NR3C1 mRNA
Aldosterone binds to NR3C1 protein mutant form 		CTD PMID:1597467 PMID:8969928 PMID:11861974 PMID:15362971 PMID:15774500 More... NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 multiple interactions
increases activity
increases phosphorylation
decreases expression
affects localization
increases expression
affects binding 		ISO
EXP 		acephate inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; acephate inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; alachlor inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; alachlor inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; Aldosterone binds to and results in increased activity of NR3C2 protein; Aldosterone inhibits the reaction [TSG101 protein binds to NR3C2 protein]; Aldosterone results in decreased expression of and affects the ubiquitination of NR3C2 protein; Atrazine metabolite inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; Atrazine metabolite inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; bifenthrin inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; bifenthrin inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; bisphenol A inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; bisphenol AF inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; bisphenol B inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; cypermethrin inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; cypermethrin inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; DDT inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; DDT inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; Dihydrotestosterone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; Dimethoate inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; Dimethoate inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; fenvalerate inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; fipronil inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; Methoxychlor inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; Methoxychlor inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; Metribolone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; o,p'-DDT inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; o,p'-DDT inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; Permethrin inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; Permethrin inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; Pesticides inhibits the reaction [Aldosterone results in increased expression of NR3C2 mRNA]; Soil Pollutants inhibits the reaction [Aldosterone results in increased expression of NR3C2 mRNA]; Spironolactone inhibits the reaction [Aldosterone affects the ubiquitination of NR3C2 protein]; Spironolactone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; terbutylazine inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; terbutylazine inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; Testosterone inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]; Zineb inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; Zineb inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein]
Aldosterone results in increased phosphorylation of NR3C2 protein
Aldosterone results in decreased expression of NR3C2 protein
Aldosterone inhibits the reaction [TSG101 protein binds to NR3C2 protein]; FR 180204 inhibits the reaction [Aldosterone results in increased phosphorylation of NR3C2 protein]
Aldosterone results in increased expression of NR3C2 mRNA; Aldosterone results in increased expression of NR3C2 protein
Aldosterone binds to NR3C2 protein
Aldosterone results in decreased expression of NR3C2 mRNA
Aldosterone promotes the reaction [NR3C2 protein binds to CREBBP protein]; Aldosterone results in increased expression of and results in increased localization of NR3C2 protein; NR3C2 protein promotes the reaction [Aldosterone results in increased expression of GAS6 protein]; torsemide inhibits the reaction [Aldosterone binds to NR3C2 protein] 		CTD PMID:7954537 PMID:8798622 PMID:8969928 PMID:15362971 PMID:15780662 More... NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Olr1 oxidized low density lipoprotein receptor 1 multiple interactions
increases expression 		ISO Spironolactone inhibits the reaction [Aldosterone results in increased expression of OLR1 mRNA]; Spironolactone inhibits the reaction [Aldosterone results in increased expression of OLR1 protein]
Aldosterone results in increased expression of OLR1 mRNA; Aldosterone results in increased expression of OLR1 protein 		CTD PMID:20508287 NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:164,612,463...164,634,598 		JBrowse link
G Plat plasminogen activator, tissue type multiple interactions EXP [Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of PLAT mRNA CTD PMID:27773435 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Plg plasminogen multiple interactions EXP [Aldosterone co-treated with Sodium Chloride, Dietary] results in increased activity of PLG protein modified form CTD PMID:27773435 NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320 		JBrowse link
G Pomc proopiomelanocortin multiple interactions
increases secretion
increases abundance
decreases abundance 		ISO
EXP 		Dexamethasone inhibits the reaction [POMC protein results in increased abundance of Aldosterone]
POMC results in increased secretion of Aldosterone
POMC protein results in decreased abundance of Aldosterone 		CTD PMID:1659878 PMID:2551692 PMID:3015796 NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma affects abundance ISO PPARG protein affects the abundance of Aldosterone CTD PMID:16007095 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha increases expression EXP Aldosterone results in increased expression of PPARGC1A mRNA CTD PMID:19808358 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit increases activity
multiple interactions 		EXP Aldosterone results in increased activity of RELA protein
Bezafibrate inhibits the reaction [Aldosterone results in increased activity of RELA protein]; pioglitazone inhibits the reaction [Aldosterone results in increased activity of RELA protein]; prolinedithiocarbamate inhibits the reaction [Aldosterone results in increased activity of RELA protein]; SN50 peptide inhibits the reaction [Aldosterone results in increased activity of RELA protein] 		CTD PMID:18660453 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Ren renin multiple interactions ISO [AGT co-treated with REN] results in increased abundance of Aldosterone; candesartan inhibits the reaction [[AGT co-treated with REN] results in increased abundance of Aldosterone]; Enalapril inhibits the reaction [[AGT co-treated with REN] results in increased abundance of Aldosterone] CTD PMID:18679781 NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543 		JBrowse link
G Scnn1a sodium channel epithelial 1 subunit alpha increases expression
affects expression
multiple interactions 		ISO Aldosterone results in increased expression of SCNN1A mRNA; Aldosterone results in increased expression of SCNN1A protein
Aldosterone affects the expression of SCNN1A mRNA
Aldosterone inhibits the reaction [NEDD4L gene mutant form results in decreased cleavage of SCNN1A protein] 		CTD PMID:16555725 PMID:18665318 PMID:23348737 NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:159,809,170...159,832,405 		JBrowse link
G Scnn1b sodium channel epithelial 1 subunit beta increases expression ISO Aldosterone results in increased expression of SCNN1B mRNA; Aldosterone results in increased expression of SCNN1B protein CTD PMID:18665318 NCBI chr 1:185,861,326...185,915,717
Ensembl chr 1:185,854,733...185,916,049 		JBrowse link
G Scnn1g sodium channel epithelial 1 subunit gamma increases expression ISO Aldosterone results in increased expression of SCNN1G mRNA; Aldosterone results in increased expression of SCNN1G protein CTD PMID:18665318 NCBI chr 1:185,736,225...185,770,099
Ensembl chr 1:185,736,191...185,770,097 		JBrowse link
G Serpine1 serpin family E member 1 multiple interactions
increases expression 		EXP
ISO 		[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA; [Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein; [Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of SERPINE1 mRNA; [Eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; [Eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein]; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein]; Eplerenone inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 mRNA]; Eplerenone inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased expression of SERPINE1 protein]
Aldosterone results in increased expression of SERPINE1 mRNA 		CTD PMID:18682491 PMID:27773435 PMID:30809271 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 multiple interactions
decreases expression
increases expression 		EXP
ISO 		Spironolactone inhibits the reaction [Aldosterone results in increased expression of SGK1 mRNA]
Aldosterone results in decreased expression of SGK1 protein
TSG101 mutant form inhibits the reaction [Aldosterone results in decreased expression of SGK1 protein] 		CTD PMID:15130897 PMID:19429930 PMID:22798426 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
G Slc12a2 solute carrier family 12 member 2 multiple interactions EXP Spironolactone inhibits the reaction [Aldosterone results in increased activity of SLC12A2 protein] CTD PMID:12668585 NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470 		JBrowse link
G Slc30a1 solute carrier family 30 member 1 multiple interactions
increases expression 		EXP Spironolactone inhibits the reaction [Aldosterone results in increased expression of SLC30A1 mRNA] CTD PMID:19333130 NCBI chr13:106,022,019...106,025,892
Ensembl chr13:106,022,019...106,025,892 		JBrowse link
G Slc39a1 solute carrier family 39 member 1 multiple interactions
increases expression 		EXP Spironolactone inhibits the reaction [Aldosterone results in increased expression of SLC39A1 mRNA] CTD PMID:19333130 NCBI chr 2:178,001,052...178,006,689
Ensembl chr 2:178,001,119...178,006,689 		JBrowse link
G Slc9a1 solute carrier family 9 member A1 increases expression
multiple interactions 		EXP Aldosterone results in increased expression of SLC9A1 mRNA
eplerenone inhibits the reaction [Aldosterone results in increased expression of SLC9A1 mRNA] 		CTD PMID:16373419 NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:150,860,228...150,913,517 		JBrowse link
G Slc9a3 solute carrier family 9 member A3 multiple interactions
increases abundance 		ISO AGT protein affects the reaction [SLC9A3 gene mutant form results in increased abundance of Aldosterone] CTD PMID:26564064 NCBI chr 1:30,953,215...30,996,209
Ensembl chr 1:30,953,216...30,996,002 		JBrowse link
G Snai1 snail family transcriptional repressor 1 multiple interactions
increases expression 		ISO Acetylcysteine inhibits the reaction [Aldosterone results in increased expression of SNAI1 mRNA]; eplerenone inhibits the reaction [Aldosterone results in increased expression of SNAI1 mRNA]; Rotenone inhibits the reaction [Aldosterone results in increased expression of SNAI1 mRNA]; U 0126 inhibits the reaction [Aldosterone results in increased expression of SNAI1 mRNA] CTD PMID:17596522 NCBI chr 3:176,667,476...176,671,965 JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions
increases activity 		EXP [Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in decreased activity of SOD1 protein; [Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in increased activity of SOD1 protein; Amlodipine inhibits the reaction [Aldosterone results in increased activity of SOD1 protein]; Spironolactone inhibits the reaction [[Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in decreased activity of SOD1 protein]; Spironolactone inhibits the reaction [[Aldosterone co-treated with Sodium Chloride co-treated with Potassium Chloride] results in increased activity of SOD1 protein]; Spironolactone inhibits the reaction [Aldosterone results in increased activity of SOD1 protein] CTD PMID:17616752 PMID:19333130 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Tat tyrosine aminotransferase multiple interactions EXP Aldosterone promotes the reaction [[NR3C1 protein binds to TAT promoter] which results in increased expression of TAT mRNA] CTD PMID:22465009 NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases secretion
multiple interactions
increases expression 		EXP Aldosterone results in increased secretion of TGFB1 protein
[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein; [Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of TGFB1 mRNA; [Eplerenone co-treated with Enalapril] inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; [Eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]; Enalapril inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; Eplerenone inhibits the reaction [[Aldosterone co-treated with Glucose] results in increased secretion of TGFB1 protein]; Eplerenone inhibits the reaction [[Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of TGFB1 mRNA]; Eplerenone inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of TGFB1 mRNA]]; Spironolactone inhibits the reaction [Aldosterone results in increased expression of TGFB1 mRNA]; Spironolactone inhibits the reaction [Aldosterone results in increased secretion of TGFB1 protein]; tempol inhibits the reaction [Aldosterone results in increased expression of TGFB1 mRNA] 		CTD PMID:15130897 PMID:18682491 PMID:25204689 PMID:27773435 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP [Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of TNF mRNA; Eplerenone inhibits the reaction [[Aldosterone co-treated with Sodium Chloride, Dietary] results in increased expression of TNF mRNA] CTD PMID:27773435 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Trpm4 transient receptor potential cation channel, subfamily M, member 4 increases expression ISO Aldosterone results in increased expression of TRPM4 protein CTD PMID:28214884 NCBI chr 1:104,918,462...104,949,453
Ensembl chr 1:104,918,462...104,948,653 		JBrowse link
G Tsg101 tumor susceptibility 101 multiple interactions ISO Aldosterone inhibits the reaction [TSG101 protein binds to NR3C2 protein]; TSG101 mutant form inhibits the reaction [Aldosterone results in decreased expression of SGK1 protein] CTD PMID:22798426 NCBI chr 1:106,549,035...106,578,859
Ensembl chr 1:106,535,021...106,578,775 		JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 multiple interactions
increases glucuronidation 		ISO alclofenac inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Anti-Inflammatory Agents, Non-Steroidal inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; cicloprofen inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Diclofenac inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Diflunisal inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Fenoprofen inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Ibuprofen inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Indomethacin inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Ketoprofen inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Ketorolac inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Meclofenamic Acid inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Mefenamic Acid inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; Naproxen inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; pirprofen inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone]; tiaprofenic acid inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Aldosterone] CTD PMID:19740398 NCBI chr14:21,251,535...21,274,451
Ensembl chr14:21,251,535...21,274,451 		JBrowse link
Alphaxolone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gabra1 gamma-aminobutyric acid type A receptor subunit alpha 1 multiple interactions EXP alphaxalone promotes the reaction [Flunitrazepam binds to GABRA1 protein]; alphaxalone promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; alphaxalone results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] CTD PMID:8397295 PMID:12939268 NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442 		JBrowse link
G Gabra2 gamma-aminobutyric acid type A receptor subunit alpha 2 multiple interactions EXP alphaxalone promotes the reaction [Flunitrazepam binds to GABRA2 protein] CTD PMID:8397295 NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,450,683...37,587,457 		JBrowse link
G Gabrb2 gamma-aminobutyric acid type A receptor subunit beta 2 multiple interactions
affects response to substance 		EXP alphaxalone promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; alphaxalone promotes the reaction [Muscimol binds to GABRB2 protein]; alphaxalone results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]
GABRB2 protein affects the susceptibility to alphaxalone 		CTD PMID:8397295 PMID:12939268 NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171 		JBrowse link
G Gabrb3 gamma-aminobutyric acid type A receptor subunit beta 3 multiple interactions EXP alphaxalone promotes the reaction [Muscimol binds to GABRB3 protein] CTD PMID:8397295 NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:117,431,842...117,836,725 		JBrowse link
G Gabrg2 gamma-aminobutyric acid type A receptor subunit gamma 2 multiple interactions EXP alphaxalone promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; alphaxalone results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] CTD PMID:12939268 NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523 		JBrowse link
beclomethasone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
increases expression
increases secretion 		ISO Beclomethasone inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin]; Beclomethasone inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Elacridar inhibits the reaction [ABCB1 protein results in increased secretion of Beclomethasone]; valspodar inhibits the reaction [ABCB1 protein results in increased secretion of Beclomethasone]
Beclomethasone results in increased expression of ABCB1 mRNA; Beclomethasone results in increased expression of ABCB1 protein 		CTD PMID:15370884 PMID:16442095 PMID:22464980 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 increases expression ISO Beclomethasone results in increased expression of ABCB4 mRNA CTD PMID:15370884 NCBI chr 4:26,106,895...26,164,440 JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 increases expression ISO Beclomethasone results in increased expression of ABCC1 mRNA CTD PMID:15370884 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 multiple interactions
increases activity 		ISO Beclomethasone inhibits the reaction [ABCG2 protein affects the transport of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]; Beclomethasone inhibits the reaction [ABCG2 protein results in increased export of Mitoxantrone]
Beclomethasone results in increased activity of ABCG2 protein 		CTD PMID:15365089 PMID:16442095 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Acp5 acid phosphatase 5, tartrate resistant decreases activity ISO Beclomethasone results in decreased activity of ACP5 protein CTD PMID:8429434 NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929 		JBrowse link
G Adrb2 adrenoceptor beta 2 increases expression ISO Beclomethasone results in increased expression of ADRB2 mRNA CTD PMID:9032216 PMID:15679717 NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803 		JBrowse link
G Bdkrb1 bradykinin receptor B1 decreases expression ISO Beclomethasone results in decreased expression of BDKRB1 mRNA CTD PMID:18039523 NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein decreases expression ISO Beclomethasone results in decreased expression of BGLAP protein CTD PMID:7746775 PMID:9232087 PMID:9544892 NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Casp9 caspase 9 increases activity ISO Beclomethasone results in increased activity of CASP9 protein CTD PMID:11734450 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase increases expression ISO Beclomethasone results in increased expression of CAT protein CTD PMID:10445599 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccl11 C-C motif chemokine ligand 11 multiple interactions ISO Beclomethasone inhibits the reaction [IL13 protein results in increased expression of CCL11 protein] CTD PMID:17988555 NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO Beclomethasone results in decreased expression of CCL2 protein CTD PMID:20116850 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO Beclomethasone results in increased expression of CCL3 protein CTD PMID:20116850 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression ISO Beclomethasone results in increased expression of CCL4 protein CTD PMID:20116850 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions
decreases expression 		ISO [Beclomethasone co-treated with Albuterol] results in decreased secretion of CCL5 protein; [Beclomethasone co-treated with Formoterol Fumarate] results in decreased secretion of CCL5 protein; Beclomethasone inhibits the reaction [TNF protein results in increased secretion of CCL5 protein]
Beclomethasone results in decreased expression of CCL5 mRNA; Beclomethasone results in decreased expression of CCL5 protein 		CTD PMID:8534483 PMID:10903220 PMID:14643170 PMID:15679717 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Cd44 CD44 molecule multiple interactions ISO Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Albuterol promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]; Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]] CTD PMID:18076728 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions
decreases secretion
increases activity 		ISO [Beclomethasone co-treated with Albuterol] results in decreased secretion of CSF2 protein; [Beclomethasone co-treated with Formoterol Fumarate] results in decreased secretion of CSF2 protein; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CSF2 mRNA]; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of CSF2 protein]; Beclomethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]
Beclomethasone results in decreased secretion of CSF2 protein
Beclomethasone results in increased activity of CSF2 protein 		CTD PMID:7545059 PMID:10460758 PMID:10868704 PMID:11167953 PMID:11730731 More... NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 decreases secretion ISO Beclomethasone results in decreased secretion of CXCL10 protein CTD PMID:17996064 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 decreases expression ISO Beclomethasone results in decreased expression of CYP2S1 mRNA CTD PMID:22155357 NCBI chr 1:90,437,741...90,453,073
Ensembl chr 1:90,438,224...90,453,073 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions
increases expression 		ISO 1-aminobenzotriazole inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Ketoconazole inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Mifepristone inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Paraoxon inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA]; Physostigmine inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA] CTD PMID:12538830 PMID:23512537 PMID:24555085 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Epx eosinophil peroxidase multiple interactions EXP Beclomethasone inhibits the reaction [sephadex results in increased expression of EPX protein] CTD PMID:10850854 NCBI chr10:73,164,096...73,175,180
Ensembl chr10:73,164,096...73,175,180 		JBrowse link
G Fcer1g Fc epsilon receptor Ig decreases expression EXP Beclomethasone results in decreased expression of FCER1G protein CTD PMID:1834581 NCBI chr13:86,181,908...86,186,766
Ensembl chr13:86,181,908...86,186,859 		JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions
decreases activity 		ISO [Beclomethasone co-treated with Albuterol] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein]; [Beclomethasone co-treated with Formoterol Fumarate] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein]; Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]]; Albuterol promotes the reaction [Beclomethasone results in decreased activity of FGF2 protein]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of CD44 protein]]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]]; Formoterol Fumarate promotes the reaction [Beclomethasone results in decreased activity of FGF2 protein] CTD PMID:18076728 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493 		JBrowse link
G Fn1 fibronectin 1 multiple interactions ISO [Beclomethasone co-treated with Albuterol] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein]; [Beclomethasone co-treated with Formoterol Fumarate] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein] CTD PMID:18076728 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit decreases expression ISO Beclomethasone results in decreased expression of FOS protein CTD PMID:9797757 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Ggt5 gamma-glutamyltransferase 5 increases activity
increases expression
multiple interactions 		ISO Beclomethasone results in increased activity of GGT5 protein
Beclomethasone results in increased expression of GGT5 mRNA
[Beclomethasone results in increased activity of GGT5 protein] which results in increased metabolism of Leukotriene C4 		CTD PMID:11447392 NCBI chr20:13,042,694...13,070,960
Ensembl chr20:13,042,696...13,070,892 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 increases metabolic processing ISO HSD11B2 protein results in increased metabolism of Beclomethasone CTD PMID:16549198 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO Beclomethasone inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] CTD PMID:9150321 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Il10 interleukin 10 decreases secretion ISO Beclomethasone results in decreased secretion of IL10 protein CTD PMID:9819297 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il13 interleukin 13 multiple interactions
increases activity 		ISO Beclomethasone inhibits the reaction [IL13 protein results in increased expression of CCL11 protein]; Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 mRNA]; Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 protein]
Beclomethasone results in increased activity of IL13 protein 		CTD PMID:17988555 NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483 		JBrowse link
G Il1b interleukin 1 beta multiple interactions
decreases secretion
decreases expression 		ISO Beclomethasone inhibits the reaction [IL1B protein results in increased expression of SELE mRNA]; Beclomethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]
Beclomethasone results in decreased secretion of IL1B protein
Beclomethasone results in decreased expression of IL1B protein 		CTD PMID:7545059 PMID:9176529 PMID:9371735 PMID:10460758 PMID:15337628 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1rn interleukin 1 receptor antagonist decreases expression ISO Beclomethasone results in decreased expression of IL1RN protein CTD PMID:11015126 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732 		JBrowse link
G Il2ra interleukin 2 receptor subunit alpha decreases expression ISO Beclomethasone results in decreased expression of IL2RA protein CTD PMID:8111605 PMID:9314351 NCBI chr17:71,759,802...71,808,475
Ensembl chr17:71,759,802...71,808,507 		JBrowse link
G Il3 interleukin 3 multiple interactions ISO Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IL3 mRNA]; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of IL3 protein] CTD PMID:11167953 NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,906,460...38,908,810 		JBrowse link
G Il4 interleukin 4 multiple interactions
decreases expression 		ISO Albuterol promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]]; Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [IL4 protein results in decreased expression of CD44 protein]]
Beclomethasone results in decreased expression of IL4 protein 		CTD PMID:7988651 PMID:18076728 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il5 interleukin 5 multiple interactions
decreases expression 		ISO Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IL5 mRNA]; Beclomethasone inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of IL5 protein]
Beclomethasone results in decreased expression of IL5 protein 		CTD PMID:7988651 PMID:10813552 PMID:11167953 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 mRNA]; Beclomethasone inhibits the reaction [IL13 protein results in increased expression of IL6 protein] CTD PMID:17988555 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Klk1c10 kallikrein 1-related peptidase C10 increases expression ISO Beclomethasone results in increased expression of KLK3 mRNA CTD PMID:9815800 NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586 		JBrowse link
G Ltf lactotransferrin multiple interactions
decreases secretion 		ISO Beclomethasone inhibits the reaction [methylcholine results in increased secretion of LTF protein]
Beclomethasone results in decreased secretion of LTF protein 		CTD PMID:11112886 NCBI chr 8:119,878,344...119,901,189
Ensembl chr 8:119,878,344...119,901,189 		JBrowse link
G Mefv MEFV innate immunity regulator, pyrin increases response to substance ISO MEFV mutant form results in increased susceptibility to Beclomethasone CTD PMID:20828792 NCBI chr10:12,288,514...12,303,337
Ensembl chr10:12,293,782...12,303,333 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions ISO Beclomethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein] CTD PMID:10455257 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
decreases expression 		ISO Beclomethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]
Beclomethasone results in decreased expression of MMP9 protein 		CTD PMID:10452757 PMID:10455257 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Nos2 nitric oxide synthase 2 decreases expression ISO Beclomethasone results in decreased expression of NOS2 protein CTD PMID:12668791 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity ISO Beclomethasone results in increased activity of NR1I2 protein CTD PMID:21068194 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 affects localization
increases expression
affects binding
multiple interactions
increases activity 		ISO
EXP 		Beclomethasone affects the localization of NR3C1 protein
Beclomethasone results in increased expression of NR3C1 mRNA
Beclomethasone binds to NR3C1 protein
[Beclomethasone co-treated with Albuterol] affects the localization of NR3C1 protein; [Beclomethasone co-treated with Formoterol Fumarate] affects the localization of NR3C1 protein; Beclomethasone affects the localization of and results in increased activity of NR3C1 protein; Beclomethasone binds to and results in increased activity of NR3C1 protein
Beclomethasone results in increased activity of NR3C1 protein 		CTD PMID:16814 PMID:2207292 PMID:15362971 PMID:15679717 PMID:15860753 More... NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 increases activity ISO Beclomethasone results in increased activity of NR3C2 protein CTD PMID:15362971 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Pla1a phospholipase A1 member A multiple interactions ISO Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA1A mRNA] CTD PMID:20573295 NCBI chr11:75,825,626...75,863,296
Ensembl chr11:75,825,585...75,878,165 		JBrowse link
G Pla2g4a phospholipase A2 group 4A decreases activity
multiple interactions 		ISO Beclomethasone results in decreased activity of PLA2G4A protein
Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PLA2G4A mRNA] 		CTD PMID:15337628 PMID:20573295 NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641 		JBrowse link
G Ppp1r14a protein phosphatase 1, regulatory (inhibitor) subunit 14A multiple interactions EXP Beclomethasone inhibits the reaction [Acetylcholine results in increased phosphorylation of PPP1R14A protein] CTD PMID:18577381 NCBI chr 1:93,708,269...93,718,218
Ensembl chr 1:93,708,218...93,719,147 		JBrowse link
G Rhoa ras homolog family member A multiple interactions EXP Beclomethasone inhibits the reaction [[[Antigens, Bacterial co-treated with Allergens] results in increased expression of and results in increased activity of RHOA protein] which results in increased susceptibility to Acetylcholine]; Beclomethasone inhibits the reaction [[Antigens, Bacterial co-treated with Allergens] results in increased expression of and results in increased activity of RHOA protein]; Beclomethasone inhibits the reaction [[Antigens, Bacterial co-treated with Allergens] results in increased expression of RHOA mRNA] CTD PMID:18391481 NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302 		JBrowse link
G Rnase2 ribonuclease A family member 2 decreases expression ISO Beclomethasone results in decreased expression of RNASE2 protein CTD PMID:12166584 NCBI chr15:26,923,125...26,923,934
Ensembl chr15:26,923,134...26,923,955 		JBrowse link
G Rnase3 ribonuclease A family member 3 multiple interactions
decreases expression 		ISO [Salmeterol Xinafoate co-treated with Beclomethasone] affects the reaction [Allergens results in increased expression of RNASE3 protein]; Beclomethasone affects the reaction [Allergens results in increased expression of RNASE3 protein]
Beclomethasone results in decreased expression of RNASE3 protein 		CTD PMID:1443864 PMID:10513351 PMID:10573242 PMID:12166584 PMID:12587966 More... NCBI chr15:26,985,399...26,986,269
Ensembl chr15:26,985,271...26,986,400 		JBrowse link
G Sele selectin E multiple interactions ISO Beclomethasone inhibits the reaction [IL1B protein results in increased expression of SELE mRNA] CTD PMID:9371735 NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Beclomethasone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Thy1 Thy-1 cell surface antigen multiple interactions ISO Albuterol promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]]; Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]; Formoterol Fumarate promotes the reaction [Beclomethasone inhibits the reaction [FGF2 protein results in decreased expression of THY1 protein]] CTD PMID:18076728 NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:53,286,148...53,291,540 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression ISO Beclomethasone results in increased expression of TIMP1 protein CTD PMID:10452757 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
decreases secretion 		ISO Beclomethasone inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Beclomethasone inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Beclomethasone inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Beclomethasone inhibits the reaction [TNF protein results in increased secretion of CCL5 protein]; Beclomethasone inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein]
Beclomethasone results in decreased secretion of TNF protein 		CTD PMID:8937731 PMID:9150321 PMID:9819297 PMID:10100995 PMID:10903220 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO Beclomethasone inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] CTD PMID:10100995 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO Beclomethasone results in decreased expression of VEGFA protein CTD PMID:20116850 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
betamethasone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aqp4 aquaporin 4 increases expression EXP Betamethasone results in increased expression of AQP4 mRNA CTD PMID:9409467 NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098 		JBrowse link
G Ar androgen receptor multiple interactions ISO Betamethasone binds to and results in increased activity of AR protein CTD PMID:25752796 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression ISO Betamethasone results in decreased expression of CCL2 protein CTD PMID:20116850 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO Betamethasone results in increased expression of CCL3 protein CTD PMID:20116850 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression ISO Betamethasone results in increased expression of CCL4 protein CTD PMID:20116850 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Egr1 early growth response 1 affects expression ISO Betamethasone affects the expression of EGR1 mRNA CTD PMID:23461915 NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Fshb follicle stimulating hormone subunit beta decreases expression EXP Betamethasone results in decreased expression of FSHB protein CTD PMID:27132128 NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072 		JBrowse link
G Fxn frataxin increases expression ISO Betamethasone results in increased expression of FXN mRNA CTD PMID:23418481 NCBI chr 1:231,300,457...231,323,989
Ensembl chr 1:231,300,150...231,323,989 		JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase multiple interactions ISO Betamethasone results in increased expression of and results in increased activity of HPGD protein CTD PMID:15680906 NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions
increases metabolic processing 		EXP
ISO 		Betamethasone inhibits the reaction [HSD11B2 protein affects the metabolism of Corticosterone]
HSD11B2 protein results in increased metabolism of Betamethasone 		CTD PMID:16549198 PMID:19490994 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Hsd17b4 hydroxysteroid (17-beta) dehydrogenase 4 increases expression ISO Betamethasone results in increased expression of HSD17B4 mRNA CTD PMID:29901742 NCBI chr18:45,515,427...45,604,467
Ensembl chr18:45,515,373...45,604,467 		JBrowse link
G Lhb luteinizing hormone subunit beta increases expression EXP Betamethasone results in increased expression of LHB protein CTD PMID:27132128 NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions
increases activity
affects binding 		ISO NR3C1 protein alternative form inhibits the reaction [Betamethasone results in increased activity of NR3C1 protein alternative form]
Betamethasone binds to NR3C1 protein 		CTD PMID:15362971 PMID:15755863 PMID:16507850 PMID:21543282 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 increases activity ISO Betamethasone results in increased activity of NR3C2 protein CTD PMID:15362971 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO Betamethasone results in decreased expression of VEGFA protein CTD PMID:20116850 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
budesonide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions
decreases activity 		ISO Budesonide inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
Budesonide results in decreased activity of ABCB11 protein 		CTD PMID:24014644 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A increases expression ISO Budesonide results in increased expression of ABCB1 protein CTD PMID:22464980 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Adrb2 adrenoceptor beta 2 increases expression ISO Budesonide results in increased expression of ADRB2 protein CTD PMID:20061444 NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803 		JBrowse link
G Ar androgen receptor multiple interactions ISO Budesonide binds to and results in decreased activity of AR protein; Budesonide inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:18324785 PMID:25752796 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO Budesonide results in decreased expression of BCL2 protein CTD PMID:15475437 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein decreases expression ISO Budesonide results in decreased expression of BGLAP protein CTD PMID:9232087 NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO Budesonide results in decreased expression of BIRC5 mRNA CTD PMID:17163412 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Casp3 caspase 3 decreases expression ISO Budesonide results in decreased expression of CASP3 mRNA CTD PMID:17163412 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp9 caspase 9 increases activity ISO Budesonide results in increased activity of CASP9 protein CTD PMID:11734450 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Ccl11 C-C motif chemokine ligand 11 multiple interactions ISO Budesonide inhibits the reaction [IL13 protein results in increased expression of CCL11 protein] CTD PMID:17988555 NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575 		JBrowse link
G Ccl17 C-C motif chemokine ligand 17 decreases expression ISO Budesonide results in decreased expression of CCL17 protein CTD PMID:15679716 NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,208,120...10,209,895 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression
multiple interactions 		ISO
EXP 		Budesonide results in decreased expression of CCL2 protein
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein] 		CTD PMID:15734790 PMID:20116850 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO Budesonide results in increased expression of CCL3 protein CTD PMID:20116850 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression ISO Budesonide results in increased expression of CCL4 protein CTD PMID:20116850 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions ISO Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 mRNA]; Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] CTD PMID:10903220 PMID:14643170 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccnb2 cyclin B2 decreases expression ISO Budesonide results in decreased expression of CCNB2 mRNA CTD PMID:17163412 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682 		JBrowse link
G Ccne1 cyclin E1 decreases expression ISO Budesonide results in decreased expression of CCNE1 mRNA CTD PMID:17163412 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions
increases expression 		ISO Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1A protein]
Budesonide results in increased expression of CDKN1A mRNA 		CTD PMID:12117777 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions ISO Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1B protein] CTD PMID:12117777 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Crebbp CREB binding protein increases expression ISO Budesonide results in increased expression of CREBBP protein CTD PMID:39714734 NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266 		JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions
increases activity
decreases secretion 		ISO Budesonide inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]
Budesonide results in increased activity of CSF2 protein
Budesonide results in decreased secretion of CSF2 protein 		CTD PMID:7621058 PMID:10460758 PMID:10868704 PMID:11730731 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Csnk2a1 casein kinase 2 alpha 1 increases expression ISO Budesonide results in increased expression of CSNK2A1 mRNA CTD PMID:39714734 NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:161,170,405...161,215,698 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL1 mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL1 protein] CTD PMID:15734790 NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL2 mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL2 protein] CTD PMID:15734790 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL3 mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL3 protein] CTD PMID:15734790 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases expression
increases expression
multiple interactions 		EXP
ISO 		Budesonide results in decreased expression of CYP3A2 mRNA
Budesonide results in increased expression of CYP3A4 mRNA
[Budesonide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA 		CTD PMID:19562681 PMID:20888898 PMID:25455453 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases expression
multiple interactions 		EXP
ISO 		Budesonide results in increased expression of CYP3A9 mRNA
Ketoconazole inhibits the reaction [Budesonide results in increased expression of CYP3A5 mRNA]; Mifepristone inhibits the reaction [Budesonide results in increased expression of CYP3A5 mRNA] 		CTD PMID:12538830 PMID:19562681 PMID:20888898 PMID:24555085 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Epx eosinophil peroxidase multiple interactions EXP Budesonide inhibits the reaction [sephadex results in increased expression of EPX protein] CTD PMID:10850854 NCBI chr10:73,164,096...73,175,180
Ensembl chr10:73,164,096...73,175,180 		JBrowse link
G Gcg glucagon decreases expression
multiple interactions 		EXP Budesonide results in decreased expression of GCG mRNA
[Fatty Acids co-treated with Budesonide] results in increased expression of GCG mRNA 		CTD PMID:12524409 PMID:14705828 NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:67,522,489...67,531,533 		JBrowse link
G Ifng interferon gamma decreases secretion
multiple interactions 		ISO
EXP 		Budesonide results in decreased secretion of IFNG protein
Budesonide inhibits the reaction [Tobacco Smoke Pollution results in decreased secretion of IFNG protein]
[zafirlukast co-treated with Prednisone co-treated with Budesonide] inhibits the reaction [Antigens results in increased secretion of IFNG protein] 		CTD PMID:7621058 PMID:15569474 PMID:16160912 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Igf2 insulin-like growth factor 2 multiple interactions ISO Budesonide inhibits the reaction [vinyl carbamate results in decreased methylation of IGF2 protein] CTD PMID:15824018 NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667 		JBrowse link
G Il13 interleukin 13 multiple interactions
increases activity 		ISO Budesonide inhibits the reaction [IL13 protein results in increased expression of CCL11 protein]; Budesonide inhibits the reaction [IL13 protein results in increased expression of IL6 mRNA]; Budesonide inhibits the reaction [IL13 protein results in increased expression of IL6 protein]
Budesonide results in increased activity of IL13 protein 		CTD PMID:17988555 NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483 		JBrowse link
G Il17a interleukin 17A multiple interactions ISO Budesonide inhibits the reaction [Ozone results in increased expression of IL17A protein]; Progesterone promotes the reaction [Budesonide inhibits the reaction [Ozone results in increased expression of IL17A protein]] CTD PMID:28279894 NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331 		JBrowse link
G Il1b interleukin 1 beta decreases secretion
multiple interactions 		ISO
EXP 		Budesonide results in decreased secretion of IL1B protein
Budesonide inhibits the reaction [IL1B protein results in increased acetylation of H4C16 protein]; Budesonide inhibits the reaction [IL1B protein results in increased expression of SELE mRNA]; Budesonide inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; Budesonide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Hydrogen Peroxide inhibits the reaction [Budesonide inhibits the reaction [IL1B protein results in increased acetylation of H4C16 protein]]; Theophylline inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Budesonide inhibits the reaction [IL1B protein results in increased acetylation of H4C16 protein]]]
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B protein]
Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Formoterol Fumarate]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Salmeterol Xinafoate]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Terbutaline]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of PTGS2 mRNA]; Budesonide inhibits the reaction [Ozone results in increased expression of IL1B protein] 		CTD PMID:7621058 PMID:9371735 PMID:10460758 PMID:15337628 PMID:15734790 More... NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il4 interleukin 4 decreases expression
multiple interactions 		ISO
EXP 		Budesonide results in decreased expression of IL4 protein
Budesonide inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of IL4 protein] 		CTD PMID:7988651 PMID:12406821 PMID:15086961 PMID:15569474 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il4r interleukin 4 receptor decreases expression ISO Budesonide results in decreased expression of IL4R protein CTD PMID:15679716 NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636 		JBrowse link
G Il5 interleukin 5 decreases expression ISO Budesonide results in decreased expression of IL5 protein CTD PMID:7988651 PMID:12406821 PMID:15086961 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO
EXP 		Budesonide inhibits the reaction [IL13 protein results in increased expression of IL6 mRNA]; Budesonide inhibits the reaction [IL13 protein results in increased expression of IL6 protein]
Budesonide inhibits the reaction [Ozone results in increased expression of IL6 protein]; Progesterone promotes the reaction [Budesonide inhibits the reaction [Ozone results in increased expression of IL6 protein]]
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein] 		CTD PMID:15734790 PMID:17988555 PMID:28279894 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Ins1 insulin 1 multiple interactions EXP Budesonide inhibits the reaction [Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Budesonide inhibits the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:25851902 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit decreases expression EXP Budesonide results in decreased expression of JUN mRNA CTD PMID:12524409 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Ltf lactotransferrin multiple interactions
decreases secretion 		ISO Budesonide inhibits the reaction [methylcholine results in increased secretion of LTF protein]
Budesonide results in decreased secretion of LTF protein 		CTD PMID:11112886 NCBI chr 8:119,878,344...119,901,189
Ensembl chr 8:119,878,344...119,901,189 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions ISO Budesonide inhibits the reaction [Ozone results in increased phosphorylation of MAPK14 protein] CTD PMID:28279894 NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294 		JBrowse link
G Mmp12 matrix metallopeptidase 12 multiple interactions EXP Budesonide inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of MMP12 protein] CTD PMID:15569474 NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:12,866,641...12,884,478 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP Budesonide inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 mRNA]; Budesonide promotes the reaction [Formoterol Fumarate inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]]; Formoterol Fumarate promotes the reaction [Budesonide inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]] CTD PMID:15734790 PMID:25313925 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mpo myeloperoxidase multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MPO protein] CTD PMID:15734790 NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056 		JBrowse link
G Mt2 metallothionein 2 increases expression
multiple interactions 		ISO Budesonide results in increased expression of MT2A mRNA
Terbutaline affects the reaction [Budesonide results in increased expression of MT2A mRNA] 		CTD PMID:9973176 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions ISO Budesonide inhibits the reaction [Benzo(a)pyrene results in increased expression of MYC mRNA] CTD PMID:15969944 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Nos2 nitric oxide synthase 2 decreases expression
multiple interactions 		ISO
EXP 		Budesonide results in decreased expression of NOS2 mRNA
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA] 		CTD PMID:15734790 PMID:17163412 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases expression
multiple interactions
increases activity 		EXP
ISO 		Budesonide results in increased expression of NR1I2 mRNA
[Budesonide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA 		CTD PMID:19562681 PMID:25455453 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions
affects binding
increases activity
decreases expression 		ISO
EXP 		2,2',3,5',6-pentachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,3',4,4',5-pentachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,4,2',4'-tetrachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,4,4'-trichlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,4,5,2',5'-pentachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,5,2',5'-tetrachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; Budesonide affects the reaction [Terbutaline results in increased expression of NR3C1 mRNA]
[Budesonide binds to NR3C1 protein] which results in increased expression of SLC51A mRNA; [Budesonide binds to NR3C1 protein] which results in increased expression of SLC51B mRNA
Budesonide results in decreased expression of NR3C1 mRNA 		CTD PMID:8977508 PMID:9973176 PMID:10335001 PMID:15362971 PMID:16507850 More... NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 increases activity ISO Budesonide results in increased activity of NR3C2 protein CTD PMID:15362971 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO Budesonide results in decreased expression of PCNA protein CTD PMID:12117777 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO Budesonide binds to and results in increased activity of PGR protein CTD PMID:25752796 NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271 		JBrowse link
G Pla2g4a phospholipase A2 group 4A decreases activity ISO Budesonide results in decreased activity of PLA2G4A protein CTD PMID:15337628 NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO [Budesonide co-treated with Glucose] binds to PPARA protein; Budesonide inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]] CTD PMID:18812576 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714 		JBrowse link
G Ppm1l protein phosphatase, Mg2+/Mn2+ dependent, 1L increases expression ISO Budesonide results in increased expression of PPM1L protein CTD PMID:39714734 NCBI chr 2:155,876,605...156,149,371
Ensembl chr 2:155,876,605...156,149,371 		JBrowse link
G Ptch2 patched 2 decreases expression ISO Budesonide results in decreased expression of PTCH2 mRNA CTD PMID:39714734 NCBI chr 5:135,808,856...135,829,087
Ensembl chr 5:135,808,895...135,828,986 		JBrowse link
G Ptges2 prostaglandin E synthase 2 multiple interactions EXP Budesonide promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGES2 protein] CTD PMID:15734790 NCBI chr 3:36,088,246...36,095,430
Ensembl chr 3:36,088,246...36,097,694 		JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 multiple interactions EXP Budesonide promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS1 mRNA] CTD PMID:15734790 NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO
EXP 		Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of PTGS2 mRNA]
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA] 		CTD PMID:15734790 PMID:20061444 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of RELA protein] CTD PMID:15734790 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Rnase3 ribonuclease A family member 3 decreases expression ISO Budesonide results in decreased expression of RNASE3 protein CTD PMID:15612964 NCBI chr15:26,985,399...26,986,269
Ensembl chr15:26,985,271...26,986,400 		JBrowse link
G Sele selectin E multiple interactions EXP
ISO 		Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of SELE mRNA]
Budesonide inhibits the reaction [IL1B protein results in increased expression of SELE mRNA] 		CTD PMID:9371735 PMID:15734790 NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903 		JBrowse link
G Sell selectin L multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of SELL mRNA] CTD PMID:15734790 NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600 		JBrowse link
G Selp selectin P multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of SELP mRNA] CTD PMID:15734790 NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Budesonide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Slc22a3 solute carrier family 22 member 3 multiple interactions ISO Budesonide inhibits the reaction [SLC22A3 protein results in increased uptake of Formoterol Fumarate]; SLC22A3 protein results in increased susceptibility to [Budesonide results in decreased transport of Formoterol Fumarate] CTD PMID:17920670 PMID:21914487 NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353 		JBrowse link
G Slc51a solute carrier family 51 member A increases expression
multiple interactions 		ISO
EXP 		Budesonide results in increased expression of SLC51A mRNA
[Budesonide binds to NR3C1 protein] which results in increased expression of SLC51A mRNA 		CTD PMID:19562681 NCBI chr11:81,804,141...81,818,539
Ensembl chr11:81,803,972...81,818,539 		JBrowse link
G Slc51b SLC51 subunit beta increases expression
multiple interactions 		ISO
EXP 		Budesonide results in increased expression of SLC51B mRNA
[Budesonide binds to NR3C1 protein] which results in increased expression of SLC51B mRNA 		CTD PMID:19562681 NCBI chr 8:74,827,047...74,835,109
Ensembl chr 8:74,827,047...74,835,109 		JBrowse link
G Slco1b2 solute carrier organic anion transporter family member 1B2 multiple interactions ISO Budesonide inhibits the reaction [SLCO1B3 protein results in increased uptake of Mesalamine]; Budesonide inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein] CTD PMID:21430235 NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:176,282,584...176,351,083 		JBrowse link
G Slco2b1 solute carrier organic anion transporter family, member 2b1 multiple interactions ISO Budesonide inhibits the reaction [SLCO2B1 protein results in increased uptake of Mesalamine]; Budesonide inhibits the reaction [SLCO2B1 protein results in increased uptake of Sulfobromophthalein] CTD PMID:21430235 NCBI chr 1:163,371,410...163,419,412
Ensembl chr 1:163,371,410...163,419,279 		JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression ISO Budesonide results in increased expression of SPP1 protein CTD PMID:21885873 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Star steroidogenic acute regulatory protein multiple interactions ISO Budesonide promotes the reaction [LG 100268 promotes the reaction [T0901317 results in increased expression of STAR mRNA]]; Budesonide promotes the reaction [LG 100268 promotes the reaction [T0901317 results in increased expression of STAR protein]]; Budesonide promotes the reaction [T0901317 promotes the reaction [LG 100268 results in increased expression of STAR protein]] CTD PMID:23362264 NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO Budesonide inhibits the reaction [Ozone results in increased expression of TGFB1 protein] CTD PMID:28279894 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Tgfbr2 transforming growth factor, beta receptor 2 increases expression ISO Budesonide results in increased expression of TGFBR2 protein CTD PMID:39714734 NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469 		JBrowse link
G Tgm2 transglutaminase 2 increases expression ISO Budesonide results in increased expression of TGM2 protein CTD PMID:21885873 NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TIMP1 mRNA] CTD PMID:15734790 NCBI chr  X:3,766,509...3,772,578
Ensembl chr  X:3,766,510...3,771,135 		JBrowse link
G Tnf tumor necrosis factor decreases expression
multiple interactions
decreases secretion 		ISO
EXP 		Budesonide results in decreased expression of TNF protein
Budesonide inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 mRNA]; Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein]; Budesonide inhibits the reaction [TNF protein results in increased secretion of CXCL8 mRNA]; Budesonide inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein]
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein]
Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Formoterol Fumarate]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Salmeterol Xinafoate]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Terbutaline]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of PTGS2 mRNA]; Budesonide inhibits the reaction [Ozone results in increased expression of TNF protein]
Budesonide results in decreased secretion of TNF protein 		CTD PMID:7621058 PMID:10100995 PMID:10903220 PMID:14643170 PMID:15589479 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tp53 tumor protein p53 decreases expression ISO Budesonide results in decreased expression of TP53 protein CTD PMID:15475437 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Ubc ubiquitin C decreases expression ISO Budesonide results in decreased expression of UBC mRNA CTD PMID:39714734 NCBI chr12:36,899,673...36,905,275
Ensembl chr12:36,900,127...36,905,275 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions EXP
ISO 		Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of VCAM1 mRNA]
Budesonide inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] 		CTD PMID:10100995 PMID:15734790 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression
multiple interactions 		ISO Budesonide results in decreased expression of VEGFA protein
Budesonide inhibits the reaction [Benzo(a)pyrene results in increased expression of VEGFA mRNA]; Budesonide inhibits the reaction [Benzo(a)pyrene results in increased expression of VEGFA protein] 		CTD PMID:15969944 PMID:20116850 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
Chlormadinone acetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ace2 angiotensin converting enzyme 2 decreases expression ISO Chlormadinone Acetate results in decreased expression of ACE2 mRNA CTD PMID:32808185 NCBI chr  X:33,925,458...33,972,851
Ensembl chr  X:33,925,458...33,971,596 		JBrowse link
G Ar androgen receptor decreases activity ISO Chlormadinone Acetate results in decreased activity of AR protein CTD PMID:15316697 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Chlormadinone Acetate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
clobetasol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aacs acetoacetyl-CoA synthetase increases expression ISO Clobetasol results in increased expression of AACS mRNA CTD PMID:27462272 NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543 		JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 increases expression ISO Clobetasol results in increased expression of ABCA1 mRNA CTD PMID:27462272 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473 		JBrowse link
G Abca2 ATP binding cassette subfamily A member 2 decreases expression ISO Clobetasol results in decreased expression of ABCA2 mRNA CTD PMID:27462272 NCBI chr 3:28,642,660...28,662,689
Ensembl chr 3:28,642,758...28,662,681 		JBrowse link
G Abcb6 ATP binding cassette subfamily B member 6 increases expression ISO Clobetasol results in increased expression of ABCB6 mRNA CTD PMID:27462272 NCBI chr 9:84,117,222...84,125,939
Ensembl chr 9:84,117,220...84,125,526 		JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 decreases expression ISO Clobetasol results in decreased expression of ABCC1 mRNA CTD PMID:16882163 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404 		JBrowse link
G Abcf1 ATP binding cassette subfamily F member 1 decreases expression ISO Clobetasol results in decreased expression of ABCF1 mRNA CTD PMID:27462272 NCBI chr20:2,807,315...2,820,240
Ensembl chr20:2,807,106...2,820,240 		JBrowse link
G Acaa1a acetyl-CoA acyltransferase 1A increases expression ISO Clobetasol results in increased expression of ACAA1A mRNA CTD PMID:27462272 NCBI chr 8:127,956,126...127,966,348
Ensembl chr 8:127,956,129...127,966,241 		JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 increases expression ISO Clobetasol results in increased expression of ACAA2 mRNA CTD PMID:27462272 NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha increases expression ISO Clobetasol results in increased expression of ACACA mRNA CTD PMID:27462272 NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888 		JBrowse link
G Acot11 acyl-CoA thioesterase 11 increases expression ISO Clobetasol results in increased expression of ACOT11 mRNA CTD PMID:27462272 NCBI chr 5:126,756,255...126,804,526
Ensembl chr 5:126,756,255...126,804,507 		JBrowse link
G Acsbg1 acyl-CoA synthetase bubblegum family member 1 increases expression ISO Clobetasol results in increased expression of ACSBG1 mRNA CTD PMID:27462272 NCBI chr 8:63,887,433...63,943,486
Ensembl chr 8:63,887,435...63,984,178 		JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 increases expression ISO Clobetasol results in increased expression of ACSS2 mRNA CTD PMID:27462272 NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830 		JBrowse link
G Acta2 actin alpha 2, smooth muscle increases expression ISO Clobetasol results in increased expression of ACTA2 mRNA CTD PMID:27462272 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Actb actin, beta increases expression ISO Clobetasol results in increased expression of ACTB mRNA CTD PMID:27462272 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Actg1 actin, gamma 1 increases expression ISO Clobetasol results in increased expression of ACTG1 mRNA CTD PMID:27462272 NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951 		JBrowse link
G Actr1b actin related protein 1B increases expression ISO Clobetasol results in increased expression of ACTR1B mRNA CTD PMID:27462272 NCBI chr 9:46,424,677...46,434,341
Ensembl chr 9:46,424,678...46,434,341 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression ISO Clobetasol results in increased expression of ADAMTS1 mRNA CTD PMID:27462272 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adprh ADP-ribosylarginine hydrolase increases expression ISO Clobetasol results in increased expression of ADPRH mRNA CTD PMID:27462272 NCBI chr11:75,805,347...75,811,686
Ensembl chr11:75,805,310...75,812,452 		JBrowse link
G Agpat1 1-acylglycerol-3-phosphate O-acyltransferase 1 increases expression ISO Clobetasol results in increased expression of AGPAT1 mRNA CTD PMID:27462272 NCBI chr20:4,140,565...4,149,531
Ensembl chr20:4,140,565...4,150,445 		JBrowse link
G Ahcyl1 adenosylhomocysteinase-like 1 increases expression ISO Clobetasol results in increased expression of AHCYL1 mRNA CTD PMID:27462272 NCBI chr 2:197,982,335...198,016,770
Ensembl chr 2:197,982,344...198,033,930 		JBrowse link
G Ahnak AHNAK nucleoprotein decreases expression ISO Clobetasol results in decreased expression of AHNAK mRNA CTD PMID:27462272 NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:215,321,931...215,400,675 		JBrowse link
G Ak3 adenylate kinase 3 increases expression ISO Clobetasol results in increased expression of AK3 mRNA CTD PMID:27462272 NCBI chr 1:236,151,012...236,178,689
Ensembl chr 1:236,151,012...236,178,183 		JBrowse link
G Ak5 adenylate kinase 5 decreases expression ISO Clobetasol results in decreased expression of AK5 mRNA CTD PMID:27462272 NCBI chr 2:244,057,240...244,241,372
Ensembl chr 2:244,057,240...244,241,366 		JBrowse link
G Akap13 A-kinase anchoring protein 13 decreases expression ISO Clobetasol results in decreased expression of AKAP13 mRNA CTD PMID:27462272 NCBI chr 1:138,722,445...139,029,401
Ensembl chr 1:138,724,150...139,029,401 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 increases expression ISO Clobetasol results in increased expression of AKR1B1 mRNA CTD PMID:27462272 NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule decreases expression ISO Clobetasol results in decreased expression of ALCAM mRNA CTD PMID:27462272 NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 increases expression ISO Clobetasol results in increased expression of ALDH1A1 mRNA CTD PMID:27462272 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 decreases expression ISO Clobetasol results in decreased expression of ALDH1L2 mRNA CTD PMID:27462272 NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398 		JBrowse link
G Alms1 ALMS1, centrosome and basal body associated protein decreases expression ISO Clobetasol results in decreased expression of ALMS1 mRNA CTD PMID:27462272 NCBI chr 4:119,683,085...119,783,471
Ensembl chr 4:119,683,076...119,783,471 		JBrowse link
G Amfr autocrine motility factor receptor increases expression ISO Clobetasol results in increased expression of AMFR mRNA CTD PMID:27462272 NCBI chr19:11,002,451...11,038,182
Ensembl chr19:11,002,101...11,038,364 		JBrowse link
G Ankhd1 ankyrin repeat and KH domain containing 1 decreases expression ISO Clobetasol results in decreased expression of ANKHD1 mRNA CTD PMID:27462272 NCBI chr18:28,436,296...28,534,954
Ensembl chr18:28,436,394...28,534,954 		JBrowse link
G Ankrd11 ankyrin repeat domain containing 11 decreases expression ISO Clobetasol results in decreased expression of ANKRD11 mRNA CTD PMID:27462272 NCBI chr19:67,848,836...68,007,491
Ensembl chr19:67,848,844...68,007,491 		JBrowse link
G Ankrd12 ankyrin repeat domain 12 decreases expression ISO Clobetasol results in decreased expression of ANKRD12 mRNA CTD PMID:27462272 NCBI chr 9:113,030,127...113,134,816
Ensembl chr 9:113,030,919...113,134,762 		JBrowse link
G Ankrd46 ankyrin repeat domain 46 increases expression ISO Clobetasol results in increased expression of ANKRD46 mRNA CTD PMID:27462272 NCBI chr 7:69,532,303...69,553,311
Ensembl chr 7:69,532,304...69,545,421 		JBrowse link
G Ankrd52 ankyrin repeat domain 52 decreases expression ISO Clobetasol results in decreased expression of ANKRD52 mRNA CTD PMID:27462272 NCBI chr 7:1,390,730...1,410,139
Ensembl chr 7:1,391,325...1,407,410 		JBrowse link
G Aox1 aldehyde oxidase 1 increases expression ISO Clobetasol results in increased expression of AOX1 mRNA CTD PMID:27462272 NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980 		JBrowse link
G Ap1m1 adaptor related protein complex 1 subunit mu 1 increases expression ISO Clobetasol results in increased expression of AP1M1 mRNA CTD PMID:27462272 NCBI chr16:17,620,910...17,636,431
Ensembl chr16:17,616,187...17,636,462 		JBrowse link
G Ap3d1 adaptor related protein complex 3 subunit delta 1 decreases expression ISO Clobetasol results in decreased expression of AP3D1 mRNA CTD PMID:27462272 NCBI chr 7:9,620,909...9,656,350
Ensembl chr 7:9,620,968...9,656,342 		JBrowse link
G Apc APC regulator of WNT signaling pathway decreases expression ISO Clobetasol results in decreased expression of APC mRNA CTD PMID:27462272 NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022 		JBrowse link
G Apc2 APC regulator of WNT signaling pathway 2 decreases expression ISO Clobetasol results in decreased expression of APC2 mRNA CTD PMID:27462272 NCBI chr 7:10,043,010...10,065,037
Ensembl chr 7:10,043,010...10,065,210 		JBrowse link
G Apcdd1 APC down-regulated 1 decreases expression ISO Clobetasol results in decreased expression of APCDD1 mRNA CTD PMID:27462272 NCBI chr18:58,655,696...58,686,359
Ensembl chr18:58,655,919...58,686,356 		JBrowse link
G Apln apelin decreases expression ISO Clobetasol results in decreased expression of APLN mRNA CTD PMID:27462272 NCBI chr  X:132,058,739...132,091,518
Ensembl chr  X:132,081,759...132,091,246 		JBrowse link
G Arf3 ARF GTPase 3 increases expression ISO Clobetasol results in increased expression of ARF3 mRNA CTD PMID:27462272 NCBI chr 7:131,765,039...131,792,075
Ensembl chr 7:131,750,672...131,770,123 		JBrowse link
G Arf4 ARF GTPase 4 increases expression ISO Clobetasol results in increased expression of ARF4 mRNA CTD PMID:27462272 NCBI chr16:1,903,238...1,920,012
Ensembl chr16:1,903,371...1,920,011 		JBrowse link
G Arf5 ARF GTPase 5 increases expression ISO Clobetasol results in increased expression of ARF5 mRNA CTD PMID:27462272 NCBI chr 4:58,003,919...58,006,898
Ensembl chr 4:58,003,932...58,006,835 		JBrowse link
G Arfgef1 ARF guanine nucleotide exchange factor 1 decreases expression ISO Clobetasol results in decreased expression of ARFGEF1 mRNA CTD PMID:27462272 NCBI chr 5:13,764,507...13,859,237
Ensembl chr 5:13,764,975...13,859,237 		JBrowse link
G Arfgef2 ARF guanine nucleotide exchange factor 2 decreases expression ISO Clobetasol results in decreased expression of ARFGEF2 mRNA CTD PMID:27462272 NCBI chr 3:175,966,575...176,052,715
Ensembl chr 3:175,966,579...176,052,713 		JBrowse link
G Arhgap23 Rho GTPase activating protein 23 decreases expression ISO Clobetasol results in decreased expression of ARHGAP23 mRNA CTD PMID:27462272 NCBI chr10:82,891,021...82,993,230
Ensembl chr10:82,890,853...82,993,228 		JBrowse link
G Arhgap31 Rho GTPase activating protein 31 affects expression ISO Clobetasol affects the expression of ARHGAP31 mRNA CTD PMID:27462272 NCBI chr11:75,544,176...75,657,087
Ensembl chr11:75,544,040...75,661,076 		JBrowse link
G Arhgap35 Rho GTPase activating protein 35 decreases expression ISO Clobetasol results in decreased expression of ARHGAP35 mRNA CTD PMID:27462272 NCBI chr 1:86,330,566...86,447,414
Ensembl chr 1:86,330,566...86,447,414 		JBrowse link
G Arhgap5 Rho GTPase activating protein 5 decreases expression ISO Clobetasol results in decreased expression of ARHGAP5 mRNA CTD PMID:27462272 NCBI chr 6:75,711,199...75,774,636
Ensembl chr 6:75,711,515...75,774,636 		JBrowse link
G Arhgef26 Rho guanine nucleotide exchange factor 26 decreases expression ISO Clobetasol results in decreased expression of ARHGEF26 mRNA CTD PMID:27462272 NCBI chr 2:148,889,405...149,000,538
Ensembl chr 2:148,889,423...149,000,538 		JBrowse link
G Arhgef4 Rho guanine nucleotide exchange factor 4 decreases expression ISO Clobetasol results in decreased expression of ARHGEF4 mRNA CTD PMID:27462272 NCBI chr 9:44,357,716...44,500,959
Ensembl chr 9:44,357,736...44,501,550 		JBrowse link
G Arid1b AT-rich interaction domain 1B decreases expression ISO Clobetasol results in decreased expression of ARID1B mRNA CTD PMID:27462272 NCBI chr 1:47,973,199...48,328,793
Ensembl chr 1:47,973,997...48,328,793 		JBrowse link
G Arid2 AT-rich interaction domain 2 decreases expression ISO Clobetasol results in decreased expression of ARID2 mRNA CTD PMID:27462272 NCBI chr 7:129,326,371...129,443,813
Ensembl chr 7:129,324,137...129,443,187 		JBrowse link
G Arl1 ARF like GTPase 1 increases expression ISO Clobetasol results in increased expression of ARL1 mRNA CTD PMID:27462272 NCBI chr 7:25,007,401...25,018,572
Ensembl chr 7:25,006,981...25,019,319 		JBrowse link
G Arl2 ARF like GTPase 2 increases expression ISO Clobetasol results in increased expression of ARL2 mRNA CTD PMID:27462272 NCBI chr 1:212,863,422...212,875,425
Ensembl chr 1:212,863,423...212,875,373 		JBrowse link
G Arl2bp ARF like GTPase 2 binding protein decreases expression ISO Clobetasol results in decreased expression of ARL2BP mRNA CTD PMID:27462272 NCBI chr19:10,342,895...10,352,529
Ensembl chr19:10,342,895...10,352,514 		JBrowse link
G Arl4a ARF like GTPase 4A decreases expression ISO Clobetasol results in decreased expression of ARL4A mRNA CTD PMID:27462272 NCBI chr 6:62,809,287...62,811,297
Ensembl chr 6:62,804,548...62,820,760 		JBrowse link
G Arl6ip1 ARL6 interacting reticulophagy regulator 1 increases expression ISO Clobetasol results in increased expression of ARL6IP1 mRNA CTD PMID:27462272 NCBI chr 1:181,864,717...181,874,232
Ensembl chr 1:181,864,746...181,874,232 		JBrowse link
G Armcx4 armadillo repeat containing, X-linked 4 decreases expression ISO Clobetasol results in decreased expression of ARMCX4 mRNA CTD PMID:27462272 NCBI chr  X:102,153,743...102,164,173
Ensembl chr  X:102,153,800...102,164,633 		JBrowse link
G Ash1l ASH1 like histone lysine methyltransferase decreases expression ISO Clobetasol results in decreased expression of ASH1L mRNA CTD PMID:27462272 NCBI chr 2:176,644,393...176,780,848
Ensembl chr 2:176,644,924...176,780,847 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression ISO Clobetasol results in increased expression of ASNS mRNA CTD PMID:27462272 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Asphd2 aspartate beta-hydroxylase domain containing 2 increases expression ISO Clobetasol results in increased expression of ASPHD2 mRNA CTD PMID:27462272 NCBI chr12:49,908,539...49,919,060
Ensembl chr12:49,908,241...49,925,254 		JBrowse link
G Asxl3 ASXL transcriptional regulator 3 decreases expression ISO Clobetasol results in decreased expression of ASXL3 mRNA CTD PMID:27462272 NCBI chr18:13,868,223...14,040,867
Ensembl chr18:13,868,674...14,037,373 		JBrowse link
G Atg13 autophagy related 13 increases expression ISO Clobetasol results in increased expression of ATG13 mRNA CTD PMID:27462272 NCBI chr 3:98,102,831...98,136,741
Ensembl chr 3:98,101,552...98,136,743 		JBrowse link
G Atg4b autophagy related 4B, cysteine peptidase increases expression ISO Clobetasol results in increased expression of ATG4B mRNA CTD PMID:27462272 NCBI chr 9:101,729,772...101,761,456
Ensembl chr 9:101,726,782...101,761,622 		JBrowse link
G Atox1 antioxidant 1 copper chaperone increases expression ISO Clobetasol results in increased expression of ATOX1 mRNA CTD PMID:27462272 NCBI chr10:40,065,525...40,080,627
Ensembl chr10:40,065,527...40,080,585 		JBrowse link
G Atp10b ATPase phospholipid transporting 10B decreases expression ISO Clobetasol results in decreased expression of ATP10B mRNA CTD PMID:27462272 NCBI chr10:27,996,729...28,252,801
Ensembl chr10:27,910,295...28,251,450 		JBrowse link
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 increases expression ISO Clobetasol results in increased expression of ATP1A1 mRNA CTD PMID:27462272 NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425 		JBrowse link
G Atp1b2 ATPase Na+/K+ transporting subunit beta 2 increases expression ISO Clobetasol results in increased expression of ATP1B2 mRNA CTD PMID:27462272 NCBI chr10:54,817,473...54,823,708
Ensembl chr10:54,817,476...54,823,708 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha increases expression ISO Clobetasol results in increased expression of ATP5F1A mRNA CTD PMID:27462272 NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922 		JBrowse link
G Atp5f1b ATP synthase F1 subunit beta increases expression ISO Clobetasol results in increased expression of ATP5F1B mRNA CTD PMID:27462272 NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462 		JBrowse link
G Atp5mc2 ATP synthase membrane subunit c locus 2 increases expression ISO Clobetasol results in increased expression of ATP5MC2 mRNA CTD PMID:27462272 NCBI chr 7:135,669,847...135,680,839
Ensembl chr 7:135,669,848...135,678,231 		JBrowse link
G Atp5mf ATP synthase membrane subunit f increases expression ISO Clobetasol results in increased expression of ATP5MF mRNA CTD PMID:27462272 NCBI chr12:14,535,435...14,542,007
Ensembl chr12:14,522,832...14,542,709 		JBrowse link
G Atp5mj ATP synthase membrane subunit j increases expression ISO Clobetasol results in increased expression of ATP5MJ mRNA CTD PMID:27462272 NCBI chr 6:136,839,890...136,845,640
Ensembl chr 1:177,906,475...177,907,045
Ensembl chr 1:177,906,475...177,907,045 		JBrowse link
G Atp5pd ATP synthase peripheral stalk subunit d increases expression ISO Clobetasol results in increased expression of ATP5PD mRNA CTD PMID:27462272 NCBI chr10:101,156,673...101,161,926
Ensembl chr10:101,156,673...101,162,954 		JBrowse link
G Atp5po ATP synthase peripheral stalk subunit OSCP increases expression ISO Clobetasol results in increased expression of ATP5PO mRNA CTD PMID:27462272 NCBI chr11:44,651,171...44,657,483
Ensembl chr11:44,651,173...44,657,520 		JBrowse link
G Atp6v0b ATPase H+ transporting V0 subunit B increases expression ISO Clobetasol results in increased expression of ATP6V0B mRNA CTD PMID:27462272 NCBI chr 5:136,708,823...136,710,339
Ensembl chr 5:136,708,823...136,716,828 		JBrowse link
G Atp6v0c ATPase H+ transporting V0 subunit C increases expression ISO Clobetasol results in increased expression of ATP6V0C mRNA CTD PMID:27462272 NCBI chr10:13,700,764...13,707,147
Ensembl chr10:13,700,764...13,706,245 		JBrowse link
G Atp6v0e2 ATPase, H+ transporting V0 subunit e2 increases expression ISO Clobetasol results in increased expression of ATP6V0E2 mRNA CTD PMID:27462272 NCBI chr 4:78,815,771...78,818,919
Ensembl chr 4:78,813,129...78,819,680 		JBrowse link
G Atrx ATRX, chromatin remodeler decreases expression ISO Clobetasol results in decreased expression of ATRX mRNA CTD PMID:27462272 NCBI chr  X:74,916,548...75,062,880
Ensembl chr  X:74,916,548...75,062,880 		JBrowse link
G Atxn2 ataxin 2 decreases expression ISO Clobetasol results in decreased expression of ATXN2 mRNA CTD PMID:27462272 NCBI chr12:40,413,657...40,509,895
Ensembl chr12:40,414,904...40,510,473 		JBrowse link
G Atxn7l3b ataxin 7-like 3B increases expression ISO Clobetasol results in increased expression of ATXN7L3B mRNA CTD PMID:27462272 NCBI chr 7:50,208,666...50,212,190
Ensembl chr 7:50,208,676...50,212,190 		JBrowse link
G Aurkb aurora kinase B increases expression ISO Clobetasol results in increased expression of AURKB mRNA CTD PMID:27462272 NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285 		JBrowse link
G B3gat1 beta-1,3-glucuronyltransferase 1 decreases expression ISO Clobetasol results in decreased expression of B3GAT1 mRNA CTD PMID:27462272 NCBI chr 8:33,362,791...33,390,446
Ensembl chr 8:33,363,048...33,390,443 		JBrowse link
G B3gat2 beta-1,3-glucuronyltransferase 2 decreases expression ISO Clobetasol results in decreased expression of B3GAT2 mRNA CTD PMID:27462272 NCBI chr 9:33,663,482...33,746,466
Ensembl chr 9:33,663,482...33,746,466 		JBrowse link
G Bach2 BTB domain and CNC homolog 2 decreases expression ISO Clobetasol results in decreased expression of BACH2 mRNA CTD PMID:27462272 NCBI chr 5:51,428,802...51,779,030
Ensembl chr 5:51,434,870...51,774,234 		JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 decreases expression ISO Clobetasol results in decreased expression of BASP1 mRNA CTD PMID:27462272 NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression ISO Clobetasol results in increased expression of BAX mRNA CTD PMID:27462272 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bckdk branched chain ketoacid dehydrogenase kinase increases expression ISO Clobetasol results in increased expression of BCKDK mRNA CTD PMID:27462272 NCBI chr 1:191,945,809...191,950,480
Ensembl chr 1:191,946,471...191,953,453 		JBrowse link
G Bcl6 BCL6, transcription repressor increases expression ISO Clobetasol results in increased expression of BCL6 mRNA CTD PMID:27462272 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047 		JBrowse link
G Bcl7a BAF chromatin remodeling complex subunit BCL7A decreases expression ISO Clobetasol results in decreased expression of BCL7A mRNA CTD PMID:27462272 NCBI chr12:38,872,851...38,904,770
Ensembl chr12:38,872,851...38,904,770 		JBrowse link
G Bcl9 BCL9, transcription coactivator decreases expression ISO Clobetasol results in decreased expression of BCL9 mRNA CTD PMID:27462272 NCBI chr 2:187,449,425...187,475,241
Ensembl chr 2:187,449,425...187,475,241 		JBrowse link
G Bcorl1 BCL6 co-repressor-like 1 decreases expression ISO Clobetasol results in decreased expression of BCORL1 mRNA CTD PMID:27462272 NCBI chr  X:132,394,703...132,462,414
Ensembl chr  X:132,397,069...132,461,976 		JBrowse link
G Bcr BCR activator of RhoGEF and GTPase decreases expression ISO Clobetasol results in decreased expression of BCR mRNA CTD PMID:27462272 NCBI chr20:13,468,732...13,596,333
Ensembl chr20:13,468,732...13,596,333 		JBrowse link
G Bdp1 BDP1 general transcription factor IIIB subunit decreases expression ISO Clobetasol results in decreased expression of BDP1 mRNA CTD PMID:27462272 NCBI chr 2:33,112,518...33,204,270
Ensembl chr 2:33,112,518...33,204,241 		JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 increases expression ISO Clobetasol results in increased expression of BHLHE40 mRNA CTD PMID:27462272 NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783 		JBrowse link
G Birc6 baculoviral IAP repeat-containing 6 decreases expression ISO Clobetasol results in decreased expression of BIRC6 mRNA CTD PMID:27462272 NCBI chr 6:26,474,843...26,668,275
Ensembl chr 6:26,474,843...26,668,507 		JBrowse link
G Bltp3a bridge-like lipid transfer protein family member 3A decreases expression ISO Clobetasol results in decreased expression of BLTP3A mRNA CTD PMID:27462272 NCBI chr20:5,912,033...5,956,404
Ensembl chr20:5,912,106...5,956,403 		JBrowse link
G Bmp7 bone morphogenetic protein 7 increases expression ISO Clobetasol results in increased expression of BMP7 mRNA CTD PMID:27462272 NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137 		JBrowse link
G Bmpr2 bone morphogenetic protein receptor type 2 decreases expression ISO Clobetasol results in decreased expression of BMPR2 mRNA CTD PMID:27462272 NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350 		JBrowse link
G Bok BCL2 family apoptosis regulator BOK increases expression ISO Clobetasol results in increased expression of BOK mRNA CTD PMID:27462272 NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833 		JBrowse link
G Bop1 BOP1 ribosomal biogenesis factor increases expression ISO Clobetasol results in increased expression of BOP1 mRNA CTD PMID:27462272 NCBI chr 7:110,052,716...110,076,529
Ensembl chr 7:110,052,720...110,076,529 		JBrowse link
G Bora bora, aurora kinase A activator decreases expression ISO Clobetasol results in decreased expression of BORA mRNA CTD PMID:27462272 NCBI chr15:82,205,467...82,243,499
Ensembl chr15:82,205,697...82,244,052 		JBrowse link
G Brd7 bromodomain containing 7 decreases expression ISO Clobetasol results in decreased expression of BRD7 mRNA CTD PMID:27462272 NCBI chr19:34,882,238...34,910,944
Ensembl chr19:34,882,304...34,910,944 		JBrowse link
G Brk1 BRICK1 subunit of SCAR/WAVE actin nucleating complex increases expression ISO Clobetasol results in increased expression of BRK1 mRNA CTD PMID:27462272 NCBI chr 4:148,306,436...148,321,668
Ensembl chr 4:148,306,398...148,321,984 		JBrowse link
G Brwd1 bromodomain and WD repeat domain containing 1 increases expression ISO Clobetasol results in increased expression of BRWD1 mRNA CTD PMID:27462272 NCBI chr11:48,756,174...48,853,692
Ensembl chr11:48,756,811...48,848,256 		JBrowse link
G Bsn bassoon (presynaptic cytomatrix protein) decreases expression ISO Clobetasol results in decreased expression of BSN mRNA CTD PMID:27462272 NCBI chr 8:117,663,447...117,754,412
Ensembl chr 8:117,670,334...117,754,412 		JBrowse link
G Btbd2 BTB domain containing 2 increases expression ISO Clobetasol results in increased expression of BTBD2 mRNA CTD PMID:27462272 NCBI chr 7:9,710,392...9,726,032
Ensembl chr 7:9,712,269...9,726,032 		JBrowse link
G Bub3 BUB3 mitotic checkpoint protein increases expression ISO Clobetasol results in increased expression of BUB3 mRNA CTD PMID:27462272 NCBI chr 1:195,760,532...195,771,140
Ensembl chr 1:195,758,105...195,791,028 		JBrowse link
G C2 complement C2 increases expression ISO Clobetasol results in increased expression of C2 mRNA CTD PMID:27462272 NCBI chr20:3,944,722...3,975,006
Ensembl chr20:3,955,776...3,981,740 		JBrowse link
G Ca8 carbonic anhydrase 8 decreases expression ISO Clobetasol results in decreased expression of CAR8 mRNA CTD PMID:27462272 NCBI chr 5:26,102,767...26,199,819
Ensembl chr 5:26,102,813...26,199,796 		JBrowse link
G Cabin1 calcineurin binding protein 1 decreases expression ISO Clobetasol results in decreased expression of CABIN1 mRNA CTD PMID:27462272 NCBI chr20:12,892,750...13,014,801
Ensembl chr20:12,892,771...13,014,800 		JBrowse link
G Calr calreticulin increases expression ISO Clobetasol results in increased expression of CALR mRNA CTD PMID:27462272 NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236 		JBrowse link
G Cand2 cullin-associated and neddylation-dissociated 2 (putative) decreases expression ISO Clobetasol results in decreased expression of CAND2 mRNA CTD PMID:27462272 NCBI chr 4:150,507,659...150,535,755
Ensembl chr 4:150,507,657...150,541,293 		JBrowse link
G Capn10 calpain 10 increases expression ISO Clobetasol results in increased expression of CAPN10 mRNA CTD PMID:27462272 NCBI chr 9:100,943,665...100,957,910
Ensembl chr 9:100,945,551...100,957,912 		JBrowse link
G Capn6 calpain 6 decreases expression ISO Clobetasol results in decreased expression of CAPN6 mRNA CTD PMID:27462272 NCBI chr  X:112,177,467...112,202,178
Ensembl chr  X:112,177,467...112,202,178 		JBrowse link
G Capza1 capping actin protein of muscle Z-line subunit alpha 1 increases expression ISO Clobetasol results in increased expression of CAPZA1 mRNA CTD PMID:27462272 NCBI chr 2:195,008,035...195,053,100
Ensembl chr 2:195,008,039...195,053,100 		JBrowse link
G Caskin2 cask-interacting protein 2 decreases expression ISO Clobetasol results in decreased expression of CASKIN2 mRNA CTD PMID:27462272 NCBI chr10:101,526,131...101,540,362
Ensembl chr10:101,526,195...101,540,349 		JBrowse link
G Casp3 caspase 3 increases activity ISO Clobetasol results in increased activity of CASP3 protein CTD PMID:15086553 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp6 caspase 6 increases expression ISO Clobetasol results in increased expression of CASP6 mRNA CTD PMID:27462272 NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726 		JBrowse link
G Cbr3 carbonyl reductase 3 increases expression ISO Clobetasol results in increased expression of CBR3 mRNA CTD PMID:27462272 NCBI chr11:46,478,295...46,486,555
Ensembl chr11:46,478,274...46,486,558 		JBrowse link
G Cc2d1a coiled-coil and C2 domain containing 1A decreases expression ISO Clobetasol results in decreased expression of CC2D1A mRNA CTD PMID:27462272 NCBI chr19:40,916,587...40,931,702
Ensembl chr19:40,916,532...40,931,701 		JBrowse link
G Cc2d2a coiled-coil and C2 domain containing 2A decreases expression ISO Clobetasol results in decreased expression of CC2D2A mRNA CTD PMID:27462272 NCBI chr14:71,563,835...71,648,352
Ensembl chr14:71,563,835...71,648,331 		JBrowse link
G Ccdc88a coiled coil domain containing 88A decreases expression ISO Clobetasol results in decreased expression of CCDC88A mRNA CTD PMID:27462272 NCBI chr14:107,304,654...107,456,104
Ensembl chr14:107,305,199...107,453,285 		JBrowse link
G Ccdc88c coiled-coil domain containing 88C decreases expression ISO Clobetasol results in decreased expression of CCDC88C mRNA CTD PMID:27462272 NCBI chr 6:125,899,337...126,019,162
Ensembl chr 6:125,899,526...126,018,865 		JBrowse link
G Ccn2 cellular communication network factor 2 increases expression ISO Clobetasol results in increased expression of CCN2 mRNA CTD PMID:27462272 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccs copper chaperone for superoxide dismutase increases expression ISO Clobetasol results in increased expression of CCS mRNA CTD PMID:27462272 NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:211,542,701...211,564,260 		JBrowse link
G Cct2 chaperonin containing TCP1 subunit 2 increases expression ISO Clobetasol results in increased expression of CCT2 mRNA CTD PMID:27462272 NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977 		JBrowse link
G Cct3 chaperonin containing TCP1 subunit 3 increases expression ISO Clobetasol results in increased expression of CCT3 mRNA CTD PMID:27462272 NCBI chr 2:176,063,529...176,088,180
Ensembl chr 2:176,063,526...176,089,925 		JBrowse link
G Cct7 chaperonin containing TCP1 subunit 7 increases expression ISO Clobetasol results in increased expression of CCT7 mRNA CTD PMID:27462272 NCBI chr 4:119,546,730...119,563,973
Ensembl chr 4:119,546,730...119,563,973 		JBrowse link
G Cd109 CD109 molecule increases expression ISO Clobetasol results in increased expression of CD109 mRNA CTD PMID:27462272 NCBI chr 8:88,334,736...88,449,463
Ensembl chr 8:88,334,736...88,449,462 		JBrowse link
G Cd40 CD40 molecule decreases expression ISO Clobetasol results in decreased expression of CD40 protein CTD PMID:15086553 NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847 		JBrowse link
G Cd80 Cd80 molecule decreases expression ISO Clobetasol results in decreased expression of CD80 protein CTD PMID:15086553 NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540 		JBrowse link
G Cd81 Cd81 molecule increases expression ISO Clobetasol results in increased expression of CD81 mRNA CTD PMID:27462272 NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092 		JBrowse link
G Cd86 CD86 molecule decreases expression ISO Clobetasol results in decreased expression of CD86 protein CTD PMID:15086553 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361 		JBrowse link
G Cdc42bpb CDC42 binding protein kinase beta decreases expression ISO Clobetasol results in decreased expression of CDC42BPB mRNA CTD PMID:27462272 NCBI chr 6:136,154,905...136,241,259
Ensembl chr 6:136,154,905...136,237,570 		JBrowse link
G Cdc42ep1 CDC42 effector protein 1 increases expression ISO Clobetasol results in increased expression of CDC42EP1 mRNA CTD PMID:27462272 NCBI chr 7:112,275,759...112,283,665
Ensembl chr 7:112,275,792...112,283,664 		JBrowse link
G Cdca7 cell division cycle associated 7 increases expression ISO Clobetasol results in increased expression of CDCA7 mRNA CTD PMID:27462272 NCBI chr 3:77,730,315...77,740,950
Ensembl chr 3:77,729,970...77,740,947 		JBrowse link
G Cdh13 cadherin 13 increases expression ISO Clobetasol results in increased expression of CDH13 mRNA CTD PMID:27462272 NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119 		JBrowse link
G Cdh4 cadherin 4 decreases expression ISO Clobetasol results in decreased expression of CDH4 mRNA CTD PMID:27462272 NCBI chr 3:186,902,763...187,381,020
Ensembl chr 3:186,902,751...187,381,020 		JBrowse link
G Cdk5 cyclin-dependent kinase 5 increases expression ISO Clobetasol results in increased expression of CDK5 mRNA CTD PMID:27462272 NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777 		JBrowse link
G Cdkl5 cyclin-dependent kinase-like 5 increases expression ISO Clobetasol results in increased expression of CDKL5 mRNA CTD PMID:27462272 NCBI chr  X:37,566,320...37,796,766
Ensembl chr  X:37,566,378...37,796,760 		JBrowse link
G Cdkn2aipnl CDKN2A interacting protein N-terminal like increases expression ISO Clobetasol results in increased expression of CDKN2AIPNL mRNA CTD PMID:27462272 NCBI chr10:36,731,983...36,741,500
Ensembl chr10:36,732,013...36,741,495 		JBrowse link
G Cdr2 cerebellar degeneration-related protein 2 increases expression ISO Clobetasol results in increased expression of CDR2 mRNA CTD PMID:27462272 NCBI chr 1:184,934,128...184,959,036
Ensembl chr 1:184,934,129...184,968,863 		JBrowse link
G Cecr2 CECR2, histone acetyl-lysine reader decreases expression ISO Clobetasol results in decreased expression of CECR2 mRNA CTD PMID:27462272 NCBI chr 4:155,562,576...155,670,253
Ensembl chr 4:155,562,727...155,666,741 		JBrowse link
G Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 decreases expression ISO Clobetasol results in decreased expression of CELSR1 mRNA CTD PMID:27462272 NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:118,867,450...119,004,856 		JBrowse link
G Cenpe centromere protein E decreases expression ISO Clobetasol results in decreased expression of CENPE mRNA CTD PMID:27462272 NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636 		JBrowse link
G Cenpf centromere protein F decreases expression ISO Clobetasol results in decreased expression of CENPF mRNA CTD PMID:27462272 NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886 		JBrowse link
G Cep131 centrosomal protein 131 decreases expression ISO Clobetasol results in decreased expression of CEP131 mRNA CTD PMID:27462272 NCBI chr10:105,844,433...105,868,811
Ensembl chr10:105,844,433...105,868,797 		JBrowse link
G Cep350 centrosomal protein 350 decreases expression ISO Clobetasol results in decreased expression of CEP350 mRNA CTD PMID:27462272 NCBI chr13:70,573,597...70,714,673
Ensembl chr13:70,573,597...70,714,673 		JBrowse link
G Cfl1 cofilin 1 increases expression ISO Clobetasol results in increased expression of CFL1 mRNA CTD PMID:27462272 NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353 		JBrowse link
G Cftr CF transmembrane conductance regulator increases expression ISO Clobetasol results in increased expression of CFTR mRNA CTD PMID:27462272 NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643 		JBrowse link
G Chchd2 coiled-coil-helix-coiled-coil-helix domain containing 2 increases expression ISO Clobetasol results in increased expression of CHCHD2 mRNA CTD PMID:27462272 NCBI chr12:32,464,847...32,470,871
Ensembl chr12:32,464,824...32,470,871 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 decreases expression ISO Clobetasol results in decreased expression of CHD2 mRNA CTD PMID:27462272 NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335 		JBrowse link
G Chd3 chromodomain helicase DNA binding protein 3 decreases expression ISO Clobetasol results in decreased expression of CHD3 mRNA CTD PMID:27462272 NCBI chr10:54,562,437...54,588,842
Ensembl chr10:54,562,437...54,588,810 		JBrowse link
G Chd7 chromodomain helicase DNA binding protein 7 decreases expression ISO Clobetasol results in decreased expression of CHD7 mRNA CTD PMID:27462272 NCBI chr 5:26,609,245...26,792,736
Ensembl chr 5:26,609,407...26,792,734 		JBrowse link
G Chd8 chromodomain helicase DNA binding protein 8 decreases expression ISO Clobetasol results in decreased expression of CHD8 mRNA CTD PMID:27462272 NCBI chr15:27,379,285...27,438,959
Ensembl chr15:27,379,285...27,417,851 		JBrowse link
G Chmp7 charged multivesicular body protein 7 increases expression ISO Clobetasol results in increased expression of CHMP7 mRNA CTD PMID:27462272 NCBI chr15:51,200,759...51,215,992
Ensembl chr15:51,201,298...51,215,992 		JBrowse link
G Chst2 carbohydrate sulfotransferase 2 increases expression ISO Clobetasol results in increased expression of CHST2 mRNA CTD PMID:27462272 NCBI chr 8:104,839,716...104,845,961
Ensembl chr 8:104,831,292...104,860,301 		JBrowse link
G Chst3 carbohydrate sulfotransferase 3 decreases expression ISO Clobetasol results in decreased expression of CHST3 mRNA CTD PMID:27462272 NCBI chr20:28,657,308...28,694,976
Ensembl chr20:28,657,308...28,694,526 		JBrowse link
G Ciao2b cytosolic iron-sulfur assembly component 2B increases expression ISO Clobetasol results in increased expression of CIAO2B mRNA CTD PMID:27462272 NCBI chr19:350,644...352,518
Ensembl chr19:350,653...352,518 		JBrowse link
G Ciapin1 cytokine induced apoptosis inhibitor 1 increases expression ISO Clobetasol results in increased expression of CIAPIN1 mRNA CTD PMID:27462272 NCBI chr19:10,185,955...10,199,120
Ensembl chr19:10,182,088...10,201,495 		JBrowse link
G Cisd1 CDGSH iron sulfur domain 1 increases expression ISO Clobetasol results in increased expression of CISD1 mRNA CTD PMID:27462272 NCBI chr20:17,254,462...17,267,843
Ensembl chr20:17,254,187...17,271,042 		JBrowse link
G Ckb creatine kinase B increases expression ISO Clobetasol results in increased expression of CKB mRNA CTD PMID:27462272 NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478 		JBrowse link
G Cks1b CDC28 protein kinase regulatory subunit 1B increases expression ISO Clobetasol results in increased expression of CKS1B mRNA CTD PMID:27462272 NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365 		JBrowse link
G Clasp2 cytoplasmic linker associated protein 2 decreases expression ISO Clobetasol results in decreased expression of CLASP2 mRNA CTD PMID:27462272 NCBI chr 8:122,555,532...122,736,934
Ensembl chr 8:122,555,524...122,737,587 		JBrowse link
G Clip3 CAP-GLY domain containing linker protein 3 decreases expression ISO Clobetasol results in decreased expression of CLIP3 mRNA CTD PMID:27462272 NCBI chr 1:94,674,492...94,690,643
Ensembl chr 1:94,674,661...94,690,642 		JBrowse link
G Clpp caseinolytic mitochondrial matrix peptidase proteolytic subunit increases expression ISO Clobetasol results in increased expression of CLPP mRNA CTD PMID:27462272 NCBI chr 9:1,917,305...1,924,706
Ensembl chr 9:1,918,682...1,924,705 		JBrowse link
G Clptm1 CLPTM1 regulator of GABA type A receptor forward trafficking increases expression ISO Clobetasol results in increased expression of CLPTM1 mRNA CTD PMID:27462272 NCBI chr 1:88,417,447...88,449,047
Ensembl chr 1:88,417,447...88,449,446 		JBrowse link
G Clptm1l CLPTM1-like increases expression ISO Clobetasol results in increased expression of CLPTM1L mRNA CTD PMID:27462272 NCBI chr 1:31,496,094...31,512,148
Ensembl chr 1:31,496,094...31,512,077 		JBrowse link
G Clybl citramalyl-CoA lyase increases expression ISO Clobetasol results in increased expression of CLYBL mRNA CTD PMID:27462272 NCBI chr15:105,690,283...105,912,347
Ensembl chr15:105,690,295...105,912,345 		JBrowse link
G Cmss1 cms1 ribosomal small subunit homolog increases expression ISO Clobetasol results in increased expression of CMSS1 mRNA CTD PMID:27462272 NCBI chr11:56,403,620...56,701,751
Ensembl chr11:56,403,499...56,701,755 		JBrowse link
G Coa3 cytochrome C oxidase assembly factor 3 increases expression ISO Clobetasol results in increased expression of COA3 mRNA CTD PMID:27462272 NCBI chr10:86,720,454...86,721,435
Ensembl chr10:86,720,456...86,721,440 		JBrowse link
G Col11a1 collagen type XI alpha 1 chain decreases expression ISO Clobetasol results in decreased expression of COL11A1 mRNA CTD PMID:27462272 NCBI chr 2:204,509,136...204,702,264
Ensembl chr 2:204,509,136...204,702,264 		JBrowse link
G Col12a1 collagen type XII alpha 1 chain decreases expression ISO Clobetasol results in decreased expression of COL12A1 mRNA CTD PMID:27462272 NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711 		JBrowse link
G Col3a1 collagen type III alpha 1 chain decreases expression ISO Clobetasol results in decreased expression of COL3A1 mRNA CTD PMID:27462272 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col4a2 collagen type IV alpha 2 chain decreases expression ISO Clobetasol results in decreased expression of COL4A2 mRNA CTD PMID:27462272 NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520 		JBrowse link
G Col5a1 collagen type V alpha 1 chain decreases expression ISO Clobetasol results in decreased expression of COL5A1 mRNA CTD PMID:27462272 NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:31,606,486...31,753,020 		JBrowse link
G Col9a1 collagen type IX alpha 1 chain decreases expression ISO Clobetasol results in decreased expression of COL9A1 mRNA CTD PMID:27462272 NCBI chr 9:34,081,364...34,164,552
Ensembl chr 9:34,003,905...34,164,543 		JBrowse link
G Copb1 COPI coat complex subunit beta 1 increases expression ISO Clobetasol results in increased expression of COPB1 mRNA CTD PMID:27462272 NCBI chr 1:177,838,751...177,876,688
Ensembl chr 1:177,838,752...177,872,840 		JBrowse link
G Cope COPI coat complex subunit epsilon increases expression ISO Clobetasol results in increased expression of COPE mRNA CTD PMID:27462272 NCBI chr16:19,148,832...19,159,052
Ensembl chr16:19,148,832...19,159,212 		JBrowse link
G Cops8 COP9 signalosome subunit 8 increases expression ISO Clobetasol results in increased expression of COPS8 mRNA CTD PMID:27462272 NCBI chr 9:98,655,031...98,664,861
Ensembl chr 9:98,654,870...98,665,381 		JBrowse link
G Cotl1 coactosin-like F-actin binding protein 1 increases expression ISO Clobetasol results in increased expression of COTL1 mRNA CTD PMID:27462272 NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840 		JBrowse link
G Cox14 cytochrome c oxidase assembly factor COX14 increases expression ISO Clobetasol results in increased expression of COX14 mRNA CTD PMID:27462272 NCBI chr 7:132,731,069...132,733,159
Ensembl chr 7:132,731,069...132,733,159 		JBrowse link
G Cox17 cytochrome c oxidase copper chaperone COX17 increases expression ISO Clobetasol results in increased expression of COX17 mRNA CTD PMID:27462272 NCBI chr11:75,906,245...75,912,036
Ensembl chr11:75,906,248...75,912,019 		JBrowse link
G Cox19 cytochrome c oxidase assembly factor COX19 increases expression ISO Clobetasol results in increased expression of COX19 mRNA CTD PMID:27462272 NCBI chr12:20,417,389...20,426,868
Ensembl chr12:20,417,341...20,426,868 		JBrowse link
G Cox5a cytochrome c oxidase subunit 5A increases expression ISO Clobetasol results in increased expression of COX5A mRNA CTD PMID:27462272 NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279 		JBrowse link
G Cox6a1 cytochrome c oxidase subunit 6A1 increases expression ISO Clobetasol results in increased expression of COX6A1 mRNA CTD PMID:27462272 NCBI chr12:46,922,709...46,925,762
Ensembl chr12:46,912,648...46,925,768 		JBrowse link
G Cox8a cytochrome c oxidase subunit 8A increases expression ISO Clobetasol results in increased expression of COX8A mRNA CTD PMID:27462272 NCBI chr 1:213,831,302...213,833,623
Ensembl chr 1:213,831,298...213,833,623 		JBrowse link
G Cpe carboxypeptidase E increases expression ISO Clobetasol results in increased expression of CPE mRNA CTD PMID:27462272 NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524 		JBrowse link
G Cplane1 ciliogenesis and planar polarity effector complex subunit 1 decreases expression ISO Clobetasol results in decreased expression of CPLANE1 mRNA CTD PMID:27462272 NCBI chr 2:58,996,119...59,096,817
Ensembl chr 2:58,996,130...59,096,817 		JBrowse link
G Crb2 crumbs cell polarity complex component 2 decreases expression ISO Clobetasol results in decreased expression of CRB2 mRNA CTD PMID:27462272 NCBI chr 3:41,946,694...41,974,629
Ensembl chr 3:41,947,325...41,974,629 		JBrowse link
G Creb3 cAMP responsive element binding protein 3 increases expression ISO Clobetasol results in increased expression of CREB3 mRNA CTD PMID:27462272 NCBI chr 5:62,613,652...62,619,019
Ensembl chr 5:62,613,638...62,619,500 		JBrowse link
G Crebbp CREB binding protein decreases expression ISO Clobetasol results in decreased expression of CREBBP mRNA CTD PMID:27462272 NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266 		JBrowse link
G Creld1 cysteine-rich with EGF-like domains 1 increases expression ISO Clobetasol results in increased expression of CRELD1 mRNA CTD PMID:27462272 NCBI chr 4:148,187,510...148,197,120
Ensembl chr 4:148,187,265...148,197,116 		JBrowse link
G Creld2 cysteine-rich with EGF-like domains 2 increases expression ISO Clobetasol results in increased expression of CRELD2 mRNA CTD PMID:27462272 NCBI chr 7:121,788,754...121,796,230
Ensembl chr 7:121,788,745...121,796,228 		JBrowse link
G Crtc3 CREB regulated transcription coactivator 3 decreases expression ISO Clobetasol results in decreased expression of CRTC3 mRNA CTD PMID:27462272 NCBI chr 1:143,962,038...144,064,324
Ensembl chr 1:143,962,038...144,064,288 		JBrowse link
G Cry1 cryptochrome circadian regulator 1 increases expression ISO Clobetasol results in increased expression of CRY1 mRNA CTD PMID:27462272 NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822 		JBrowse link
G Cs citrate synthase increases expression ISO Clobetasol results in increased expression of CS mRNA CTD PMID:27462272 NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938 		JBrowse link
G Csad cysteine sulfinic acid decarboxylase increases expression ISO Clobetasol results in increased expression of CSAD mRNA CTD PMID:27462272 NCBI chr 7:135,187,175...135,216,495
Ensembl chr 7:135,187,175...135,215,581 		JBrowse link
G Csdc2 cold shock domain containing C2 increases expression ISO Clobetasol results in increased expression of CSDC2 mRNA CTD PMID:27462272 NCBI chr 7:115,332,134...115,346,599
Ensembl chr 7:115,332,128...115,346,596 		JBrowse link
G Csf2 colony stimulating factor 2 decreases secretion ISO Clobetasol results in decreased secretion of CSF2 protein CTD PMID:15086553 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Csnk2a1 casein kinase 2 alpha 1 increases expression ISO Clobetasol results in increased expression of CSNK2A1 mRNA CTD PMID:27462272 NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:161,170,405...161,215,698 		JBrowse link
G Csrp1 cysteine and glycine-rich protein 1 increases expression ISO Clobetasol results in increased expression of CSRP1 mRNA CTD PMID:27462272 NCBI chr13:49,709,928...49,731,141
Ensembl chr13:49,709,914...49,731,139 		JBrowse link
G Csrp2 cysteine and glycine-rich protein 2 increases expression ISO Clobetasol results in increased expression of CSRP2 mRNA CTD PMID:27462272 NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238 		JBrowse link
G Ctnnal1 catenin alpha-like 1 decreases expression ISO Clobetasol results in decreased expression of CTNNAL1 mRNA CTD PMID:27462272 NCBI chr 5:76,309,546...76,375,869
Ensembl chr 5:76,309,546...76,364,637 		JBrowse link
G Ctsb cathepsin B increases expression ISO Clobetasol results in increased expression of CTSB mRNA CTD PMID:27462272 NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478 		JBrowse link
G Ctso cathepsin O increases expression ISO Clobetasol results in increased expression of CTSO mRNA CTD PMID:27462272 NCBI chr 2:169,528,468...169,551,975
Ensembl chr 2:169,528,511...169,554,995 		JBrowse link
G Cuedc1 CUE domain containing 1 decreases expression ISO Clobetasol results in decreased expression of CUEDC1 mRNA CTD PMID:27462272 NCBI chr10:73,389,798...73,484,914
Ensembl chr10:73,389,841...73,483,749 		JBrowse link
G Cux2 cut-like homeobox 2 decreases expression ISO Clobetasol results in decreased expression of CUX2 mRNA CTD PMID:27462272 NCBI chr12:40,168,402...40,368,303
Ensembl chr12:40,149,292...40,366,528 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 increases expression ISO Clobetasol results in increased expression of CXCL12 mRNA CTD PMID:27462272 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627 		JBrowse link
G Cycs cytochrome c, somatic increases expression ISO Clobetasol results in increased expression of CYCS mRNA CTD PMID:27462272 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression
multiple interactions 		ISO Clobetasol results in increased expression of CYP1A1 mRNA
Tretinoin inhibits the reaction [Clobetasol results in increased expression of CYP1A1 mRNA] 		CTD PMID:7697808 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions ISO [Clobetasol results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA CTD PMID:25455453 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases expression ISO Clobetasol results in increased expression of CYP3A5 mRNA CTD PMID:16882163 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Cyp51 cytochrome P450, family 51 increases expression ISO Clobetasol results in increased expression of CYP51 mRNA CTD PMID:27462272 NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450 		JBrowse link
G Daam2 dishevelled associated activator of morphogenesis 2 decreases expression ISO Clobetasol results in decreased expression of DAAM2 mRNA CTD PMID:27462272 NCBI chr 9:18,926,620...19,044,672
Ensembl chr 9:18,926,623...19,044,671 		JBrowse link
G Dad1 defender against cell death 1 increases expression ISO Clobetasol results in increased expression of DAD1 mRNA CTD PMID:27462272 NCBI chr15:31,647,326...31,667,159
Ensembl chr15:31,647,326...31,667,287 		JBrowse link
G Dazap2 DAZ associated protein 2 increases expression ISO Clobetasol results in increased expression of DAZAP2 mRNA CTD PMID:27462272 NCBI chr 7:133,593,503...133,599,044
Ensembl chr 7:133,593,512...133,599,047 		JBrowse link
G Dcaf12 DDB1 and CUL4 associated factor 12 increases expression ISO Clobetasol results in increased expression of DCAF12 mRNA CTD PMID:27462272 NCBI chr 5:61,256,353...61,278,155
Ensembl chr 5:61,256,353...61,278,119 		JBrowse link
G Dcdc2 doublecortin domain containing 2 decreases expression ISO Clobetasol results in decreased expression of DCDC2A mRNA CTD PMID:27462272 NCBI chr17:40,274,009...40,459,757
Ensembl chr17:40,274,009...40,458,790 		JBrowse link
G Dchs1 dachsous cadherin-related 1 decreases expression ISO Clobetasol results in decreased expression of DCHS1 mRNA CTD PMID:27462272 NCBI chr 1:169,516,758...169,550,789
Ensembl chr 1:169,516,762...169,536,639 		JBrowse link
G Dck deoxycytidine kinase increases expression ISO Clobetasol results in increased expression of DCK mRNA CTD PMID:27462272 NCBI chr14:19,589,298...19,610,326
Ensembl chr14:19,589,298...19,610,326 		JBrowse link
G Ddb1 damage-specific DNA binding protein 1 increases expression ISO Clobetasol results in increased expression of DDB1 mRNA CTD PMID:27462272 NCBI chr 1:216,677,810...216,703,605
Ensembl chr 1:216,677,810...216,703,596 		JBrowse link
G Ddt D-dopachrome tautomerase increases expression ISO Clobetasol results in increased expression of DDT mRNA CTD PMID:27462272 NCBI chr20:12,883,025...12,886,121 JBrowse link
G Degs1 delta(4)-desaturase, sphingolipid 1 increases expression ISO Clobetasol results in increased expression of DEGS1 mRNA CTD PMID:27462272 NCBI chr13:96,478,645...96,485,302
Ensembl chr13:96,478,646...96,485,302 		JBrowse link
G Derl1 derlin 1 increases expression ISO Clobetasol results in increased expression of DERL1 mRNA CTD PMID:27462272 NCBI chr 7:91,293,963...91,316,639
Ensembl chr 7:91,258,382...91,316,678 		JBrowse link
G Dgkk diacylglycerol kinase kappa decreases expression ISO Clobetasol results in decreased expression of DGKK mRNA CTD PMID:27462272 NCBI chr  X:18,253,849...18,385,805
Ensembl chr  X:18,256,463...18,385,640 		JBrowse link
G Dhcr24 24-dehydrocholesterol reductase increases expression ISO Clobetasol results in increased expression of DHCR24 mRNA CTD PMID:27462272 NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:126,573,338...126,599,936 		JBrowse link
G Dhcr7 7-dehydrocholesterol reductase increases expression ISO Clobetasol results in increased expression of DHCR7 mRNA CTD PMID:27462272 NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382 		JBrowse link
G Dhfr dihydrofolate reductase decreases expression ISO Clobetasol results in decreased expression of DHFR mRNA CTD PMID:27462272 NCBI chr 2:25,320,895...25,346,004 JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein decreases expression ISO Clobetasol results in decreased expression of DIABLO mRNA CTD PMID:27462272 NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265 		JBrowse link
G Dido1 death inducer-obliterator 1 decreases expression ISO Clobetasol results in decreased expression of DIDO1 mRNA CTD PMID:27462272 NCBI chr 3:188,150,100...188,203,445
Ensembl chr 3:188,150,100...188,194,823 		JBrowse link
G Dlgap4 DLG associated protein 4 decreases expression ISO Clobetasol results in decreased expression of DLGAP4 mRNA CTD PMID:27462272 NCBI chr 3:165,584,271...165,731,868
Ensembl chr 3:165,584,360...165,730,604 		JBrowse link
G Dll3 delta like canonical Notch ligand 3 increases expression ISO Clobetasol results in increased expression of DLL3 mRNA CTD PMID:27462272 NCBI chr 1:92,689,577...92,698,125
Ensembl chr 1:92,689,577...92,697,406 		JBrowse link
G Dnaaf3 dynein, axonemal, assembly factor 3 increases expression ISO Clobetasol results in increased expression of DNAAF3 mRNA CTD PMID:27462272 NCBI chr 1:78,333,985...78,342,034
Ensembl chr 1:78,333,971...78,342,685 		JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 increases expression ISO Clobetasol results in increased expression of DNAJB11 mRNA CTD PMID:27462272 NCBI chr11:91,656,334...91,672,800
Ensembl chr11:91,656,335...91,672,800 		JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 increases expression ISO Clobetasol results in increased expression of DNAJC3 mRNA CTD PMID:27462272 NCBI chr15:102,432,667...102,475,643
Ensembl chr15:102,432,663...102,475,643 		JBrowse link
G Dnm3 dynamin 3 decreases expression ISO Clobetasol results in decreased expression of DNM3 mRNA CTD PMID:27462272 NCBI chr13:76,892,381...77,371,346
Ensembl chr13:76,892,171...77,371,350 		JBrowse link
G Dnph1 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 increases expression ISO Clobetasol results in increased expression of DNPH1 mRNA CTD PMID:27462272 NCBI chr 9:21,978,894...21,981,631
Ensembl chr 9:21,978,894...21,981,631 		JBrowse link
G Dpysl2 dihydropyrimidinase-like 2 increases expression ISO Clobetasol results in increased expression of DPYSL2 mRNA CTD PMID:27462272 NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065 		JBrowse link
G Dpysl4 dihydropyrimidinase-like 4 decreases expression ISO Clobetasol results in decreased expression of DPYSL4 mRNA CTD PMID:27462272 NCBI chr 1:203,312,646...203,328,523
Ensembl chr 1:203,311,694...203,328,523 		JBrowse link
G Draxin dorsal inhibitory axon guidance protein decreases expression ISO Clobetasol results in decreased expression of DRAXIN mRNA CTD PMID:27462272 NCBI chr 5:163,813,308...163,846,609
Ensembl chr 5:163,816,502...163,855,174 		JBrowse link
G Dscam DS cell adhesion molecule decreases expression ISO Clobetasol results in decreased expression of DSCAM mRNA CTD PMID:27462272 NCBI chr11:49,391,385...49,976,861
Ensembl chr11:49,347,531...49,976,238 		JBrowse link
G Dusp6 dual specificity phosphatase 6 increases expression ISO Clobetasol results in increased expression of DUSP6 mRNA CTD PMID:27462272 NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833 		JBrowse link
G Dvl3 dishevelled segment polarity protein 3 decreases expression ISO Clobetasol results in decreased expression of DVL3 mRNA CTD PMID:27462272 NCBI chr11:93,869,834...93,887,013
Ensembl chr11:93,869,834...93,886,903 		JBrowse link
G Dync1h1 dynein cytoplasmic 1 heavy chain 1 decreases expression ISO Clobetasol results in decreased expression of DYNC1H1 mRNA CTD PMID:27462272 NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116 		JBrowse link
G Dynlt1 dynein light chain Tctex-type 1 increases expression ISO Clobetasol results in increased expression of DYNLT1B mRNA CTD PMID:27462272 NCBI chr 1:49,292,093...49,299,051
Ensembl chr 1:49,282,243...49,298,951 		JBrowse link
G Ebp EBP, cholestenol delta-isomerase increases expression ISO Clobetasol results in increased expression of EBP mRNA CTD PMID:27462272 NCBI chr  X:16,971,372...16,977,782
Ensembl chr  X:16,971,405...16,977,781 		JBrowse link
G Edf1 endothelial differentiation-related factor 1 increases expression ISO Clobetasol results in increased expression of EDF1 mRNA CTD PMID:27462272 NCBI chr 3:28,764,906...28,779,499 JBrowse link
G Eea1 early endosome antigen 1 decreases expression ISO Clobetasol results in decreased expression of EEA1 mRNA CTD PMID:27462272 NCBI chr 7:32,441,281...32,608,808
Ensembl chr 7:32,441,272...32,608,476 		JBrowse link
G Eef2 eukaryotic translation elongation factor 2 increases expression ISO Clobetasol results in increased expression of EEF2 mRNA CTD PMID:27462272 NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544 		JBrowse link
G Eif2b2 eukaryotic translation initiation factor 2B subunit beta increases expression ISO Clobetasol results in increased expression of EIF2B2 mRNA CTD PMID:27462272 NCBI chr 6:110,597,979...110,604,403
Ensembl chr 6:110,597,729...110,604,403 		JBrowse link
G Eif3g eukaryotic translation initiation factor 3, subunit G increases expression ISO Clobetasol results in increased expression of EIF3G mRNA CTD PMID:27462272 NCBI chr 8:27,705,914...27,709,946
Ensembl chr 8:27,705,915...27,709,987 		JBrowse link
G Eif3i eukaryotic translation initiation factor 3, subunit I increases expression ISO Clobetasol results in increased expression of EIF3I mRNA CTD PMID:27462272 NCBI chr 5:147,219,457...147,226,910
Ensembl chr 5:147,219,366...147,241,232 		JBrowse link
G Eif4a3 eukaryotic translation initiation factor 4A3 increases expression ISO Clobetasol results in increased expression of EIF4A3 mRNA CTD PMID:27462272 NCBI chr10:105,047,567...105,057,561
Ensembl chr10:105,047,568...105,058,207 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 increases expression ISO Clobetasol results in increased expression of EIF4EBP1 mRNA CTD PMID:27462272 NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874 		JBrowse link
G Eif5b eukaryotic translation initiation factor 5B decreases expression ISO Clobetasol results in decreased expression of EIF5B mRNA CTD PMID:27462272 NCBI chr 9:47,718,706...47,773,289
Ensembl chr 9:47,718,706...47,778,583 		JBrowse link
G Eif6 eukaryotic translation initiation factor 6 increases expression ISO Clobetasol results in increased expression of EIF6 mRNA CTD PMID:27462272 NCBI chr 3:164,785,162...164,791,410
Ensembl chr 3:164,785,163...164,791,525 		JBrowse link
G Elavl3 ELAV like RNA binding protein 3 decreases expression ISO Clobetasol results in decreased expression of ELAVL3 mRNA CTD PMID:27462272 NCBI chr 8:28,823,120...28,859,395
Ensembl chr 8:28,825,707...28,859,659 		JBrowse link
G Elfn1 extracellular leucine-rich repeat and fibronectin type III domain containing 1 decreases expression ISO Clobetasol results in decreased expression of ELFN1 mRNA CTD PMID:27462272 NCBI chr12:19,773,911...19,839,375
Ensembl chr12:19,772,908...19,841,961 		JBrowse link
G Elovl5 ELOVL fatty acid elongase 5 increases expression ISO Clobetasol results in increased expression of ELOVL5 mRNA CTD PMID:27462272 NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:87,671,159...87,737,616 		JBrowse link
G Emc4 ER membrane protein complex subunit 4 increases expression ISO Clobetasol results in increased expression of EMC4 mRNA CTD PMID:27462272 NCBI chr 3:119,624,100...119,633,170
Ensembl chr 3:119,624,100...119,629,118 		JBrowse link
G Emc7 ER membrane protein complex subunit 7 increases expression ISO Clobetasol results in increased expression of EMC7 mRNA CTD PMID:27462272 NCBI chr 3:119,714,617...119,728,748
Ensembl chr 3:119,718,357...119,730,486 		JBrowse link
G Emg1 EMG1 N1-specific pseudouridine methyltransferase increases expression ISO Clobetasol results in increased expression of EMG1 mRNA CTD PMID:27462272 NCBI chr 4:159,195,545...159,203,826
Ensembl chr 4:159,195,564...159,203,826 		JBrowse link
G Entpd6 ectonucleoside triphosphate diphosphohydrolase 6 increases expression ISO Clobetasol results in increased expression of ENTPD6 mRNA CTD PMID:27462272 NCBI chr 3:160,036,055...160,058,580
Ensembl chr 3:160,036,121...160,059,451 		JBrowse link
G Ep300 E1A binding protein p300 decreases expression ISO Clobetasol results in decreased expression of EP300 mRNA CTD PMID:27462272 NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574 		JBrowse link
G Epb41 erythrocyte membrane protein band 4.1 decreases expression ISO Clobetasol results in decreased expression of EPB41 mRNA CTD PMID:27462272 NCBI chr 5:149,394,080...149,548,178
Ensembl chr 5:149,394,096...149,543,540 		JBrowse link
G Erg28 ergosterol biosynthesis 28 homolog increases expression ISO Clobetasol results in increased expression of ERG28 mRNA CTD PMID:27462272 NCBI chr 6:111,205,102...111,214,068
Ensembl chr 6:111,205,103...111,214,068 		JBrowse link
G Evpl envoplakin decreases expression ISO Clobetasol results in decreased expression of EVPL mRNA CTD PMID:27462272 NCBI chr10:101,957,107...101,973,656
Ensembl chr10:101,941,064...101,973,656 		JBrowse link
G Faap24 FA core complex associated protein 24 increases expression ISO Clobetasol results in increased expression of FAAP24 mRNA CTD PMID:27462272 NCBI chr 1:97,188,678...97,194,899
Ensembl chr 1:97,188,678...97,194,882 		JBrowse link
G Fabp7 fatty acid binding protein 7 increases expression ISO Clobetasol results in increased expression of FABP7 mRNA CTD PMID:27462272 NCBI chr20:37,667,125...37,673,299
Ensembl chr20:37,669,601...37,675,907 		JBrowse link
G Fads1 fatty acid desaturase 1 increases expression ISO Clobetasol results in increased expression of FADS1 mRNA CTD PMID:27462272 NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615 		JBrowse link
G Fads2 fatty acid desaturase 2 increases expression ISO Clobetasol results in increased expression of FADS2 mRNA CTD PMID:27462272 NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066 		JBrowse link
G Fam184a family with sequence similarity 184, member A decreases expression ISO Clobetasol results in decreased expression of FAM184A mRNA CTD PMID:27462272 NCBI chr20:33,477,089...33,599,296
Ensembl chr20:33,477,089...33,599,293 		JBrowse link
G Fam185a family with sequence similarity 185, member A decreases expression ISO Clobetasol results in decreased expression of FAM185A mRNA CTD PMID:27462272 NCBI chr 4:14,469,165...14,555,167
Ensembl chr 4:14,499,869...14,555,167 		JBrowse link
G Fam193a family with sequence similarity 193, member A decreases expression ISO Clobetasol results in decreased expression of FAM193A mRNA CTD PMID:27462272 NCBI chr14:80,480,742...80,607,086
Ensembl chr14:80,480,742...80,607,024 		JBrowse link
G Fas Fas cell surface death receptor increases expression ISO Clobetasol results in increased expression of FAS protein CTD PMID:15086553 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Fasn fatty acid synthase increases expression ISO Clobetasol results in increased expression of FASN mRNA CTD PMID:27462272 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fat1 FAT atypical cadherin 1 decreases expression ISO Clobetasol results in decreased expression of FAT1 mRNA CTD PMID:27462272 NCBI chr16:53,909,759...54,029,175
Ensembl chr16:53,909,556...54,028,609 		JBrowse link
G Fat3 FAT atypical cadherin 3 decreases expression ISO Clobetasol results in decreased expression of FAT3 mRNA CTD PMID:27462272 NCBI chr 8:20,972,840...21,555,679
Ensembl chr 8:20,972,840...21,555,240 		JBrowse link
G Fbl fibrillarin increases expression ISO Clobetasol results in increased expression of FBL mRNA CTD PMID:27462272 NCBI chr 1:92,597,407...92,606,507
Ensembl chr 1:92,597,258...92,606,506 		JBrowse link
G Fbxl18 F-box and leucine-rich repeat protein 18 decreases expression ISO Clobetasol results in decreased expression of FBXL18 mRNA CTD PMID:27462272 NCBI chr12:16,781,901...16,812,728
Ensembl chr12:16,789,665...16,814,240 		JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 increases expression ISO Clobetasol results in increased expression of FDFT1 mRNA CTD PMID:27462272 NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168 		JBrowse link
G Fez1 fasciculation and elongation protein zeta 1 decreases expression ISO Clobetasol results in decreased expression of FEZ1 mRNA CTD PMID:27462272 NCBI chr 8:44,733,288...44,778,519
Ensembl chr 8:44,733,300...44,784,097 		JBrowse link
G Flrt2 fibronectin leucine rich transmembrane protein 2 decreases expression ISO Clobetasol results in decreased expression of FLRT2 mRNA CTD PMID:27462272 NCBI chr 6:120,507,998...120,603,133
Ensembl chr 6:120,507,689...120,609,004 		JBrowse link
G Flvcr2 FLVCR choline and putative heme transporter 2 decreases expression ISO Clobetasol results in decreased expression of FLVCR2 mRNA CTD PMID:27462272 NCBI chr 6:111,139,352...111,203,345
Ensembl chr 6:111,139,295...111,203,345 		JBrowse link
G Fmc1 formation of mitochondrial complex V assembly factor 1 increases expression ISO Clobetasol results in increased expression of FMC1 mRNA CTD PMID:27462272 NCBI chr 4:68,241,009...68,249,045
Ensembl chr 4:68,241,009...68,268,534 		JBrowse link
G Fmnl2 formin-like 2 decreases expression ISO Clobetasol results in decreased expression of FMNL2 mRNA CTD PMID:27462272 NCBI chr 3:57,758,236...58,033,832
Ensembl chr 3:57,758,191...58,033,831 		JBrowse link
G Fnbp4 formin binding protein 4 decreases expression ISO Clobetasol results in decreased expression of FNBP4 mRNA CTD PMID:27462272 NCBI chr 3:97,188,852...97,218,916
Ensembl chr 3:97,188,884...97,219,435 		JBrowse link
G Fndc10 fibronectin type III domain containing 10 increases expression ISO Clobetasol results in increased expression of FNDC10 mRNA CTD PMID:27462272 NCBI chr 5:171,581,960...171,584,519
Ensembl chr 5:171,580,033...171,595,399 		JBrowse link
G Foxk1 forkhead box K1 decreases expression ISO Clobetasol results in decreased expression of FOXK1 mRNA CTD PMID:27462272 NCBI chr12:17,223,599...17,288,564
Ensembl chr12:17,229,430...17,288,564 		JBrowse link
G Foxred1 FAD-dependent oxidoreductase domain containing 1 increases expression ISO Clobetasol results in increased expression of FOXRED1 mRNA CTD PMID:27462272 NCBI chr 8:41,789,557...41,818,064
Ensembl chr 8:41,808,843...41,817,980 		JBrowse link
G Frmd8 FERM domain containing 8 increases expression ISO Clobetasol results in increased expression of FRMD8 mRNA CTD PMID:27462272 NCBI chr 1:212,572,534...212,593,181
Ensembl chr 1:212,572,537...212,592,695 		JBrowse link
G Frmpd1 FERM and PDZ domain containing 1 decreases expression ISO Clobetasol results in decreased expression of FRMPD1 mRNA CTD PMID:27462272 NCBI chr 5:64,238,730...64,340,778
Ensembl chr 5:64,238,768...64,340,776 		JBrowse link
G Fry FRY microtubule binding protein increases expression ISO Clobetasol results in increased expression of FRY mRNA CTD PMID:27462272 NCBI chr12:9,530,360...9,773,391
Ensembl chr12:9,530,360...9,897,603 		JBrowse link
G Frzb frizzled-related protein increases expression ISO Clobetasol results in increased expression of FRZB mRNA CTD PMID:27462272 NCBI chr 3:85,739,162...85,772,168
Ensembl chr 3:85,739,165...85,772,096 		JBrowse link
G Fth1 ferritin heavy chain 1 increases expression ISO Clobetasol results in increased expression of FTH1 mRNA CTD PMID:27462272 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214 		JBrowse link
G Gabarapl2 GABA type A receptor associated protein like 2 increases expression ISO Clobetasol results in increased expression of GABARAPL2 mRNA CTD PMID:27462272 NCBI chr19:56,819,826...56,830,662
Ensembl chr19:56,819,791...56,830,660 		JBrowse link
G Gabbr2 gamma-aminobutyric acid type B receptor subunit 2 decreases expression ISO Clobetasol results in decreased expression of GABBR2 mRNA CTD PMID:27462272 NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695 		JBrowse link
G Galk1 galactokinase 1 increases expression ISO Clobetasol results in increased expression of GALK1 mRNA CTD PMID:27462272 NCBI chr10:101,742,067...101,746,244
Ensembl chr10:101,735,061...101,746,258 		JBrowse link
G Gap43 growth associated protein 43 decreases expression ISO Clobetasol results in decreased expression of GAP43 mRNA CTD PMID:27462272 NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797 		JBrowse link
G Gars1 glycyl-tRNA synthetase 1 increases expression ISO Clobetasol results in increased expression of GARS1 mRNA CTD PMID:27462272 NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit decreases expression ISO Clobetasol results in decreased expression of GCLC mRNA CTD PMID:16882163 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gcn1 GCN1 activator of EIF2AK4 decreases expression ISO Clobetasol results in decreased expression of GCN1 mRNA CTD PMID:27462272 NCBI chr12:46,652,273...46,715,119
Ensembl chr12:46,652,273...46,713,488 		JBrowse link
G Gcsh glycine cleavage system protein H increases expression ISO Clobetasol results in increased expression of GCSH mRNA CTD PMID:27462272 NCBI chr19:61,944,850...61,955,607
Ensembl chr19:61,944,850...61,955,607 		JBrowse link
G Gdf11 growth differentiation factor 11 decreases expression ISO Clobetasol results in decreased expression of GDF11 mRNA CTD PMID:27462272 NCBI chr 7:1,896,229...1,909,147
Ensembl chr 7:1,896,229...1,905,222 		JBrowse link
G Gdi1 GDP dissociation inhibitor 1 increases expression ISO Clobetasol results in increased expression of GDI1 mRNA CTD PMID:27462272 NCBI chr  X:157,238,900...157,245,562
Ensembl chr  X:157,238,892...157,245,560 		JBrowse link
G Gdpd3 glycerophosphodiester phosphodiesterase domain containing 3 increases expression ISO Clobetasol results in increased expression of GDPD3 mRNA CTD PMID:27462272 NCBI chr 1:190,804,053...190,813,609
Ensembl chr 1:190,803,993...190,813,606 		JBrowse link
G Get3 guided entry of tail-anchored proteins factor 3, ATPase increases expression ISO Clobetasol results in increased expression of GET3 mRNA CTD PMID:27462272 NCBI chr19:40,034,675...40,043,064
Ensembl chr19:40,034,967...40,043,061 		JBrowse link
G Gfpt2 glutamine-fructose-6-phosphate transaminase 2 increases expression ISO Clobetasol results in increased expression of GFPT2 mRNA CTD PMID:27462272 NCBI chr10:34,616,146...34,662,420
Ensembl chr10:34,615,370...34,662,419 		JBrowse link
G Glmp glycosylated lysosomal membrane protein increases expression ISO Clobetasol results in increased expression of GLMP mRNA CTD PMID:27462272 NCBI chr 2:176,092,098...176,095,688
Ensembl chr 2:176,091,839...176,097,208 		JBrowse link
G Glo1 glyoxalase 1 increases expression ISO Clobetasol results in increased expression of GLO1 mRNA CTD PMID:27462272 NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,665,061...8,683,191 		JBrowse link
G Glrx3 glutaredoxin 3 increases expression ISO Clobetasol results in increased expression of GLRX3 mRNA CTD PMID:27462272 NCBI chr 1:201,671,410...201,701,722
Ensembl chr 1:201,671,481...201,701,717 		JBrowse link
G Glrx5 glutaredoxin 5 increases expression ISO Clobetasol results in increased expression of GLRX5 mRNA CTD PMID:27462272 NCBI chr 6:129,752,902...129,763,278
Ensembl chr 6:129,752,840...129,763,278 		JBrowse link
G Glul glutamate-ammonia ligase increases expression ISO Clobetasol results in increased expression of GLUL mRNA CTD PMID:27462272 NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520 		JBrowse link
G Gm2a ganglioside GM2 activator increases expression ISO Clobetasol results in increased expression of GM2A mRNA CTD PMID:27462272 NCBI chr10:39,719,919...39,732,452
Ensembl chr10:39,719,938...39,732,451 		JBrowse link
G Gmcl1 germ cell-less 1, spermatogenesis associated increases expression ISO Clobetasol results in increased expression of GMCL1 mRNA CTD PMID:27462272 NCBI chr 4:120,697,976...120,737,267
Ensembl chr 4:120,697,976...120,737,257 		JBrowse link
G Gna13 G protein subunit alpha 13 increases expression ISO Clobetasol results in increased expression of GNA13 mRNA CTD PMID:27462272 NCBI chr10:94,837,271...94,870,290
Ensembl chr10:94,836,444...94,874,968 		JBrowse link
G Gnai3 G protein subunit alpha i3 increases expression ISO Clobetasol results in increased expression of GNAI3 mRNA CTD PMID:27462272 NCBI chr 2:198,430,920...198,468,874 JBrowse link
G Gnb2 G protein subunit beta 2 increases expression ISO Clobetasol results in increased expression of GNB2 mRNA CTD PMID:27462272 NCBI chr12:24,795,505...24,800,796
Ensembl chr12:24,795,827...24,800,796 		JBrowse link
G Golgb1 golgin B1 decreases expression ISO Clobetasol results in decreased expression of GOLGB1 mRNA CTD PMID:27462272 NCBI chr11:77,348,573...77,406,165
Ensembl chr11:77,348,961...77,406,006 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases expression ISO Clobetasol results in increased expression of GOT1 mRNA CTD PMID:27462272 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 increases expression ISO Clobetasol results in increased expression of GPD1 mRNA CTD PMID:27462272 NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368 		JBrowse link
G Gper1 G protein-coupled estrogen receptor 1 increases expression ISO Clobetasol results in increased expression of GPER1 mRNA CTD PMID:27462272 NCBI chr12:20,331,073...20,336,527
Ensembl chr12:20,327,679...20,337,144 		JBrowse link
G Gpi glucose-6-phosphate isomerase increases expression ISO Clobetasol results in increased expression of GPI1 mRNA CTD PMID:27462272 NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:95,965,396...95,993,261 		JBrowse link
G Gpr17 G protein-coupled receptor 17 decreases expression ISO Clobetasol results in decreased expression of GPR17 mRNA CTD PMID:27462272 NCBI chr18:23,850,460...23,857,381
Ensembl chr18:23,850,107...23,857,702 		JBrowse link
G Gprc5b G protein-coupled receptor, class C, group 5, member B increases expression ISO Clobetasol results in increased expression of GPRC5B mRNA CTD PMID:27462272 NCBI chr 1:182,748,247...182,772,711
Ensembl chr 1:182,748,247...182,772,757 		JBrowse link
G Gpx1 glutathione peroxidase 1 increases expression ISO Clobetasol results in increased expression of GPX1 mRNA CTD PMID:27462272 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Grhpr glyoxylate and hydroxypyruvate reductase increases expression ISO Clobetasol results in increased expression of GRHPR mRNA CTD PMID:27462272 NCBI chr 5:64,029,856...64,039,287
Ensembl chr 5:64,022,368...64,039,276 		JBrowse link
G Grik3 glutamate ionotropic receptor kainate type subunit 3 decreases expression ISO Clobetasol results in decreased expression of GRIK3 mRNA CTD PMID:27462272 NCBI chr 5:143,052,442...143,268,873
Ensembl chr 5:143,052,442...143,268,873 		JBrowse link
G Grina glutamate ionotropic receptor NMDA type subunit associated protein 1 increases expression ISO Clobetasol results in increased expression of GRINA mRNA CTD PMID:27462272 NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:109,843,196...109,846,042 		JBrowse link
G Grm3 glutamate metabotropic receptor 3 decreases expression ISO Clobetasol results in decreased expression of GRM3 mRNA CTD PMID:27462272 NCBI chr 4:25,319,218...25,600,721
Ensembl chr 4:25,319,942...25,564,764 		JBrowse link
G Gsk3a glycogen synthase kinase 3 alpha increases expression ISO Clobetasol results in increased expression of GSK3A mRNA CTD PMID:27462272 NCBI chr 1:89,943,669...89,953,514
Ensembl chr 1:89,943,669...89,953,593 		JBrowse link
G Gsr glutathione-disulfide reductase increases expression ISO Clobetasol results in increased expression of GSR mRNA CTD PMID:27462272 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gstm2 glutathione S-transferase mu 2 increases expression ISO Clobetasol results in increased expression of GSTM5 mRNA CTD PMID:27462272 NCBI chr 2:198,312,179...198,316,962 JBrowse link
G Gstp1 glutathione S-transferase pi 1 increases expression ISO Clobetasol results in increased expression of GSTP1 mRNA CTD PMID:27462272 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gtpbp1 GTP binding protein 1 increases expression ISO Clobetasol results in increased expression of GTPBP1 mRNA CTD PMID:27462272 NCBI chr 7:113,128,645...113,153,094
Ensembl chr 7:113,128,670...113,154,621 		JBrowse link
G Gucy1a1 guanylate cyclase 1 soluble subunit alpha 1 increases expression ISO Clobetasol results in increased expression of GUCY1A1 mRNA CTD PMID:27462272 NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737 		JBrowse link
G H1f0 H1.0 linker histone increases expression ISO Clobetasol results in increased expression of H1F0 mRNA CTD PMID:27462272 NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:112,473,222...112,475,006 		JBrowse link
G H2aj H2A.J histone increases expression ISO Clobetasol results in increased expression of H2AJ mRNA CTD PMID:27462272 NCBI chr 4:171,406,922...171,407,406
Ensembl chr 4:171,406,177...171,408,845 		JBrowse link
G Hars1 histidyl-tRNA synthetase 1 increases expression ISO Clobetasol results in increased expression of HARS1 mRNA CTD PMID:27462272 NCBI chr18:28,655,669...28,672,712
Ensembl chr18:28,655,671...28,672,712 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor decreases expression ISO Clobetasol results in decreased expression of HBEGF mRNA CTD PMID:27462272 NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220 		JBrowse link
G Hcfc1 host cell factor C1 decreases expression ISO Clobetasol results in decreased expression of HCFC1 mRNA CTD PMID:27462272 NCBI chr  X:156,839,100...156,864,132
Ensembl chr  X:156,839,100...156,863,813 		JBrowse link
G Hdac3 histone deacetylase 3 increases expression ISO Clobetasol results in increased expression of HDAC3 mRNA CTD PMID:27462272 NCBI chr18:30,021,847...30,041,061
Ensembl chr18:30,021,941...30,041,025 		JBrowse link
G Hectd4 HECT domain E3 ubiquitin protein ligase 4 decreases expression ISO Clobetasol results in decreased expression of HECTD4 mRNA CTD PMID:27462272 NCBI chr12:40,800,232...40,991,584
Ensembl chr12:40,843,770...40,991,798 		JBrowse link
G Hepacam hepatic and glial cell adhesion molecule increases expression ISO Clobetasol results in increased expression of HEPACAM mRNA CTD PMID:27462272 NCBI chr 8:45,276,594...45,294,006
Ensembl chr 8:45,276,683...45,295,548 		JBrowse link
G Herc1 HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 decreases expression ISO Clobetasol results in decreased expression of HERC1 mRNA CTD PMID:27462272 NCBI chr 8:75,796,347...75,965,347
Ensembl chr 8:75,796,357...75,965,347 		JBrowse link
G Hip1r huntingtin interacting protein 1 related decreases expression ISO Clobetasol results in decreased expression of HIP1R mRNA CTD PMID:27462272 NCBI chr12:38,251,085...38,279,756
Ensembl chr12:38,251,086...38,279,654 		JBrowse link
G Hivep1 HIVEP zinc finger 1 decreases expression ISO Clobetasol results in decreased expression of HIVEP1 mRNA CTD PMID:27462272 NCBI chr17:22,790,855...22,920,359
Ensembl chr17:22,790,855...22,917,196 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase increases expression ISO Clobetasol results in increased expression of HMGCR mRNA CTD PMID:27462272 NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533 		JBrowse link
G Hook3 hook microtubule-tethering protein 3 decreases expression ISO Clobetasol results in decreased expression of HOOK3 mRNA CTD PMID:27462272 NCBI chr16:72,656,929...72,751,696
Ensembl chr16:72,657,019...72,764,071 		JBrowse link
G Hoxa5 homeo box A5 decreases expression ISO Clobetasol results in decreased expression of HOXA5 mRNA CTD PMID:27462272 NCBI chr 4:82,632,958...82,636,851
Ensembl chr 4:82,632,306...82,639,038 		JBrowse link
G Hr HR, lysine demethylase and nuclear receptor corepressor decreases expression ISO Clobetasol results in decreased expression of HR mRNA CTD PMID:27462272 NCBI chr15:52,036,540...52,056,019
Ensembl chr15:52,036,540...52,056,015 		JBrowse link
G Hs3st1 heparan sulfate-glucosamine 3-sulfotransferase 1 increases expression ISO Clobetasol results in increased expression of HS3ST1 mRNA CTD PMID:27462272 NCBI chr14:75,398,101...75,429,628
Ensembl chr14:75,398,026...75,436,848 		JBrowse link
G Hsd17b4 hydroxysteroid (17-beta) dehydrogenase 4 increases expression ISO Clobetasol results in increased expression of HSD17B4 mRNA CTD PMID:27462272 NCBI chr18:45,515,427...45,604,467
Ensembl chr18:45,515,373...45,604,467 		JBrowse link
G Hsd17b7 hydroxysteroid (17-beta) dehydrogenase 7 increases expression ISO Clobetasol results in increased expression of HSD17B7 mRNA CTD PMID:27462272 NCBI chr13:84,702,875...84,722,810
Ensembl chr13:84,705,631...84,722,754 		JBrowse link
G Hspe1 heat shock protein family E (Hsp10) member 1 increases expression ISO Clobetasol results in increased expression of HSPE1 mRNA CTD PMID:27462272 NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502 		JBrowse link
G Hspg2 heparan sulfate proteoglycan 2 decreases expression ISO Clobetasol results in decreased expression of HSPG2 mRNA CTD PMID:27462272 NCBI chr 5:154,960,818...155,061,971
Ensembl chr 5:154,960,846...155,061,971 		JBrowse link
G Hypk Huntingtin interacting protein K increases expression ISO Clobetasol results in increased expression of HYPK mRNA CTD PMID:27462272 NCBI chr 3:128,888,709...128,890,089
Ensembl chr 3:128,888,717...128,891,405 		JBrowse link
G Icam1 intercellular adhesion molecule 1 decreases expression ISO Clobetasol results in decreased expression of ICAM1 protein CTD PMID:15086553 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Id1 inhibitor of DNA binding 1 increases expression ISO Clobetasol results in increased expression of ID1 mRNA CTD PMID:27462272 NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685 		JBrowse link
G Id3 inhibitor of DNA binding 3 increases expression ISO Clobetasol results in increased expression of ID3 mRNA CTD PMID:27462272 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856 		JBrowse link
G Idh2 isocitrate dehydrogenase (NADP(+)) 2 increases expression ISO Clobetasol results in increased expression of IDH2 mRNA CTD PMID:27462272 NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248 		JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 increases expression ISO Clobetasol results in increased expression of IDI1 mRNA CTD PMID:27462272 NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524 		JBrowse link
G Ier3ip1 immediate early response 3 interacting protein 1 increases expression ISO Clobetasol results in increased expression of IER3IP1 mRNA CTD PMID:27462272 NCBI chr18:72,749,976...72,761,060
Ensembl chr18:72,749,976...72,801,679 		JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 increases expression ISO Clobetasol results in increased expression of IGFBP2 mRNA CTD PMID:27462272 NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 increases expression ISO Clobetasol results in increased expression of IGFBP3 mRNA CTD PMID:27462272 NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 decreases expression ISO Clobetasol results in decreased expression of IGFBP5 mRNA CTD PMID:27462272 NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390 		JBrowse link
G Igsf10 immunoglobulin superfamily, member 10 decreases expression ISO Clobetasol results in decreased expression of IGSF10 mRNA CTD PMID:27462272 NCBI chr 2:145,725,868...145,754,850
Ensembl chr 2:145,725,878...145,754,579 		JBrowse link
G Igsf9b immunoglobulin superfamily, member 9B decreases expression ISO Clobetasol results in decreased expression of IGSF9B mRNA CTD PMID:27462272 NCBI chr 8:33,971,779...34,027,390
Ensembl chr 8:33,971,779...34,018,128 		JBrowse link
G Il1a interleukin 1 alpha decreases secretion ISO Clobetasol results in decreased secretion of IL1A protein CTD PMID:15086553 NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013 		JBrowse link
G Il2ra interleukin 2 receptor subunit alpha decreases expression ISO Clobetasol results in decreased expression of IL2RA protein CTD PMID:15086553 NCBI chr17:71,759,802...71,808,475
Ensembl chr17:71,759,802...71,808,507 		JBrowse link
G Ilf2 interleukin enhancer binding factor 2 decreases expression ISO Clobetasol results in decreased expression of ILF2 mRNA CTD PMID:27462272 NCBI chr 2:178,256,927...178,268,773
Ensembl chr 2:178,248,585...178,268,920 		JBrowse link
G Imp3 IMP U3 small nucleolar ribonucleoprotein 3 increases expression ISO Clobetasol results in increased expression of IMP3 mRNA CTD PMID:27462272 NCBI chr 8:66,235,498...66,236,386 JBrowse link
G Impact impact RWD domain protein increases expression ISO Clobetasol results in increased expression of IMPACT mRNA CTD PMID:27462272 NCBI chr18:4,383,546...4,422,280
Ensembl chr18:4,383,575...4,422,278 		JBrowse link
G Impdh2 inosine monophosphate dehydrogenase 2 increases expression ISO Clobetasol results in increased expression of IMPDH2 mRNA CTD PMID:27462272 NCBI chr 8:118,135,204...118,139,892
Ensembl chr 8:118,135,262...118,139,873 		JBrowse link
G Ino80 INO80 complex ATPase subunit decreases expression ISO Clobetasol results in decreased expression of INO80 mRNA CTD PMID:27462272 NCBI chr 3:126,822,280...126,919,532
Ensembl chr 3:126,822,280...126,919,532 		JBrowse link
G Insig1 insulin induced gene 1 increases expression ISO Clobetasol results in increased expression of INSIG1 mRNA CTD PMID:27462272 NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778 		JBrowse link
G Ints11 integrator complex subunit 11 increases expression ISO Clobetasol results in increased expression of INTS11 mRNA CTD PMID:27462272 NCBI chr 5:171,761,370...171,779,883
Ensembl chr 5:171,761,371...171,779,883 		JBrowse link
G Ints5 integrator complex subunit 5 increases expression ISO Clobetasol results in increased expression of INTS5 mRNA CTD PMID:27462272 NCBI chr 1:215,218,012...215,222,790
Ensembl chr 1:215,218,017...215,223,240 		JBrowse link
G Iqgap2 IQ motif containing GTPase activating protein 2 decreases expression ISO Clobetasol results in decreased expression of IQGAP2 mRNA CTD PMID:27462272 NCBI chr 2:28,629,558...28,904,649
Ensembl chr 2:28,629,558...28,904,649 		JBrowse link
G Iqsec1 IQ motif and Sec7 domain ArfGEF 1 decreases expression ISO Clobetasol results in decreased expression of IQSEC1 mRNA CTD PMID:27462272 NCBI chr 4:124,725,917...125,045,351
Ensembl chr 4:124,725,917...125,045,550 		JBrowse link
G Irs2 insulin receptor substrate 2 decreases expression ISO Clobetasol results in decreased expression of IRS2 mRNA CTD PMID:27462272 NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543 		JBrowse link
G Itpa inosine triphosphatase increases expression ISO Clobetasol results in increased expression of ITPA mRNA CTD PMID:27462272 NCBI chr 3:138,338,549...138,350,329
Ensembl chr 3:138,338,349...138,350,329 		JBrowse link
G Itsn1 intersectin 1 decreases expression ISO Clobetasol results in decreased expression of ITSN1 mRNA CTD PMID:27462272 NCBI chr11:44,464,515...44,646,598
Ensembl chr11:44,513,186...44,646,598 		JBrowse link
G Ivd isovaleryl-CoA dehydrogenase increases expression ISO Clobetasol results in increased expression of IVD mRNA CTD PMID:27462272 NCBI chr 3:126,305,584...126,326,016
Ensembl chr 3:126,305,364...126,328,160 		JBrowse link
G Iws1 interacts with SUPT6H, CTD assembly factor 1 decreases expression ISO Clobetasol results in decreased expression of IWS1 mRNA CTD PMID:27462272 NCBI chr18:23,969,352...24,011,560
Ensembl chr18:23,969,733...24,010,415 		JBrowse link
G Jak1 Janus kinase 1 decreases expression ISO Clobetasol results in decreased expression of JAK1 mRNA CTD PMID:27462272 NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758 		JBrowse link
G Jam3 junctional adhesion molecule 3 increases expression ISO Clobetasol results in increased expression of JAM3 mRNA CTD PMID:27462272 NCBI chr 8:33,767,606...33,828,451
Ensembl chr 8:33,767,607...33,828,623 		JBrowse link
G Jmjd1c jumonji domain containing 1C decreases expression ISO Clobetasol results in decreased expression of JMJD1C mRNA CTD PMID:27462272 NCBI chr20:21,330,990...21,508,580
Ensembl chr20:21,330,990...21,461,916 		JBrowse link
G Jmjd8 jumonji domain containing 8 increases expression ISO Clobetasol results in increased expression of JMJD8 mRNA CTD PMID:27462272 NCBI chr10:15,353,460...15,356,392
Ensembl chr10:15,353,475...15,356,393 		JBrowse link
G Jmy junction mediating and regulatory protein, p53 cofactor decreases expression ISO Clobetasol results in decreased expression of JMY mRNA CTD PMID:27462272 NCBI chr 2:26,401,047...26,465,959
Ensembl chr 2:26,409,969...26,465,649 		JBrowse link
G Jpt1 Jupiter microtubule associated homolog 1 increases expression ISO Clobetasol results in increased expression of JPT1 mRNA CTD PMID:27462272 NCBI chr10:101,243,428...101,261,464
Ensembl chr10:101,243,424...101,261,469 		JBrowse link
G Kank4 KN motif and ankyrin repeat domains 4 decreases expression ISO Clobetasol results in decreased expression of KANK4 mRNA CTD PMID:27462272 NCBI chr 5:118,516,994...118,581,024
Ensembl chr 5:118,517,971...118,581,002 		JBrowse link
G Kazn kazrin, periplakin interacting protein decreases expression ISO Clobetasol results in decreased expression of KAZN mRNA CTD PMID:27462272 NCBI chr 5:159,675,803...160,666,084
Ensembl chr 5:159,675,803...160,664,154 		JBrowse link
G Kcna2 potassium voltage-gated channel subfamily A member 2 decreases expression ISO Clobetasol results in decreased expression of KCNA2 mRNA CTD PMID:27462272 NCBI chr 2:197,392,746...197,406,606
Ensembl chr 2:197,392,698...197,407,519 		JBrowse link
G Kcnmb4 potassium calcium-activated channel subfamily M regulatory beta subunit 4 increases expression ISO Clobetasol results in increased expression of KCNMB4 mRNA CTD PMID:27462272 NCBI chr 7:53,952,150...54,005,101
Ensembl chr 7:53,949,881...54,005,281 		JBrowse link
G Kcnt1 potassium sodium-activated channel subfamily T member 1 increases expression ISO Clobetasol results in increased expression of KCNT1 mRNA CTD PMID:27462272 NCBI chr 3:29,081,071...29,136,902
Ensembl chr 3:29,081,321...29,134,768 		JBrowse link
G Kctd5 potassium channel tetramerization domain containing 5 increases expression ISO Clobetasol results in increased expression of KCTD5 mRNA CTD PMID:27462272 NCBI chr10:13,583,781...13,609,762
Ensembl chr10:13,583,781...13,610,062 		JBrowse link
G Kdelr2 KDEL endoplasmic reticulum protein retention receptor 2 increases expression ISO Clobetasol results in increased expression of KDELR2 mRNA CTD PMID:27462272 NCBI chr12:16,252,424...16,270,737
Ensembl chr12:16,252,424...16,270,719 		JBrowse link
G Kdm6b lysine demethylase 6B decreases expression ISO Clobetasol results in decreased expression of KDM6B mRNA CTD PMID:27462272 NCBI chr10:54,619,520...54,641,014
Ensembl chr10:54,619,544...54,629,610 		JBrowse link
G Khdrbs1 KH RNA binding domain containing, signal transduction associated 1 decreases expression ISO Clobetasol results in decreased expression of KHDRBS1 mRNA CTD PMID:27462272 NCBI chr 5:147,337,048...147,374,604
Ensembl chr 5:147,347,904...147,373,448 		JBrowse link
G Kif13a kinesin family member 13A decreases expression ISO Clobetasol results in decreased expression of KIF13A mRNA CTD PMID:27462272 NCBI chr17:17,972,227...18,154,763
Ensembl chr17:17,972,325...18,154,760 		JBrowse link
G Kif5a kinesin family member 5A decreases expression ISO Clobetasol results in decreased expression of KIF5A mRNA CTD PMID:27462272 NCBI chr 7:64,937,210...64,974,339
Ensembl chr 7:64,934,740...64,978,272 		JBrowse link
G Kirrel2 kirre like nephrin family adhesion molecule 2 increases expression ISO Clobetasol results in increased expression of KIRREL2 mRNA CTD PMID:27462272 NCBI chr 1:94,836,243...94,846,119
Ensembl chr 1:94,836,243...94,846,119 		JBrowse link
G Klf9 KLF transcription factor 9 increases expression ISO Clobetasol results in increased expression of KLF9 mRNA CTD PMID:27462272 NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:230,126,646...230,151,641 		JBrowse link
G Kmt2c lysine methyltransferase 2C decreases expression ISO Clobetasol results in decreased expression of KMT2C mRNA CTD PMID:27462272 NCBI chr 4:10,353,698...10,755,965
Ensembl chr 4:10,353,735...10,568,620 		JBrowse link
G Kmt2d lysine methyltransferase 2D decreases expression ISO Clobetasol results in decreased expression of KMT2D mRNA CTD PMID:27462272 NCBI chr 7:131,859,696...131,901,032
Ensembl chr 7:131,859,696...131,900,072 		JBrowse link
G Kmt2e lysine methyltransferase 2E decreases expression ISO Clobetasol results in decreased expression of KMT2E mRNA CTD PMID:27462272 NCBI chr 4:12,550,570...12,655,329
Ensembl chr 4:12,550,570...12,619,721 		JBrowse link
G Knl1 kinetochore scaffold 1 decreases expression ISO Clobetasol results in decreased expression of KNL1 mRNA CTD PMID:27462272 NCBI chr 3:126,483,498...126,545,774
Ensembl chr 3:126,483,544...126,545,774 		JBrowse link
G Krtcap2 keratinocyte associated protein 2 increases expression ISO Clobetasol results in increased expression of KRTCAP2 mRNA CTD PMID:27462272 NCBI chr 2:176,952,167...176,956,163
Ensembl chr 2:176,949,809...176,956,163 		JBrowse link
G Kti12 KTI12 chromatin associated increases expression ISO Clobetasol results in increased expression of KTI12 mRNA CTD PMID:27462272 NCBI chr 5:128,829,751...128,831,273
Ensembl chr 5:128,826,844...128,834,910 		JBrowse link
G Lama1 laminin subunit alpha 1 decreases expression ISO Clobetasol results in decreased expression of LAMA1 mRNA CTD PMID:27462272 NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:115,139,548...115,264,251 		JBrowse link
G Lamtor1 late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 increases expression ISO Clobetasol results in increased expression of LAMTOR1 mRNA CTD PMID:27462272 NCBI chr 1:165,684,001...165,689,698
Ensembl chr 1:165,684,091...165,703,178 		JBrowse link
G Lamtor5 late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 increases expression ISO Clobetasol results in increased expression of LAMTOR5 mRNA CTD PMID:27462272 NCBI chr 2:197,588,242...197,593,598
Ensembl chr 2:197,588,242...197,593,598 		JBrowse link
G Laptm4b lysosomal protein transmembrane 4 beta increases expression ISO Clobetasol results in increased expression of LAPTM4B mRNA CTD PMID:27462272 NCBI chr 7:67,319,438...67,362,547
Ensembl chr 7:67,319,542...67,363,258 		JBrowse link
G Larp1 La ribonucleoprotein 1, translational regulator decreases expression ISO Clobetasol results in decreased expression of LARP1 mRNA CTD PMID:27462272 NCBI chr10:42,691,833...42,746,816
Ensembl chr10:42,691,600...42,746,816 		JBrowse link
G Lbh LBH regulator of WNT signaling pathway increases expression ISO Clobetasol results in increased expression of LBH mRNA CTD PMID:27462272 NCBI chr 6:28,321,040...28,344,855
Ensembl chr 6:28,321,040...28,370,238 		JBrowse link
G Leng8 leukocyte receptor cluster member 8 decreases expression ISO Clobetasol results in decreased expression of LENG8 mRNA CTD PMID:27462272 NCBI chr 1:79,113,038...79,124,868
Ensembl chr 1:79,113,038...79,124,738 		JBrowse link
G Lfng LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase increases expression ISO Clobetasol results in increased expression of LFNG mRNA CTD PMID:27462272 NCBI chr12:19,144,474...19,152,951
Ensembl chr12:19,124,662...19,152,918 		JBrowse link
G Lgals1 galectin 1 increases expression ISO Clobetasol results in increased expression of LGALS1 mRNA CTD PMID:27462272 NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800 		JBrowse link
G Lgalsl galectin-like increases expression ISO Clobetasol results in increased expression of LGALSL mRNA CTD PMID:27462272 NCBI chr14:99,198,340...99,205,846
Ensembl chr14:99,198,339...99,206,487 		JBrowse link
G Lin52 lin-52 DREAM MuvB core complex component increases expression ISO Clobetasol results in increased expression of LIN52 mRNA CTD PMID:27462272 NCBI chr 6:109,829,896...109,927,122
Ensembl chr 6:109,830,131...109,925,310 		JBrowse link
G Litaf lipopolysaccharide-induced TNF factor increases expression ISO Clobetasol results in increased expression of LITAF mRNA CTD PMID:27462272 NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930 		JBrowse link
G Lman2 lectin, mannose-binding 2 increases expression ISO Clobetasol results in increased expression of LMAN2 mRNA CTD PMID:27462272 NCBI chr17:9,274,362...9,294,950
Ensembl chr17:9,274,136...9,292,370 		JBrowse link
G Lmcd1 LIM and cysteine-rich domains 1 increases expression ISO Clobetasol results in increased expression of LMCD1 mRNA CTD PMID:27462272 NCBI chr 4:146,948,993...147,007,878
Ensembl chr 4:146,948,958...147,007,875 		JBrowse link
G Lpo lactoperoxidase increases expression ISO Clobetasol results in increased expression of LPO mRNA CTD PMID:27462272 NCBI chr10:73,104,170...73,124,683
Ensembl chr10:73,104,188...73,123,456 		JBrowse link
G Lrp1 LDL receptor related protein 1 decreases expression ISO Clobetasol results in decreased expression of LRP1 mRNA CTD PMID:27462272 NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:65,265,639...65,346,196 		JBrowse link
G Lrp2 LDL receptor related protein 2 increases expression ISO Clobetasol results in increased expression of LRP2 mRNA CTD PMID:27462272 NCBI chr 3:74,597,148...74,754,535
Ensembl chr 3:74,597,148...74,754,535 		JBrowse link
G Lrrc4b leucine rich repeat containing 4B decreases expression ISO Clobetasol results in decreased expression of LRRC4B mRNA CTD PMID:27462272 NCBI chr 1:104,058,558...104,092,831
Ensembl chr 1:104,072,128...104,093,298 		JBrowse link
G Lrrtm2 leucine rich repeat transmembrane neuronal 2 decreases expression ISO Clobetasol results in decreased expression of LRRTM2 mRNA CTD PMID:27462272 NCBI chr18:27,091,919...27,096,967
Ensembl chr18:27,091,919...27,096,967 		JBrowse link
G Lsm4 LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated increases expression ISO Clobetasol results in increased expression of LSM4 mRNA CTD PMID:27462272 NCBI chr16:18,789,466...18,795,164
Ensembl chr16:18,789,467...18,794,886 		JBrowse link
G Lsm8 LSM8 homolog, U6 small nuclear RNA associated increases expression ISO Clobetasol results in increased expression of LSM8 mRNA CTD PMID:27462272 NCBI chr 4:48,272,128...48,277,994
Ensembl chr 4:48,272,164...48,280,162 		JBrowse link
G Ly75 lymphocyte antigen 75 decreases expression ISO Clobetasol results in decreased expression of LY75 protein CTD PMID:15086553 NCBI chr 3:65,173,395...65,260,878
Ensembl chr 3:65,173,395...65,260,878 		JBrowse link
G Macrod1 mono-ADP ribosylhydrolase 1 increases expression ISO Clobetasol results in increased expression of MACROD1 mRNA CTD PMID:27462272 NCBI chr 1:213,675,413...213,831,571
Ensembl chr 1:213,675,406...213,816,348 		JBrowse link
G Mafk MAF bZIP transcription factor K increases expression ISO Clobetasol results in increased expression of MAFK mRNA CTD PMID:27462272 NCBI chr12:19,948,473...19,970,351
Ensembl chr12:19,948,476...19,959,192 		JBrowse link
G Magee1 MAGE family member E1 decreases expression ISO Clobetasol results in decreased expression of MAGEE1 mRNA CTD PMID:27462272 NCBI chr  X:74,254,848...74,258,395
Ensembl chr  X:74,254,958...74,258,371 		JBrowse link
G Mageh1 MAGE family member H1 increases expression ISO Clobetasol results in increased expression of MAGEH1 mRNA CTD PMID:27462272 NCBI chr  X:21,725,709...21,726,965
Ensembl chr  X:21,718,669...21,727,219 		JBrowse link
G Manbal mannosidase beta like increases expression ISO Clobetasol results in increased expression of MANBAL mRNA CTD PMID:27462272 NCBI chr 3:166,455,067...166,484,652
Ensembl chr 3:166,455,066...166,487,431 		JBrowse link
G Manf mesencephalic astrocyte-derived neurotrophic factor increases expression ISO Clobetasol results in increased expression of MANF mRNA CTD PMID:27462272 NCBI chr 8:116,427,053...116,430,259
Ensembl chr 8:116,427,048...116,429,910 		JBrowse link
G Map1b microtubule-associated protein 1B decreases expression ISO Clobetasol results in decreased expression of MAP1B mRNA CTD PMID:27462272 NCBI chr 2:32,551,423...32,644,471
Ensembl chr 2:32,551,423...32,657,094 		JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta increases expression ISO Clobetasol results in increased expression of MAP1LC3B mRNA CTD PMID:27462272 NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358 		JBrowse link
G Map2 microtubule-associated protein 2 decreases expression ISO Clobetasol results in decreased expression of MAP2 mRNA CTD PMID:27462272 NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459 		JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 increases expression ISO Clobetasol results in increased expression of MAP2K1 mRNA CTD PMID:27462272 NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184 		JBrowse link
G Mapk8ip2 mitogen-activated protein kinase 8 interacting protein 2 increases expression ISO Clobetasol results in increased expression of MAPK8IP2 mRNA CTD PMID:27462272 NCBI chr 7:122,406,350...122,416,602
Ensembl chr 7:122,406,350...122,416,602 		JBrowse link
G Marf1 meiosis regulator and mRNA stability factor 1 decreases expression ISO Clobetasol results in decreased expression of MARF1 mRNA CTD PMID:27462272 NCBI chr10:1,395,271...1,439,974
Ensembl chr10:1,395,282...1,439,974 		JBrowse link
G Mast4 microtubule associated serine/threonine kinase family member 4 decreases expression ISO Clobetasol results in decreased expression of MAST4 mRNA CTD PMID:27462272 NCBI chr 2:35,627,190...36,219,090
Ensembl chr 2:35,627,190...36,218,832 		JBrowse link
G Mcm3ap minichromosome maintenance complex component 3 associated protein decreases expression ISO Clobetasol results in decreased expression of MCM3AP mRNA CTD PMID:27462272 NCBI chr20:12,127,060...12,164,651
Ensembl chr20:12,127,060...12,164,651 		JBrowse link
G Mdc1 mediator of DNA damage checkpoint 1 decreases expression ISO Clobetasol results in decreased expression of MDC1 mRNA CTD PMID:27462272 NCBI chr20:2,898,496...2,914,960
Ensembl chr20:2,900,308...2,914,960 		JBrowse link
G Mdh1 malate dehydrogenase 1 increases expression ISO Clobetasol results in increased expression of MDH1 mRNA CTD PMID:27462272 NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232 		JBrowse link
G Mdh2 malate dehydrogenase 2 increases expression ISO Clobetasol results in increased expression of MDH2 mRNA CTD PMID:27462272 NCBI chr12:26,530,886...26,543,841
Ensembl chr12:26,530,881...26,543,841 		JBrowse link
G Mdn1 midasin AAA ATPase 1 decreases expression ISO Clobetasol results in decreased expression of MDN1 mRNA CTD PMID:27462272 NCBI chr 5:51,851,785...51,982,688
Ensembl chr 5:51,851,809...51,982,688 		JBrowse link
G Mecr mitochondrial trans-2-enoyl-CoA reductase increases expression ISO Clobetasol results in increased expression of MECR mRNA CTD PMID:27462272 NCBI chr 5:149,313,765...149,339,964
Ensembl chr 5:149,313,774...149,342,825 		JBrowse link
G Megf9 multiple EGF-like-domains 9 increases expression ISO Clobetasol results in increased expression of MEGF9 mRNA CTD PMID:27462272 NCBI chr 5:89,008,679...89,120,731
Ensembl chr 5:89,008,679...89,120,731 		JBrowse link
G Mertk MER proto-oncogene, tyrosine kinase increases expression ISO Clobetasol results in increased expression of MERTK mRNA CTD PMID:27462272 NCBI chr 3:136,391,936...136,498,366
Ensembl chr 3:136,383,560...136,500,192 		JBrowse link
G Mesd mesoderm development LRP chaperone increases expression ISO Clobetasol results in increased expression of MESD mRNA CTD PMID:27462272 NCBI chr 1:147,275,904...147,289,134
Ensembl chr 1:147,275,396...147,289,134 		JBrowse link
G Metap1 methionyl aminopeptidase 1 increases expression ISO Clobetasol results in increased expression of METAP1 mRNA CTD PMID:27462272 NCBI chr 2:229,664,677...229,697,730
Ensembl chr 2:229,664,677...229,719,084 		JBrowse link
G Metrn meteorin, glial cell differentiation regulator increases expression ISO Clobetasol results in increased expression of METRN mRNA CTD PMID:27462272 NCBI chr10:15,321,200...15,323,218
Ensembl chr10:15,321,200...15,323,642 		JBrowse link
G Mex3a mex-3 RNA binding family member A decreases expression ISO Clobetasol results in decreased expression of MEX3A mRNA CTD PMID:27462272 NCBI chr 2:176,287,900...176,297,369
Ensembl chr 2:176,287,900...176,297,369 		JBrowse link
G Mfsd2a MFSD2 lysolipid transporter A, lysophospholipid increases expression ISO Clobetasol results in increased expression of MFSD2A mRNA CTD PMID:27462272 NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:140,510,953...140,525,916 		JBrowse link
G Mia3 MIA SH3 domain ER export factor 3 decreases expression ISO Clobetasol results in decreased expression of MIA3 mRNA CTD PMID:27462272 NCBI chr13:97,502,040...97,547,155
Ensembl chr13:97,494,275...97,543,587 		JBrowse link
G Mical3 microtubule associated monooxygenase, calponin and LIM domain containing 3 decreases expression ISO Clobetasol results in decreased expression of MICAL3 mRNA CTD PMID:27462272 NCBI chr 4:155,824,941...156,025,003
Ensembl chr 4:155,824,946...156,005,238 		JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO Clobetasol results in decreased expression of MKI67 mRNA CTD PMID:27462272 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mkrn3 makorin, ring finger protein, 3 increases expression ISO Clobetasol results in increased expression of MKRN3 mRNA CTD PMID:27462272 NCBI chr 1:125,338,664...125,341,178
Ensembl chr 1:125,338,564...125,341,164 		JBrowse link
G Mlec malectin increases expression ISO Clobetasol results in increased expression of MLEC mRNA CTD PMID:27462272 NCBI chr12:47,118,918...47,133,598
Ensembl chr12:47,118,855...47,130,064 		JBrowse link
G Mllt1 MLLT1, super elongation complex subunit decreases expression ISO Clobetasol results in decreased expression of MLLT1 mRNA CTD PMID:27462272 NCBI chr 9:1,818,204...1,863,091
Ensembl chr 9:1,818,204...1,863,089 		JBrowse link
G Mmadhc metabolism of cobalamin associated D increases expression ISO Clobetasol results in increased expression of MMADHC mRNA CTD PMID:27462272 NCBI chr 3:55,117,832...55,135,735
Ensembl chr 3:55,117,833...55,135,851 		JBrowse link
G Mpc2 mitochondrial pyruvate carrier 2 increases expression ISO Clobetasol results in increased expression of MPC2 mRNA CTD PMID:27462272 NCBI chr13:80,261,143...80,280,668
Ensembl chr13:80,259,727...80,280,668 		JBrowse link
G Mrpl14 mitochondrial ribosomal protein L14 increases expression ISO Clobetasol results in increased expression of MRPL14 mRNA CTD PMID:27462272 NCBI chr 9:22,800,286...22,812,711
Ensembl chr 9:22,795,744...22,812,855 		JBrowse link
G Mrpl34 mitochondrial ribosomal protein L34 increases expression ISO Clobetasol results in increased expression of MRPL34 mRNA CTD PMID:27462272 NCBI chr16:18,186,447...18,187,182
Ensembl chr16:18,185,306...18,187,181 		JBrowse link
G Mrpl46 mitochondrial ribosomal protein L46 increases expression ISO Clobetasol results in increased expression of MRPL46 mRNA CTD PMID:27462272 NCBI chr 1:142,108,266...142,117,030
Ensembl chr 1:142,106,531...142,117,030 		JBrowse link
G Mrps14 mitochondrial ribosomal protein S14 increases expression ISO Clobetasol results in increased expression of MRPS14 mRNA CTD PMID:27462272 NCBI chr13:74,962,597...74,968,344
Ensembl chr13:74,962,515...74,970,975 		JBrowse link
G Mrps26 mitochondrial ribosomal protein S26 increases expression ISO Clobetasol results in increased expression of MRPS26 mRNA CTD PMID:27462272 NCBI chr 3:138,222,324...138,223,987
Ensembl chr 3:138,222,165...138,223,987 		JBrowse link
G Mrps27 mitochondrial ribosomal protein S27 increases expression ISO Clobetasol results in increased expression of MRPS27 mRNA CTD PMID:27462272 NCBI chr 2:32,474,178...32,542,741
Ensembl chr 2:32,473,965...32,542,738 		JBrowse link
G Msmo1 methylsterol monooxygenase 1 increases expression ISO Clobetasol results in increased expression of MSMO1 mRNA CTD PMID:27462272 NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445 		JBrowse link
G Msn moesin increases expression ISO Clobetasol results in increased expression of MSN mRNA CTD PMID:27462272 NCBI chr  X:65,005,546...65,073,512
Ensembl chr  X:65,005,458...65,075,129 		JBrowse link
G Mtcl2 microtubule crosslinking factor 2 decreases expression ISO Clobetasol results in decreased expression of MTCL2 mRNA CTD PMID:27462272 NCBI chr 3:166,089,141...166,161,043
Ensembl chr 3:166,095,480...166,161,102 		JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase increases expression ISO Clobetasol results in increased expression of MTHFD2 mRNA CTD PMID:27462272 NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350 		JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases expression ISO Clobetasol results in decreased expression of MTOR mRNA CTD PMID:27462272 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435 		JBrowse link
G Mvb12b multivesicular body subunit 12B decreases expression ISO Clobetasol results in decreased expression of MVB12B mRNA CTD PMID:27462272 NCBI chr 3:37,431,636...37,590,276
Ensembl chr 3:37,431,636...37,615,407 		JBrowse link
G Mxd3 Max dimerization protein 3 increases expression ISO Clobetasol results in increased expression of MXD3 mRNA CTD PMID:27462272 NCBI chr17:9,306,552...9,310,278
Ensembl chr17:9,302,321...9,310,278 		JBrowse link
G Mycbp2 MYC binding protein 2 decreases expression ISO Clobetasol results in decreased expression of MYCBP2 mRNA CTD PMID:27462272 NCBI chr15:86,352,061...86,590,126
Ensembl chr15:86,352,061...86,590,325 		JBrowse link
G Myh9 myosin, heavy chain 9 decreases expression ISO Clobetasol results in decreased expression of MYH9 mRNA CTD PMID:27462272 NCBI chr 7:111,224,291...111,304,963
Ensembl chr 7:111,224,291...111,304,963 		JBrowse link
G Myo9a myosin IXA decreases expression ISO Clobetasol results in decreased expression of MYO9A mRNA CTD PMID:27462272 NCBI chr 8:69,044,853...69,248,094
Ensembl chr 8:69,044,885...69,245,231 		JBrowse link
G Nabp2 nucleic acid binding protein 2 increases expression ISO Clobetasol results in increased expression of NABP2 mRNA CTD PMID:27462272 NCBI chr 7:1,415,491...1,421,113
Ensembl chr 7:1,415,492...1,422,682 		JBrowse link
G Nav3 neuron navigator 3 decreases expression ISO Clobetasol results in decreased expression of NAV3 mRNA CTD PMID:27462272 NCBI chr 7:46,938,577...47,726,839
Ensembl chr 7:46,940,670...47,504,893 		JBrowse link
G Ncam2 neural cell adhesion molecule 2 decreases expression ISO Clobetasol results in decreased expression of NCAM2 mRNA CTD PMID:27462272 NCBI chr11:33,591,748...34,078,788
Ensembl chr11:33,591,713...34,078,788 		JBrowse link
G Nckap5l NCK-associated protein 5-like decreases expression ISO Clobetasol results in decreased expression of NCKAP5L mRNA CTD PMID:27462272 NCBI chr 7:132,433,569...132,470,638
Ensembl chr 7:132,433,574...132,470,836 		JBrowse link
G Ncl nucleolin decreases expression ISO Clobetasol results in decreased expression of NCL mRNA CTD PMID:27462272 NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:94,446,682...94,456,083 		JBrowse link
G Ncln nicalin increases expression ISO Clobetasol results in increased expression of NCLN mRNA CTD PMID:27462272 NCBI chr 7:8,862,324...8,872,699
Ensembl chr 7:8,862,751...8,872,698 		JBrowse link
G Ndc1 NDC1 transmembrane nucleoporin increases expression ISO Clobetasol results in increased expression of NDC1 mRNA CTD PMID:27462272 NCBI chr 5:127,384,172...127,431,093
Ensembl chr 5:127,384,665...127,431,090 		JBrowse link
G Ndfip1 Nedd4 family interacting protein 1 increases expression ISO Clobetasol results in increased expression of NDFIP1 mRNA CTD PMID:27462272 NCBI chr18:30,516,931...30,567,199
Ensembl chr18:30,516,981...30,568,471 		JBrowse link
G Ndufa2 NADH:ubiquinone oxidoreductase subunit A2 increases expression ISO Clobetasol results in increased expression of NDUFA2 mRNA CTD PMID:27462272 NCBI chr18:28,629,795...28,631,884
Ensembl chr18:28,629,795...28,631,884 		JBrowse link
G Ndufa8 NADH:ubiquinone oxidoreductase subunit A8 increases expression ISO Clobetasol results in increased expression of NDUFA8 mRNA CTD PMID:27462272 NCBI chr 3:39,783,479...39,799,507
Ensembl chr 3:39,783,479...39,799,507 		JBrowse link
G Ndufa9 NADH:ubiquinone oxidoreductase subunit A9 increases expression ISO Clobetasol results in increased expression of NDUFA9 mRNA CTD PMID:27462272 NCBI chr 4:161,345,398...161,374,188
Ensembl chr 4:161,345,400...161,375,025 		JBrowse link
G Ndufb10 NADH:ubiquinone oxidoreductase subunit B10 increases expression ISO Clobetasol results in increased expression of NDUFB10 mRNA CTD PMID:27462272 NCBI chr10:14,253,805...14,255,966
Ensembl chr10:14,253,805...14,255,966 		JBrowse link
G Ndufb3 NADH:ubiquinone oxidoreductase subunit B3 increases expression ISO Clobetasol results in increased expression of NDUFB3 mRNA CTD PMID:27462272 NCBI chr 9:67,623,417...67,633,629
Ensembl chr 9:67,623,614...67,633,613 		JBrowse link
G Ndufb5 NADH:ubiquinone oxidoreductase subunit B5 increases expression ISO Clobetasol results in increased expression of NDUFB5 mRNA CTD PMID:27462272 NCBI chr 2:117,447,605...117,461,943
Ensembl chr 2:117,447,035...117,461,590 		JBrowse link
G Ndufb6 NADH:ubiquinone oxidoreductase subunit B6 increases expression ISO Clobetasol results in increased expression of NDUFB6 mRNA CTD PMID:27462272 NCBI chr 5:60,196,585...60,206,152
Ensembl chr 5:60,196,585...60,206,055 		JBrowse link
G Ndufc1 NADH:ubiquinone oxidoreductase subunit C1 increases expression ISO Clobetasol results in increased expression of NDUFC1 mRNA CTD PMID:27462272 NCBI chr 2:137,597,944...137,601,819
Ensembl chr 2:137,600,156...137,601,735 		JBrowse link
G Ndufc2 NADH:ubiquinone oxidoreductase subunit C2 increases expression ISO Clobetasol results in increased expression of NDUFC2 mRNA CTD PMID:27462272 NCBI chr 1:161,122,370...161,129,413
Ensembl chr 1:161,123,150...161,129,419 		JBrowse link
G Ndufs7 NADH:ubiquinone oxidoreductase core subunit S7 increases expression ISO Clobetasol results in increased expression of NDUFS7 mRNA CTD PMID:27462272 NCBI chr 7:10,103,226...10,110,862
Ensembl chr 7:10,103,227...10,110,691 		JBrowse link
G Ndufv1 NADH:ubiquinone oxidoreductase core subunit V1 increases expression ISO Clobetasol results in increased expression of NDUFV1 mRNA CTD PMID:27462272 NCBI chr 1:210,729,856...210,735,103
Ensembl chr 1:210,729,858...210,734,949 		JBrowse link
G Nell2 neural EGFL like 2 increases expression ISO Clobetasol results in increased expression of NELL2 mRNA CTD PMID:27462272 NCBI chr 7:128,222,333...128,542,127
Ensembl chr 7:128,078,103...128,651,917 		JBrowse link
G Neu1 neuraminidase 1 increases expression ISO Clobetasol results in increased expression of NEU1 mRNA CTD PMID:27462272 NCBI chr20:3,902,120...3,906,383
Ensembl chr20:3,902,120...3,906,383 		JBrowse link
G Nfasc neurofascin decreases expression ISO Clobetasol results in decreased expression of NFASC mRNA CTD PMID:27462272 NCBI chr13:46,549,369...46,735,989
Ensembl chr13:46,549,369...46,736,139 		JBrowse link
G Ngdn neuroguidin increases expression ISO Clobetasol results in increased expression of NGDN mRNA CTD PMID:27462272 NCBI chr15:32,459,898...32,467,260
Ensembl chr15:32,399,109...32,467,260 		JBrowse link
G Nhp2 NHP2 ribonucleoprotein increases expression ISO Clobetasol results in increased expression of NHP2 mRNA CTD PMID:27462272 NCBI chr10:36,378,020...36,381,362
Ensembl chr10:36,377,997...36,381,354 		JBrowse link
G Ninj1 ninjurin 1 increases expression ISO Clobetasol results in increased expression of NINJ1 mRNA CTD PMID:27462272 NCBI chr17:15,659,208...15,668,115
Ensembl chr17:15,659,200...15,668,063 		JBrowse link
G Ninl ninein-like decreases expression ISO Clobetasol results in decreased expression of NINL mRNA CTD PMID:27462272 NCBI chr 3:160,208,757...160,275,077
Ensembl chr 3:160,196,883...160,275,108 		JBrowse link
G Nle1 notchless homolog 1 increases expression ISO Clobetasol results in increased expression of NLE1 mRNA CTD PMID:27462272 NCBI chr10:68,331,609...68,342,562
Ensembl chr10:68,331,609...68,340,386 		JBrowse link
G Nlgn2 neuroligin 2 decreases expression ISO Clobetasol results in decreased expression of NLGN2 mRNA CTD PMID:27462272 NCBI chr10:55,042,175...55,056,578
Ensembl chr10:55,043,185...55,056,578 		JBrowse link
G Nme1 NME/NM23 nucleoside diphosphate kinase 1 increases expression ISO Clobetasol results in increased expression of NME1 mRNA CTD PMID:27462272 NCBI chr10:79,403,939...79,426,620
Ensembl chr10:79,403,940...79,413,310 		JBrowse link
G Nme4 NME/NM23 nucleoside diphosphate kinase 4 increases expression ISO Clobetasol results in increased expression of NME4 mRNA CTD PMID:27462272 NCBI chr10:15,619,106...15,622,961
Ensembl chr10:15,619,106...15,623,098 		JBrowse link
G Nop10 NOP10 ribonucleoprotein increases expression ISO Clobetasol results in increased expression of NOP10 mRNA CTD PMID:27462272 NCBI chr 3:119,521,255...119,522,340
Ensembl chr 3:119,521,255...119,522,340 		JBrowse link
G Nopchap1 NOP protein chaperone 1 increases expression ISO Clobetasol results in increased expression of NOPCHAP1 mRNA CTD PMID:27462272 NCBI chr 7:22,241,236...22,247,150
Ensembl chr 7:22,241,236...22,247,150 		JBrowse link
G Notch1 notch receptor 1 decreases expression ISO Clobetasol results in decreased expression of NOTCH1 mRNA CTD PMID:27462272 NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613 		JBrowse link
G Notch2 notch receptor 2 decreases expression ISO Clobetasol results in decreased expression of NOTCH2 mRNA CTD PMID:27462272 NCBI chr 2:188,299,336...188,432,823
Ensembl chr 2:188,299,336...188,432,823 		JBrowse link
G Nova1 NOVA alternative splicing regulator 1 decreases expression ISO Clobetasol results in decreased expression of NOVA1 mRNA CTD PMID:27462272 NCBI chr 6:69,506,983...69,632,437
Ensembl chr 6:69,506,983...69,632,437 		JBrowse link
G Npc1 NPC intracellular cholesterol transporter 1 increases expression ISO Clobetasol results in increased expression of NPC1 mRNA CTD PMID:27462272 NCBI chr18:3,654,237...3,699,853
Ensembl chr18:3,654,237...3,699,800 		JBrowse link
G Npc2 NPC intracellular cholesterol transporter 2 increases expression ISO Clobetasol results in increased expression of NPC2 mRNA CTD PMID:27462272 NCBI chr 6:110,128,325...110,149,245
Ensembl chr 6:110,128,325...110,150,004 		JBrowse link
G Npm3 nucleophosmin/nucleoplasmin, 3 increases expression ISO Clobetasol results in increased expression of NPM3 mRNA CTD PMID:27462272 NCBI chr 1:254,544,664...254,546,649
Ensembl chr 1:254,544,664...254,546,649 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression ISO Clobetasol results in increased expression of NQO1 mRNA CTD PMID:27462272 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 decreases expression ISO Clobetasol results in decreased expression of NR1D2 mRNA CTD PMID:27462272 NCBI chr15:9,955,034...9,981,329
Ensembl chr15:9,954,906...9,981,330 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity
multiple interactions 		ISO Clobetasol results in increased activity of NR1I2 protein
[Clobetasol results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA 		CTD PMID:25455453 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 decreases expression ISO Clobetasol results in decreased expression of NR2F1 mRNA CTD PMID:27462272 NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:9,776,179...9,785,924 		JBrowse link
G Nsdhl NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL increases expression ISO Clobetasol results in increased expression of NSDHL mRNA CTD PMID:27462272 NCBI chr  X:155,817,301...155,848,224
Ensembl chr  X:155,817,340...155,848,220 		JBrowse link
G Nsg1 neuronal vesicle trafficking associated 1 increases expression ISO Clobetasol results in increased expression of NSG1 mRNA CTD PMID:27462272 NCBI chr14:76,861,079...76,882,822
Ensembl chr14:76,860,746...76,883,390 		JBrowse link
G Nsmce3 NSE3 homolog, SMC5-SMC6 complex component increases expression ISO Clobetasol results in increased expression of NSMCE3 mRNA CTD PMID:27462272 NCBI chr 1:127,812,572...127,813,899 JBrowse link
G Nt5dc2 5'-nucleotidase domain containing 2 increases expression ISO Clobetasol results in increased expression of NT5DC2 mRNA CTD PMID:27462272 NCBI chr16:6,328,925...6,336,978
Ensembl chr16:6,328,523...6,336,980 		JBrowse link
G Ntn1 netrin 1 decreases expression ISO Clobetasol results in decreased expression of NTN1 mRNA CTD PMID:27462272 NCBI chr10:53,398,852...53,597,595
Ensembl chr10:53,398,852...53,584,060 		JBrowse link
G Nubp2 NUBP iron-sulfur cluster assembly factor 2 increases expression ISO Clobetasol results in increased expression of NUBP2 mRNA CTD PMID:27462272 NCBI chr10:14,407,743...14,411,428
Ensembl chr10:14,407,745...14,411,600 		JBrowse link
G Nudt9 nudix hydrolase 9 increases expression ISO Clobetasol results in increased expression of NUDT9 mRNA CTD PMID:27462272 NCBI chr14:5,980,042...5,997,998
Ensembl chr14:5,980,043...6,005,783 		JBrowse link
G Nxn nucleoredoxin increases expression ISO Clobetasol results in increased expression of NXN mRNA CTD PMID:27462272 NCBI chr10:61,607,557...61,745,807
Ensembl chr10:61,607,568...61,745,807 		JBrowse link
G Odc1 ornithine decarboxylase 1 increases expression ISO Clobetasol results in increased expression of ODC1 mRNA CTD PMID:27462272 NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146 		JBrowse link
G Olfm2 olfactomedin 2 increases expression ISO Clobetasol results in increased expression of OLFM2 mRNA CTD PMID:27462272 NCBI chr 8:27,480,703...27,558,416
Ensembl chr 8:27,480,711...27,558,460 		JBrowse link
G Olig1 oligodendrocyte transcription factor 1 increases expression ISO Clobetasol results in increased expression of OLIG1 mRNA CTD PMID:27462272 NCBI chr11:44,000,450...44,002,592
Ensembl chr11:44,000,281...44,002,592 		JBrowse link
G Onecut2 one cut homeobox 2 decreases expression ISO Clobetasol results in decreased expression of ONECUT2 mRNA CTD PMID:27462272 NCBI chr18:60,101,967...60,161,095
Ensembl chr18:60,102,126...60,107,668 		JBrowse link
G P4hb prolyl 4-hydroxylase subunit beta increases expression ISO Clobetasol results in increased expression of P4HB mRNA CTD PMID:27462272 NCBI chr10:106,335,300...106,346,911
Ensembl chr10:106,335,300...106,346,911 		JBrowse link
G P4htm prolyl 4-hydroxylase, transmembrane increases expression ISO Clobetasol results in increased expression of P4HTM mRNA CTD PMID:27462272 NCBI chr 8:118,153,158...118,172,199
Ensembl chr 8:118,153,158...118,171,002 		JBrowse link
G Pabpc1 poly(A) binding protein, cytoplasmic 1 decreases expression ISO Clobetasol results in decreased expression of PABPC1 mRNA CTD PMID:27462272 NCBI chr 7:69,662,513...69,674,806
Ensembl chr 7:69,663,068...69,675,050 		JBrowse link
G Parl presenilin associated, rhomboid-like increases expression ISO Clobetasol results in increased expression of PARL mRNA CTD PMID:27462272 NCBI chr11:94,097,559...94,124,915
Ensembl chr11:94,097,934...94,148,287 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 decreases expression ISO Clobetasol results in decreased expression of PARP1 mRNA CTD PMID:27462272 NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Pbxip1 PBX homeobox interacting protein 1 decreases expression ISO Clobetasol results in decreased expression of PBXIP1 mRNA CTD PMID:27462272 NCBI chr 2:177,154,056...177,167,810
Ensembl chr 2:177,154,101...177,167,328 		JBrowse link
G Pcdh10 protocadherin 10 decreases expression ISO Clobetasol results in decreased expression of PCDH10 mRNA CTD PMID:27462272 NCBI chr 2:130,553,432...130,619,591
Ensembl chr 2:130,553,425...130,613,407 		JBrowse link
G Pcdh17 protocadherin 17 decreases expression ISO Clobetasol results in decreased expression of PCDH17 mRNA CTD PMID:27462272 NCBI chr15:66,631,549...66,725,007
Ensembl chr15:66,633,142...66,722,105 		JBrowse link
G Pcdhga2 protocadherin gamma subfamily A, 2 decreases expression ISO Clobetasol results in decreased expression of PCDHGA2 mRNA CTD PMID:27462272 NCBI chr18:29,745,189...29,919,095 JBrowse link
G Pcdhgc3 protocadherin gamma subfamily C, 3 decreases expression ISO Clobetasol results in decreased expression of PCDHGC3 mRNA CTD PMID:27462272 NCBI chr18:29,884,245...29,919,095 JBrowse link
G Pcf11 PCF11 cleavage and polyadenylation factor subunit increases expression ISO Clobetasol results in increased expression of PCF11 mRNA CTD PMID:27462272 NCBI chr 1:156,109,724...156,136,950
Ensembl chr 1:156,109,724...156,136,435 		JBrowse link
G Pcolce procollagen C-endopeptidase enhancer increases expression ISO Clobetasol results in increased expression of PCOLCE mRNA CTD PMID:27462272 NCBI chr12:24,720,972...24,727,287
Ensembl chr12:24,720,936...24,727,287 		JBrowse link
G Pcyox1l prenylcysteine oxidase 1 like increases expression ISO Clobetasol results in increased expression of PCYOX1L mRNA CTD PMID:27462272 NCBI chr18:57,420,971...57,431,632
Ensembl chr18:57,420,977...57,431,632 		JBrowse link
G Pdcl3 phosducin-like 3 increases expression ISO Clobetasol results in increased expression of PDCL3 mRNA CTD PMID:27462272 NCBI chr 9:48,730,083...48,738,554
Ensembl chr 9:48,723,767...48,739,529 		JBrowse link
G Pdia4 protein disulfide isomerase family A, member 4 increases expression ISO Clobetasol results in increased expression of PDIA4 mRNA CTD PMID:27462272 NCBI chr 4:78,134,144...78,153,191
Ensembl chr 4:78,134,144...78,153,191 		JBrowse link
G Pdia6 protein disulfide isomerase family A, member 6 increases expression ISO Clobetasol results in increased expression of PDIA6 mRNA CTD PMID:27462272 NCBI chr 6:45,791,704...45,808,947
Ensembl chr 6:45,791,678...45,810,091 		JBrowse link
G Peak1 pseudopodium-enriched atypical kinase 1 decreases expression ISO Clobetasol results in decreased expression of PEAK1 mRNA CTD PMID:27462272 NCBI chr 8:65,501,068...65,715,768
Ensembl chr 8:65,505,043...65,715,111 		JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 increases expression ISO Clobetasol results in increased expression of PEBP1 mRNA CTD PMID:27462272 NCBI chr12:44,946,307...44,967,890
Ensembl chr12:44,963,675...44,971,780 		JBrowse link
G Pfdn6 prefoldin subunit 6 increases expression ISO Clobetasol results in increased expression of PFDN6 mRNA CTD PMID:27462272 NCBI chr20:4,947,844...4,949,318
Ensembl chr20:4,947,844...4,949,318 		JBrowse link
G Pfn1 profilin 1 increases expression ISO Clobetasol results in increased expression of PFN1 mRNA CTD PMID:27462272 NCBI chr10:55,863,882...55,866,587
Ensembl chr10:55,863,881...55,868,611 		JBrowse link
G Pgam1 phosphoglycerate mutase 1 increases expression ISO Clobetasol results in increased expression of PGAM1 mRNA CTD PMID:27462272 NCBI chr 1:250,673,152...250,680,762
Ensembl chr 1:250,673,049...250,690,203 		JBrowse link
G Pgd phosphogluconate dehydrogenase increases expression ISO Clobetasol results in increased expression of PGD mRNA CTD PMID:27462272 NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:164,865,830...164,882,029 		JBrowse link
G Pgk1 phosphoglycerate kinase 1 increases expression ISO Clobetasol results in increased expression of PGK1 mRNA CTD PMID:27462272 NCBI chr  X:75,336,988...75,352,962
Ensembl chr  X:75,336,687...75,352,959 		JBrowse link
G Phb1 prohibitin 1 increases expression ISO Clobetasol results in increased expression of PHB1 mRNA CTD PMID:27462272 NCBI chr10:81,102,043...81,114,815
Ensembl chr10:81,102,028...81,116,233 		JBrowse link
G Phf3 PHD finger protein 3 decreases expression ISO Clobetasol results in decreased expression of PHF3 mRNA CTD PMID:27462272 NCBI chr 9:40,559,929...40,632,096
Ensembl chr 9:40,559,929...40,632,056 		JBrowse link
G Phf5a PHD finger protein 5A increases expression ISO Clobetasol results in increased expression of PHF5A mRNA CTD PMID:27462272 NCBI chr 7:115,258,609...115,265,174
Ensembl chr 7:115,258,609...115,265,174 		JBrowse link
G Phgdh phosphoglycerate dehydrogenase increases expression ISO Clobetasol results in increased expression of PHGDH mRNA CTD PMID:27462272 NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789 		JBrowse link
G Phrf1 PHD and ring finger domains 1 decreases expression ISO Clobetasol results in decreased expression of PHRF1 mRNA CTD PMID:27462272 NCBI chr 1:205,763,264...205,796,478
Ensembl chr 1:205,763,549...205,801,557 		JBrowse link
G Pigs phosphatidylinositol glycan anchor biosynthesis, class S increases expression ISO Clobetasol results in increased expression of PIGS mRNA CTD PMID:27462272 NCBI chr10:63,720,568...63,735,255
Ensembl chr10:63,720,661...63,735,253 		JBrowse link
G Pik3c2b phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta decreases expression ISO Clobetasol results in decreased expression of PIK3C2B mRNA CTD PMID:27462272 NCBI chr13:47,046,866...47,107,733
Ensembl chr13:47,047,127...47,107,725 		JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 increases expression ISO Clobetasol results in increased expression of PIK3R1 mRNA CTD PMID:27462272 NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347 		JBrowse link
G Pim3 Pim-3 proto-oncogene, serine/threonine kinase increases expression ISO Clobetasol results in increased expression of PIM3 mRNA CTD PMID:27462272 NCBI chr 7:121,822,076...121,836,257
Ensembl chr 7:121,832,742...121,836,259 		JBrowse link
G Pip4k2a phosphatidylinositol-5-phosphate 4-kinase type 2 alpha increases expression ISO Clobetasol results in increased expression of PIP4K2A mRNA CTD PMID:27462272 NCBI chr17:86,405,080...86,576,597
Ensembl chr17:86,405,081...86,576,430 		JBrowse link
G Pip4p2 phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 increases expression ISO Clobetasol results in increased expression of PIP4P2 mRNA CTD PMID:27462272 NCBI chr 5:33,057,046...33,104,448
Ensembl chr 5:33,056,684...33,104,451 		JBrowse link
G Pkm pyruvate kinase M1/2 increases expression ISO Clobetasol results in increased expression of PKM mRNA CTD PMID:27462272 NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396 		JBrowse link
G Plcg2 phospholipase C, gamma 2 decreases expression ISO Clobetasol results in decreased expression of PLCG2 mRNA CTD PMID:27462272 NCBI chr19:62,456,196...62,592,684
Ensembl chr19:62,453,259...62,592,684 		JBrowse link
G Plk2 polo-like kinase 2 increases expression ISO Clobetasol results in increased expression of PLK2 mRNA CTD PMID:27462272 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296 		JBrowse link
G Plod1 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 increases expression ISO Clobetasol results in increased expression of PLOD1 mRNA CTD PMID:27462272 NCBI chr 5:163,623,847...163,650,737
Ensembl chr 5:163,623,848...163,651,110 		JBrowse link
G Plod3 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 increases expression ISO Clobetasol results in increased expression of PLOD3 mRNA CTD PMID:27462272 NCBI chr12:25,313,070...25,323,631
Ensembl chr12:25,313,072...25,323,631 		JBrowse link
G Pltp phospholipid transfer protein increases expression ISO Clobetasol results in increased expression of PLTP mRNA CTD PMID:27462272 NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:173,994,162...174,012,505 		JBrowse link
G Plxna1 plexin A1 decreases expression ISO Clobetasol results in decreased expression of PLXNA1 mRNA CTD PMID:27462272 NCBI chr 4:123,295,165...123,340,132
Ensembl chr 4:123,297,244...123,340,428 		JBrowse link
G Plxna2 plexin A2 decreases expression ISO Clobetasol results in decreased expression of PLXNA2 mRNA CTD PMID:27462272 NCBI chr13:108,683,155...108,888,336
Ensembl chr13:108,691,530...108,887,453 		JBrowse link
G Plxna4 plexin A4 decreases expression ISO Clobetasol results in decreased expression of PLXNA4 mRNA CTD PMID:27462272 NCBI chr 4:61,687,483...62,129,467
Ensembl chr 4:61,687,510...62,129,445 		JBrowse link
G Plxnc1 plexin C1 decreases expression ISO Clobetasol results in decreased expression of PLXNC1 mRNA CTD PMID:27462272 NCBI chr 7:31,276,978...31,430,823
Ensembl chr 7:31,276,978...31,431,092 		JBrowse link
G Plxnd1 plexin D1 decreases expression ISO Clobetasol results in decreased expression of PLXND1 mRNA CTD PMID:27462272 NCBI chr 4:150,675,377...150,715,706
Ensembl chr 4:150,675,377...150,715,566 		JBrowse link
G Polr1c RNA polymerase I and III subunit C increases expression ISO Clobetasol results in increased expression of POLR1C mRNA CTD PMID:27462272 NCBI chr 9:22,233,318...22,237,430
Ensembl chr 9:22,233,305...22,237,428 		JBrowse link
G Polr1d RNA polymerase I and III subunit D increases expression ISO Clobetasol results in increased expression of POLR1D mRNA CTD PMID:27462272 NCBI chr12:13,084,505...13,118,069
Ensembl chr12:13,084,512...13,095,627 		JBrowse link
G Polr2a RNA polymerase II subunit A decreases expression ISO Clobetasol results in decreased expression of POLR2A mRNA CTD PMID:27462272 NCBI chr10:54,951,162...54,977,179
Ensembl chr10:54,951,162...54,977,179 		JBrowse link
G Polr2i RNA polymerase II subunit I increases expression ISO Clobetasol results in increased expression of POLR2I mRNA CTD PMID:27462272 NCBI chr 1:94,610,976...94,612,413
Ensembl chr 1:94,610,942...94,613,000 		JBrowse link
G Polr2l RNA polymerase II, I and III subunit L increases expression ISO Clobetasol results in increased expression of POLR2L mRNA CTD PMID:27462272 NCBI chr 1:205,999,607...206,001,615
Ensembl chr19:8,341,868...8,342,071 		JBrowse link
G Polr3h RNA polymerase III subunit H increases expression ISO Clobetasol results in increased expression of POLR3H mRNA CTD PMID:27462272 NCBI chr 7:115,309,571...115,319,881
Ensembl chr 7:115,309,589...115,319,915 		JBrowse link
G Polr3k RNA polymerase III subunit K increases expression ISO Clobetasol results in increased expression of POLR3K mRNA CTD PMID:27462272 NCBI chr 3:189,360,349...189,364,546
Ensembl chr 3:189,360,171...189,366,697 		JBrowse link
G Ppie peptidylprolyl isomerase E increases expression ISO Clobetasol results in increased expression of PPIE mRNA CTD PMID:27462272 NCBI chr 5:140,691,285...140,704,347
Ensembl chr 5:140,683,801...140,740,767 		JBrowse link
G Ppil1 peptidylprolyl isomerase like 1 increases expression ISO Clobetasol results in increased expression of PPIL1 mRNA CTD PMID:27462272 NCBI chr20:7,303,919...7,323,962
Ensembl chr20:7,303,922...7,318,781 		JBrowse link
G Ppm1k protein phosphatase, Mg2+/Mn2+ dependent, 1K increases expression ISO Clobetasol results in increased expression of PPM1K mRNA CTD PMID:27462272 NCBI chr 4:88,942,226...88,969,139
Ensembl chr 4:88,942,386...88,969,136 		JBrowse link
G Ppme1 protein phosphatase methylesterase 1 increases expression ISO Clobetasol results in increased expression of PPME1 mRNA CTD PMID:27462272 NCBI chr 1:164,080,242...164,127,261
Ensembl chr 1:164,080,242...164,127,220 		JBrowse link
G Ppp1ca protein phosphatase 1 catalytic subunit alpha increases expression ISO Clobetasol results in increased expression of PPP1CA mRNA CTD PMID:27462272 NCBI chr 1:210,914,576...210,918,193
Ensembl chr 1:210,914,567...210,918,193 		JBrowse link
G Ppp1cb protein phosphatase 1 catalytic subunit beta increases expression ISO Clobetasol results in increased expression of PPP1CB mRNA CTD PMID:27462272 NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:29,681,100...29,712,924 		JBrowse link
G Ppp1r14b protein phosphatase 1, regulatory (inhibitor) subunit 14B increases expression ISO Clobetasol results in increased expression of PPP1R14B mRNA CTD PMID:27462272 NCBI chr 1:213,594,416...213,596,527
Ensembl chr12:21,088,517...21,101,431
Ensembl chr 1:21,088,517...21,101,431 		JBrowse link
G Ppp1r26 protein phosphatase 1, regulatory subunit 26 decreases expression ISO Clobetasol results in decreased expression of PPP1R26 mRNA CTD PMID:27462272 NCBI chr 3:32,179,686...32,188,069
Ensembl chr 3:32,177,235...32,188,264 		JBrowse link
G Ppp1r35 protein phosphatase 1, regulatory subunit 35 increases expression ISO Clobetasol results in increased expression of PPP1R35 mRNA CTD PMID:27462272 NCBI chr12:24,552,709...24,556,040 JBrowse link
G Ppp1r3c protein phosphatase 1, regulatory subunit 3C increases expression ISO Clobetasol results in increased expression of PPP1R3C mRNA CTD PMID:27462272 NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835 		JBrowse link
G Ppp2r1a protein phosphatase 2 scaffold subunit A alpha increases expression ISO Clobetasol results in increased expression of PPP2R1A mRNA CTD PMID:27462272 NCBI chr 1:69,213,198...69,232,441
Ensembl chr 1:69,213,038...69,238,242 		JBrowse link
G Ppp4c protein phosphatase 4, catalytic subunit increases expression ISO Clobetasol results in increased expression of PPP4C mRNA CTD PMID:27462272 NCBI chr 1:190,823,447...190,830,247
Ensembl chr 1:190,823,486...190,830,168 		JBrowse link
G Ppp5c protein phosphatase 5, catalytic subunit increases expression ISO Clobetasol results in increased expression of PPP5C mRNA CTD PMID:27462272 NCBI chr 1:86,818,297...86,842,505
Ensembl chr 1:86,818,297...86,842,950 		JBrowse link
G Prag1 PEAK1 related kinase activating pseudokinase 1 decreases expression ISO Clobetasol results in decreased expression of PRAG1 mRNA CTD PMID:27462272 NCBI chr16:62,791,249...62,844,532
Ensembl chr16:62,786,329...62,844,532 		JBrowse link
G Prdx1 peroxiredoxin 1 increases expression ISO Clobetasol results in increased expression of PRDX1 mRNA CTD PMID:27462272 NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504 		JBrowse link
G Prdx2 peroxiredoxin 2 increases expression ISO Clobetasol results in increased expression of PRDX2 mRNA CTD PMID:27462272 NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006 		JBrowse link
G Prdx3 peroxiredoxin 3 increases expression ISO Clobetasol results in increased expression of PRDX3 mRNA CTD PMID:27462272 NCBI chr 1:269,987,691...270,000,111
Ensembl chr 1:269,987,685...270,000,300 		JBrowse link
G Prdx5 peroxiredoxin 5 increases expression ISO Clobetasol results in increased expression of PRDX5 mRNA CTD PMID:27462272 NCBI chr 1:213,529,042...213,532,787
Ensembl chr 1:213,529,035...213,533,020 		JBrowse link
G Prkca protein kinase C, alpha decreases expression ISO Clobetasol results in decreased expression of PRKCA mRNA CTD PMID:27462272 NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572 		JBrowse link
G Prkcb protein kinase C, beta decreases expression ISO Clobetasol results in decreased expression of PRKCB mRNA CTD PMID:27462272 NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740 		JBrowse link
G Prob1 proline-rich basic protein 1 decreases expression ISO Clobetasol results in decreased expression of PROB1 mRNA CTD PMID:27462272 NCBI chr18:27,516,599...27,521,443
Ensembl chr18:27,516,332...27,523,808 		JBrowse link
G Prps2 phosphoribosyl pyrophosphate synthetase 2 increases expression ISO Clobetasol results in increased expression of PRPS2 mRNA CTD PMID:27462272 NCBI chr  X:30,592,845...30,630,127
Ensembl chr  X:30,593,019...30,630,126 		JBrowse link
G Prr12 proline rich 12 decreases expression ISO Clobetasol results in decreased expression of PRR12 mRNA CTD PMID:27462272 NCBI chr 1:104,646,492...104,670,454
Ensembl chr 1:104,646,492...104,670,454 		JBrowse link
G Prrc2b proline-rich coiled-coil 2B decreases expression ISO Clobetasol results in decreased expression of PRRC2B mRNA CTD PMID:27462272 NCBI chr 3:35,831,017...35,916,854
Ensembl chr 3:35,863,046...35,916,854 		JBrowse link
G Prrc2c proline-rich coiled-coil 2C decreases expression ISO Clobetasol results in decreased expression of PRRC2C mRNA CTD PMID:27462272 NCBI chr13:77,537,226...77,606,926
Ensembl chr13:77,537,814...77,607,001 		JBrowse link
G Prune2 prune homolog 2 with BCH domain increases expression ISO Clobetasol results in increased expression of PRUNE2 mRNA CTD PMID:27462272 NCBI chr 1:223,779,617...224,130,058
Ensembl chr 1:223,969,102...224,051,592 		JBrowse link
G Psma2 proteasome 20S subunit alpha 2 increases expression ISO Clobetasol results in increased expression of PSMA2 mRNA CTD PMID:27462272 NCBI chr17:55,250,054...55,260,441
Ensembl chr17:55,247,442...55,339,673 		JBrowse link
G Psma5 proteasome 20S subunit alpha 5 increases expression ISO Clobetasol results in increased expression of PSMA5 mRNA CTD PMID:27462272 NCBI chr 2:198,584,502...198,607,867
Ensembl chr 2:198,584,505...198,607,867 		JBrowse link
G Psma6 proteasome 20S subunit alpha 6 increases expression ISO Clobetasol results in increased expression of PSMA6 mRNA CTD PMID:27462272 NCBI chr 6:78,500,676...78,531,693
Ensembl chr 6:78,500,736...78,531,717 		JBrowse link
G Psmb3 proteasome 20S subunit beta 3 increases expression ISO Clobetasol results in increased expression of PSMB3 mRNA CTD PMID:27462272 NCBI chr10:83,193,787...83,200,883
Ensembl chr10:83,193,787...83,200,883 		JBrowse link
G Psmb4 proteasome 20S subunit beta 4 increases expression ISO Clobetasol results in increased expression of PSMB4 mRNA CTD PMID:27462272 NCBI chr 2:185,131,787...185,134,561
Ensembl chr 2:185,131,786...185,135,287 		JBrowse link
G Psmb5 proteasome 20S subunit beta 5 increases expression ISO Clobetasol results in increased expression of PSMB5 mRNA CTD PMID:27462272 NCBI chr15:32,042,784...32,047,379
Ensembl chr15:32,042,787...32,047,379 		JBrowse link
G Psmb7 proteasome 20S subunit beta 7 increases expression ISO Clobetasol results in increased expression of PSMB7 mRNA CTD PMID:27462272 NCBI chr 3:42,767,500...42,827,470
Ensembl chr 3:42,767,501...42,827,601 		JBrowse link
G Psmc5 proteasome 26S subunit, ATPase 5 increases expression ISO Clobetasol results in increased expression of PSMC5 mRNA CTD PMID:27462272 NCBI chr10:91,687,553...91,693,487
Ensembl chr10:91,686,295...91,695,921 		JBrowse link
G Psmd13 proteasome 26S subunit, non-ATPase 13 increases expression ISO Clobetasol results in increased expression of PSMD13 mRNA CTD PMID:27462272 NCBI chr 1:205,394,248...205,406,525
Ensembl chr 1:205,393,746...205,411,651 		JBrowse link
G Psmd6 proteasome 26S subunit, non-ATPase 6 increases expression ISO Clobetasol results in increased expression of PSMD6 mRNA CTD PMID:27462272 NCBI chr15:13,532,675...13,542,682
Ensembl chr15:13,532,675...13,542,682 		JBrowse link
G Psph phosphoserine phosphatase increases expression ISO Clobetasol results in increased expression of PSPH mRNA CTD PMID:27462272 NCBI chr12:32,527,091...32,541,182
Ensembl chr12:32,519,269...32,541,180 		JBrowse link
G Ptbp2 polypyrimidine tract binding protein 2 decreases expression ISO Clobetasol results in decreased expression of PTBP2 mRNA CTD PMID:27462272 NCBI chr 2:210,497,610...210,558,497
Ensembl chr 2:210,497,706...210,558,291 		JBrowse link
G Ptcd2 pentatricopeptide repeat domain 2 increases expression ISO Clobetasol results in increased expression of PTCD2 mRNA CTD PMID:27462272 NCBI chr 2:32,446,441...32,474,114
Ensembl chr 2:32,446,182...32,474,285 		JBrowse link
G Ptdss2 phosphatidylserine synthase 2 increases expression ISO Clobetasol results in increased expression of PTDSS2 mRNA CTD PMID:27462272 NCBI chr 1:205,671,024...205,695,556
Ensembl chr 1:205,671,041...205,695,553 		JBrowse link
G Ptges2 prostaglandin E synthase 2 increases expression ISO Clobetasol results in increased expression of PTGES2 mRNA CTD PMID:27462272 NCBI chr 3:36,088,246...36,095,430
Ensembl chr 3:36,088,246...36,097,694 		JBrowse link
G Ptgfrn prostaglandin F2 receptor inhibitor increases expression ISO Clobetasol results in increased expression of PTGFRN mRNA CTD PMID:27462272 NCBI chr 2:191,158,166...191,233,432
Ensembl chr 2:191,158,166...191,234,115 		JBrowse link
G Ptpa protein phosphatase 2 phosphatase activator increases expression ISO Clobetasol results in increased expression of PTPA mRNA CTD PMID:27462272 NCBI chr 3:34,087,637...34,118,100
Ensembl chr 3:34,087,575...34,162,772 		JBrowse link
G Ptprf protein tyrosine phosphatase, receptor type, F decreases expression ISO Clobetasol results in decreased expression of PTPRF mRNA CTD PMID:27462272 NCBI chr 5:137,027,376...137,109,405
Ensembl chr 5:137,028,164...137,095,426 		JBrowse link
G Ptprs protein tyrosine phosphatase, receptor type, S decreases expression ISO Clobetasol results in decreased expression of PTPRS mRNA CTD PMID:27462272 NCBI chr 9:1,332,558...1,394,161
Ensembl chr 9:1,332,559...1,394,093 		JBrowse link
G Pttg1ip PTTG1 interacting protein increases expression ISO Clobetasol results in increased expression of PTTG1IP mRNA CTD PMID:27462272 NCBI chr20:11,029,608...11,047,395
Ensembl chr20:11,029,608...11,046,909 		JBrowse link
G Pxmp2 peroxisomal membrane protein 2 increases expression ISO Clobetasol results in increased expression of PXMP2 mRNA CTD PMID:27462272 NCBI chr12:52,053,951...52,064,283
Ensembl chr12:52,053,788...52,064,283 		JBrowse link
G Pycr2 pyrroline-5-carboxylate reductase 2 increases expression ISO Clobetasol results in increased expression of PYCR2 mRNA CTD PMID:27462272 NCBI chr13:95,158,236...95,162,030
Ensembl chr13:95,158,183...95,162,029 		JBrowse link
G Qdpr quinoid dihydropteridine reductase increases expression ISO Clobetasol results in increased expression of QDPR mRNA CTD PMID:27462272 NCBI chr14:69,882,776...69,896,378
Ensembl chr14:69,882,612...69,896,379 		JBrowse link
G Qser1 glutamine and serine rich 1 decreases expression ISO Clobetasol results in decreased expression of QSER1 mRNA CTD PMID:27462272 NCBI chr 3:111,592,377...111,658,825
Ensembl chr 3:111,595,171...111,657,103 		JBrowse link
G R3hdm1 R3H domain containing 1 decreases expression ISO Clobetasol results in decreased expression of R3HDM1 mRNA CTD PMID:27462272 NCBI chr13:42,148,281...42,286,311
Ensembl chr13:42,148,290...42,286,311 		JBrowse link
G Rab1a RAB1A, member RAS oncogene family increases expression ISO Clobetasol results in increased expression of RAB1A mRNA CTD PMID:27462272 NCBI chr14:98,623,582...98,648,766
Ensembl chr14:98,623,635...98,661,582 		JBrowse link
G Rabl6 RAB, member RAS oncogene family-like 6 decreases expression ISO Clobetasol results in decreased expression of RABL6 mRNA CTD PMID:27462272 NCBI chr 3:28,800,802...28,826,722
Ensembl chr 3:28,800,802...28,826,722 		JBrowse link
G Raph1 Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 decreases expression ISO Clobetasol results in decreased expression of RAPH1 mRNA CTD PMID:27462272 NCBI chr 9:69,397,272...69,484,174
Ensembl chr 9:69,401,517...69,484,019 		JBrowse link
G Raver2 ribonucleoprotein, PTB-binding 2 increases expression ISO Clobetasol results in increased expression of RAVER2 mRNA CTD PMID:27462272 NCBI chr 5:120,796,807...120,898,281
Ensembl chr 5:120,800,126...120,895,825 		JBrowse link
G Rbbp4 RB binding protein 4, chromatin remodeling factor increases expression ISO Clobetasol results in increased expression of RBBP4 mRNA CTD PMID:27462272 NCBI chr 5:146,940,207...146,959,501
Ensembl chr 5:146,922,611...146,959,501 		JBrowse link
G Rbbp6 RB binding protein 6, ubiquitin ligase decreases expression ISO Clobetasol results in decreased expression of RBBP6 mRNA CTD PMID:27462272 NCBI chr 1:186,934,563...186,966,852
Ensembl chr 1:186,934,938...186,966,852 		JBrowse link
G Rbm15b RNA binding motif protein 15B decreases expression ISO Clobetasol results in decreased expression of RBM15B mRNA CTD PMID:27462272 NCBI chr 8:116,422,309...116,425,374
Ensembl chr 8:116,421,540...116,425,940 		JBrowse link
G Rcc2 regulator of chromosome condensation 2 increases expression ISO Clobetasol results in increased expression of RCC2 mRNA CTD PMID:27462272 NCBI chr 5:158,277,476...158,300,294
Ensembl chr 5:158,277,476...158,300,294 		JBrowse link
G Reep5 receptor accessory protein 5 increases expression ISO Clobetasol results in increased expression of REEP5 mRNA CTD PMID:27462272 NCBI chr18:26,219,528...26,257,505
Ensembl chr18:26,219,530...26,250,660 		JBrowse link
G Rere arginine-glutamic acid dipeptide repeats decreases expression ISO Clobetasol results in decreased expression of RERE mRNA CTD PMID:27462272 NCBI chr 5:166,048,770...166,380,559
Ensembl chr 5:166,048,844...166,380,558 		JBrowse link
G Rev3l REV3 like, DNA directed polymerase zeta catalytic subunit decreases expression ISO Clobetasol results in decreased expression of REV3L mRNA CTD PMID:27462272 NCBI chr20:44,686,482...44,844,668
Ensembl chr20:44,686,940...44,844,668 		JBrowse link
G Rex1bd required for excision 1-B domain containing increases expression ISO Clobetasol results in increased expression of REX1BD mRNA CTD PMID:27462272 NCBI chr16:18,956,023...18,958,494
Ensembl chr16:18,955,969...18,958,494 		JBrowse link
G Rflnb refilin B increases expression ISO Clobetasol results in increased expression of RFLNB mRNA CTD PMID:27462272 NCBI chr10:61,391,947...61,398,224
Ensembl chr10:61,390,659...61,398,224 		JBrowse link
G Rfx7 regulatory factor X, 7 decreases expression ISO Clobetasol results in decreased expression of RFX7 mRNA CTD PMID:27462272 NCBI chr 8:82,134,747...82,219,898
Ensembl chr 8:82,134,747...82,219,898 		JBrowse link
G Rheb Ras homolog, mTORC1 binding increases expression ISO Clobetasol results in increased expression of RHEB mRNA CTD PMID:27462272 NCBI chr 4:11,012,173...11,053,860
Ensembl chr 4:11,012,643...11,053,931 		JBrowse link
G Rhot2 ras homolog family member T2 increases expression ISO Clobetasol results in increased expression of RHOT2 mRNA CTD PMID:27462272 NCBI chr10:15,363,467...15,369,263
Ensembl chr10:15,361,726...15,369,006 		JBrowse link
G Rnf145 ring finger protein 145 increases expression ISO Clobetasol results in increased expression of RNF145 mRNA CTD PMID:27462272 NCBI chr10:29,507,779...29,552,153
Ensembl chr10:29,507,772...29,552,151 		JBrowse link
G Rnf168 ring finger protein 168 decreases expression ISO Clobetasol results in decreased expression of RNF168 mRNA CTD PMID:27462272 NCBI chr11:81,991,352...82,013,306
Ensembl chr11:81,991,360...82,013,306 		JBrowse link
G Rnf187 ring finger protein 187 increases expression ISO Clobetasol results in increased expression of RNF187 mRNA CTD PMID:27462272 NCBI chr10:44,209,080...44,214,979
Ensembl chr10:44,202,332...44,215,470 		JBrowse link
G Rnf5 ring finger protein 5 increases expression ISO Clobetasol results in increased expression of RNF5 mRNA CTD PMID:27462272 NCBI chr20:4,150,032...4,152,593
Ensembl chr20:4,150,138...4,152,591 		JBrowse link
G Ro60 Ro60, Y RNA binding protein decreases expression ISO Clobetasol results in decreased expression of RO60 mRNA CTD PMID:27462272 NCBI chr13:58,049,838...58,070,828
Ensembl chr13:58,049,858...58,076,264 		JBrowse link
G Robo1 roundabout guidance receptor 1 decreases expression ISO Clobetasol results in decreased expression of ROBO1 mRNA CTD PMID:27462272 NCBI chr11:24,067,869...25,108,694
Ensembl chr11:24,067,878...25,108,694 		JBrowse link
G Rock1 Rho-associated coiled-coil containing protein kinase 1 decreases expression ISO Clobetasol results in decreased expression of ROCK1 mRNA CTD PMID:27462272 NCBI chr18:1,387,360...1,509,218
Ensembl chr18:1,387,360...1,509,147 		JBrowse link
G Rpl12 ribosomal protein L12 increases expression ISO Clobetasol results in increased expression of RPL12 mRNA CTD PMID:27462272 NCBI chr 3:36,661,940...36,664,314
Ensembl chr 3:36,661,939...36,664,306 		JBrowse link
G Rpl13 ribosomal protein L13 increases expression ISO Clobetasol results in increased expression of RPL13 mRNA CTD PMID:27462272 NCBI chr19:68,062,442...68,065,065
Ensembl chr19:68,062,493...68,065,059 		JBrowse link
G Rpl13a ribosomal protein L13A decreases expression ISO Clobetasol results in decreased expression of RPL13A mRNA CTD PMID:27462272 NCBI chr 1:104,746,223...104,748,975
Ensembl chr 1:104,746,223...104,748,914 		JBrowse link
G Rpl14 ribosomal protein L14 increases expression ISO Clobetasol results in increased expression of RPL14 mRNA CTD PMID:27462272 NCBI chr 8:129,163,620...129,166,745
Ensembl chr 8:129,163,317...129,167,459 		JBrowse link
G Rpl18 ribosomal protein L18 increases expression ISO Clobetasol results in increased expression of RPL18 mRNA CTD PMID:27462272 NCBI chr 1:105,325,269...105,327,911
Ensembl chr 1:105,325,250...105,327,910 		JBrowse link
G Rpl24 ribosomal protein L24 increases expression ISO Clobetasol results in increased expression of RPL24 mRNA CTD PMID:27462272 NCBI chr11:58,122,997...58,128,405
Ensembl chr11:58,122,997...58,128,405 		JBrowse link
G Rpl27 ribosomal protein L27 increases expression ISO Clobetasol results in increased expression of RPL27 mRNA CTD PMID:27462272 NCBI chr10:86,875,758...86,879,457
Ensembl chr10:86,876,024...86,879,441 		JBrowse link
G Rpl37a ribosomal protein L37A increases expression ISO Clobetasol results in increased expression of RPL37A mRNA CTD PMID:27462272 NCBI chr 9:81,748,091...81,750,174
Ensembl chr 9:81,748,103...81,751,975 		JBrowse link
G Rpl39 ribosomal protein L39 increases expression ISO Clobetasol results in increased expression of RPL39 mRNA CTD PMID:27462272 NCBI chr  X:121,192,901...121,195,896
Ensembl chr 7:31,721,884...31,722,039
Ensembl chr15:31,721,884...31,722,039
Ensembl chr  X:31,721,884...31,722,039 		JBrowse link
G Rpl8 ribosomal protein L8 increases expression ISO Clobetasol results in increased expression of RPL8 mRNA CTD PMID:27462272 NCBI chr 7:110,506,815...110,509,106
Ensembl chr 7:110,506,800...110,509,103
Ensembl chr 3:110,506,800...110,509,103 		JBrowse link
G Rpl9 ribosomal protein L9 increases expression ISO Clobetasol results in increased expression of RPL9 mRNA CTD PMID:27462272 NCBI chr14:43,247,536...43,250,784
Ensembl chr14:43,247,588...43,250,782
Ensembl chr 1:43,247,588...43,250,782 		JBrowse link
G Rplp0 ribosomal protein lateral stalk subunit P0 increases expression ISO Clobetasol results in increased expression of RPLP0 mRNA CTD PMID:27462272 NCBI chr12:46,715,121...46,718,390
Ensembl chr12:46,715,124...46,718,422 		JBrowse link
G Rpn2 ribophorin II increases expression ISO Clobetasol results in increased expression of RPN2 mRNA CTD PMID:27462272 NCBI chr 3:166,361,955...166,409,272
Ensembl chr 3:166,362,049...166,409,922 		JBrowse link
G Rpp25l ribonuclease P/MRP subunit p25 like increases expression ISO Clobetasol results in increased expression of RPP25L mRNA CTD PMID:27462272 NCBI chr 5:61,674,299...61,675,844
Ensembl chr 5:61,672,199...61,675,168 		JBrowse link
G Rps11 ribosomal protein S11 increases expression ISO Clobetasol results in increased expression of RPS11 mRNA CTD PMID:27462272 NCBI chr 1:104,742,153...104,744,261
Ensembl chr 1:104,742,155...104,744,337 		JBrowse link
G Rps14 ribosomal protein S14 affects expression ISO Clobetasol affects the expression of RPS14 mRNA CTD PMID:27462272 NCBI chr18:56,492,010...56,503,092
Ensembl chr18:56,498,245...56,503,091 		JBrowse link
G Rps15a ribosomal protein S15a increases expression ISO Clobetasol results in increased expression of RPS15A mRNA CTD PMID:27462272 NCBI chr 1:181,854,396...181,861,330
Ensembl chr 1:181,854,396...181,861,201 		JBrowse link
G Rps18 ribosomal protein S18 increases expression ISO Clobetasol results in increased expression of RPS18 mRNA CTD PMID:27462272 NCBI chr20:4,933,741...4,937,423
Ensembl chr20:4,917,095...4,937,423 		JBrowse link
G Rps27l ribosomal protein S27-like increases expression ISO Clobetasol results in increased expression of RPS27L mRNA CTD PMID:27462272 NCBI chr 8:76,443,658...76,448,593
Ensembl chr12:33,713,661...33,714,130
Ensembl chr 8:33,713,661...33,714,130 		JBrowse link
G Rps5 ribosomal protein S5 increases expression ISO Clobetasol results in increased expression of RPS5 mRNA CTD PMID:27462272 NCBI chr 1:82,610,965...82,615,262
Ensembl chr 1:82,610,965...82,615,262 		JBrowse link
G Rps8 ribosomal protein S8 increases expression ISO Clobetasol results in increased expression of RPS8 mRNA CTD PMID:27462272 NCBI chr 5:135,866,941...135,869,511
Ensembl chr 5:135,866,941...135,869,548 		JBrowse link
G Rsf1 remodeling and spacing factor 1 decreases expression ISO Clobetasol results in decreased expression of RSF1 mRNA CTD PMID:27462272 NCBI chr 1:161,303,596...161,426,326
Ensembl chr 1:161,303,660...161,420,290 		JBrowse link
G Rsl24d1 ribosomal L24 domain containing 1 increases expression ISO Clobetasol results in increased expression of RSL24D1 mRNA CTD PMID:27462272 NCBI chr 8:82,733,627...82,742,632
Ensembl chr 8:82,733,649...82,744,497 		JBrowse link
G RT1-DMa RT1 class II, locus DMa increases expression ISO Clobetasol results in increased expression of H2-DMA mRNA CTD PMID:27462272 NCBI chr20:4,708,932...4,712,335
Ensembl chr20:4,708,933...4,712,335 		JBrowse link
G Rtcb RNA 2',3'-cyclic phosphate and 5'-OH ligase increases expression ISO Clobetasol results in increased expression of RTCB mRNA CTD PMID:27462272 NCBI chr 7:19,795,393...19,814,875
Ensembl chr 7:19,795,393...19,814,875 		JBrowse link
G Rtl5 retrotransposon Gag like 5 decreases expression ISO Clobetasol results in decreased expression of RTL5 mRNA CTD PMID:27462272 NCBI chr  X:71,223,914...71,228,713
Ensembl chr  X:71,221,371...71,232,653 		JBrowse link
G Rtn4ip1 reticulon 4 interacting protein 1 increases expression ISO Clobetasol results in increased expression of RTN4IP1 mRNA CTD PMID:27462272 NCBI chr20:48,964,903...49,004,235
Ensembl chr20:48,964,816...49,006,456 		JBrowse link
G Ruvbl2 RuvB-like AAA ATPase 2 increases expression ISO Clobetasol results in increased expression of RUVBL2 mRNA CTD PMID:27462272 NCBI chr 1:105,038,487...105,051,851
Ensembl chr 1:105,038,174...105,051,720 		JBrowse link
G Ryr3 ryanodine receptor 3 decreases expression ISO Clobetasol results in decreased expression of RYR3 mRNA CTD PMID:27462272 NCBI chr 3:119,886,129...120,433,465
Ensembl chr 3:119,885,878...120,433,677 		JBrowse link
G S100a10 S100 calcium binding protein A10 increases expression ISO Clobetasol results in increased expression of S100A10 mRNA CTD PMID:27462272 NCBI chr 2:181,904,454...181,913,101
Ensembl chr 2:181,904,261...181,913,103 		JBrowse link
G Sac3d1 SAC3 domain containing 1 increases expression ISO Clobetasol results in increased expression of SAC3D1 mRNA CTD PMID:27462272 NCBI chr 1:212,843,463...212,845,842
Ensembl chr 1:212,843,463...212,845,883 		JBrowse link
G Sall1 spalt-like transcription factor 1 decreases expression ISO Clobetasol results in decreased expression of SALL1 mRNA CTD PMID:27462272 NCBI chr19:34,179,316...34,196,278
Ensembl chr19:34,181,078...34,196,278 		JBrowse link
G Samd4b sterile alpha motif domain containing 4B decreases expression ISO Clobetasol results in decreased expression of SAMD4B mRNA CTD PMID:27462272 NCBI chr 1:92,816,955...92,855,243
Ensembl chr 1:92,809,800...92,841,393 		JBrowse link
G Samm50 SAMM50 sorting and assembly machinery component increases expression ISO Clobetasol results in increased expression of SAMM50 mRNA CTD PMID:27462272 NCBI chr 7:117,197,460...117,221,668
Ensembl chr 7:117,197,381...117,224,581 		JBrowse link
G Samtor S-adenosylmethionine sensor upstream of mTORC1 increases expression ISO Clobetasol results in increased expression of SAMTOR mRNA CTD PMID:27462272 NCBI chr 4:42,847,720...42,911,546
Ensembl chr 4:42,836,172...42,917,567 		JBrowse link
G Sap18 Sin3A associated protein 18 increases expression ISO Clobetasol results in increased expression of SAP18 mRNA CTD PMID:27462272 NCBI chr15:36,058,784...36,063,089
Ensembl chr10:87,156,914...87,158,257
Ensembl chr15:87,156,914...87,158,257 		JBrowse link
G Sap30 Sin3A associated protein 30 increases expression ISO Clobetasol results in increased expression of SAP30 mRNA CTD PMID:27462272 NCBI chr16:37,758,494...37,763,825
Ensembl chr16:37,757,656...37,763,823 		JBrowse link
G Sar1a secretion associated, Ras related GTPase 1A increases expression ISO Clobetasol results in increased expression of SAR1A mRNA CTD PMID:27462272 NCBI chr20:30,166,310...30,178,718
Ensembl chr20:30,166,334...30,178,710 		JBrowse link
G Sar1b secretion associated, Ras related GTPase 1B increases expression ISO Clobetasol results in increased expression of SAR1B mRNA CTD PMID:27462272 NCBI chr10:36,525,365...36,555,009
Ensembl chr10:36,519,384...36,555,005 		JBrowse link
G Saraf store-operated calcium entry-associated regulatory factor increases expression ISO Clobetasol results in increased expression of SARAF mRNA CTD PMID:27462272 NCBI chr16:64,720,404...64,738,653
Ensembl chr16:64,720,418...64,738,653 		JBrowse link
G Sash1 SAM and SH3 domain containing 1 decreases expression ISO Clobetasol results in decreased expression of SASH1 mRNA CTD PMID:27462272 NCBI chr 1:4,940,207...5,238,777
Ensembl chr 1:4,940,207...5,238,530 		JBrowse link
G Sbno2 strawberry notch homolog 2 decreases expression ISO Clobetasol results in decreased expression of SBNO2 mRNA CTD PMID:27462272 NCBI chr 7:10,256,221...10,300,175
Ensembl chr 7:10,253,248...10,300,176 		JBrowse link
G Scaf11 SR-related CTD-associated factor 11 decreases expression ISO Clobetasol results in decreased expression of SCAF11 mRNA CTD PMID:27462272 NCBI chr 7:129,450,872...129,503,280
Ensembl chr 7:129,417,955...129,503,280 		JBrowse link
G Scd stearoyl-CoA desaturase increases expression ISO Clobetasol results in increased expression of SCD1 mRNA CTD PMID:27462272 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785 		JBrowse link
G Scrg1 stimulator of chondrogenesis 1 increases expression ISO Clobetasol results in increased expression of SCRG1 mRNA CTD PMID:27462272 NCBI chr16:37,770,739...37,799,010
Ensembl chr16:37,770,739...37,799,010 		JBrowse link
G Sdc4 syndecan 4 increases expression ISO Clobetasol results in increased expression of SDC4 mRNA CTD PMID:27462272 NCBI chr 3:173,574,239...173,592,923
Ensembl chr 3:173,574,239...173,593,670 		JBrowse link
G Sdf2 stromal cell derived factor 2 increases expression ISO Clobetasol results in increased expression of SDF2 mRNA CTD PMID:27462272 NCBI chr10:63,638,634...63,649,109
Ensembl chr10:63,638,634...63,649,108 		JBrowse link
G Sdf2l1 stromal cell-derived factor 2-like 1 increases expression ISO Clobetasol results in increased expression of SDF2L1 mRNA CTD PMID:27462272 NCBI chr11:97,376,878...97,379,120
Ensembl chr11:97,376,878...97,379,120 		JBrowse link
G Sdha succinate dehydrogenase complex flavoprotein subunit A increases expression ISO Clobetasol results in increased expression of SDHA mRNA CTD PMID:27462272 NCBI chr 1:30,764,553...30,789,523
Ensembl chr 1:30,764,590...30,790,121 		JBrowse link
G Sdhc succinate dehydrogenase complex subunit C increases expression ISO Clobetasol results in increased expression of SDHC mRNA CTD PMID:27462272 NCBI chr13:86,077,133...86,098,025
Ensembl chr13:86,077,134...86,098,044 		JBrowse link
G Sdk2 sidekick cell adhesion molecule 2 decreases expression ISO Clobetasol results in decreased expression of SDK2 mRNA CTD PMID:27462272 NCBI chr10:99,324,047...99,601,683
Ensembl chr10:99,324,047...99,601,683 		JBrowse link
G Sec11a SEC11 homolog A, signal peptidase complex subunit increases expression ISO Clobetasol results in increased expression of SEC11A mRNA CTD PMID:27462272 NCBI chr 1:144,290,680...144,318,658
Ensembl chr 1:144,284,497...144,324,009 		JBrowse link
G Sec13 SEC13 homolog, nuclear pore and COPII coat complex component increases expression ISO Clobetasol results in increased expression of SEC13 mRNA CTD PMID:27462272 NCBI chr 4:148,433,344...148,446,735
Ensembl chr 4:148,433,349...148,446,755 		JBrowse link
G Sec61a1 SEC61 translocon subunit alpha 1 increases expression ISO Clobetasol results in increased expression of SEC61A1 mRNA CTD PMID:27462272 NCBI chr 4:122,530,785...122,545,141
Ensembl chr 4:122,530,789...122,545,141 		JBrowse link
G Sec61b SEC61 translocon subunit beta increases expression ISO Clobetasol results in increased expression of SEC61B mRNA CTD PMID:27462272 NCBI chr 5:66,569,184...66,577,394
Ensembl chr 5:66,569,196...66,580,028 		JBrowse link
G Sel1l3 SEL1L family member 3 increases expression ISO Clobetasol results in increased expression of SEL1L3 mRNA CTD PMID:27462272 NCBI chr14:61,988,350...62,095,542
Ensembl chr14:61,988,346...62,095,542 		JBrowse link
G Selenbp1 selenium binding protein 1 increases expression ISO Clobetasol results in increased expression of SELENBP1 mRNA CTD PMID:27462272 NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:185,183,004...185,194,295 		JBrowse link
G Selenok selenoprotein K increases expression ISO Clobetasol results in increased expression of SELENOK mRNA CTD PMID:27462272 NCBI chr16:5,158,601...5,167,183
Ensembl chr16:5,158,621...5,168,512 		JBrowse link
G Serinc5 serine incorporator 5 increases expression ISO Clobetasol results in increased expression of SERINC5 mRNA CTD PMID:27462272 NCBI chr 2:25,581,952...25,685,403
Ensembl chr 2:25,581,951...25,685,403 		JBrowse link
G Serpine2 serpin family E member 2 increases expression ISO Clobetasol results in increased expression of SERPINE2 mRNA CTD PMID:27462272 NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:88,573,149...88,637,202 		JBrowse link
G Setbp1 SET binding protein 1 decreases expression ISO Clobetasol results in decreased expression of SETBP1 mRNA CTD PMID:27462272 NCBI chr18:74,465,616...74,827,455
Ensembl chr18:74,465,616...74,827,455 		JBrowse link
G Setd1a SET domain containing 1A, histone lysine methyltransferase decreases expression ISO Clobetasol results in decreased expression of SETD1A mRNA CTD PMID:27462272 NCBI chr 1:191,818,752...191,842,167
Ensembl chr 1:191,818,752...191,842,160 		JBrowse link
G Setd2 SET domain containing 2, histone lysine methyltransferase decreases expression ISO Clobetasol results in decreased expression of SETD2 mRNA CTD PMID:27462272 NCBI chr 8:119,390,207...119,475,863
Ensembl chr 8:119,390,207...119,475,863 		JBrowse link
G Sf3b3 splicing factor 3b, subunit 3 increases expression ISO Clobetasol results in increased expression of SF3B3 mRNA CTD PMID:27462272 NCBI chr19:55,692,124...55,729,640
Ensembl chr19:55,692,126...55,729,621 		JBrowse link
G Sgsm2 small G protein signaling modulator 2 decreases expression ISO Clobetasol results in decreased expression of SGSM2 mRNA CTD PMID:27462272 NCBI chr10:60,216,556...60,258,199
Ensembl chr10:60,216,556...60,257,817 		JBrowse link
G Sh3bgrl3 SH3 domain binding glutamate-rich protein like 3 increases expression ISO Clobetasol results in increased expression of SH3BGRL3 mRNA CTD PMID:27462272 NCBI chr 5:151,637,897...151,639,270
Ensembl chr 5:151,637,674...151,639,395 		JBrowse link
G Sh3bp4 SH3-domain binding protein 4 decreases expression ISO Clobetasol results in decreased expression of SH3BP4 mRNA CTD PMID:27462272 NCBI chr 9:97,107,877...97,186,878
Ensembl chr 9:97,107,877...97,186,878 		JBrowse link
G Sh3d19 SH3 domain containing 19 decreases expression ISO Clobetasol results in decreased expression of SH3D19 mRNA CTD PMID:27462272 NCBI chr 2:173,654,234...173,814,030
Ensembl chr 2:173,654,420...173,814,025 		JBrowse link
G Shisa3 shisa family member 3 increases expression ISO Clobetasol results in increased expression of SHISA3 mRNA CTD PMID:27462272 NCBI chr14:40,917,563...40,922,135
Ensembl chr14:40,917,564...40,922,135 		JBrowse link
G Slc10a6 solute carrier family 10 member 6 increases expression ISO Clobetasol results in increased expression of SLC10A6 mRNA CTD PMID:27462272 NCBI chr14:6,385,348...6,407,532
Ensembl chr14:6,385,537...6,408,894 		JBrowse link
G Slc11a2 solute carrier family 11 member 2 increases expression ISO Clobetasol results in increased expression of SLC11A2 mRNA CTD PMID:27462272 NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:133,381,878...133,418,941 		JBrowse link
G Slc12a9 solute carrier family 12, member 9 increases expression ISO Clobetasol results in increased expression of SLC12A9 mRNA CTD PMID:27462272 NCBI chr12:25,005,741...25,022,628
Ensembl chr12:25,005,738...25,022,607 		JBrowse link
G Slc25a11 solute carrier family 25 member 11 increases expression ISO Clobetasol results in increased expression of SLC25A11 mRNA CTD PMID:27462272 NCBI chr10:55,856,209...55,859,060
Ensembl chr10:55,855,979...55,859,060 		JBrowse link
G Slc25a18 solute carrier family 25 member 18 increases expression ISO Clobetasol results in increased expression of SLC25A18 mRNA CTD PMID:27462272 NCBI chr 4:155,672,939...155,693,549
Ensembl chr 4:155,673,169...155,693,548 		JBrowse link
G Slc25a29 solute carrier family 25 member 29 increases expression ISO Clobetasol results in increased expression of SLC25A29 mRNA CTD PMID:27462272 NCBI chr 6:133,506,403...133,517,322
Ensembl chr 6:133,506,331...133,517,827 		JBrowse link
G Slc25a3 solute carrier family 25 member 3 increases expression ISO Clobetasol results in increased expression of SLC25A3 mRNA CTD PMID:27462272 NCBI chr 7:27,499,164...27,506,685
Ensembl chr 7:27,499,165...27,506,309 		JBrowse link
G Slc25a33 solute carrier family 25 member 33 increases expression ISO Clobetasol results in increased expression of SLC25A33 mRNA CTD PMID:27462272 NCBI chr 5:165,478,070...165,518,186
Ensembl chr 5:165,478,072...165,502,973 		JBrowse link
G Slc25a39 solute carrier family 25, member 39 increases expression ISO Clobetasol results in increased expression of SLC25A39 mRNA CTD PMID:27462272 NCBI chr10:87,862,630...87,867,626
Ensembl chr10:87,862,631...87,866,973 		JBrowse link
G Slc25a4 solute carrier family 25 member 4 increases expression ISO Clobetasol results in increased expression of SLC25A4 mRNA CTD PMID:27462272 NCBI chr16:52,805,521...52,809,316
Ensembl chr16:52,805,523...52,811,700 		JBrowse link
G Slc25a5 solute carrier family 25 member 5 increases expression ISO Clobetasol results in increased expression of SLC25A5 mRNA CTD PMID:27462272 NCBI chr  X:120,897,616...120,900,683
Ensembl chr  X:120,897,563...120,900,688 		JBrowse link
G Slc2a1 solute carrier family 2 member 1 increases expression ISO Clobetasol results in increased expression of SLC2A1 mRNA CTD PMID:27462272 NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742 		JBrowse link
G Slc35a1 solute carrier family 35 member A1 increases expression ISO Clobetasol results in increased expression of SLC35A1 mRNA CTD PMID:27462272 NCBI chr 5:54,021,896...54,044,677
Ensembl chr 5:54,021,896...54,044,677 		JBrowse link
G Slc38a2 solute carrier family 38, member 2 increases expression ISO Clobetasol results in increased expression of SLC38A2 mRNA CTD PMID:27462272 NCBI chr 7:129,730,450...129,742,619
Ensembl chr 7:129,730,450...129,742,619 		JBrowse link
G Slc39a1 solute carrier family 39 member 1 increases expression ISO Clobetasol results in increased expression of SLC39A1 mRNA CTD PMID:27462272 NCBI chr 2:178,001,052...178,006,689
Ensembl chr 2:178,001,119...178,006,689 		JBrowse link
G Slc44a5 solute carrier family 44, member 5 increases expression ISO Clobetasol results in increased expression of SLC44A5 mRNA CTD PMID:27462272 NCBI chr 2:245,570,875...245,866,369
Ensembl chr 2:245,570,829...245,867,780 		JBrowse link
G Slc48a1 solute carrier family 48 member 1 increases expression ISO Clobetasol results in increased expression of SLC48A1 mRNA CTD PMID:27462272 NCBI chr 7:130,794,233...130,802,119
Ensembl chr 7:130,794,245...130,803,022 		JBrowse link
G Slc6a1 solute carrier family 6 member 1 decreases expression ISO Clobetasol results in decreased expression of SLC6A1 mRNA CTD PMID:27462272 NCBI chr 4:149,004,447...149,037,840
Ensembl chr 4:149,004,635...149,037,839 		JBrowse link
G Slc6a9 solute carrier family 6 member 9 increases expression ISO Clobetasol results in increased expression of SLC6A9 mRNA CTD PMID:27462272 NCBI chr 5:136,660,022...136,694,173
Ensembl chr 5:136,659,948...136,694,172 		JBrowse link
G Slc7a5 solute carrier family 7 member 5 increases expression ISO Clobetasol results in increased expression of SLC7A5 mRNA CTD PMID:27462272 NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412 		JBrowse link
G Slit3 slit guidance ligand 3 increases expression ISO Clobetasol results in increased expression of SLIT3 mRNA CTD PMID:27462272 NCBI chr10:20,075,929...20,660,704
Ensembl chr10:20,076,021...20,660,704 		JBrowse link
G Slx4 SLX4 structure-specific endonuclease subunit decreases expression ISO Clobetasol results in decreased expression of SLX4 mRNA CTD PMID:27462272 NCBI chr10:12,032,131...12,055,685
Ensembl chr10:12,033,048...12,055,650 		JBrowse link
G Smim7 small integral membrane protein 7 increases expression ISO Clobetasol results in increased expression of SMIM7 mRNA CTD PMID:27462272 NCBI chr16:17,308,466...17,312,384
Ensembl chr16:17,308,395...17,312,371 		JBrowse link
G Snd1 staphylococcal nuclease and tudor domain containing 1 increases expression ISO Clobetasol results in increased expression of SND1 mRNA CTD PMID:27462272 NCBI chr 4:58,060,689...58,459,926
Ensembl chr 4:58,060,640...58,459,925 		JBrowse link
G Sned1 sushi, nidogen and EGF-like domains 1 decreases expression ISO Clobetasol results in decreased expression of SNED1 mRNA CTD PMID:27462272 NCBI chr 9:101,221,497...101,281,401
Ensembl chr 9:101,221,530...101,281,401 		JBrowse link
G Snrnp25 small nuclear ribonucleoprotein U11/U12 subunit 25 increases expression ISO Clobetasol results in increased expression of SNRNP25 mRNA CTD PMID:27462272 NCBI chr10:15,924,932...15,928,279
Ensembl chr10:15,924,940...15,928,252 		JBrowse link
G Snrnp40 small nuclear ribonucleoprotein U5 subunit 40 increases expression ISO Clobetasol results in increased expression of SNRNP40 mRNA CTD PMID:27462272 NCBI chr 5:147,984,758...148,017,932
Ensembl chr 5:147,984,656...148,018,725 		JBrowse link
G Snrpb small nuclear ribonucleoprotein polypeptides B and B1 increases expression ISO Clobetasol results in increased expression of SNRPB mRNA CTD PMID:27462272 NCBI chr 3:137,824,870...137,832,479
Ensembl chr 3:137,824,683...137,832,515 		JBrowse link
G Snrpd2 small nuclear ribonucleoprotein D2 polypeptide increases expression ISO Clobetasol results in increased expression of SNRPD2 mRNA CTD PMID:27462272 NCBI chr 1:87,926,030...87,929,259
Ensembl chr 1:87,926,048...87,933,339
Ensembl chr20:87,926,048...87,933,339 		JBrowse link
G Snx17 sorting nexin 17 increases expression ISO Clobetasol results in increased expression of SNX17 mRNA CTD PMID:27462272 NCBI chr 6:30,897,500...30,902,972
Ensembl chr 6:30,897,501...30,902,972 		JBrowse link
G Sobp sine oculis binding protein homolog decreases expression ISO Clobetasol results in decreased expression of SOBP mRNA CTD PMID:27462272 NCBI chr20:48,064,445...48,243,607
Ensembl chr20:48,064,445...48,243,607 		JBrowse link
G Son SON DNA and RNA binding protein decreases expression ISO Clobetasol results in decreased expression of SON mRNA CTD PMID:27462272 NCBI chr11:44,336,818...44,409,127
Ensembl chr11:44,377,976...44,409,127 		JBrowse link
G Sox11 SRY-box transcription factor 11 decreases expression ISO Clobetasol results in decreased expression of SOX11 mRNA CTD PMID:27462272 NCBI chr 6:49,736,773...49,738,794
Ensembl chr 6:49,736,304...49,738,691 		JBrowse link
G Sox4 SRY-box transcription factor 4 decreases expression ISO Clobetasol results in decreased expression of SOX4 mRNA CTD PMID:27462272 NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,875,756...35,884,024 		JBrowse link
G Sox6 SRY-box transcription factor 6 decreases expression ISO Clobetasol results in decreased expression of SOX6 mRNA CTD PMID:27462272 NCBI chr 1:179,157,678...179,769,243
Ensembl chr 1:179,163,566...179,711,727 		JBrowse link
G Sox9 SRY-box transcription factor 9 decreases expression ISO Clobetasol results in decreased expression of SOX9 mRNA CTD PMID:27462272 NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250 		JBrowse link
G Spcs2 signal peptidase complex subunit 2 increases expression ISO Clobetasol results in increased expression of SPCS2 mRNA CTD PMID:27462272 NCBI chr 1:163,575,842...163,595,269
Ensembl chr 1:163,575,842...163,595,271 		JBrowse link
G Specc1 sperm antigen with calponin homology and coiled-coil domains 1 decreases expression ISO Clobetasol results in decreased expression of SPECC1 mRNA CTD PMID:27462272 NCBI chr10:47,138,351...47,412,311
Ensembl chr10:47,138,398...47,412,319 		JBrowse link
G Spock2 SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2 increases expression ISO Clobetasol results in increased expression of SPOCK2 mRNA CTD PMID:27462272 NCBI chr20:28,580,262...28,607,198
Ensembl chr20:28,580,226...28,608,409 		JBrowse link
G Spry4 sprouty RTK signaling antagonist 4 increases expression ISO Clobetasol results in increased expression of SPRY4 mRNA CTD PMID:27462272 NCBI chr18:30,687,633...30,702,546
Ensembl chr18:30,687,039...30,704,173 		JBrowse link
G Spryd4 SPRY domain containing 4 increases expression ISO Clobetasol results in increased expression of SPRYD4 mRNA CTD PMID:27462272 NCBI chr 7:1,217,984...1,222,231
Ensembl chr 7:1,218,122...1,219,942 		JBrowse link
G Sptbn1 spectrin, beta, non-erythrocytic 1 decreases expression ISO Clobetasol results in decreased expression of SPTBN1 mRNA CTD PMID:27462272 NCBI chr14:108,042,629...108,217,884
Ensembl chr14:108,042,629...108,217,836 		JBrowse link
G Sptbn2 spectrin, beta, non-erythrocytic 2 decreases expression ISO Clobetasol results in decreased expression of SPTBN2 mRNA CTD PMID:27462272 NCBI chr 1:211,432,373...211,473,016
Ensembl chr 1:211,432,373...211,473,306 		JBrowse link
G Sptssa serine palmitoyltransferase, small subunit A increases expression ISO Clobetasol results in increased expression of SPTSSA mRNA CTD PMID:27462272 NCBI chr 6:77,879,931...77,891,344
Ensembl chr 6:77,879,941...77,891,403 		JBrowse link
G Srcap Snf2-related CREBBP activator protein decreases expression ISO Clobetasol results in decreased expression of SRCAP mRNA CTD PMID:27462272 NCBI chr 1:191,554,043...191,607,096
Ensembl chr 1:191,554,043...191,604,265 		JBrowse link
G Srcin1 SRC kinase signaling inhibitor 1 decreases expression ISO Clobetasol results in decreased expression of SRCIN1 mRNA CTD PMID:27462272 NCBI chr10:82,999,295...83,066,359
Ensembl chr10:82,991,033...83,067,419 		JBrowse link
G Srgap3 SLIT-ROBO Rho GTPase activating protein 3 decreases expression ISO Clobetasol results in decreased expression of SRGAP3 mRNA CTD PMID:27462272 NCBI chr 4:147,391,082...147,626,407
Ensembl chr 4:147,395,880...147,625,713 		JBrowse link
G Srm spermidine synthase increases expression ISO Clobetasol results in increased expression of SRM mRNA CTD PMID:27462272 NCBI chr 5:164,309,002...164,312,203
Ensembl chr 5:164,308,991...164,332,705 		JBrowse link
G Srpra SRP receptor subunit alpha increases expression ISO Clobetasol results in increased expression of SRPRA mRNA CTD PMID:27462272 NCBI chr 8:41,818,199...41,824,292
Ensembl chr 8:41,818,229...41,824,280 		JBrowse link
G Srxn1 sulfiredoxin 1 increases expression ISO Clobetasol results in increased expression of SRXN1 mRNA CTD PMID:27462272 NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765 		JBrowse link
G Ss18l2 SS18 like 2 increases expression ISO Clobetasol results in increased expression of SS18L2 mRNA CTD PMID:27462272 NCBI chr 8:130,252,774...130,255,388
Ensembl chr 8:130,252,782...130,257,367 		JBrowse link
G Ssr3 signal sequence receptor subunit 3 increases expression ISO Clobetasol results in increased expression of SSR3 mRNA CTD PMID:27462272 NCBI chr 2:151,915,101...151,935,162
Ensembl chr 2:151,906,149...151,935,170 		JBrowse link
G Star steroidogenic acute regulatory protein decreases expression ISO Clobetasol results in decreased expression of STAR mRNA CTD PMID:27462272 NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447 		JBrowse link
G Stard4 StAR-related lipid transfer domain containing 4 increases expression ISO Clobetasol results in increased expression of STARD4 mRNA CTD PMID:27462272 NCBI chr18:25,088,831...25,104,172
Ensembl chr18:25,091,255...25,104,172 		JBrowse link
G Stard9 StAR-related lipid transfer domain containing 9 decreases expression ISO Clobetasol results in decreased expression of STARD9 mRNA CTD PMID:27462272 NCBI chr 3:128,034,866...128,150,493
Ensembl chr 3:128,034,908...128,127,402 		JBrowse link
G Stmn3 stathmin 3 increases expression ISO Clobetasol results in increased expression of STMN3 mRNA CTD PMID:27462272 NCBI chr 3:188,794,358...188,802,494
Ensembl chr 3:188,794,358...188,802,873 		JBrowse link
G Ston2 stonin 2 decreases expression ISO Clobetasol results in decreased expression of STON2 mRNA CTD PMID:27462272 NCBI chr 6:116,291,898...116,441,391
Ensembl chr 6:116,298,198...116,407,092 		JBrowse link
G Stub1 STIP1 homology and U-box containing protein 1 increases expression ISO Clobetasol results in increased expression of STUB1 mRNA CTD PMID:27462272 NCBI chr10:15,355,278...15,357,559
Ensembl chr10:15,355,279...15,357,559 		JBrowse link
G Sub1 SUB1 regulator of transcription increases expression ISO Clobetasol results in increased expression of SUB1 mRNA CTD PMID:27462272 NCBI chr 2:62,735,379...62,747,545
Ensembl chr 2:62,732,736...62,747,679 		JBrowse link
G Suco SUN domain containing ossification factor decreases expression ISO Clobetasol results in decreased expression of SUCO mRNA CTD PMID:27462272 NCBI chr13:76,726,095...76,791,174
Ensembl chr13:76,726,859...76,791,174 		JBrowse link
G Supt6h SPT6 homolog, histone chaperone and transcription elongation factor decreases expression ISO Clobetasol results in decreased expression of SUPT6 mRNA CTD PMID:27462272 NCBI chr10:63,601,990...63,638,851
Ensembl chr10:63,601,993...63,638,851 		JBrowse link
G Surf4 surfeit 4 increases expression ISO Clobetasol results in increased expression of SURF4 mRNA CTD PMID:27462272 NCBI chr 3:30,646,435...30,659,641
Ensembl chr 3:30,638,299...30,661,390 		JBrowse link
G Syne1 spectrin repeat containing nuclear envelope protein 1 decreases expression ISO Clobetasol results in decreased expression of SYNE1 mRNA CTD PMID:27462272 NCBI chr 1:43,917,640...44,388,802
Ensembl chr 1:43,895,994...44,388,721 		JBrowse link
G Syne2 spectrin repeat containing nuclear envelope protein 2 decreases expression ISO Clobetasol results in decreased expression of SYNE2 mRNA CTD PMID:27462272 NCBI chr 6:100,272,729...100,586,364
Ensembl chr 6:100,272,729...100,583,723 		JBrowse link
G Synrg synergin, gamma decreases expression ISO Clobetasol results in decreased expression of SYNRG mRNA CTD PMID:27462272 NCBI chr10:69,346,154...69,428,714
Ensembl chr10:69,322,114...69,428,714 		JBrowse link
G Tab2 TGF-beta activated kinase 1/MAP3K7 binding protein 2 decreases expression ISO Clobetasol results in decreased expression of TAB2 mRNA CTD PMID:27462272 NCBI chr 1:4,195,400...4,245,485
Ensembl chr 1:4,195,400...4,245,485 		JBrowse link
G Tagln2 transgelin 2 increases expression ISO Clobetasol results in increased expression of TAGLN2 mRNA CTD PMID:27462272 NCBI chr13:87,499,350...87,506,328
Ensembl chr13:87,499,394...87,506,330 		JBrowse link
G Taok1 TAO kinase 1 decreases expression ISO Clobetasol results in decreased expression of TAOK1 mRNA CTD PMID:27462272 NCBI chr10:62,871,198...62,989,049
Ensembl chr10:62,871,198...62,957,595 		JBrowse link
G Tasor2 transcription activation suppressor family member 2 decreases expression ISO Clobetasol results in decreased expression of TASOR2 mRNA CTD PMID:27462272 NCBI chr17:71,504,656...71,559,878
Ensembl chr17:71,504,822...71,559,035 		JBrowse link
G Tbcc tubulin folding cofactor C increases expression ISO Clobetasol results in increased expression of TBCC mRNA CTD PMID:27462272 NCBI chr 9:21,596,472...21,597,660
Ensembl chr 9:21,595,615...21,597,842 		JBrowse link
G Tbcd tubulin folding cofactor D increases expression ISO Clobetasol results in increased expression of TBCD mRNA CTD PMID:27462272 NCBI chr10:107,215,626...107,372,398
Ensembl chr10:107,215,633...107,372,402 		JBrowse link
G Tcim transcriptional and immune response regulator increases expression ISO Clobetasol results in increased expression of TCIM mRNA CTD PMID:27462272 NCBI chr16:74,298,344...74,299,637
Ensembl chr16:74,298,344...74,299,636 		JBrowse link
G Tef TEF transcription factor, PAR bZIP family member decreases expression ISO Clobetasol results in decreased expression of TEF mRNA CTD PMID:27462272 NCBI chr 7:115,197,180...115,221,930
Ensembl chr 7:115,193,282...115,221,928 		JBrowse link
G Ten1 TEN1 subunit of CST complex increases expression ISO Clobetasol results in increased expression of TEN1 mRNA CTD PMID:27462272 NCBI chr10:101,930,212...101,951,932
Ensembl chr10:101,930,222...101,953,979 		JBrowse link
G Tia1 TIA1 cytotoxic granule-associated RNA binding protein decreases expression ISO Clobetasol results in decreased expression of TIA1 mRNA CTD PMID:27462272 NCBI chr 4:120,410,180...120,440,676
Ensembl chr 4:120,410,251...120,440,665 		JBrowse link
G Timm10 translocase of inner mitochondrial membrane 10 increases expression ISO Clobetasol results in increased expression of TIMM10 mRNA CTD PMID:27462272 NCBI chr 3:90,315,048...90,318,613
Ensembl chr 3:90,315,092...90,318,614 		JBrowse link
G Timm13 translocase of inner mitochondrial membrane 13 increases expression ISO Clobetasol results in increased expression of TIMM13 mRNA CTD PMID:27462272 NCBI chr 7:9,459,490...9,460,849
Ensembl chr 7:9,459,582...9,460,862 		JBrowse link
G Timm8a1 translocase of inner mitochondrial membrane 8A1 increases expression ISO Clobetasol results in increased expression of TIMM8A1 mRNA CTD PMID:27462272 NCBI chr  X:102,011,206...102,015,444
Ensembl chr  X:102,011,206...102,015,444 		JBrowse link
G Timp4 TIMP metallopeptidase inhibitor 4 increases expression ISO Clobetasol results in increased expression of TIMP4 mRNA CTD PMID:27462272 NCBI chr 4:149,978,667...149,985,350
Ensembl chr 4:149,978,685...149,985,452 		JBrowse link
G Tln1 talin 1 decreases expression ISO Clobetasol results in decreased expression of TLN1 mRNA CTD PMID:27462272 NCBI chr 5:62,583,730...62,613,687
Ensembl chr 5:62,583,731...62,613,687 		JBrowse link
G Tm2d2 TM2 domain containing 2 increases expression ISO Clobetasol results in increased expression of TM2D2 mRNA CTD PMID:27462272 NCBI chr16:73,719,331...73,724,853
Ensembl chr16:73,719,332...73,724,981 		JBrowse link
G Tmed3 transmembrane p24 trafficking protein 3 increases expression ISO Clobetasol results in increased expression of TMED3 mRNA CTD PMID:27462272 NCBI chr 8:99,121,361...99,129,653
Ensembl chr 8:99,121,361...99,129,215 		JBrowse link
G Tmed4 transmembrane p24 trafficking protein 4 increases expression ISO Clobetasol results in increased expression of TMED4 mRNA CTD PMID:27462272 NCBI chr14:85,338,980...85,343,577
Ensembl chr14:85,338,980...85,343,577 		JBrowse link
G Tmem101 transmembrane protein 101 increases expression ISO Clobetasol results in increased expression of TMEM101 mRNA CTD PMID:27462272 NCBI chr10:87,605,300...87,609,053
Ensembl chr10:87,605,300...87,608,999 		JBrowse link
G Tmem109 transmembrane protein 109 increases expression ISO Clobetasol results in increased expression of TMEM109 mRNA CTD PMID:27462272 NCBI chr 1:216,944,516...216,955,091
Ensembl chr 1:216,944,519...216,955,138 		JBrowse link
G Tmem128 transmembrane protein 128 increases expression ISO Clobetasol results in increased expression of TMEM128 mRNA CTD PMID:27462272 NCBI chr14:76,751,848...76,761,576
Ensembl chr14:76,752,603...76,772,217 		JBrowse link
G Tmem131 transmembrane protein 131 decreases expression ISO Clobetasol results in decreased expression of TMEM131 mRNA CTD PMID:27462272 NCBI chr 9:46,512,328...46,658,624
Ensembl chr 9:46,512,328...46,658,481 		JBrowse link
G Tmem135 transmembrane protein 135 increases expression ISO Clobetasol results in increased expression of TMEM135 mRNA CTD PMID:27462272 NCBI chr 1:152,418,929...152,692,405
Ensembl chr 1:152,418,930...152,633,717 		JBrowse link
G Tmem151b transmembrane protein 151B decreases expression ISO Clobetasol results in decreased expression of TMEM151B mRNA CTD PMID:27462272 NCBI chr 9:22,953,881...22,961,726
Ensembl chr 9:22,953,881...22,961,726 		JBrowse link
G Tmem160 transmembrane protein 160 increases expression ISO Clobetasol results in increased expression of TMEM160 mRNA CTD PMID:27462272 NCBI chr 1:86,292,582...86,295,290
Ensembl chr 1:86,292,753...86,297,780 		JBrowse link
G Tmem179 transmembrane protein 179 increases expression ISO Clobetasol results in increased expression of TMEM179 mRNA CTD PMID:27462272 NCBI chr 6:137,390,422...137,401,438
Ensembl chr 6:137,390,423...137,401,438 		JBrowse link
G Tmem208 transmembrane protein 208 increases expression ISO Clobetasol results in increased expression of TMEM208 mRNA CTD PMID:27462272 NCBI chr19:50,113,494...50,116,210
Ensembl chr19:50,113,510...50,124,153 		JBrowse link
G Tmem229a transmembrane protein 229A increases expression ISO Clobetasol results in increased expression of TMEM229A mRNA CTD PMID:27462272 NCBI chr 4:54,405,822...54,410,802
Ensembl chr 4:54,399,867...54,412,225 		JBrowse link
G Tmem256 transmembrane protein 256 increases expression ISO Clobetasol results in increased expression of TMEM256 mRNA CTD PMID:27462272 NCBI chr10:55,056,959...55,058,869
Ensembl chr10:55,056,760...55,058,862 		JBrowse link
G Tmem35a transmembrane protein 35A increases expression ISO Clobetasol results in increased expression of TMEM35A mRNA CTD PMID:27462272 NCBI chr  X:101,796,623...101,807,471
Ensembl chr  X:101,796,623...101,807,470 		JBrowse link
G Tmem43 transmembrane protein 43 increases expression ISO Clobetasol results in increased expression of TMEM43 mRNA CTD PMID:27462272 NCBI chr 4:125,534,844...125,549,986
Ensembl chr 4:125,534,813...125,549,988 		JBrowse link
G Tmem50b transmembrane protein 50B increases expression ISO Clobetasol results in increased expression of TMEM50B mRNA CTD PMID:27462272 NCBI chr11:44,290,805...44,323,650
Ensembl chr11:44,290,807...44,323,607 		JBrowse link
G Tmem59 transmembrane protein 59 increases expression ISO Clobetasol results in increased expression of TMEM59 mRNA CTD PMID:27462272 NCBI chr 5:127,191,320...127,212,436
Ensembl chr 5:127,191,030...127,217,531 		JBrowse link
G Tmem97 transmembrane protein 97 increases expression ISO Clobetasol results in increased expression of TMEM97 mRNA CTD PMID:27462272 NCBI chr10:63,936,276...63,945,359
Ensembl chr10:63,936,271...63,945,818 		JBrowse link
G Tnf tumor necrosis factor decreases secretion ISO Clobetasol results in decreased secretion of TNF protein CTD PMID:15086553 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfrsf1a TNF receptor superfamily member 1A increases expression ISO Clobetasol results in increased expression of TNFRSF1A mRNA CTD PMID:27462272 NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816 		JBrowse link
G Tnr tenascin R decreases expression ISO Clobetasol results in decreased expression of TNR mRNA CTD PMID:27462272 NCBI chr13:74,285,141...74,706,174
Ensembl chr13:74,507,366...74,701,115 		JBrowse link
G Tnrc18 trinucleotide repeat containing 18 decreases expression ISO Clobetasol results in decreased expression of TNRC18 mRNA CTD PMID:27462272 NCBI chr12:16,868,930...16,965,224
Ensembl chr12:16,868,978...16,965,217 		JBrowse link
G Tob2 transducer of ERBB2, 2 increases expression ISO Clobetasol results in increased expression of TOB2 mRNA CTD PMID:27462272 NCBI chr 7:115,242,843...115,251,563
Ensembl chr 7:115,239,895...115,258,155 		JBrowse link
G Tollip toll interacting protein increases expression ISO Clobetasol results in increased expression of TOLLIP mRNA CTD PMID:27462272 NCBI chr 1:206,391,120...206,413,809
Ensembl chr 1:206,380,308...206,411,988 		JBrowse link
G Tpi1 triosephosphate isomerase 1 increases expression ISO Clobetasol results in increased expression of TPI1 mRNA CTD PMID:27462272 NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:159,301,562...159,305,413 		JBrowse link
G Tpr translocated promoter region, nuclear basket protein decreases expression ISO Clobetasol results in decreased expression of TPR mRNA CTD PMID:27462272 NCBI chr13:64,974,419...65,037,604
Ensembl chr13:64,974,419...65,037,602 		JBrowse link
G Tprn taperin increases expression ISO Clobetasol results in increased expression of TPRN mRNA CTD PMID:27462272 NCBI chr 3:28,474,322...28,481,800
Ensembl chr 3:28,473,620...28,482,117 		JBrowse link
G Tra2a transformer 2 alpha decreases expression ISO Clobetasol results in decreased expression of TRA2A mRNA CTD PMID:27462272 NCBI chr 4:79,551,699...79,570,621
Ensembl chr 4:79,551,542...79,570,619 		JBrowse link
G Triap1 TP53 regulated inhibitor of apoptosis 1 increases expression ISO Clobetasol results in increased expression of TRIAP1 mRNA CTD PMID:27462272 NCBI chr12:46,928,273...46,930,766
Ensembl chr12:46,928,273...46,930,766 		JBrowse link
G Tril TLR4 interactor with leucine-rich repeats decreases expression ISO Clobetasol results in decreased expression of TRIL mRNA CTD PMID:27462272 NCBI chr 4:84,252,781...84,257,626
Ensembl chr 4:84,239,028...84,260,209 		JBrowse link
G Trim35 tripartite motif-containing 35 increases expression ISO Clobetasol results in increased expression of TRIM35 mRNA CTD PMID:27462272 NCBI chr15:44,669,222...44,685,766
Ensembl chr15:44,656,322...44,685,765 		JBrowse link
G Trim67 tripartite motif-containing 67 decreases expression ISO Clobetasol results in decreased expression of TRIM67 mRNA CTD PMID:27462272 NCBI chr19:69,659,857...69,703,290
Ensembl chr19:69,661,777...69,698,805 		JBrowse link
G Trio trio Rho guanine nucleotide exchange factor decreases expression ISO Clobetasol results in decreased expression of TRIO mRNA CTD PMID:27462272 NCBI chr 2:80,235,485...80,531,824
Ensembl chr 2:80,235,485...80,531,612 		JBrowse link
G Trmt10b tRNA methyltransferase 10B increases expression ISO Clobetasol results in increased expression of TRMT10B mRNA CTD PMID:27462272 NCBI chr 5:64,344,491...64,368,175
Ensembl chr 5:64,344,545...64,368,172 		JBrowse link
G Trrap transformation/transcription domain-associated protein decreases expression ISO Clobetasol results in decreased expression of TRRAP mRNA CTD PMID:27462272 NCBI chr12:14,851,758...14,941,444
Ensembl chr12:14,851,758...14,941,407 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 decreases expression ISO Clobetasol results in decreased expression of TSC22D1 mRNA CTD PMID:27462272 NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322 		JBrowse link
G Tsc22d3 TSC22 domain family, member 3 increases expression ISO Clobetasol results in increased expression of TSC22D3 mRNA CTD PMID:27462272 NCBI chr  X:109,006,410...109,066,389
Ensembl chr  X:109,006,420...109,015,519 		JBrowse link
G Tsc22d4 TSC22 domain family, member 4 increases expression ISO Clobetasol results in increased expression of TSC22D4 mRNA CTD PMID:27462272 NCBI chr12:24,575,948...24,588,806
Ensembl chr12:24,567,176...24,587,894 		JBrowse link
G Tsn translin increases expression ISO Clobetasol results in increased expression of TSN mRNA CTD PMID:27462272 NCBI chr13:31,917,133...31,930,069
Ensembl chr13:31,919,231...31,930,417 		JBrowse link
G Tspan13 tetraspanin 13 increases expression ISO Clobetasol results in increased expression of TSPAN13 mRNA CTD PMID:27462272 NCBI chr 6:58,466,051...58,492,804
Ensembl chr 6:58,465,684...58,492,819 		JBrowse link
G Tspan3 tetraspanin 3 increases expression ISO Clobetasol results in increased expression of TSPAN3 mRNA CTD PMID:27462272 NCBI chr 8:65,442,100...65,465,961
Ensembl chr 8:65,442,101...65,465,844 		JBrowse link
G Tspan31 tetraspanin 31 increases expression ISO Clobetasol results in increased expression of TSPAN31 mRNA CTD PMID:27462272 NCBI chr 7:64,774,881...64,783,534
Ensembl chr 7:64,774,910...64,777,726 		JBrowse link
G Ttbk1 tau tubulin kinase 1 decreases expression ISO Clobetasol results in decreased expression of TTBK1 mRNA CTD PMID:27462272 NCBI chr 9:21,990,973...22,035,961
Ensembl chr 9:21,990,973...22,035,961 		JBrowse link
G Ttc17 tetratricopeptide repeat domain 17 decreases expression ISO Clobetasol results in decreased expression of TTC17 mRNA CTD PMID:27462272 NCBI chr 3:100,718,820...100,829,464
Ensembl chr 3:100,718,827...100,829,129 		JBrowse link
G Ttc28 tetratricopeptide repeat domain 28 decreases expression ISO Clobetasol results in decreased expression of TTC28 mRNA CTD PMID:27462272 NCBI chr12:51,002,816...51,443,461
Ensembl chr12:51,005,089...51,443,531 		JBrowse link
G Ttll12 tubulin tyrosine ligase like 12 increases expression ISO Clobetasol results in increased expression of TTLL12 mRNA CTD PMID:27462272 NCBI chr 7:116,612,609...116,631,244
Ensembl chr 7:116,612,609...116,631,577 		JBrowse link
G Tub TUB bipartite transcription factor decreases expression ISO Clobetasol results in decreased expression of TUB mRNA CTD PMID:27462272 NCBI chr 1:172,386,772...172,465,791
Ensembl chr 1:172,382,197...172,465,790 		JBrowse link
G Tuba1a tubulin, alpha 1A increases expression ISO Clobetasol results in increased expression of TUBA1A mRNA CTD PMID:27462272 NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:131,968,770...131,996,035 		JBrowse link
G Tuba1b tubulin, alpha 1B increases expression ISO Clobetasol results in increased expression of TUBA1B mRNA CTD PMID:27462272 NCBI chr 7:131,969,606...131,972,587
Ensembl chr 7:131,968,770...131,996,035 		JBrowse link
G Tuba1c tubulin, alpha 1C increases expression ISO Clobetasol results in increased expression of TUBA1C mRNA CTD PMID:27462272 NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311 		JBrowse link
G Tubb2a tubulin, beta 2A class IIa increases expression ISO Clobetasol results in increased expression of TUBB2A mRNA CTD PMID:27462272 NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,983,387...31,006,838 		JBrowse link
G Tubb5 tubulin, beta 5 class I increases expression ISO Clobetasol results in increased expression of TUBB5 mRNA CTD PMID:27462272 NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726 		JBrowse link
G Txlnb taxilin beta decreases expression ISO Clobetasol results in decreased expression of TXLNB mRNA CTD PMID:27462272 NCBI chr 1:14,224,647...14,269,837
Ensembl chr 1:14,195,329...14,269,835 		JBrowse link
G Txnl1 thioredoxin-like 1 increases expression ISO Clobetasol results in increased expression of TXNL1 mRNA CTD PMID:27462272 NCBI chr18:59,397,275...59,428,072
Ensembl chr18:59,398,535...59,435,518 		JBrowse link
G Tyw5 tRNA-yW synthesizing protein 5 increases expression ISO Clobetasol results in increased expression of TYW5 mRNA CTD PMID:27462272 NCBI chr 9:66,455,364...66,473,446
Ensembl chr 9:66,455,370...66,473,446 		JBrowse link
G Ubac2 UBA domain containing 2 increases expression ISO Clobetasol results in increased expression of UBAC2 mRNA CTD PMID:27462272 NCBI chr15:105,366,776...105,514,435
Ensembl chr15:105,366,697...105,514,444 		JBrowse link
G Ubald2 UBA-like domain containing 2 increases expression ISO Clobetasol results in increased expression of UBALD2 mRNA CTD PMID:27462272 NCBI chr10:102,161,370...102,165,952
Ensembl chr10:102,160,866...102,168,041 		JBrowse link
G Ube2g2 ubiquitin-conjugating enzyme E2G 2 increases expression ISO Clobetasol results in increased expression of UBE2G2 mRNA CTD PMID:27462272 NCBI chr20:10,983,322...11,005,060
Ensembl chr20:10,983,325...11,005,187 		JBrowse link
G Ubfd1 ubiquitin family domain containing 1 increases expression ISO Clobetasol results in increased expression of UBFD1 mRNA CTD PMID:27462272 NCBI chr 1:186,057,267...186,068,832
Ensembl chr 1:186,057,123...186,066,103 		JBrowse link
G Ubl5 ubiquitin-like 5 increases expression ISO Clobetasol results in increased expression of UBL5 mRNA CTD PMID:27462272 NCBI chr 8:27,457,738...27,461,458 JBrowse link
G Ubr4 ubiquitin protein ligase E3 component n-recognin 4 decreases expression ISO Clobetasol results in decreased expression of UBR4 mRNA CTD PMID:27462272 NCBI chr 5:156,919,029...157,027,127
Ensembl chr 5:156,919,085...157,027,127 		JBrowse link
G Ubr7 ubiquitin protein ligase E3 component n-recognin 7 increases expression ISO Clobetasol results in increased expression of UBR7 mRNA CTD PMID:27462272 NCBI chr 6:127,663,454...127,683,302
Ensembl chr 6:127,663,447...127,694,390 		JBrowse link
G Ubxn4 UBX domain protein 4 decreases expression ISO Clobetasol results in decreased expression of UBXN4 mRNA CTD PMID:27462272 NCBI chr13:42,292,346...42,324,928
Ensembl chr13:42,292,528...42,326,143 		JBrowse link
G Ucp2 uncoupling protein 2 increases expression ISO Clobetasol results in increased expression of UCP2 mRNA CTD PMID:27462272 NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743 		JBrowse link
G Unc80 unc-80 homolog, NALCN channel complex subunit decreases expression ISO Clobetasol results in decreased expression of UNC80 mRNA CTD PMID:27462272 NCBI chr 9:75,461,618...75,639,849
Ensembl chr 9:75,461,599...75,639,842 		JBrowse link
G Uqcc2 ubiquinol-cytochrome c reductase complex assembly factor 2 increases expression ISO Clobetasol results in increased expression of UQCC2 mRNA CTD PMID:27462272 NCBI chr20:5,204,682...5,217,080
Ensembl chr17:12,088,037...12,088,606
Ensembl chr20:12,088,037...12,088,606 		JBrowse link
G Uqcr10 ubiquinol-cytochrome c reductase, complex III subunit X increases expression ISO Clobetasol results in increased expression of UQCR10 mRNA CTD PMID:27462272 NCBI chr14:83,789,657...83,791,914
Ensembl chr14:83,789,658...83,791,914 		JBrowse link
G Uqcrc1 ubiquinol-cytochrome c reductase core protein 1 increases expression ISO Clobetasol results in increased expression of UQCRC1 mRNA CTD PMID:27462272 NCBI chr 8:118,468,223...118,479,968
Ensembl chr 8:118,468,200...118,479,964 		JBrowse link
G Usp34 ubiquitin specific peptidase 34 decreases expression ISO Clobetasol results in decreased expression of USP34 mRNA CTD PMID:27462272 NCBI chr14:101,487,110...101,677,519
Ensembl chr14:101,487,153...101,678,632 		JBrowse link
G Usp54 ubiquitin specific peptidase 54 increases expression ISO Clobetasol results in increased expression of USP54 mRNA CTD PMID:27462272 NCBI chr15:3,706,013...3,806,935
Ensembl chr15:3,741,311...3,806,932 		JBrowse link
G Utp14a UTP14A small subunit processome component decreases expression ISO Clobetasol results in decreased expression of UTP14A mRNA CTD PMID:27462272 NCBI chr  X:132,317,163...132,342,524
Ensembl chr  X:132,317,159...132,342,523 		JBrowse link
G Utrn utrophin decreases expression ISO Clobetasol results in decreased expression of UTRN mRNA CTD PMID:27462272 NCBI chr 1:8,541,061...9,044,487
Ensembl chr 1:8,542,798...9,044,487 		JBrowse link
G Vash1 vasohibin 1 increases expression ISO Clobetasol results in increased expression of VASH1 mRNA CTD PMID:27462272 NCBI chr 6:112,060,086...112,076,689
Ensembl chr 6:112,060,086...112,076,689 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 decreases expression ISO Clobetasol results in decreased expression of VCAM1 mRNA CTD PMID:27462272 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vdac1 voltage-dependent anion channel 1 increases expression ISO Clobetasol results in increased expression of VDAC1 mRNA CTD PMID:27462272 NCBI chr10:37,029,377...37,060,542
Ensembl chr10:37,023,145...37,060,541 		JBrowse link
G Vdac2 voltage-dependent anion channel 2 increases expression ISO Clobetasol results in increased expression of VDAC2 mRNA CTD PMID:27462272 NCBI chr15:2,512,214...2,526,105
Ensembl chr15:2,512,216...2,532,229 		JBrowse link
G Vim vimentin increases expression ISO Clobetasol results in increased expression of VIM mRNA CTD PMID:27462272 NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746 		JBrowse link
G Vkorc1 vitamin K epoxide reductase complex, subunit 1 increases expression ISO Clobetasol results in increased expression of VKORC1 mRNA CTD PMID:27462272 NCBI chr 1:191,932,969...191,935,490 JBrowse link
G Vps13b vacuolar protein sorting 13 homolog B decreases expression ISO Clobetasol results in decreased expression of VPS13B mRNA CTD PMID:27462272 NCBI chr 7:68,436,996...69,013,574
Ensembl chr 7:68,443,655...69,013,574 		JBrowse link
G Vps37b VPS37B subunit of ESCRT-I decreases expression ISO Clobetasol results in decreased expression of VPS37B mRNA CTD PMID:27462272 NCBI chr12:38,220,973...38,249,935
Ensembl chr12:38,220,959...38,249,935 		JBrowse link
G Vxn vexin decreases expression ISO Clobetasol results in decreased expression of VXN mRNA CTD PMID:27462272 NCBI chr 5:14,442,040...14,467,500
Ensembl chr 5:14,442,040...14,467,500 		JBrowse link
G Wasf1 WASP family member 1 decreases expression ISO Clobetasol results in decreased expression of WASF1 mRNA CTD PMID:27462272 NCBI chr20:45,908,458...45,956,118
Ensembl chr20:45,908,750...45,955,640 		JBrowse link
G Wbp2 WW domain binding protein 2 increases expression ISO Clobetasol results in increased expression of WBP2 mRNA CTD PMID:27462272 NCBI chr10:101,811,308...101,819,766
Ensembl chr10:101,812,321...101,819,770 		JBrowse link
G Wdfy3 WD repeat and FYVE domain containing 3 decreases expression ISO Clobetasol results in decreased expression of WDFY3 mRNA CTD PMID:27462272 NCBI chr14:7,873,946...8,115,002
Ensembl chr14:7,911,151...8,114,993 		JBrowse link
G Wdr26 WD repeat domain 26 decreases expression ISO Clobetasol results in decreased expression of WDR26 mRNA CTD PMID:27462272 NCBI chr13:95,462,017...95,503,826
Ensembl chr13:95,462,020...95,503,738 		JBrowse link
G Wdr46 WD repeat domain 46 increases expression ISO Clobetasol results in increased expression of WDR46 mRNA CTD PMID:27462272 NCBI chr20:4,939,721...4,947,619
Ensembl chr20:4,939,732...4,947,741 		JBrowse link
G Wfs1 wolframin ER transmembrane glycoprotein increases expression ISO Clobetasol results in increased expression of WFS1 mRNA CTD PMID:27462272 NCBI chr14:78,035,205...78,059,718
Ensembl chr14:78,034,864...78,060,459 		JBrowse link
G Wipf2 WAS/WASL interacting protein family, member 2 decreases expression ISO Clobetasol results in decreased expression of WIPF2 mRNA CTD PMID:27462272 NCBI chr10:84,317,305...84,357,862
Ensembl chr10:84,317,334...84,356,123 		JBrowse link
G Wnt7a Wnt family member 7A decreases expression ISO Clobetasol results in decreased expression of WNT7A mRNA CTD PMID:27462272 NCBI chr 4:125,420,276...125,466,149
Ensembl chr 4:125,420,276...125,466,149 		JBrowse link
G Wscd1 WSC domain containing 1 decreases expression ISO Clobetasol results in decreased expression of WSCD1 mRNA CTD PMID:27462272 NCBI chr10:56,884,404...56,924,013
Ensembl chr10:56,884,583...56,924,013 		JBrowse link
G Wtap WT1 associated protein decreases expression ISO Clobetasol results in decreased expression of WTAP mRNA CTD PMID:27462272 NCBI chr 1:50,070,973...50,096,074
Ensembl chr 1:50,070,769...50,096,072 		JBrowse link
G Wwc2 WW and C2 domain containing 2 decreases expression ISO Clobetasol results in decreased expression of WWC2 mRNA CTD PMID:27462272 NCBI chr16:50,991,096...51,154,529
Ensembl chr16:50,991,096...51,154,526 		JBrowse link
G Yif1a Yip1 interacting factor homolog A, membrane trafficking protein increases expression ISO Clobetasol results in increased expression of YIF1A mRNA CTD PMID:27462272 NCBI chr 1:211,823,921...211,828,437
Ensembl chr 1:211,824,273...211,828,802 		JBrowse link
G Yipf3 Yip1 domain family, member 3 increases expression ISO Clobetasol results in increased expression of YIPF3 mRNA CTD PMID:27462272 NCBI chr 9:22,227,867...22,233,177
Ensembl chr 9:22,227,871...22,233,177 		JBrowse link
G Ylpm1 YLP motif containing 1 decreases expression ISO Clobetasol results in decreased expression of YLPM1 mRNA CTD PMID:27462272 NCBI chr 6:110,373,371...110,449,578
Ensembl chr 6:110,373,686...110,449,578 		JBrowse link
G Ypel4 yippee-like 4 decreases expression ISO Clobetasol results in decreased expression of YPEL4 mRNA CTD PMID:27462272 NCBI chr 3:90,222,060...90,227,395
Ensembl chr 3:90,222,803...90,227,381 		JBrowse link
G Ythdc1 YTH N6-methyladenosine RNA binding protein C1 decreases expression ISO Clobetasol results in decreased expression of YTHDC1 mRNA CTD PMID:27462272 NCBI chr14:21,540,276...21,570,724
Ensembl chr14:21,540,278...21,570,769 		JBrowse link
G Yy1 YY1 transcription factor decreases expression ISO Clobetasol results in decreased expression of YY1 mRNA CTD PMID:27462272 NCBI chr 6:133,471,615...133,500,875
Ensembl chr 6:133,471,562...133,497,257 		JBrowse link
G Zbed6 zinc finger, BED-type containing 6 decreases expression ISO Clobetasol results in decreased expression of ZBED6 mRNA CTD PMID:27462272 NCBI chr13:47,659,269...47,665,540
Ensembl chr13:47,658,667...47,668,221 		JBrowse link
G Zc3h7b zinc finger CCCH-type containing 7B decreases expression ISO Clobetasol results in decreased expression of ZC3H7B mRNA CTD PMID:27462272 NCBI chr 7:115,142,245...115,190,513
Ensembl chr 7:115,142,420...115,190,513 		JBrowse link
G Zcchc14 zinc finger CCHC-type containing 14 decreases expression ISO Clobetasol results in decreased expression of ZCCHC14 mRNA CTD PMID:27462272 NCBI chr19:66,582,800...66,627,136
Ensembl chr19:66,582,800...66,627,136 		JBrowse link
G Zfc3h1 zinc finger, C3H1-type containing decreases expression ISO Clobetasol results in decreased expression of ZFC3H1 mRNA CTD PMID:27462272 NCBI chr 7:52,894,417...52,950,755
Ensembl chr 7:52,894,172...52,950,758 		JBrowse link
G Zfhx2 zinc finger homeobox 2 decreases expression ISO Clobetasol results in decreased expression of ZFHX2 mRNA CTD PMID:27462272 NCBI chr15:32,501,755...32,541,720
Ensembl chr15:32,503,115...32,535,085 		JBrowse link
G Zfhx3 zinc finger homeobox 3 decreases expression ISO Clobetasol results in decreased expression of ZFHX3 mRNA CTD PMID:27462272 NCBI chr19:52,789,146...53,795,664
Ensembl chr19:53,551,488...53,795,664 		JBrowse link
G Zfhx4 zinc finger homeobox 4 decreases expression ISO Clobetasol results in decreased expression of ZFHX4 mRNA CTD PMID:27462272 NCBI chr 2:98,131,996...98,321,070
Ensembl chr 2:98,131,996...98,315,469 		JBrowse link
G Zfp282 zinc finger protein 282 decreases expression ISO Clobetasol results in decreased expression of ZFP282 mRNA CTD PMID:27462272 NCBI chr 4:78,215,940...78,241,193
Ensembl chr 4:78,215,898...78,241,192 		JBrowse link
G Zfp316 zinc finger protein 316 decreases expression ISO Clobetasol results in decreased expression of ZFP316 mRNA CTD PMID:27462272 NCBI chr12:16,408,032...16,427,427
Ensembl chr12:16,408,464...16,427,427 		JBrowse link
G Zfp334 zinc finger protein 334 decreases expression ISO Clobetasol results in decreased expression of ZFP334 mRNA CTD PMID:27462272 NCBI chr 3:174,531,835...174,544,374
Ensembl chr 3:174,533,517...174,544,400 		JBrowse link
G Zfp423 zinc finger protein 423 decreases expression ISO Clobetasol results in decreased expression of ZFP423 mRNA CTD PMID:27462272 NCBI chr19:35,282,149...35,580,775
Ensembl chr19:35,282,110...35,580,773 		JBrowse link
G Zfp462 zinc finger protein 462 decreases expression ISO Clobetasol results in decreased expression of ZFP462 mRNA CTD PMID:27462272 NCBI chr 5:74,465,383...74,606,020
Ensembl chr 5:74,468,643...74,606,020 		JBrowse link
G Zfp488 zinc finger protein 488 decreases expression ISO Clobetasol results in decreased expression of ZFP488 mRNA CTD PMID:27462272 NCBI chr16:9,289,286...9,299,928
Ensembl chr16:9,280,322...9,300,400 		JBrowse link
G Zfp57 zinc finger protein 57 increases expression ISO Clobetasol results in increased expression of ZFP57 mRNA CTD PMID:27462272 NCBI chr20:1,526,565...1,546,480
Ensembl chr20:1,527,961...1,535,041 		JBrowse link
G Zfp592 zinc finger protein 592 decreases expression ISO Clobetasol results in decreased expression of ZFP592 mRNA CTD PMID:27462272 NCBI chr 1:144,355,227...144,411,686
Ensembl chr 1:144,361,654...144,411,684 		JBrowse link
G Zfp609 zinc finger protein 609 decreases expression ISO Clobetasol results in decreased expression of ZFP609 mRNA CTD PMID:27462272 NCBI chr 8:75,109,676...75,243,045
Ensembl chr 8:75,109,676...75,213,086 		JBrowse link
G Zfp638 zinc finger protein 638 decreases expression ISO Clobetasol results in decreased expression of ZFP638 mRNA CTD PMID:27462272 NCBI chr 4:117,913,528...118,032,644
Ensembl chr 4:117,913,545...118,032,643 		JBrowse link
G Zfp706 zinc finger protein 706 increases expression ISO Clobetasol results in increased expression of ZFP706 mRNA CTD PMID:27462272 NCBI chr 7:70,050,960...70,059,588
Ensembl chr 7:70,052,534...70,059,159 		JBrowse link
G Zkscan3 zinc finger with KRAB and SCAN domains 3 decreases expression ISO Clobetasol results in decreased expression of ZKSCAN3 mRNA CTD PMID:27462272 NCBI chr17:47,912,816...47,928,553
Ensembl chr17:47,912,912...47,928,551 		JBrowse link
G Zzef1 zinc finger ZZ-type and EF-hand domain containing 1 decreases expression ISO Clobetasol results in decreased expression of ZZEF1 mRNA CTD PMID:27462272 NCBI chr10:57,911,728...58,049,412
Ensembl chr10:57,911,728...58,049,412 		JBrowse link
corticosterone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin increases expression EXP Corticosterone results in increased expression of A2M mRNA CTD PMID:15755911 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 decreases activity ISO Corticosterone results in decreased activity of ABCG2 protein CTD PMID:15365089 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha multiple interactions EXP [Corticosterone co-treated with oleoyl-estrone] affects the expression of ACACA mRNA CTD PMID:19545626 NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888 		JBrowse link
G Acan aggrecan decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of ACAN mRNA; Corticosterone results in decreased expression of ACAN protein
3-methyladenine promotes the reaction [Corticosterone results in decreased expression of ACAN protein]; bafilomycin A1 promotes the reaction [Corticosterone results in decreased expression of ACAN protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of ACAN mRNA]; MIR421 affects the reaction [Corticosterone results in decreased expression of ACAN protein]; Sirolimus inhibits the reaction [Corticosterone results in decreased expression of ACAN protein] 		CTD PMID:29660438 PMID:29966748 PMID:32663519 PMID:38759937 NCBI chr 1:142,390,951...142,453,779
Ensembl chr 1:142,390,951...142,453,779 		JBrowse link
G Ace angiotensin I converting enzyme increases expression
multiple interactions
decreases methylation 		EXP Corticosterone results in increased expression of ACE mRNA
Mifepristone inhibits the reaction [Corticosterone results in increased expression of ACE mRNA]
Corticosterone results in decreased methylation of ACE promoter 		CTD PMID:15755911 PMID:30423288 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942 		JBrowse link
G Ache acetylcholinesterase multiple interactions ISO [Corticosterone co-treated with Physostigmine] results in decreased activity of ACHE protein; ACHE protein inhibits the reaction [Paraoxon results in increased abundance of Corticosterone]; Corticosterone inhibits the reaction [Isoflurophate results in decreased activity of ACHE protein]; Corticosterone inhibits the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased activity of ACHE protein] CTD PMID:17005312 PMID:28500787 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410 		JBrowse link
G Acly ATP citrate lyase multiple interactions EXP [Corticosterone co-treated with oleoyl-estrone] affects the expression of ACLY mRNA CTD PMID:19545626 NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631 		JBrowse link
G Acta1 actin, alpha 1, skeletal muscle increases expression EXP Corticosterone results in increased expression of ACTA1 mRNA CTD PMID:15755911 NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178 		JBrowse link
G Actg2 actin gamma 2, smooth muscle increases expression EXP Corticosterone results in increased expression of ACTG2 mRNA CTD PMID:15755911 NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression EXP Corticosterone results in increased expression of ADAMTS1 mRNA CTD PMID:15755911 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions
increases expression 		ISO [Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein
Corticosterone results in increased expression of ADIPOQ mRNA 		CTD PMID:29782964 PMID:34801515 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Adm adrenomedullin increases expression EXP Corticosterone results in increased expression of ADM mRNA CTD PMID:15755911 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Adora1 adenosine A1 receptor multiple interactions
decreases expression 		ISO Edaravone inhibits the reaction [Corticosterone results in decreased expression of ADORA1 mRNA] CTD PMID:31344373 NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190 		JBrowse link
G Adrb2 adrenoceptor beta 2 increases expression EXP Corticosterone results in increased expression of ADRB2 mRNA CTD PMID:15755911 NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803 		JBrowse link
G Agt angiotensinogen increases secretion ISO AGT protein results in increased secretion of Corticosterone CTD PMID:28235592 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a multiple interactions
decreases expression 		EXP Mifepristone inhibits the reaction [Corticosterone results in increased expression of AGTR1A mRNA]
Corticosterone results in decreased expression of AGTR1A mRNA 		CTD PMID:30423288 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Agtr2 angiotensin II receptor, type 2 multiple interactions
decreases expression 		EXP Mifepristone inhibits the reaction [Corticosterone results in decreased expression of AGTR2 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of AGTR2 protein]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of AGTR2 mRNA]
Corticosterone results in decreased expression of AGTR2 mRNA; Corticosterone results in decreased expression of AGTR2 protein 		CTD PMID:30423288 PMID:37972751 NCBI chr  X:116,914,320...116,918,504
Ensembl chr  X:116,913,656...116,918,745 		JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 multiple interactions ISO [AKR1D1 protein co-treated with NADP] results in increased reduction of Corticosterone CTD PMID:25500266 NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 decreases expression EXP Corticosterone results in decreased expression of AKT1 mRNA CTD PMID:29966748 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Aldh18a1 aldehyde dehydrogenase 18 family, member A1 decreases expression EXP Corticosterone results in decreased expression of ALDH18A1 mRNA CTD PMID:15755911 NCBI chr 1:249,325,082...249,357,383
Ensembl chr 1:249,325,082...249,357,383 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions
decreases expression 		EXP Enalapril inhibits the reaction [Corticosterone results in decreased expression of ALPL mRNA] CTD PMID:30423288 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Angptl2 angiopoietin-like 2 decreases expression EXP Corticosterone results in decreased expression of ANGPTL2 mRNA CTD PMID:15755911 NCBI chr 3:36,914,876...36,944,715
Ensembl chr 3:36,914,745...36,945,876 		JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 affects localization
multiple interactions 		EXP Corticosterone affects the localization of APEX1 protein
[Corticosterone co-treated with Ethanol] affects the localization of APEX1 protein 		CTD PMID:38259729 NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329 		JBrowse link
G Aqp1 aquaporin 1 increases expression EXP Corticosterone results in increased expression of AQP1 mRNA CTD PMID:15755911 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Ar androgen receptor multiple interactions
increases activity
affects binding 		ISO
EXP 		[Testosterone co-treated with Estradiol co-treated with Corticosterone] promotes the reaction [AR protein binds to TRAF6 protein]; Corticosterone binds to and results in increased activity of AR protein mutant form; Corticosterone inhibits the reaction [Metribolone results in increased activity of AR protein]; Corticosterone inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein]
Corticosterone results in increased activity of AR protein
Corticosterone binds to AR protein 		CTD PMID:11956172 PMID:14565775 PMID:18324785 PMID:21543282 PMID:29162470 More... NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Arrb1 arrestin, beta 1 decreases expression
multiple interactions 		ISO Corticosterone results in decreased expression of ARRB1 mRNA
Fluoxetine inhibits the reaction [Corticosterone results in decreased expression of ARRB1 mRNA] 		CTD PMID:19477151 NCBI chr 1:163,249,654...163,321,711
Ensembl chr 1:163,250,157...163,340,859 		JBrowse link
G Arrb2 arrestin, beta 2 decreases expression
multiple interactions 		ISO Corticosterone results in decreased expression of ARRB2 mRNA
Fluoxetine inhibits the reaction [Corticosterone results in decreased expression of ARRB2 mRNA] 		CTD PMID:19477151 NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,645,357...55,653,487 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) decreases expression EXP Corticosterone results in decreased expression of ASNS mRNA CTD PMID:15755911 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Atp1a3 ATPase Na+/K+ transporting subunit alpha 3 decreases expression EXP Corticosterone results in decreased expression of ATP1A3 mRNA CTD PMID:15755911 NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:89,700,649...89,729,825 		JBrowse link
G Atp6v1g1 ATPase H+ transporting V1 subunit G1 decreases expression EXP Corticosterone results in decreased expression of ATP6V1G1 mRNA CTD PMID:15755911 NCBI chr 5:81,976,959...81,983,139
Ensembl chr 5:81,977,015...81,985,930 		JBrowse link
G Aurkb aurora kinase B decreases expression EXP Corticosterone results in decreased expression of AURKB mRNA CTD PMID:15755911 NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285 		JBrowse link
G Avp arginine vasopressin decreases expression EXP Corticosterone results in decreased expression of AVP mRNA CTD PMID:32437893 NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:138,246,554...138,248,522 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
affects expression
multiple interactions 		EXP Corticosterone results in increased expression of BAX protein
Corticosterone affects the expression of BAX mRNA
Estradiol inhibits the reaction [Corticosterone results in increased expression of BAX protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased expression of BAX protein]]; so-ochim-tang-gamibang affects the reaction [Corticosterone affects the expression of BAX mRNA]; Testosterone inhibits the reaction [Corticosterone results in increased expression of BAX protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of BAX protein]] 		CTD PMID:27988398 PMID:29625166 NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
affects expression
decreases expression 		EXP Estradiol inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]]; so-ochim-tang-gamibang affects the reaction [Corticosterone affects the expression of BCL2 mRNA]; Testosterone inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]] CTD PMID:27988398 PMID:29625166 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions
increases expression 		EXP [Corticosterone results in increased expression of BCL2L1 protein] which results in decreased susceptibility to Doxorubicin; BCL2L1 protein affects the reaction [Corticosterone results in decreased susceptibility to Doxorubicin]; JUN protein affects the reaction [Corticosterone results in increased expression of BCL2L1 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of BCL2L1 protein]
Corticosterone results in increased expression of BCL2L1 mRNA; Corticosterone results in increased expression of BCL2L1 protein 		CTD PMID:15755911 PMID:24480152 PMID:26915917 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bdnf brain-derived neurotrophic factor decreases expression
affects expression
multiple interactions 		ISO
EXP 		Corticosterone results in decreased expression of BDNF protein
Corticosterone affects the expression of BDNF protein
O-1602 compound affects the reaction [Corticosterone affects the expression of BDNF protein]; so-ochim-tang-gamibang inhibits the reaction [Corticosterone results in decreased expression of BDNF mRNA]
2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of BDNF protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of BDNF protein]] 		CTD PMID:22244747 PMID:22850435 PMID:27988398 PMID:32733244 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Bex2 brain expressed X-linked 2 decreases expression EXP Corticosterone results in decreased expression of BEX1 mRNA CTD PMID:15755911 NCBI chr  X:103,811,458...103,812,986
Ensembl chr  X:103,808,935...103,812,092 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of BGLAP mRNA
Enalapril inhibits the reaction [Corticosterone results in decreased expression of BGLAP mRNA] 		CTD PMID:30423288 NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Bmp2 bone morphogenetic protein 2 increases expression EXP Corticosterone results in increased expression of BMP2 mRNA CTD PMID:15755911 NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760 		JBrowse link
G Bmp6 bone morphogenetic protein 6 increases expression EXP Corticosterone results in increased expression of BMP6 mRNA CTD PMID:15755911 NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression EXP Corticosterone results in increased expression of BTG2 mRNA CTD PMID:15755911 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G C3 complement C3 affects expression EXP Corticosterone affects the expression of C3 mRNA CTD PMID:18363858 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G Calca calcitonin-related polypeptide alpha increases abundance
increases expression
multiple interactions 		EXP CALCA protein results in increased abundance of Corticosterone
Corticosterone results in increased expression of CALCA protein
O-1602 compound inhibits the reaction [Corticosterone results in increased expression of CALCA protein] 		CTD PMID:12639925 PMID:32733244 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529 		JBrowse link
G Capn6 calpain 6 decreases expression EXP Corticosterone results in decreased expression of CAPN6 mRNA CTD PMID:15755911 NCBI chr  X:112,177,467...112,202,178
Ensembl chr  X:112,177,467...112,202,178 		JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 decreases expression EXP Corticosterone results in decreased expression of CARS1 mRNA CTD PMID:15755911 NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407 		JBrowse link
G Cartpt CART prepropeptide increases abundance
multiple interactions 		EXP CARTPT protein results in increased abundance of Corticosterone
astressin B inhibits the reaction [CARTPT protein results in increased abundance of Corticosterone] 		CTD PMID:15271883 NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:32,989,215...32,999,712 		JBrowse link
G Casp12 caspase 12 decreases expression EXP Corticosterone results in decreased expression of CASP12 mRNA CTD PMID:15755911 NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases expression
increases cleavage 		EXP Corticosterone inhibits the reaction [Deoxyglucose results in increased activity of CASP3 protein]; Corticosterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Corticosterone inhibits the reaction [Palmitates results in increased activity of CASP3 protein]; Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]]; Mifepristone inhibits the reaction [Corticosterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; so-ochim-tang-gamibang inhibits the reaction [Corticosterone results in increased expression of CASP3 mRNA]; Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]] CTD PMID:15755911 PMID:26915917 PMID:27988398 PMID:29625166 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp4 caspase 4 decreases expression EXP Corticosterone results in decreased expression of CASP4 mRNA CTD PMID:15755911 NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727 		JBrowse link
G Casp8 caspase 8 multiple interactions
increases cleavage 		EXP Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]]; Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]] CTD PMID:29625166 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Cat catalase increases activity
multiple interactions 		ISO Corticosterone results in increased activity of CAT protein
Clozapine inhibits the reaction [Corticosterone results in increased activity of CAT protein]; Clozapine inhibits the reaction [Lipopolysaccharides inhibits the reaction [Corticosterone results in increased activity of CAT protein]]; Lipopolysaccharides inhibits the reaction [Corticosterone results in increased activity of CAT protein]; Sulpiride promotes the reaction [Lipopolysaccharides inhibits the reaction [Corticosterone results in increased activity of CAT protein]] 		CTD PMID:14730115 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression
multiple interactions 		EXP
ISO 		Corticosterone results in decreased expression of CCL2 mRNA
Corticosterone promotes the reaction [Isoflurophate results in increased expression of CCL2 mRNA]
[Corticosterone co-treated with Isoflurophate] results in increased expression of CCL2 mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of CCL2 mRNA; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CCL2 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CCL2 mRNA]; Corticosterone promotes the reaction [Isoflurophate results in increased expression of CCL2 mRNA]; Corticosterone promotes the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased expression of CCL2 mRNA]; Physostigmine inhibits the reaction [Corticosterone results in decreased expression of CCL2 mRNA] 		CTD PMID:15755911 PMID:28500787 PMID:28782715 PMID:29751049 PMID:29846716 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccn3 cellular communication network factor 3 increases expression EXP Corticosterone results in increased expression of CCN3 mRNA CTD PMID:15755911 NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:87,982,216...87,994,581 		JBrowse link
G Ccnb1 cyclin B1 decreases expression EXP Corticosterone results in decreased expression of CCNB1 mRNA; Corticosterone results in decreased expression of CCNB1 protein CTD PMID:15755911 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnd1 cyclin D1 decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of CCND1 protein
Ethanol affects the reaction [Corticosterone results in decreased expression of CCND1 protein] 		CTD PMID:12807724 PMID:38259729 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnd2 cyclin D2 decreases expression EXP Corticosterone results in decreased expression of CCND2 mRNA; Corticosterone results in decreased expression of CCND2 protein CTD PMID:15755911 NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301 		JBrowse link
G Ccne1 cyclin E1 decreases expression EXP Corticosterone results in decreased expression of CCNE1 protein CTD PMID:12807724 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Cd200 Cd200 molecule decreases expression EXP Corticosterone results in decreased expression of CD200 mRNA CTD PMID:15755911 NCBI chr11:68,916,200...68,943,570
Ensembl chr11:68,916,224...68,943,569 		JBrowse link
G Cd36 CD36 molecule increases expression EXP Corticosterone results in increased expression of CD36 mRNA CTD PMID:15755911 NCBI chr 4:18,209,088...18,302,142 JBrowse link
G Cd59b CD59b molecule increases expression EXP Corticosterone results in increased expression of CD59 mRNA CTD PMID:15755911 NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:110,914,091...110,935,310 		JBrowse link
G Cd68 Cd68 molecule multiple interactions ISO [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA] CTD PMID:29751049 NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540 		JBrowse link
G Cdc20 cell division cycle 20 decreases expression EXP Corticosterone results in decreased expression of CDC20 mRNA CTD PMID:15755911 NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799 		JBrowse link
G Cdca3l1 cell division cycle associated 3 like 1 decreases expression EXP Corticosterone results in decreased expression of CDCA3L1 mRNA CTD PMID:15755911 NCBI chr 9:53,998,610...53,999,608 JBrowse link
G Cdh2 cadherin 2 multiple interactions ISO [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CDH2 protein CTD PMID:21655274 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 decreases expression EXP Corticosterone results in decreased expression of CDK1 mRNA CTD PMID:15755911 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions
decreases activity
decreases expression 		EXP Corticosterone promotes the reaction [CDKN1A protein binds to CDK2 protein]
Corticosterone results in decreased activity of CDK2 protein
Corticosterone results in decreased expression of CDK2 protein 		CTD PMID:12807724 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 multiple interactions
decreases expression
decreases activity 		EXP Corticosterone inhibits the reaction [CDKN1A protein binds to CDK4 protein]; Corticosterone promotes the reaction [CDKN1B protein binds to CDK4 protein]
Corticosterone results in decreased expression of CDK4 protein
Corticosterone results in decreased activity of CDK4 protein 		CTD PMID:12807724 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A affects expression
multiple interactions 		EXP Corticosterone affects the expression of CDKN1A protein
Corticosterone inhibits the reaction [CDKN1A protein binds to CDK4 protein]; Corticosterone promotes the reaction [CDKN1A protein binds to CDK2 protein] 		CTD PMID:12807724 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions
increases expression 		EXP Corticosterone promotes the reaction [CDKN1B protein binds to CDK4 protein]
Corticosterone results in increased expression of CDKN1B protein 		CTD PMID:12807724 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A decreases expression EXP Corticosterone results in decreased expression of CDKN2A mRNA CTD PMID:15755911 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cdo1 cysteine dioxygenase type 1 increases expression EXP Corticosterone results in increased expression of CDO1 mRNA CTD PMID:15755911 NCBI chr18:41,619,076...41,633,719
Ensembl chr18:41,619,070...41,633,891 		JBrowse link
G Ceacam4 CEA cell adhesion molecule 4 increases expression EXP Corticosterone results in increased expression of CEACAM10 mRNA CTD PMID:15755911 NCBI chr 1:89,504,555...89,510,831
Ensembl chr 1:89,504,555...89,510,831 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha increases expression EXP Corticosterone results in increased expression of CEBPA mRNA CTD PMID:30423288 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta increases expression
multiple interactions 		EXP Corticosterone results in increased expression of CEBPB mRNA
CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 protein]; Corticosterone promotes the reaction [CEBPB protein binds to PTGS2 promoter] 		CTD PMID:15755911 PMID:18650268 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta increases expression EXP
ISO 		Corticosterone results in increased expression of CEBPD mRNA CTD PMID:15755911 PMID:34801515 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824 		JBrowse link
G Cfd complement factor D decreases expression ISO Corticosterone results in decreased expression of CFD mRNA; Corticosterone results in decreased expression of CFD protein CTD PMID:2912985 NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 decreases expression EXP Corticosterone results in decreased expression of CKS2 mRNA CTD PMID:15755911 NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519 		JBrowse link
G Cldn2 claudin 2 multiple interactions ISO [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CLDN2 protein CTD PMID:29751049 NCBI chr  X:108,248,383...108,258,847
Ensembl chr  X:108,237,676...108,262,377 		JBrowse link
G Cnr1 cannabinoid receptor 1 increases abundance ISO CNR1 gene mutant form results in increased abundance of Corticosterone CTD PMID:15081793 NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252 		JBrowse link
G Col2a1 collagen type II alpha 1 chain decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of COL2A1 mRNA; Corticosterone results in decreased expression of COL2A1 protein
Mifepristone inhibits the reaction [Corticosterone results in decreased expression of COL2A1 mRNA] 		CTD PMID:29660438 PMID:29966748 PMID:32663519 NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627 		JBrowse link
G Comt catechol-O-methyltransferase multiple interactions
decreases expression 		ISO Edaravone inhibits the reaction [Corticosterone results in decreased expression of COMT mRNA] CTD PMID:31344373 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Cp ceruloplasmin increases expression EXP Corticosterone results in increased expression of CP mRNA CTD PMID:15755911 NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A increases expression EXP Corticosterone results in increased expression of CPT1A mRNA CTD PMID:15755911 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 decreases phosphorylation ISO Corticosterone results in decreased phosphorylation of CREB1 protein CTD PMID:22850435 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Crebbp CREB binding protein multiple interactions
decreases expression 		ISO 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]] CTD PMID:22850435 NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266 		JBrowse link
G Crh corticotropin releasing hormone multiple interactions
affects expression
increases abundance
increases expression
decreases expression 		EXP
ISO 		Astemizole inhibits the reaction [Corticosterone inhibits the reaction [CRH protein results in increased secretion of Adrenocorticotropic Hormone]]; Corticosterone affects the reaction [Nitroprusside results in increased secretion of CRH protein]; Corticosterone inhibits the reaction [CRH protein results in increased secretion of Adrenocorticotropic Hormone]; E 4031 inhibits the reaction [Corticosterone inhibits the reaction [CRH protein results in increased secretion of Adrenocorticotropic Hormone]]; O-1602 compound inhibits the reaction [Corticosterone results in increased expression of CRH protein]
Corticosterone affects the expression of CRH mRNA
CRH protein results in increased abundance of Corticosterone
Corticosterone results in increased expression of CRH mRNA; Corticosterone results in increased expression of CRH protein
CRH protein affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone]
Corticosterone results in decreased expression of CRH mRNA 		CTD PMID:3015567 PMID:7816204 PMID:18835572 PMID:21359208 PMID:26821211 More... NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386 		JBrowse link
G Crhr1 corticotropin releasing hormone receptor 1 decreases expression EXP Corticosterone results in decreased expression of CRHR1 mRNA CTD PMID:18363858 NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,540,192...89,583,466 		JBrowse link
G Crispld2 cysteine-rich secretory protein LCCL domain containing 2 increases expression EXP Corticosterone results in increased expression of CRISPLD2 mRNA CTD PMID:15755911 NCBI chr19:64,961,764...65,020,099
Ensembl chr19:64,961,771...65,020,349 		JBrowse link
G Cs citrate synthase decreases activity EXP Corticosterone results in decreased activity of CS protein CTD PMID:22244747 NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938 		JBrowse link
G Csrp2 cysteine and glycine-rich protein 2 increases expression EXP Corticosterone results in increased expression of CSRP2 mRNA CTD PMID:15755911 NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238 		JBrowse link
G Csrp3 cysteine and glycine rich protein 3 increases expression EXP Corticosterone results in increased expression of CSRP3 mRNA CTD PMID:15755911 NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916 		JBrowse link
G Ctnna1 catenin alpha 1 multiple interactions ISO [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNA1 protein CTD PMID:21655274 NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,999,820...27,135,007 		JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions ISO [Corticosterone results in increased phosphorylation of NDRG1 protein] promotes the reaction [NDRG1 protein binds to CTNNB1 protein]; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNB1 protein CTD PMID:21655274 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctss cathepsin S increases expression EXP Corticosterone results in increased expression of CTSS mRNA CTD PMID:15755911 NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:185,775,296...185,803,440 		JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 increases chemical synthesis ISO CYP11B1 protein results in increased chemical synthesis of Corticosterone CTD PMID:16054388 NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 affects metabolic processing
multiple interactions
increases hydroxylation
increases chemical synthesis 		ISO CYP11B2 protein affects the metabolism of Corticosterone
[CYP11B2 protein results in increased hydroxylation of Corticosterone] which results in increased chemical synthesis of Aldosterone; [CYP11B2 protein results in increased hydroxylation of Desoxycorticosterone] which results in increased chemical synthesis of Corticosterone
CYP11B2 protein results in increased chemical synthesis of Corticosterone 		CTD PMID:16054388 PMID:21384875 NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
increases expression 		EXP
ISO 		Corticosterone promotes the reaction [Ethanol results in increased expression of CYP1A2 mRNA]
Corticosterone results in increased expression of CYP1A2 mRNA 		CTD PMID:35301062 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp2a2 cytochrome P450, family 2, subfamily a, polypeptide 2 increases expression EXP Corticosterone results in increased expression of CYP2A2 mRNA CTD PMID:35301062 NCBI chr 1:91,391,492...91,417,158
Ensembl chr 1:91,391,502...91,417,158 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases expression
multiple interactions 		EXP Corticosterone results in increased expression of CYP2B1 mRNA; Corticosterone results in increased expression of CYP2B1 protein
Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B1 protein] 		CTD PMID:35301062 NCBI chr 1:90,646,098...90,669,762 JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions
increases expression 		ISO Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B6 mRNA]
Corticosterone results in increased expression of CYP2B6 mRNA; Corticosterone results in increased expression of CYP2B6 protein 		CTD PMID:35301062 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 increases expression EXP Corticosterone results in increased expression of CYP2C11 mRNA CTD PMID:35301062 NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853 		JBrowse link
G Cyp2d2 cytochrome P450, family 2, subfamily d, polypeptide 2 increases expression EXP Corticosterone results in increased expression of CYP2D2 mRNA CTD PMID:35301062 NCBI chr 7:115,815,212...115,819,281
Ensembl chr 7:115,815,212...115,819,281 		JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 increases expression
multiple interactions 		EXP
ISO 		Corticosterone results in increased expression of CYP2D4 mRNA
Corticosterone results in increased expression of CYP2D6 mRNA
Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2D6 mRNA] 		CTD PMID:15755911 PMID:35301062 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 increases expression
multiple interactions 		ISO
EXP 		Corticosterone results in increased expression of CYP2E1 mRNA; Corticosterone results in increased expression of CYP2E1 protein
Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2E1 mRNA] 		CTD PMID:35301062 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions
increases expression 		ISO [Corticosterone binds to CYP3A4 promoter] which results in increased expression of CYP3A4 mRNA; Corticosterone promotes the reaction [[NCOA1 protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Ketoconazole inhibits the reaction [Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]; Ketoconazole inhibits the reaction [Corticosterone results in increased expression of CYP3A4 mRNA]
Corticosterone results in increased expression of CYP3A4 mRNA; Corticosterone results in increased expression of CYP3A4 protein 		CTD PMID:11581012 PMID:12072427 PMID:12851153 PMID:35301062 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 multiple interactions
increases expression 		EXP Corticosterone promotes the reaction [Ethanol results in increased expression of CYP3A23-3A1 mRNA]
Corticosterone results in increased expression of CYP3A23-3A1 mRNA; Corticosterone results in increased expression of CYP3A23-3A1 protein 		CTD PMID:35301062 NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases metabolic processing ISO Corticosterone results in increased metabolism of CYP3A5 protein CTD PMID:20032461 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Dbi diazepam binding inhibitor increases expression ISO Corticosterone results in increased expression of DBI mRNA CTD PMID:16963002 NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450 		JBrowse link
G Dcxr dicarbonyl and L-xylulose reductase increases expression EXP Corticosterone results in increased expression of DCXR mRNA CTD PMID:15755911 NCBI chr10:106,504,730...106,506,619 JBrowse link
G Ddit3 DNA-damage inducible transcript 3 decreases expression EXP Corticosterone results in decreased expression of DDIT3 mRNA CTD PMID:15755911 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddt D-dopachrome tautomerase increases expression EXP Corticosterone results in increased expression of DDT mRNA CTD PMID:15755911 NCBI chr20:12,883,025...12,886,121 JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 increases expression
multiple interactions 		ISO Corticosterone results in increased expression of DKK1 protein
Mifepristone inhibits the reaction [Corticosterone results in increased expression of DKK1 protein]; NR3C1 protein promotes the reaction [Corticosterone results in increased expression of DKK1 protein] 		CTD PMID:21304589 NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650 		JBrowse link
G Dlg4 discs large MAGUK scaffold protein 4 decreases expression
multiple interactions 		ISO Corticosterone results in decreased expression of DLG4 protein
Ascorbic Acid inhibits the reaction [Corticosterone results in decreased expression of DLG4 protein]; Ketamine inhibits the reaction [Corticosterone results in decreased expression of DLG4 protein] 		CTD PMID:33872575 NCBI chr10:55,239,397...55,267,780
Ensembl chr10:55,236,869...55,265,839 		JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha decreases expression
increases expression
multiple interactions 		EXP Corticosterone results in decreased expression of DNMT3A mRNA
Corticosterone results in increased expression of DNMT3A mRNA; Corticosterone results in increased expression of DNMT3A protein
Mifepristone inhibits the reaction [Corticosterone results in increased expression of DNMT3A mRNA] 		CTD PMID:30423288 PMID:37972751 NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970 		JBrowse link
G Dpep1 dipeptidase 1 increases expression EXP Corticosterone results in increased expression of DPEP1 mRNA CTD PMID:15755911 NCBI chr19:68,118,270...68,143,781
Ensembl chr19:68,118,453...68,143,775 		JBrowse link
G Dpt dermatopontin decreases expression EXP Corticosterone results in decreased expression of DPT mRNA CTD PMID:15755911 NCBI chr13:79,656,341...79,684,759
Ensembl chr13:79,655,985...79,684,758 		JBrowse link
G Dusp8 dual specificity phosphatase 8 multiple interactions ISO [DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone; CRH protein affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone]; Dexamethasone affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone] CTD PMID:32780722 NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441 		JBrowse link
G Ecrg4 ECRG4 augurin precursor decreases expression EXP Corticosterone results in decreased expression of ECRG4 mRNA CTD PMID:15755911 NCBI chr 9:53,485,040...53,504,691
Ensembl chr 9:53,485,040...53,504,703 		JBrowse link
G Edn1 endothelin 1 increases secretion EXP EDN1 results in increased secretion of Corticosterone CTD PMID:1659878 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Edn2 endothelin 2 increases secretion EXP EDN2 results in increased secretion of Corticosterone CTD PMID:1659878 NCBI chr 5:139,036,576...139,042,074
Ensembl chr 5:139,036,492...139,043,070 		JBrowse link
G Edn3 endothelin 3 increases secretion EXP EDN3 results in increased secretion of Corticosterone CTD PMID:1659878 NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:183,980,668...184,005,329 		JBrowse link
G Eef2k eukaryotic elongation factor-2 kinase increases expression EXP Corticosterone results in increased expression of EEF2K mRNA CTD PMID:15755911 NCBI chr 1:184,824,420...184,888,048
Ensembl chr 1:184,824,420...184,888,048 		JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 increases expression EXP Corticosterone results in increased expression of EFEMP1 mRNA CTD PMID:15755911 NCBI chr14:106,811,769...106,890,961
Ensembl chr14:106,802,304...106,892,808 		JBrowse link
G Egln3 egl-9 family hypoxia-inducible factor 3 increases expression EXP Corticosterone results in increased expression of EGLN3 mRNA CTD PMID:15755911 NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO [Testosterone co-treated with Estradiol co-treated with Corticosterone] promotes the reaction [ESR1 protein binds to TRAF6 protein] CTD PMID:29625166 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit decreases expression EXP Corticosterone results in decreased expression of EZH2 mRNA CTD PMID:15755911 NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183 		JBrowse link
G Faah fatty acid amide hydrolase increases activity
multiple interactions 		EXP Corticosterone results in increased activity of FAAH protein
antalarmin inhibits the reaction [Corticosterone results in increased activity of FAAH protein] 		CTD PMID:26821211 NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:134,716,545...134,735,396 		JBrowse link
G Fabp3 fatty acid binding protein 3 decreases expression EXP Corticosterone results in decreased expression of FABP3 mRNA CTD PMID:15755911 NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions ISO [Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Corticosterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Fabp7 fatty acid binding protein 7 affects expression EXP Corticosterone affects the expression of FABP7 mRNA CTD PMID:18363858 NCBI chr20:37,667,125...37,673,299
Ensembl chr20:37,669,601...37,675,907 		JBrowse link
G Fasn fatty acid synthase multiple interactions EXP [Corticosterone co-treated with oleoyl-estrone] affects the expression of FASN mRNA CTD PMID:19545626 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fbln2 fibulin 2 decreases expression EXP Corticosterone results in decreased expression of FBLN2 mRNA CTD PMID:15755911 NCBI chr 4:125,261,464...125,321,030
Ensembl chr 4:125,261,607...125,321,029 		JBrowse link
G Fbn2 fibrillin 2 increases expression EXP Corticosterone results in increased expression of FBN2 mRNA CTD PMID:15755911 NCBI chr18:53,696,197...53,901,992
Ensembl chr18:53,697,708...53,902,191 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 decreases expression
multiple interactions 		ISO Corticosterone results in decreased expression of FKBP5 mRNA
Edaravone inhibits the reaction [Corticosterone results in decreased expression of FKBP5 mRNA] 		CTD PMID:31344373 NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 increases expression EXP Corticosterone results in increased expression of FLT1 mRNA CTD PMID:15755911 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750 		JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 increases expression EXP Corticosterone results in increased expression of FMO1 mRNA CTD PMID:15755911 NCBI chr13:77,715,405...77,747,666
Ensembl chr13:77,715,402...77,747,874 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO Corticosterone results in increased expression of FOS protein CTD PMID:28186389 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Foxs1 forkhead box S1 decreases expression EXP Corticosterone results in decreased expression of FOXS1 mRNA CTD PMID:15755911 NCBI chr 3:161,857,264...161,858,548
Ensembl chr 3:161,850,782...161,858,662 		JBrowse link
G Fshb follicle stimulating hormone subunit beta increases expression ISO Corticosterone results in increased expression of FSHB mRNA CTD PMID:16675544 NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072 		JBrowse link
G Fstl3 follistatin like 3 increases expression EXP Corticosterone results in increased expression of FSTL3 mRNA CTD PMID:15755911 NCBI chr 7:10,574,195...10,579,844
Ensembl chr 7:10,574,186...10,590,509 		JBrowse link
G Fxyd6 FXYD domain-containing ion transport regulator 6 decreases expression EXP Corticosterone results in decreased expression of FXYD6 mRNA CTD PMID:15755911 NCBI chr 8:54,575,578...54,602,715
Ensembl chr 8:54,575,591...54,602,715 		JBrowse link
G G6pc2 glucose-6-phosphatase catalytic subunit 2 increases expression ISO Corticosterone results in increased expression of G6PC2 mRNA CTD PMID:27300767 NCBI chr 3:74,404,976...74,413,391 JBrowse link
G Gad1 glutamate decarboxylase 1 multiple interactions
increases expression 		ISO
EXP 		GAD1 affects the reaction [2,5-dihydro-2,4,5-trimethylthiazoline results in increased secretion of Corticosterone]
Corticosterone results in increased expression of GAD1 mRNA 		CTD PMID:21219938 PMID:32437893 NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759 		JBrowse link
G Gal galanin and GMAP prepropeptide increases expression EXP Corticosterone results in increased expression of GAL mRNA CTD PMID:15755911 NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229 		JBrowse link
G Gas6 growth arrest specific 6 increases expression EXP Corticosterone results in increased expression of GAS6 mRNA CTD PMID:15755911 NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088 		JBrowse link
G Gatm glycine amidinotransferase decreases expression EXP Corticosterone results in decreased expression of GATM mRNA CTD PMID:15755911 NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355 		JBrowse link
G Gcnt1 glucosaminyl (N-acetyl) transferase 1 increases expression EXP Corticosterone results in increased expression of GCNT1 mRNA CTD PMID:15755911 NCBI chr 1:224,145,104...224,182,496
Ensembl chr 1:224,141,108...224,185,741 		JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions EXP [Ethanol co-treated with Corticosterone] results in increased expression of GFAP protein CTD PMID:38259729 NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685 		JBrowse link
G Gja1 gap junction protein, alpha 1 decreases expression
multiple interactions 		ISO Corticosterone results in decreased expression of GJA1 protein
protosappanin A inhibits the reaction [Corticosterone results in decreased expression of GJA1 protein] 		CTD PMID:40054743 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Gja5 gap junction protein, alpha 5 increases expression EXP Corticosterone results in increased expression of GJA5 mRNA CTD PMID:15755911 NCBI chr 2:187,291,227...187,310,770
Ensembl chr 2:187,234,674...187,318,512 		JBrowse link
G Glt8d1 glycosyltransferase 8 domain containing 1 decreases expression EXP Corticosterone results in decreased expression of GLT8D1 mRNA CTD PMID:15755911 NCBI chr16:6,198,152...6,213,671
Ensembl chr16:6,204,740...6,213,668 		JBrowse link
G Glul glutamate-ammonia ligase increases expression EXP Corticosterone results in increased expression of GLUL mRNA CTD PMID:15755911 NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520 		JBrowse link
G Gnai2 G protein subunit alpha i2 decreases expression
multiple interactions 		ISO Corticosterone results in decreased expression of GNAI2 mRNA
Fluoxetine inhibits the reaction [Corticosterone results in decreased expression of GNAI2 mRNA] 		CTD PMID:19477151 NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622 		JBrowse link
G Gpx3 glutathione peroxidase 3 increases expression EXP Corticosterone results in increased expression of GPX3 mRNA CTD PMID:15755911 NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 increases expression ISO Corticosterone results in increased expression of GREB1 mRNA CTD PMID:35307500 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist decreases expression EXP Corticosterone results in decreased expression of GREM1 mRNA CTD PMID:15755911 NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:120,966,623...120,979,089 		JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 decreases expression
multiple interactions 		ISO Corticosterone results in decreased expression of GRIA1 protein
Ketamine inhibits the reaction [Corticosterone results in decreased expression of GRIA1 protein] 		CTD PMID:33872575 NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309 		JBrowse link
G Grk5 G protein-coupled receptor kinase 5 increases expression EXP Corticosterone results in increased expression of GRK5 mRNA CTD PMID:15755911 NCBI chr 1:270,014,314...270,208,294
Ensembl chr 1:270,014,282...270,204,928 		JBrowse link
G Gsta3 glutathione S-transferase alpha 3 increases expression EXP Corticosterone results in increased expression of GSTA3 mRNA; Corticosterone results in increased expression of GSTA3 protein CTD PMID:15755911 NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:31,154,989...31,180,654 		JBrowse link
G Gstm2 glutathione S-transferase mu 2 increases expression EXP Corticosterone results in increased expression of GSTM2 mRNA; Corticosterone results in increased expression of GSTM2 protein CTD PMID:15755911 NCBI chr 2:198,312,179...198,316,962 JBrowse link
G H2ax H2A.X variant histone increases expression
multiple interactions 		EXP Corticosterone results in increased expression of H2AX protein
[Ethanol co-treated with Corticosterone] results in increased expression of H2AX protein 		CTD PMID:38259729 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G Hdac7 histone deacetylase 7 multiple interactions
increases expression 		EXP HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 protein]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of NPHS1 protein]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of HDAC7 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of HDAC7 protein]
Corticosterone results in increased expression of HDAC7 mRNA; Corticosterone results in increased expression of HDAC7 protein 		CTD PMID:31306741 NCBI chr 7:130,803,013...130,841,181
Ensembl chr 7:130,803,013...130,841,017 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of HMGB1 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of HMGB1 protein] CTD PMID:29751049 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327 		JBrowse link
G Hmgb2 high mobility group box 2 decreases expression EXP Corticosterone results in decreased expression of HMGB2 mRNA CTD PMID:15755911 NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860 		JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 increases expression EXP Corticosterone results in increased expression of HMGCS2 mRNA CTD PMID:15755911 NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242 		JBrowse link
G Hmgn2 high mobility group nucleosomal binding domain 2 decreases expression EXP Corticosterone results in decreased expression of HMGN2 mRNA CTD PMID:15755911 NCBI chr 5:151,475,907...151,479,361
Ensembl chr 5:151,475,909...151,479,397 		JBrowse link
G Hnrnpa1 heterogeneous nuclear ribonucleoprotein A1 decreases expression EXP Corticosterone results in decreased expression of HNRNPA1 mRNA CTD PMID:15755911 NCBI chr 7:136,253,633...136,260,085
Ensembl chr 7:136,253,278...136,260,085 		JBrowse link
G Hs3st1 heparan sulfate-glucosamine 3-sulfotransferase 1 increases expression EXP Corticosterone results in increased expression of HS3ST1 mRNA CTD PMID:15755911 NCBI chr14:75,398,101...75,429,628
Ensembl chr14:75,398,026...75,436,848 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 increases chemical synthesis
multiple interactions
increases oxidation
decreases abundance
increases expression 		ISO
EXP 		HSD11B1 protein results in increased chemical synthesis of Corticosterone
[[trimethyltin chloride results in increased abundance of trimethyltin] which co-treated with Corticosterone] results in increased expression of HSD11B1 mRNA; Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]]; Spironolactone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]]
HSD11B1 protein results in increased oxidation of Corticosterone
HSD11B1 gene mutant form results in decreased abundance of Corticosterone
[HSD11B1 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone; resveratrol inhibits the reaction [HSD11B1 protein results in increased chemical synthesis of Corticosterone]; Ziram inhibits the reaction [[HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone]
Corticosterone results in increased expression of HSD11B1 mRNA 		CTD PMID:15755911 PMID:16751407 PMID:23814014 PMID:25061560 PMID:26859423 More... NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions
increases oxidation
increases metabolic processing
affects metabolic processing 		EXP
ISO 		[HSD11B2 protein results in increased metabolism of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; Betamethasone inhibits the reaction [HSD11B2 protein affects the metabolism of Corticosterone]; Dexamethasone inhibits the reaction [HSD11B2 protein affects the metabolism of Corticosterone]; Ziram inhibits the reaction [[HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone]; Ziram inhibits the reaction [HSD11B2 protein results in increased oxidation of Corticosterone] CTD PMID:19490994 PMID:22796344 PMID:26859423 PMID:32243540 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Hspb1 heat shock protein family B (small) member 1 increases expression EXP Corticosterone results in increased expression of HSPB1 mRNA; Corticosterone results in increased expression of HSPB1 protein CTD PMID:15755911 NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301 		JBrowse link
G Hspb6 heat shock protein family B (small) member 6 increases expression EXP Corticosterone results in increased expression of HSPB6 mRNA CTD PMID:15755911 NCBI chr 1:94,934,372...94,936,516
Ensembl chr 1:94,933,543...94,936,512 		JBrowse link
G Htr2a 5-hydroxytryptamine receptor 2A multiple interactions
increases secretion
increases expression 		EXP [alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [HTR2A protein results in increased secretion of Corticosterone]; [Ketanserin binds to and results in decreased activity of HTR2A protein] inhibits the reaction [Methamphetamine results in increased secretion of Corticosterone]
Corticosterone results in increased expression of HTR2A mRNA 		CTD PMID:15755911 PMID:18363858 PMID:19304867 PMID:19879056 NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619 		JBrowse link
G Ier3 immediate early response 3 decreases expression EXP Corticosterone results in decreased expression of IER3 mRNA CTD PMID:15755911 NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377 		JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression
multiple interactions
increases expression 		EXP Corticosterone results in decreased expression of IGF1 mRNA; Corticosterone results in decreased expression of IGF1 protein
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of IGF1 mRNA]]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA]]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein]]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein]]; IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of IGF1 mRNA]; IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein]
Corticosterone results in increased expression of IGF1 mRNA 		CTD PMID:12807724 PMID:15755911 PMID:29343424 PMID:29966748 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of IGF1R mRNA; Corticosterone results in decreased expression of IGF1R protein
[IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]] 		CTD PMID:12807724 PMID:24667322 PMID:29966748 NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664 		JBrowse link
G Igf2 insulin-like growth factor 2 multiple interactions EXP [IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]]; IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein] CTD PMID:24667322 NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667 		JBrowse link
G Igf2r insulin-like growth factor 2 receptor multiple interactions EXP [IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]] CTD PMID:24667322 NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 decreases expression EXP Corticosterone results in decreased expression of IGFBP5 mRNA CTD PMID:15755911 NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390 		JBrowse link
G Igfbp6 insulin-like growth factor binding protein 6 increases expression EXP Corticosterone results in increased expression of IGFBP6 mRNA CTD PMID:15755911 NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795 		JBrowse link
G Il15 interleukin 15 increases expression EXP Corticosterone results in increased expression of IL15 mRNA CTD PMID:15755911 NCBI chr19:42,536,160...42,611,349
Ensembl chr19:42,545,346...42,611,348 		JBrowse link
G Il1b interleukin 1 beta increases chemical synthesis
increases expression
affects expression
multiple interactions
increases secretion 		ISO
EXP 		IL1B protein results in increased chemical synthesis of Corticosterone
Corticosterone results in increased expression of IL1B mRNA
Corticosterone affects the expression of IL1B mRNA
Corticosterone results in increased expression of IL1B mRNA; Corticosterone results in increased expression of IL1B protein
[Corticosterone co-treated with Isoflurophate] results in increased expression of IL1B mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of IL1B mRNA; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of and results in increased secretion of IL1B protein; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of IL1B mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of and results in increased secretion of IL1B protein]; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of IL1B mRNA]; O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate affects the reaction [Corticosterone affects the expression of IL1B mRNA]; Physostigmine affects the reaction [Corticosterone affects the expression of IL1B mRNA]
Corticosterone promotes the reaction [Isoflurophate results in increased expression of IL1B mRNA]; Ketorolac inhibits the reaction [IL1B protein results in increased secretion of Corticosterone]; O-1602 compound inhibits the reaction [Corticosterone results in increased expression of IL1B protein]
[Finasteride results in increased susceptibility to IL1B protein] which results in increased secretion of Corticosterone 		CTD PMID:10800959 PMID:12773775 PMID:19458216 PMID:28500787 PMID:28782715 More... NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1rl1 interleukin 1 receptor-like 1 decreases expression EXP Corticosterone results in decreased expression of IL1RL1 mRNA CTD PMID:15755911 NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891 		JBrowse link
G Il6 interleukin 6 multiple interactions
decreases expression
increases expression 		EXP
ISO 		Corticosterone inhibits the reaction [Isoflurophate results in increased expression of IL6 mRNA]
Corticosterone results in decreased expression of IL6 mRNA
[Corticosterone co-treated with Physostigmine] results in decreased expression of IL6 mRNA; [Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of IL6 mRNA; Corticosterone inhibits the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased expression of IL6 mRNA]; Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; Isoflurophate inhibits the reaction [Corticosterone results in decreased expression of IL6 mRNA]; O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate inhibits the reaction [Corticosterone results in decreased expression of IL6 mRNA]; Spironolactone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]]
Corticosterone results in increased expression of IL6 mRNA 		CTD PMID:28500787 PMID:28782715 PMID:29846716 PMID:30993381 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Ins2 insulin 2 multiple interactions ISO [Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein; [Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Corticosterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805 		JBrowse link
G Irs3 insulin receptor substrate 3 increases expression EXP Corticosterone results in increased expression of IRS3 mRNA CTD PMID:15755911 NCBI chr12:24,689,930...24,692,068
Ensembl chr12:24,689,909...24,692,068 		JBrowse link
G Itga1 integrin subunit alpha 1 decreases expression EXP Corticosterone results in decreased expression of ITGA1 mRNA CTD PMID:15755911 NCBI chr 2:48,379,181...48,545,336
Ensembl chr 2:48,386,249...48,545,284 		JBrowse link
G Itga8 integrin subunit alpha 8 increases expression EXP Corticosterone results in increased expression of ITGA8 mRNA CTD PMID:15755911 NCBI chr17:80,213,139...80,410,633
Ensembl chr17:80,213,143...80,410,633 		JBrowse link
G Itgb1bp2 integrin subunit beta 1 binding protein 2 increases expression EXP Corticosterone results in increased expression of ITGB1BP2 mRNA CTD PMID:15755911 NCBI chr  X:70,612,118...70,617,158
Ensembl chr  X:70,612,521...70,617,158 		JBrowse link
G Jak2 Janus kinase 2 multiple interactions EXP [alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [HTR2A protein results in increased secretion of Corticosterone] CTD PMID:19304867 NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP JUN protein affects the reaction [Corticosterone results in increased expression of BCL2L1 mRNA] CTD PMID:26915917 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 increases expression EXP Corticosterone results in increased expression of KCNH2 mRNA CTD PMID:18835572 NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421 		JBrowse link
G Kcnj5 potassium inwardly-rectifying channel, subfamily J, member 5 increases expression EXP Corticosterone results in increased expression of KCNJ5 mRNA CTD PMID:15755911 NCBI chr 8:38,981,598...39,011,197
Ensembl chr 8:38,983,034...39,011,101 		JBrowse link
G Kdr kinase insert domain receptor multiple interactions
decreases expression 		ISO 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Corticosterone results in decreased expression of KDR protein]; Calcium promotes the reaction [Corticosterone results in decreased expression of KDR protein]; Corticosterone inhibits the reaction [KDR protein binds to NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KDR protein]; NR3C1 protein promotes the reaction [Corticosterone results in decreased expression of KDR protein] CTD PMID:21647420 NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192 		JBrowse link
G Kif15 kinesin family member 15 decreases expression EXP Corticosterone results in decreased expression of KIF15 mRNA CTD PMID:15755911 NCBI chr 8:131,479,340...131,550,209
Ensembl chr 8:131,479,337...131,550,202 		JBrowse link
G Kifc1 kinesin family member C1 decreases expression EXP Corticosterone results in decreased expression of KIFC1 mRNA CTD PMID:15755911 NCBI chr20:5,000,929...5,018,967
Ensembl chr20:5,000,648...5,018,988 		JBrowse link
G Klf4 KLF transcription factor 4 multiple interactions
decreases expression 		EXP HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 protein]; KLF4 protein inhibits the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; KLF4 protein inhibits the reaction [Corticosterone results in decreased expression of NPHS1 protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KLF4 protein]; trichostatin A inhibits the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; trichostatin A inhibits the reaction [Corticosterone results in decreased expression of KLF4 protein]
Corticosterone results in decreased expression of KLF4 mRNA; Corticosterone results in decreased expression of KLF4 protein 		CTD PMID:31306741 NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592 		JBrowse link
G Klf9 KLF transcription factor 9 increases expression EXP Corticosterone results in increased expression of KLF9 mRNA CTD PMID:15755911 NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:230,126,646...230,151,641 		JBrowse link
G Lep leptin multiple interactions
decreases expression 		ISO 1-(3-chlorophenyl)piperazine inhibits the reaction [Corticosterone results in decreased expression of LEP protein]; 8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione inhibits the reaction [1-(3-chlorophenyl)piperazine inhibits the reaction [Corticosterone results in decreased expression of LEP protein]]; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of LEP protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of LEP protein] CTD PMID:28186389 PMID:29751049 NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661 		JBrowse link
G Lif LIF, interleukin 6 family cytokine multiple interactions
decreases expression 		EXP
ISO 		[Corticosterone co-treated with Isoflurophate] results in increased expression of LIF mRNA
[Corticosterone co-treated with Isoflurophate] results in increased expression of LIF mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of LIF mRNA; [Corticosterone co-treated with Physostigmine] results in decreased expression of LIF mRNA
Corticosterone results in decreased expression of LIF mRNA 		CTD PMID:28500787 PMID:28782715 PMID:29846716 NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053 		JBrowse link
G Lmnb1 lamin B1 decreases expression EXP Corticosterone results in decreased expression of LMNB1 mRNA CTD PMID:15755911 NCBI chr18:52,373,939...52,413,284
Ensembl chr18:52,373,757...52,413,283 		JBrowse link
G Lpar1 lysophosphatidic acid receptor 1 increases expression EXP Corticosterone results in increased expression of LPAR1 mRNA CTD PMID:15755911 NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:78,024,139...78,142,188 		JBrowse link
G Lrrk2 leucine-rich repeat kinase 2 multiple interactions
increases secretion 		ISO LRRK2 protein mutant form promotes the reaction [Paraquat results in increased secretion of Corticosterone]
LRRK2 protein mutant form results in increased secretion of Corticosterone; LRRK2 protein results in increased secretion of Corticosterone 		CTD PMID:31174552 NCBI chr 7:124,706,246...124,867,234
Ensembl chr 7:124,706,080...124,867,239 		JBrowse link
G Maged2 MAGE family member D2 decreases expression EXP Corticosterone results in decreased expression of MAGED2 mRNA CTD PMID:15755911 NCBI chr  X:23,160,928...23,364,994
Ensembl chr  X:23,160,931...23,169,104 		JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta increases lipidation
multiple interactions 		EXP Corticosterone results in increased lipidation of MAP1LC3B protein
3-methyladenine inhibits the reaction [Corticosterone results in increased lipidation of MAP1LC3B protein]; bafilomycin A1 promotes the reaction [Corticosterone results in increased lipidation of MAP1LC3B protein]; Sirolimus promotes the reaction [Corticosterone results in increased lipidation of MAP1LC3B protein] 		CTD PMID:38759937 NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358 		JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 multiple interactions EXP astragaloside VI inhibits the reaction [Corticosterone results in decreased expression of and results in decreased phosphorylation of MAP2K1 protein]; Corticosterone results in decreased expression of and results in decreased phosphorylation of MAP2K1 protein CTD PMID:36559001 NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184 		JBrowse link
G Map3k7 mitogen activated protein kinase kinase kinase 7 multiple interactions
increases phosphorylation 		EXP 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]]; Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]; Flutamide inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]] CTD PMID:29625166 NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases phosphorylation
decreases phosphorylation
multiple interactions
decreases activity 		EXP
ISO 		Corticosterone results in increased phosphorylation of MAPK1 protein
Corticosterone results in decreased phosphorylation of MAPK1 protein
2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein]]
Corticosterone results in decreased activity of MAPK1 protein
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein]]; astragaloside VI inhibits the reaction [Corticosterone results in decreased expression of and results in decreased phosphorylation of MAPK1 protein]; Corticosterone results in decreased expression of and results in decreased phosphorylation of MAPK1 protein; Curcumin inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein] 		CTD PMID:19175364 PMID:19733225 PMID:22850435 PMID:29343424 PMID:36559001 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases phosphorylation
decreases phosphorylation
multiple interactions
decreases activity 		EXP
ISO 		Corticosterone results in increased phosphorylation of MAPK3 protein
Corticosterone results in decreased phosphorylation of MAPK3 protein
2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK3 protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK3 protein]]
Corticosterone results in decreased activity of MAPK3 protein
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein]]; astragaloside VI inhibits the reaction [Corticosterone results in decreased expression of and results in decreased phosphorylation of MAPK3 protein]; Corticosterone results in decreased expression of and results in decreased phosphorylation of MAPK3 protein; Curcumin inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK3 protein]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein] 		CTD PMID:19175364 PMID:19733225 PMID:22850435 PMID:29343424 PMID:36559001 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mb myoglobin decreases expression EXP Corticosterone results in decreased expression of MB mRNA CTD PMID:15755911 NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:110,640,512...110,647,958 		JBrowse link
G Mc2r melanocortin 2 receptor multiple interactions
increases secretion 		EXP MC2R protein promotes the reaction [PRL protein results in increased secretion of Corticosterone]; PRL protein promotes the reaction [MC2R protein results in increased secretion of Corticosterone] CTD PMID:18609294 NCBI chr18:64,279,878...64,291,775
Ensembl chr18:64,277,360...64,291,881 		JBrowse link
G Mcm3 minichromosome maintenance complex component 3 decreases expression EXP Corticosterone results in decreased expression of MCM3 mRNA CTD PMID:15755911 NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746 		JBrowse link
G Mcm4 minichromosome maintenance complex component 4 decreases expression EXP Corticosterone results in decreased expression of MCM4 mRNA CTD PMID:15755911 NCBI chr11:98,762,599...98,776,300
Ensembl chr11:98,762,634...98,776,536 		JBrowse link
G Mcm6 minichromosome maintenance complex component 6 decreases expression EXP Corticosterone results in decreased expression of MCM6 mRNA CTD PMID:15755911 NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Mcm7 minichromosome maintenance complex component 7 decreases expression EXP Corticosterone results in decreased expression of MCM7 mRNA CTD PMID:15755911 NCBI chr12:22,155,921...22,163,320
Ensembl chr12:22,155,921...22,163,771 		JBrowse link
G Me1 malic enzyme 1 decreases expression EXP Corticosterone results in decreased expression of ME1 mRNA CTD PMID:15755911 NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275 		JBrowse link
G Mecp2 methyl CpG binding protein 2 multiple interactions EXP MECP2 affects the reaction [Lipopolysaccharides promotes the reaction [Ethanol results in increased secretion of Corticosterone]] CTD PMID:25409090 NCBI chr  X:156,932,481...156,995,981
Ensembl chr  X:156,941,234...156,943,560 		JBrowse link
G Melk maternal embryonic leucine zipper kinase decreases expression EXP Corticosterone results in decreased expression of MELK mRNA CTD PMID:15755911 NCBI chr 5:63,336,151...63,396,254
Ensembl chr 5:63,336,106...63,396,247 		JBrowse link
G Mfn1 mitofusin 1 decreases expression EXP Corticosterone results in decreased expression of MFN1 mRNA CTD PMID:22244747 NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:117,241,759...117,290,190 		JBrowse link
G Mfn2 mitofusin 2 decreases expression EXP Corticosterone results in decreased expression of MFN2 mRNA CTD PMID:22244747 NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495 		JBrowse link
G Mgst2 microsomal glutathione S-transferase 2 increases expression EXP Corticosterone results in increased expression of MGST2 mRNA CTD PMID:15755911 NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:137,836,140...137,866,661 		JBrowse link
G Mir421 microRNA 421 increases expression
multiple interactions 		EXP Corticosterone results in increased expression of MIR421 mRNA
MIR421 affects the reaction [Corticosterone results in decreased expression of ACAN protein]; MIR421 affects the reaction [Corticosterone results in decreased expression of and results in decreased phosphorylation of MTOR protein]; MIR421 affects the reaction [Corticosterone results in increased expression of NR3C2 mRNA] 		CTD PMID:38759937 NCBI chr  X:72,657,339...72,657,417 JBrowse link
G Mmp12 matrix metallopeptidase 12 decreases expression EXP Corticosterone results in decreased expression of MMP12 mRNA CTD PMID:15755911 NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:12,866,641...12,884,478 		JBrowse link
G Mt1a metallothionein 1A increases expression EXP Corticosterone results in increased expression of MT1 mRNA; Corticosterone results in increased expression of MT1A mRNA CTD PMID:15755911 PMID:31520820 NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases phosphorylation
multiple interactions 		ISO
EXP 		Corticosterone results in decreased phosphorylation of MTOR protein
Corticosterone results in decreased expression of and results in decreased phosphorylation of MTOR protein; MIR421 affects the reaction [Corticosterone results in decreased expression of and results in decreased phosphorylation of MTOR protein] 		CTD PMID:21647420 PMID:38759937 NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435 		JBrowse link
G Mustn1 musculoskeletal, embryonic nuclear protein 1 increases expression EXP Corticosterone results in increased expression of MUSTN1 mRNA CTD PMID:15755911 NCBI chr16:6,079,355...6,081,608
Ensembl chr16:6,079,277...6,081,586 		JBrowse link
G Myh11 myosin heavy chain 11 increases expression EXP Corticosterone results in increased expression of MYH11 mRNA CTD PMID:15755911 NCBI chr10:1,250,554...1,345,681
Ensembl chr10:1,263,194...1,345,678 		JBrowse link
G Ncapd2 non-SMC condensin I complex, subunit D2 decreases expression EXP Corticosterone results in decreased expression of NCAPD2 mRNA CTD PMID:15755911 NCBI chr 4:159,655,051...159,677,938
Ensembl chr 4:159,655,051...159,677,938 		JBrowse link
G Ncaph2 non-SMC condensin II complex, subunit H2 decreases expression EXP Corticosterone results in decreased expression of NCAPH2 mRNA CTD PMID:15755911 NCBI chr 7:122,302,550...122,319,570
Ensembl chr 7:122,300,252...122,319,569 		JBrowse link
G Ncoa1 nuclear receptor coactivator 1 multiple interactions ISO Corticosterone promotes the reaction [[NCOA1 protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] CTD PMID:11581012 NCBI chr 6:32,952,090...33,229,829
Ensembl chr 6:32,952,090...33,195,924 		JBrowse link
G Ncs1 neuronal calcium sensor 1 increases expression ISO Corticosterone results in increased expression of NCS1 protein CTD PMID:21647420 NCBI chr 3:34,920,949...34,966,554
Ensembl chr 3:34,920,971...34,968,711 		JBrowse link
G Ndrg1 N-myc downstream regulated 1 multiple interactions
increases phosphorylation 		ISO [Corticosterone results in increased phosphorylation of NDRG1 protein] promotes the reaction [NDRG1 protein binds to CTNNB1 protein]; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CDH2 protein; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNA1 protein; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNB1 protein
[Corticosterone results in increased phosphorylation of SGK1 protein] which results in increased phosphorylation of NDRG1 protein 		CTD PMID:21655274 NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913 		JBrowse link
G Ndrg2 NDRG family member 2 increases expression EXP Corticosterone results in increased expression of NDRG2 mRNA CTD PMID:15755911 NCBI chr15:27,074,481...27,087,376
Ensembl chr15:27,074,481...27,083,125 		JBrowse link
G Nfkbia NFKB inhibitor alpha increases expression EXP Corticosterone results in increased expression of NFKBIA mRNA CTD PMID:15755911 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Ngf nerve growth factor decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of NGF protein
O-1602 compound inhibits the reaction [Corticosterone results in decreased expression of NGF protein] 		CTD PMID:32733244 NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834 		JBrowse link
G Nphs1 NPHS1 adhesion molecule, nephrin decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of NPHS1 mRNA; Corticosterone results in decreased expression of NPHS1 protein
HDAC7 protein affects the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of NPHS1 protein]; KLF4 protein inhibits the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; KLF4 protein inhibits the reaction [Corticosterone results in decreased expression of NPHS1 protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of NPHS1 protein]; trichostatin A inhibits the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; trichostatin A inhibits the reaction [Corticosterone results in decreased expression of NPHS1 protein] 		CTD PMID:31306741 NCBI chr 1:94,848,261...94,876,522
Ensembl chr 1:94,848,261...94,876,521 		JBrowse link
G Nppa natriuretic peptide A increases expression
multiple interactions 		EXP Corticosterone results in increased expression of NPPA mRNA
Corticosterone promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] 		CTD PMID:16533503 NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493 		JBrowse link
G Npy neuropeptide Y decreases expression EXP Corticosterone results in decreased expression of NPY mRNA CTD PMID:15755911 NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO Corticosterone binds to and results in increased activity of NR1I2 protein; Corticosterone promotes the reaction [[NCOA1 protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Ketoconazole inhibits the reaction [Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]] CTD PMID:11581012 PMID:12072427 PMID:16054614 NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions ISO Corticosterone binds to and results in increased activity of NR1I3 protein; Corticosterone inhibits the reaction [Androstane-3,17-diol binds to and results in decreased activity of NR1I3 protein] CTD PMID:18832183 NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions
increases expression
affects localization
decreases expression
affects abundance
increases activity
affects binding 		ISO
EXP 		Corticosterone binds to and results in increased activity of NR3C1 protein
Corticosterone results in increased expression of NR3C1 mRNA; Corticosterone results in increased expression of NR3C1 protein
Corticosterone affects the localization of NR3C1 protein
Corticosterone results in decreased expression of NR3C1 protein
[Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; Corticosterone promotes the reaction [[NR3C1 protein binds to TAT promoter] which results in increased expression of TAT mRNA]; Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]; Lead inhibits the reaction [Corticosterone binds to NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]]
NR3C1 protein affects the abundance of Corticosterone
Corticosterone results in increased activity of NR3C1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Carbamazepine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Lithium inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Valproic Acid inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; Carbamazepine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Chlorpromazine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Clozapine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Corticosterone inhibits the reaction [KDR protein binds to NR3C1 protein]; Lithium inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; NR3C1 protein promotes the reaction [Corticosterone results in decreased expression of KDR protein]; NR3C1 protein promotes the reaction [Corticosterone results in increased expression of DKK1 protein]; Pregnanolone analog inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Pregnanolone inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; pyrazolanthrone inhibits the reaction [Valproic Acid inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; Valproic Acid inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein] 		CTD PMID:10509797 PMID:11861974 PMID:15249158 PMID:15705660 PMID:16049266 More... NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 affects binding
multiple interactions
increases expression 		ISO
EXP 		Corticosterone binds to NR3C2 protein
MIR421 affects the reaction [Corticosterone results in increased expression of NR3C2 mRNA] 		CTD PMID:16061183 PMID:38759937 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Nrg1 neuregulin 1 decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of NRG1 protein
astragaloside VI inhibits the reaction [Corticosterone results in decreased expression of NRG1 protein] 		CTD PMID:36559001 NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849 		JBrowse link
G Ntrk3 neurotrophic receptor tyrosine kinase 3 increases expression EXP Corticosterone results in increased expression of NTRK3 mRNA CTD PMID:18363858 NCBI chr 1:141,526,192...141,913,575
Ensembl chr 1:141,542,569...141,913,004 		JBrowse link
G Ocln occludin multiple interactions ISO [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] CTD PMID:29751049 NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411 		JBrowse link
G Omd osteomodulin increases expression EXP Corticosterone results in increased expression of OMD mRNA CTD PMID:15755911 NCBI chr17:15,266,646...15,274,870
Ensembl chr17:15,266,646...15,274,870 		JBrowse link
G Oplah 5-oxoprolinase (ATP-hydrolysing) increases expression EXP Corticosterone results in increased expression of OPLAH mRNA CTD PMID:15755911 NCBI chr 7:109,892,136...109,932,403
Ensembl chr 7:109,891,405...109,915,979 		JBrowse link
G Orm1 orosomucoid 1 increases expression EXP Corticosterone results in increased expression of ORM1 mRNA CTD PMID:15755911 NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:81,788,395...81,791,667 		JBrowse link
G Osm oncostatin M multiple interactions EXP
ISO 		[Corticosterone co-treated with Isoflurophate] results in increased expression of OSM mRNA
[Corticosterone co-treated with Isoflurophate] results in increased expression of OSM mRNA; [Corticosterone co-treated with Physostigmine] results in increased expression of OSM mRNA; Corticosterone promotes the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased expression of OSM mRNA] 		CTD PMID:28500787 PMID:28782715 PMID:29846716 NCBI chr14:83,327,202...83,332,073
Ensembl chr14:83,327,554...83,331,827 		JBrowse link
G P3h1 prolyl 3-hydroxylase 1 decreases expression EXP Corticosterone results in decreased expression of P3H1 mRNA CTD PMID:15755911 NCBI chr 5:138,127,240...138,141,974
Ensembl chr 5:138,126,860...138,142,836 		JBrowse link
G Pck2 phosphoenolpyruvate carboxykinase 2 (mitochondrial) decreases expression EXP Corticosterone results in decreased expression of PCK2 mRNA CTD PMID:15755911 NCBI chr15:32,997,853...33,006,691
Ensembl chr15:32,997,834...33,016,864 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of PCNA mRNA; Corticosterone results in decreased expression of PCNA protein
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA]]; IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA] 		CTD PMID:15755911 PMID:29343424 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pde2a phosphodiesterase 2A increases expression
multiple interactions 		ISO
EXP 		Corticosterone results in increased expression of PDE2A mRNA; Corticosterone results in increased expression of PDE2A mRNA alternative form; Corticosterone results in increased expression of PDE2A protein
Mifepristone inhibits the reaction [Corticosterone results in increased expression of PDE2A protein] 		CTD PMID:22850435 NCBI chr 1:165,235,623...165,327,466
Ensembl chr 1:165,235,623...165,327,466 		JBrowse link
G Pdk1 pyruvate dehydrogenase kinase 1 multiple interactions ISO [Corticosterone results in increased phosphorylation of and results in increased activity of PDK1 protein] which results in increased phosphorylation of and results in increased activity of SGK1 protein; Corticosterone results in increased phosphorylation of and results in increased activity of PDK1 protein CTD PMID:21655274 NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:77,113,473...77,144,145 		JBrowse link
G Pdlim5 PDZ and LIM domain 5 increases expression EXP Corticosterone results in increased expression of PDLIM5 mRNA CTD PMID:15755911 NCBI chr 2:233,625,478...233,793,582
Ensembl chr 2:233,628,503...233,793,528 		JBrowse link
G Pdlim7 PDZ and LIM domain 7 increases expression EXP Corticosterone results in increased expression of PDLIM7 mRNA CTD PMID:15755911 NCBI chr17:9,129,603...9,144,956
Ensembl chr17:9,129,525...9,144,956 		JBrowse link
G Pdyn prodynorphin multiple interactions EXP
ISO 		Corticosterone inhibits the reaction [[Oxidopamine co-treated with Levodopa] results in increased expression of PDYN mRNA]
PDYN protein promotes the reaction [Cocaine results in increased abundance of Corticosterone] 		CTD PMID:17532787 PMID:18687386 NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:137,354,161...137,366,503 		JBrowse link
G Penk proenkephalin multiple interactions EXP Corticosterone inhibits the reaction [[Oxidopamine co-treated with Levodopa] results in increased expression of PENK mRNA] CTD PMID:18687386 NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:21,981,382...21,986,705 		JBrowse link
G Pfkl phosphofructokinase, liver type increases expression EXP Corticosterone results in increased expression of PFKL mRNA CTD PMID:15755911 NCBI chr20:10,663,907...10,685,967
Ensembl chr20:10,663,955...10,685,966 		JBrowse link
G Pfkp phosphofructokinase, platelet multiple interactions ISO [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA] CTD PMID:29751049 NCBI chr17:68,639,749...68,704,055
Ensembl chr17:68,639,481...68,705,752 		JBrowse link
G Pfn2 profilin 2 decreases expression EXP Corticosterone results in decreased expression of PFN2 mRNA CTD PMID:15755911 NCBI chr 2:144,217,100...144,222,936
Ensembl chr 2:144,205,636...144,222,936 		JBrowse link
G Pim3 Pim-3 proto-oncogene, serine/threonine kinase increases expression EXP Corticosterone results in increased expression of PIM3 mRNA CTD PMID:15755911 NCBI chr 7:121,822,076...121,836,257
Ensembl chr 7:121,832,742...121,836,259 		JBrowse link
G Pla1a phospholipase A1 member A increases expression EXP Corticosterone results in increased expression of PLA1A mRNA CTD PMID:15755911 NCBI chr11:75,825,626...75,863,296
Ensembl chr11:75,825,585...75,878,165 		JBrowse link
G Plk1 polo-like kinase 1 decreases expression EXP Corticosterone results in decreased expression of PLK1 mRNA CTD PMID:15755911 NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:186,147,658...186,157,637 		JBrowse link
G Plk2 polo-like kinase 2 decreases expression EXP Corticosterone results in decreased expression of PLK2 mRNA CTD PMID:15755911 NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296 		JBrowse link
G Plk4 polo-like kinase 4 decreases expression EXP Corticosterone results in decreased expression of PLK4 mRNA CTD PMID:15755911 NCBI chr 2:125,730,480...125,748,894
Ensembl chr 2:125,730,460...125,748,892 		JBrowse link
G Podxl podocalyxin-like increases expression EXP Corticosterone results in increased expression of PODXL mRNA CTD PMID:15755911 NCBI chr 4:61,102,434...61,149,131
Ensembl chr 4:61,102,419...61,149,789 		JBrowse link
G Pomc proopiomelanocortin multiple interactions
increases secretion
increases abundance
decreases abundance
decreases secretion 		EXP
ISO 		Bromocriptine inhibits the reaction [POMC protein results in decreased secretion of Corticosterone]; Corticosterone inhibits the reaction [Nitroprusside results in increased secretion of POMC protein]; Cromolyn Sodium inhibits the reaction [POMC results in increased secretion of Corticosterone]; Fulvestrant inhibits the reaction [nonylphenol promotes the reaction [POMC protein modified form results in increased secretion of Corticosterone]]; Nitroprusside inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]; nonylphenol inhibits the reaction [Nitroprusside inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]]; nonylphenol promotes the reaction [POMC protein modified form results in increased secretion of Corticosterone]; oxophenylarsine inhibits the reaction [POMC protein results in increased abundance of Corticosterone]; pervanadate inhibits the reaction [POMC protein results in increased abundance of Corticosterone]; SB 203580 inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]
lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]; resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]]
POMC protein results in decreased abundance of Corticosterone
POMC protein modified form results in increased secretion of Corticosterone; POMC protein results in increased secretion of Corticosterone; POMC results in increased secretion of Corticosterone
Corticosterone results in decreased secretion of POMC protein; POMC protein results in decreased secretion of Corticosterone 		CTD PMID:1659878 PMID:3015567 PMID:7588239 PMID:10518784 PMID:11132610 More... NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA] CTD PMID:29751049 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] CTD PMID:29751049 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Ppp1r1b protein phosphatase 1, regulatory (inhibitor) subunit 1B multiple interactions ISO Cocaine promotes the reaction [PPP1R1B protein results in increased abundance of Corticosterone] CTD PMID:10516482 NCBI chr10:83,843,948...83,853,063
Ensembl chr10:83,844,036...83,853,063 		JBrowse link
G Ppp2r2b protein phosphatase 2, regulatory subunit B, beta decreases expression EXP Corticosterone results in decreased expression of PPP2R2B mRNA CTD PMID:15755911 NCBI chr18:34,904,686...35,357,299
Ensembl chr18:34,904,686...35,356,977 		JBrowse link
G Prim1 DNA primase subunit 1 decreases expression EXP Corticosterone results in decreased expression of PRIM1 mRNA CTD PMID:15755911 NCBI chr 7:1,031,436...1,047,134 JBrowse link
G Prkar1a protein kinase cAMP-dependent type I regulatory subunit alpha multiple interactions ISO [Androgens deficiency affects the activity of PRKAR1A gene mutant form] which results in increased secretion of Corticosterone; [PRKAR1A gene mutant form results in increased susceptibility to Androgens deficiency] which results in increased secretion of Corticosterone; Dexamethasone inhibits the reaction [[PRKAR1A gene mutant form results in increased susceptibility to Androgens deficiency] which results in increased secretion of Corticosterone]; Dexamethasone inhibits the reaction [PRKAR1A gene mutant form results in increased secretion of Corticosterone]; Dihydrotestosterone inhibits the reaction [[Androgens deficiency affects the activity of PRKAR1A gene mutant form] which results in increased secretion of Corticosterone]; Dihydrotestosterone inhibits the reaction [[PRKAR1A gene mutant form results in increased susceptibility to Androgens deficiency] which results in increased secretion of Corticosterone] CTD PMID:29367455 NCBI chr10:95,120,537...95,139,028
Ensembl chr10:95,120,487...95,139,025 		JBrowse link
G Prkca protein kinase C, alpha multiple interactions ISO 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione promotes the reaction [Corticosterone results in increased activity of PRKCA protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Corticosterone results in increased activity of PRKCA protein] CTD PMID:16581232 NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572 		JBrowse link
G Prl prolactin multiple interactions EXP MC2R protein promotes the reaction [PRL protein results in increased secretion of Corticosterone]; PRL protein promotes the reaction [MC2R protein results in increased secretion of Corticosterone] CTD PMID:18609294 NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217 		JBrowse link
G Pten phosphatase and tensin homolog increases phosphorylation ISO Corticosterone results in increased phosphorylation of PTEN protein CTD PMID:21647420 NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330 		JBrowse link
G Ptgds prostaglandin D2 synthase increases expression EXP Corticosterone results in increased expression of PTGDS mRNA CTD PMID:15755911 NCBI chr 3:28,680,044...28,682,978
Ensembl chr 3:28,680,044...28,682,978 		JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 increases expression EXP Corticosterone results in increased expression of PTGS1 mRNA; Corticosterone results in increased expression of PTGS1 protein CTD PMID:15755911 NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression 		EXP [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 protein]; Corticosterone promotes the reaction [CEBPB protein binds to PTGS2 promoter]; Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]; Dactinomycin inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; Dactinomycin inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]]
Corticosterone results in increased expression of PTGS2 mRNA; Corticosterone results in increased expression of PTGS2 protein 		CTD PMID:15755911 PMID:18650268 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Pth parathyroid hormone multiple interactions EXP [Corticosterone co-treated with PTH protein] results in decreased expression of TNFRSF11B mRNA; [Corticosterone co-treated with PTH protein] results in decreased expression of TNFSF11 mRNA CTD PMID:17476578 NCBI chr 1:176,942,901...176,946,034
Ensembl chr 1:176,943,102...176,946,034 		JBrowse link
G Ptpn3 protein tyrosine phosphatase, non-receptor type 3 decreases expression EXP Corticosterone results in decreased expression of PTPN3 mRNA CTD PMID:15755911 NCBI chr 5:76,703,687...76,822,584
Ensembl chr 5:76,703,687...76,860,470 		JBrowse link
G Pttg1 PTTG1 regulator of sister chromatid separation, securin decreases expression EXP Corticosterone results in decreased expression of PTTG1 mRNA CTD PMID:15755911 NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309 		JBrowse link
G Qsox1 quiescin sulfhydryl oxidase 1 increases expression EXP Corticosterone results in increased expression of QSOX1 mRNA CTD PMID:15755911 NCBI chr13:70,500,060...70,537,711
Ensembl chr13:70,500,060...70,537,733 		JBrowse link
G Rapgef4 Rap guanine nucleotide exchange factor 4 increases expression EXP Corticosterone results in increased expression of RAPGEF4 mRNA CTD PMID:15755911 NCBI chr 3:77,217,024...77,509,933
Ensembl chr 3:77,217,039...77,509,978 		JBrowse link
G Rbp1 retinol binding protein 1 decreases expression EXP Corticosterone results in decreased expression of RBP1 mRNA CTD PMID:15755911 NCBI chr 8:107,904,589...107,926,109
Ensembl chr 8:107,887,417...107,983,847 		JBrowse link
G Reg3b regenerating family member 3 beta decreases expression EXP Corticosterone results in decreased expression of REG3B mRNA CTD PMID:15755911 NCBI chr 4:112,419,776...112,423,014
Ensembl chr 4:112,419,776...112,423,014 		JBrowse link
G Retn resistin increases expression ISO Corticosterone results in increased expression of RETN mRNA CTD PMID:15809511 NCBI chr12:6,508,653...6,511,115
Ensembl chr12:6,508,801...6,511,116 		JBrowse link
G Rfc3 replication factor C subunit 3 decreases expression EXP Corticosterone results in decreased expression of RFC3 mRNA CTD PMID:15755911 NCBI chr12:5,836,546...5,847,331
Ensembl chr12:5,836,553...5,847,340 		JBrowse link
G Rfc4 replication factor C subunit 4 decreases expression EXP Corticosterone results in decreased expression of RFC4 mRNA CTD PMID:15755911 NCBI chr11:91,254,273...91,268,727
Ensembl chr11:91,254,243...91,268,730 		JBrowse link
G Rgcc regulator of cell cycle increases expression EXP Corticosterone results in increased expression of RGCC mRNA CTD PMID:15755911 NCBI chr15:61,071,574...61,084,408
Ensembl chr15:61,071,574...61,084,408 		JBrowse link
G Rhoj ras homolog family member J increases expression EXP Corticosterone results in increased expression of RHOJ mRNA CTD PMID:15755911 NCBI chr 6:99,771,104...99,853,366
Ensembl chr 6:99,771,252...99,853,999 		JBrowse link
G Rpa2 replication protein A2 decreases expression EXP Corticosterone results in decreased expression of RPA2 mRNA CTD PMID:15755911 NCBI chr 5:150,260,668...150,271,329
Ensembl chr 5:150,260,723...150,271,546 		JBrowse link
G Rrm1 ribonucleotide reductase catalytic subunit M1 decreases expression EXP Corticosterone results in decreased expression of RRM1 mRNA CTD PMID:15755911 NCBI chr 1:166,235,904...166,260,206
Ensembl chr 1:166,235,900...166,260,944 		JBrowse link
G Runx2 RUNX family transcription factor 2 multiple interactions
decreases expression 		EXP Enalapril inhibits the reaction [Corticosterone results in decreased expression of RUNX2 mRNA] CTD PMID:30423288 NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027 		JBrowse link
G S100b S100 calcium binding protein B multiple interactions EXP [Ethanol co-treated with Corticosterone] results in increased expression of and affects the localization of S100B protein; Corticosterone results in increased expression of and affects the localization of S100B protein CTD PMID:38259729 NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081 		JBrowse link
G Scd stearoyl-CoA desaturase decreases expression EXP Corticosterone results in decreased expression of SCD1 mRNA CTD PMID:15755911 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785 		JBrowse link
G Sdc1 syndecan 1 decreases expression EXP Corticosterone results in decreased expression of SDC1 mRNA CTD PMID:15755911 NCBI chr 6:37,282,041...37,304,503
Ensembl chr 6:37,297,010...37,304,500 		JBrowse link
G Sdc2 syndecan 2 decreases expression EXP Corticosterone results in decreased expression of SDC2 mRNA CTD PMID:15755911 NCBI chr 7:66,012,405...66,125,101
Ensembl chr 7:66,108,853...66,126,294 		JBrowse link
G Sdc4 syndecan 4 increases expression EXP Corticosterone results in increased expression of SDC4 mRNA CTD PMID:15755911 NCBI chr 3:173,574,239...173,592,923
Ensembl chr 3:173,574,239...173,593,670 		JBrowse link
G Selenop selenoprotein P increases expression EXP Corticosterone results in increased expression of SELENOP mRNA CTD PMID:15755911 NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:54,225,152...54,236,019 		JBrowse link
G Serpina3n serpin family A member 3N increases expression EXP Corticosterone results in increased expression of SERPINA3N mRNA CTD PMID:15755911 NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:129,088,398...129,097,415 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression
increases phosphorylation
multiple interactions 		EXP
ISO 		Corticosterone results in increased expression of SGK1 mRNA
[Corticosterone results in increased phosphorylation of SGK1 protein] which results in increased phosphorylation of NDRG1 protein
[Corticosterone results in increased phosphorylation of and results in increased activity of PDK1 protein] which results in increased phosphorylation of and results in increased activity of SGK1 protein
Corticosterone results in increased expression of SGK1 mRNA; Corticosterone results in increased expression of SGK1 protein 		CTD PMID:15755911 PMID:21655274 PMID:31520820 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
G Shbg sex hormone binding globulin affects binding ISO Corticosterone binds to SHBG protein CTD PMID:25349334 NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,831,718...54,838,760 		JBrowse link
G Slc18a3 solute carrier family 18 member A3 increases expression
multiple interactions 		EXP Corticosterone results in increased expression of SLC18A3 protein
O-1602 compound inhibits the reaction [Corticosterone results in increased expression of SLC18A3 protein] 		CTD PMID:32733244 NCBI chr16:7,719,953...7,722,814 JBrowse link
G Slc1a2 solute carrier family 1 member 2 multiple interactions
increases expression 		ISO Corticosterone inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC1A2 protein]; Vitamin A promotes the reaction [Corticosterone results in increased expression of SLC1A2 protein] CTD PMID:17138558 NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:109,459,630...109,605,249 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions EXP Corticosterone inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:9830022 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Slc22a3 solute carrier family 22 member 3 decreases activity
multiple interactions 		EXP
ISO 		Corticosterone results in decreased activity of SLC22A3 protein
[Corticosterone results in decreased activity of SLC22A3 protein] inhibits the reaction [Epinephrine results in increased abundance of Epinephrine metabolite]; [Corticosterone results in decreased activity of SLC22A3 protein] which results in decreased abundance of Epinephrine; [Corticosterone results in decreased activity of SLC22A3 protein] which results in decreased import of Phenylephrine; [Corticosterone results in decreased activity of SLC22A3 protein] which results in decreased import of Synephrine; Corticosterone inhibits the reaction [SLC22A3 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased transport of Histamine]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of Tetraethylammonium]
Corticosterone inhibits the reaction [SLC22A3 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of Formoterol Fumarate] 		CTD PMID:9830022 PMID:12110607 PMID:12181285 PMID:12411423 PMID:16928864 More... NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 increases expression
multiple interactions 		EXP Corticosterone results in increased expression of SLC22A8 protein
O-1602 compound inhibits the reaction [Corticosterone results in increased expression of SLC22A8 protein] 		CTD PMID:32733244 NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588 		JBrowse link
G Slc2a1 solute carrier family 2 member 1 increases expression
multiple interactions 		EXP
ISO 		Corticosterone results in increased expression of SLC2A1 mRNA
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA] 		CTD PMID:15755911 PMID:29751049 NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742 		JBrowse link
G Slc2a4 solute carrier family 2 member 4 increases expression
multiple interactions 		EXP
ISO 		Corticosterone results in increased expression of SLC2A4 mRNA
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA] 		CTD PMID:15755911 PMID:29751049 NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270 		JBrowse link
G Slc6a15 solute carrier family 6 member 15 multiple interactions
decreases expression 		ISO Edaravone inhibits the reaction [Corticosterone results in decreased expression of SLC6A15 mRNA]; Paroxetine inhibits the reaction [Corticosterone results in decreased expression of SLC6A15 mRNA] CTD PMID:31344373 NCBI chr 7:40,439,607...40,493,788
Ensembl chr 7:40,439,658...40,493,786 		JBrowse link
G Smad2 SMAD family member 2 decreases expression EXP Corticosterone results in decreased expression of SMAD2 mRNA; Corticosterone results in decreased expression of SMAD2 protein CTD PMID:29660438 PMID:32663519 NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388 		JBrowse link
G Smad3 SMAD family member 3 decreases expression EXP Corticosterone results in decreased expression of SMAD3 mRNA CTD PMID:29660438 PMID:32663519 NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324 		JBrowse link
G Smarcd2 SWI/SNF related BAF chromatin remodeling complex subunit D2 increases expression EXP Corticosterone results in increased expression of SMARCD2 mRNA CTD PMID:15755911 NCBI chr10:91,693,542...91,702,408
Ensembl chr10:91,693,542...91,702,522 		JBrowse link
G Sod1 superoxide dismutase 1 decreases expression EXP Corticosterone results in decreased expression of SOD1 mRNA CTD PMID:22244747 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions
decreases activity
decreases expression 		EXP [IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]]; IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]
Corticosterone results in decreased activity of SOD2 protein
Corticosterone results in decreased expression of SOD2 mRNA; Corticosterone results in decreased expression of SOD2 protein 		CTD PMID:22244747 PMID:24667322 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Sorbs2 sorbin and SH3 domain containing 2 increases expression EXP Corticosterone results in increased expression of SORBS2 mRNA CTD PMID:15755911 NCBI chr16:53,167,795...53,481,300
Ensembl chr16:53,167,827...53,358,986 		JBrowse link
G Sox4 SRY-box transcription factor 4 decreases expression EXP Corticosterone results in decreased expression of SOX4 mRNA CTD PMID:15755911 NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,875,756...35,884,024 		JBrowse link
G Sox9 SRY-box transcription factor 9 decreases expression EXP Corticosterone results in decreased expression of SOX9 mRNA; Corticosterone results in decreased expression of SOX9 protein CTD PMID:29660438 PMID:32663519 NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250 		JBrowse link
G Spp1 secreted phosphoprotein 1 multiple interactions
decreases expression 		EXP Enalapril inhibits the reaction [Corticosterone results in decreased expression of SPP1 mRNA] CTD PMID:30423288 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Sqstm1 sequestosome 1 decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of SQSTM1 protein
3-methyladenine inhibits the reaction [Corticosterone results in decreased expression of SQSTM1 protein]; bafilomycin A1 inhibits the reaction [Corticosterone results in decreased expression of SQSTM1 protein]; Sirolimus promotes the reaction [Corticosterone results in decreased expression of SQSTM1 protein] 		CTD PMID:38759937 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750 		JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 multiple interactions EXP
ISO 		[Corticosterone co-treated with oleoyl-estrone] affects the expression of SREBF1 mRNA
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA] 		CTD PMID:19545626 PMID:29751049 NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164 		JBrowse link
G Star steroidogenic acute regulatory protein decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of STAR mRNA; Corticosterone results in decreased expression of STAR protein
Mifepristone inhibits the reaction [Corticosterone results in decreased expression of STAR mRNA]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of STAR protein] 		CTD PMID:37972751 NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions ISO [Corticosterone co-treated with Isoflurophate] results in increased phosphorylation of STAT3 protein; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased phosphorylation of STAT3 protein CTD PMID:28500787 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359 		JBrowse link
G Stmn1 stathmin 1 decreases expression EXP Corticosterone results in decreased expression of STMN1 mRNA CTD PMID:15755911 NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842 		JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 increases expression EXP Corticosterone results in increased expression of SULT1A1 mRNA CTD PMID:15755911 NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131 		JBrowse link
G Syn1 synapsin I multiple interactions
decreases expression 		ISO Ascorbic Acid inhibits the reaction [Corticosterone results in decreased expression of SYN1 protein]; Ketamine inhibits the reaction [Corticosterone results in decreased expression of SYN1 protein] CTD PMID:33872575 NCBI chr  X:3,725,745...3,780,940
Ensembl chr  X:3,725,714...3,780,938 		JBrowse link
G Synm synemin increases expression EXP Corticosterone results in increased expression of SYNM mRNA CTD PMID:15755911 NCBI chr 1:130,743,891...130,774,254
Ensembl chr 1:130,743,897...130,773,824 		JBrowse link
G Tat tyrosine aminotransferase multiple interactions EXP [Mirex co-treated with Corticosterone] results in increased activity of TAT protein; Corticosterone promotes the reaction [[NR3C1 protein binds to TAT promoter] which results in increased expression of TAT mRNA] CTD PMID:2893471 PMID:22465009 NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482 		JBrowse link
G Tcf21 transcription factor 21 increases expression EXP Corticosterone results in increased expression of TCF21 mRNA CTD PMID:15755911 NCBI chr 1:24,520,499...24,523,358
Ensembl chr 1:24,520,481...24,523,348 		JBrowse link
G Tcp1 t-complex 1 decreases expression EXP Corticosterone results in decreased expression of TCP1 mRNA CTD PMID:15755911 NCBI chr 1:50,376,848...50,384,527
Ensembl chr 1:50,376,848...50,384,527 		JBrowse link
G Tdo2 tryptophan 2,3-dioxygenase increases activity EXP Corticosterone results in increased activity of TDO2 protein CTD PMID:7306070 NCBI chr 2:169,567,656...169,585,586
Ensembl chr 2:169,567,654...169,585,586 		JBrowse link
G Tf transferrin increases expression EXP Corticosterone results in increased expression of TF mRNA CTD PMID:15755911 NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
decreases expression 		EXP Corticosterone inhibits the reaction [TGFB1 protein results in increased secretion of VEGFA protein]
Corticosterone results in decreased expression of TGFB1 mRNA 		CTD PMID:16598785 PMID:29660438 PMID:32663519 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Tgfbr1 transforming growth factor, beta receptor 1 decreases expression
multiple interactions 		EXP Corticosterone results in decreased expression of TGFBR1 mRNA; Corticosterone results in decreased expression of TGFBR1 protein
Mifepristone inhibits the reaction [Corticosterone results in decreased expression of TGFBR1 mRNA] 		CTD PMID:29660438 PMID:32663519 NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:66,449,293...66,527,260 		JBrowse link
G Tgm2 transglutaminase 2 increases expression EXP Corticosterone results in increased expression of TGM2 mRNA CTD PMID:15755911 NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240 		JBrowse link
G Th tyrosine hydroxylase increases expression ISO Corticosterone results in increased expression of TH protein CTD PMID:28186389 NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227 		JBrowse link
G Tinagl1 tubulointerstitial nephritis antigen-like 1 increases expression EXP Corticosterone results in increased expression of TINAGL1 mRNA CTD PMID:15755911 NCBI chr 5:147,797,884...147,807,925
Ensembl chr 5:147,797,892...147,807,871 		JBrowse link
G Tk1 thymidine kinase 1 decreases expression EXP Corticosterone results in decreased expression of TK1 mRNA CTD PMID:15755911 NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,533,449...103,556,228 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR4 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR4 protein]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein] CTD PMID:29751049 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007 		JBrowse link
G Tlr5 toll-like receptor 5 multiple interactions ISO [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein] CTD PMID:29751049 NCBI chr13:97,166,430...97,190,642
Ensembl chr13:97,166,405...97,192,525 		JBrowse link
G Tnc tenascin C decreases expression EXP Corticosterone results in decreased expression of TNC mRNA CTD PMID:15755911 NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression 		ISO
EXP 		[Corticosterone co-treated with Isoflurophate] results in increased expression of TNF mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of TNF mRNA; [Corticosterone co-treated with Physostigmine] results in increased expression of TNF mRNA; [Corticosterone co-treated with Pyridostigmine Bromide] results in increased expression of TNF mRNA; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TNF mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TNF mRNA]; Corticosterone promotes the reaction [Isoflurophate results in increased expression of TNF mRNA]; Corticosterone promotes the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased expression of TNF mRNA]
Corticosterone results in increased expression of TNF protein
Corticosterone results in increased expression of TNF mRNA
[Corticosterone co-treated with Isoflurophate] results in increased expression of TNF mRNA; O-1602 compound inhibits the reaction [Corticosterone results in increased expression of TNF protein] 		CTD PMID:28500787 PMID:28782715 PMID:29751049 PMID:29846716 PMID:32733244 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B decreases expression
multiple interactions
increases expression 		EXP Corticosterone results in decreased expression of TNFRSF11B mRNA
[Corticosterone co-treated with PTH protein] results in decreased expression of TNFRSF11B mRNA; Mifepristone inhibits the reaction [Corticosterone results in increased expression of TNFRSF11B mRNA] 		CTD PMID:17476578 PMID:29981921 NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075 		JBrowse link
G Tnfsf11 TNF superfamily member 11 decreases expression
multiple interactions
increases expression 		EXP Corticosterone results in decreased expression of TNFSF11 mRNA
[Corticosterone co-treated with PTH protein] results in decreased expression of TNFSF11 mRNA; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of TNFSF11 mRNA]
Corticosterone results in increased expression of TNFSF11 mRNA 		CTD PMID:17476578 PMID:29981921 NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479 		JBrowse link
G Top2a DNA topoisomerase II alpha decreases expression EXP Corticosterone results in decreased expression of TOP2A mRNA CTD PMID:15755911 NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366 		JBrowse link
G Tpbg trophoblast glycoprotein decreases expression EXP Corticosterone results in decreased expression of TPBG mRNA CTD PMID:15755911 NCBI chr 8:95,673,993...95,677,364
Ensembl chr 8:95,629,267...95,678,394 		JBrowse link
G Tpd52l1 TPD52 like 1 increases expression EXP Corticosterone results in increased expression of TPD52L1 mRNA CTD PMID:15755911 NCBI chr 1:27,991,114...28,109,767
Ensembl chr 1:27,991,131...28,110,158 		JBrowse link
G Traf6 TNF receptor associated factor 6 multiple interactions ISO
EXP 		[Testosterone co-treated with Estradiol co-treated with Corticosterone] promotes the reaction [AR protein binds to TRAF6 protein]; [Testosterone co-treated with Estradiol co-treated with Corticosterone] promotes the reaction [ESR1 protein binds to TRAF6 protein]
1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of TRAF6 protein]]; Corticosterone results in increased expression of and results in increased ubiquitination of TRAF6 protein; Estradiol inhibits the reaction [Corticosterone results in increased expression of and results in increased ubiquitination of TRAF6 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased ubiquitination of TRAF6 protein]]; Flutamide inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of TRAF6 protein]]; Testosterone inhibits the reaction [Corticosterone results in increased ubiquitination of TRAF6 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of and results in increased ubiquitination of TRAF6 protein]] 		CTD PMID:29625166 NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:108,418,513...108,443,328 		JBrowse link
G Trhr thyrotropin releasing hormone receptor increases expression EXP Corticosterone results in increased expression of TRHR mRNA CTD PMID:15755911 NCBI chr 7:77,233,175...77,277,988
Ensembl chr 7:77,233,354...77,277,987 		JBrowse link
G Trim54 tripartite motif-containing 54 increases expression EXP Corticosterone results in increased expression of TRIM54 mRNA CTD PMID:15755911 NCBI chr 6:30,959,306...30,978,475
Ensembl chr 6:30,959,306...30,978,475 		JBrowse link
G Tsc22d3 TSC22 domain family, member 3 increases expression
multiple interactions 		EXP Corticosterone results in increased expression of TSC22D3 mRNA; Corticosterone results in increased expression of TSC22D3 protein
TSC22D3 protein affects the reaction [Corticosterone results in decreased susceptibility to Doxorubicin] 		CTD PMID:24480152 PMID:31520820 NCBI chr  X:109,006,410...109,066,389
Ensembl chr  X:109,006,420...109,015,519 		JBrowse link
G Tspo translocator protein increases expression
multiple interactions 		EXP
ISO 		Corticosterone results in increased expression of TSPO mRNA
Corticosterone results in increased expression of TSPO protein
protosappanin A inhibits the reaction [Corticosterone results in increased expression of TSPO protein] 		CTD PMID:15755911 PMID:40054743 NCBI chr 7:116,600,214...116,610,461
Ensembl chr 7:116,600,210...116,610,460 		JBrowse link
G Tubb5 tubulin, beta 5 class I decreases expression EXP Corticosterone results in decreased expression of TUBB5 mRNA CTD PMID:15755911 NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726 		JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C decreases expression EXP Corticosterone results in decreased expression of UBE2C mRNA CTD PMID:15755911 NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678 		JBrowse link
G Vcan versican decreases expression EXP Corticosterone results in decreased expression of VCAN mRNA CTD PMID:15755911 NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:22,497,035...22,595,955 		JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions
increases expression
affects expression 		EXP
ISO 		Corticosterone inhibits the reaction [TGFB1 protein results in increased secretion of VEGFA protein]
Corticosterone results in increased expression of VEGFA protein
Corticosterone affects the expression of VEGFA protein 		CTD PMID:16598785 PMID:21647420 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
G Wars1 tryptophanyl-tRNA synthetase 1 decreases expression EXP Corticosterone results in decreased expression of WARS1 mRNA CTD PMID:15755911 NCBI chr 6:133,540,463...133,571,645
Ensembl chr 6:133,539,744...133,571,645 		JBrowse link
G Wt1 WT1 transcription factor decreases expression EXP Corticosterone results in decreased expression of WT1 mRNA; Corticosterone results in decreased expression of WT1 protein CTD PMID:31306741 NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:112,021,641...112,068,444 		JBrowse link
G Xpo1 exportin 1 decreases expression EXP Corticosterone results in decreased expression of XPO1 mRNA CTD PMID:15755911 NCBI chr14:101,434,450...101,476,705
Ensembl chr14:101,434,517...101,476,714 		JBrowse link
G Zfp36 zinc finger protein 36 increases expression EXP Corticosterone results in increased expression of ZFP36 mRNA CTD PMID:15755911 NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108 		JBrowse link
cortisol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of A2M mRNA CTD PMID:34480604 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
increases secretion 		ISO Elacridar inhibits the reaction [ABCB1 protein results in increased secretion of Hydrocortisone]; valspodar inhibits the reaction [ABCB1 protein results in increased secretion of Hydrocortisone] CTD PMID:22464980 NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ABCC1 mRNA CTD PMID:34480604 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 multiple interactions
increases expression
increases activity 		ISO Hydrocortisone promotes the reaction [ABCC3 protein affects the transport of calcein AM]
Hydrocortisone results in increased expression of ABCC3 mRNA
Hydrocortisone results in increased activity of ABCC3 protein 		CTD PMID:15979871 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha increases expression
multiple interactions 		ISO Hydrocortisone results in increased expression of ACACA mRNA
[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA] 		CTD PMID:30776459 PMID:33476690 NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888 		JBrowse link
G Ackr1 atypical chemokine receptor 1 multiple interactions
increases expression 		ISO Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of ACKR1 mRNA] CTD PMID:25763180 NCBI chr13:88,314,735...88,316,354
Ensembl chr13:88,293,188...88,317,807 		JBrowse link
G Acly ATP citrate lyase increases expression ISO Hydrocortisone results in increased expression of ACLY mRNA CTD PMID:30776459 NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631 		JBrowse link
G Acsl5 acyl-CoA synthetase long-chain family member 5 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ACSL5 mRNA CTD PMID:34480604 NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:264,294,864...264,341,943 		JBrowse link
G Actn2 actinin alpha 2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ACTN2 mRNA CTD PMID:34480604 NCBI chr17:62,835,055...62,902,331
Ensembl chr17:62,812,988...62,903,552 		JBrowse link
G Adam12 ADAM metallopeptidase domain 12 decreases expression ISO Hydrocortisone results in decreased expression of ADAM12 mRNA CTD PMID:21267416 NCBI chr 1:198,116,968...198,443,680
Ensembl chr 1:198,116,975...198,447,552 		JBrowse link
G Adgre5 adhesion G protein-coupled receptor E5 decreases expression ISO Hydrocortisone results in decreased expression of ADGRE5 mRNA CTD PMID:21267416 NCBI chr19:41,302,687...41,332,183
Ensembl chr19:41,303,213...41,324,641 		JBrowse link
G Adgrg1 adhesion G protein-coupled receptor G1 decreases expression ISO Hydrocortisone results in decreased expression of ADGRG1 mRNA CTD PMID:21267416 NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions ISO [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein] CTD PMID:33476690 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Afp alpha-fetoprotein multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of AFP mRNA CTD PMID:34480604 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649 		JBrowse link
G Agt angiotensinogen decreases expression
increases secretion 		ISO Hydrocortisone results in decreased expression of AGT protein
AGT protein results in increased secretion of Hydrocortisone 		CTD PMID:7473517 PMID:28235592 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 increases reduction
multiple interactions 		ISO AKR1D1 protein results in increased reduction of Hydrocortisone
AKR1D1 protein alternative form results in increased reduction of Hydrocortisone; AKR1D1 protein results in increased reduction of Hydrocortisone
[AKR1D1 protein alternative form results in increased reduction of Hydrocortisone] which results in increased chemical synthesis of 5-dihydrocortisol 		CTD PMID:30928400 NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 decreases phosphorylation EXP Hydrocortisone results in decreased phosphorylation of AKT1 protein CTD PMID:15187100 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 decreases expression ISO Hydrocortisone results in decreased expression of AKT2 mRNA CTD PMID:31075344 PMID:32535229 NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420 		JBrowse link
G Alb albumin multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ALB mRNA CTD PMID:34480604 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Aldoa aldolase, fructose-bisphosphate A multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ALDOA mRNA CTD PMID:34480604 NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211 		JBrowse link
G Amhr2 anti-Mullerian hormone receptor type 2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of AMHR2 mRNA CTD PMID:34480604 NCBI chr 7:135,454,517...135,470,183
Ensembl chr 7:135,457,922...135,471,104 		JBrowse link
G Anxa1 annexin A1 multiple interactions
increases expression 		ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ANXA1 mRNA; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of ANXA1 mRNA] CTD PMID:25763180 PMID:34480604 NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831 		JBrowse link
G Apoa1 apolipoprotein A1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of APOA1 mRNA CTD PMID:34480604 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729 		JBrowse link
G Apob apolipoprotein B multiple interactions
decreases expression 		ISO IGF1 protein inhibits the reaction [Hydrocortisone results in decreased expression of APOB mRNA]; Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of APOB mRNA] CTD PMID:31075344 NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814 		JBrowse link
G Ar androgen receptor affects activity
affects binding
multiple interactions 		ISO
EXP 		Hydrocortisone affects the activity of AR protein
Hydrocortisone binds to AR protein
Hydrocortisone binds to AR protein mutant form
Hydrocortisone binds to and results in increased activity of AR protein; Hydrocortisone binds to and results in increased activity of AR protein mutant form 		CTD PMID:11956172 PMID:12676605 PMID:14565775 PMID:15084347 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Arg1 arginase 1 increases expression
multiple interactions 		EXP Hydrocortisone results in increased expression of ARG1 mRNA
Methoxychlor inhibits the reaction [Hydrocortisone results in increased expression of ARG1 mRNA]; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of ARG1 mRNA]; o,p'-DDT inhibits the reaction [Hydrocortisone results in increased expression of ARG1 mRNA] 		CTD PMID:26647222 NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713 		JBrowse link
G Ascl1 achaete-scute family bHLH transcription factor 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ASCL1 mRNA CTD PMID:34480604 NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:23,790,360...23,798,231 		JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 decreases expression ISO Hydrocortisone results in decreased expression of BMAL1 mRNA CTD PMID:21980503 NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739 		JBrowse link
G Bmp5 bone morphogenetic protein 5 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of BMP5 mRNA CTD PMID:34480604 NCBI chr 8:85,397,629...85,520,374
Ensembl chr 8:85,396,925...85,520,189 		JBrowse link
G Camk2b calcium/calmodulin-dependent protein kinase II beta multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CAMK2B mRNA CTD PMID:34480604 NCBI chr14:85,059,166...85,148,121
Ensembl chr14:85,059,191...85,148,485 		JBrowse link
G Casp3 caspase 3 increases activity
multiple interactions 		ISO
EXP 		Hydrocortisone results in increased activity of CASP3 protein
Hydrocortisone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] 		CTD PMID:15086553 PMID:15755911 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression
multiple interactions 		ISO
EXP 		Hydrocortisone results in decreased expression of CCL2 protein
Hydrocortisone inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] 		CTD PMID:20116850 PMID:25851902 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO Hydrocortisone results in increased expression of CCL3 protein CTD PMID:20116850 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression ISO Hydrocortisone results in increased expression of CCL4 protein CTD PMID:20116850 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Cd14 CD14 molecule decreases expression ISO Hydrocortisone results in decreased expression of CD14 mRNA CTD PMID:17033190 NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292 		JBrowse link
G Cd40 CD40 molecule decreases expression ISO Hydrocortisone results in decreased expression of CD40 protein CTD PMID:15086553 NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847 		JBrowse link
G Cd80 Cd80 molecule decreases expression ISO Hydrocortisone results in decreased expression of CD80 protein CTD PMID:15086553 PMID:15241357 NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540 		JBrowse link
G Cd86 CD86 molecule decreases expression ISO Hydrocortisone results in decreased expression of CD86 protein CTD PMID:15086553 PMID:15241357 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361 		JBrowse link
G Cdc20 cell division cycle 20 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of CDC20 mRNA CTD PMID:34480604 NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799 		JBrowse link
G Cdh10 cadherin 10 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CDH10 mRNA CTD PMID:34480604 NCBI chr 2:70,355,521...70,577,880
Ensembl chr 2:70,357,217...70,578,332 		JBrowse link
G Cdh5 cadherin 5 increases localization
multiple interactions 		ISO Hydrocortisone results in increased localization of CDH5 protein
GGTI 298 inhibits the reaction [Hydrocortisone results in increased localization of CDH5 protein] 		CTD PMID:25763180 NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822 		JBrowse link
G Ceacam6 CEA cell adhesion molecule 6 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CEACAM6 mRNA CTD PMID:34480604 NCBI chr 1:89,544,415...89,562,552
Ensembl chr 1:89,544,400...89,562,552 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha multiple interactions
increases expression 		ISO [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein; CEBPA protein affects the reaction [Hydrocortisone results in increased expression of FASN mRNA]; CEBPA protein affects the reaction [Hydrocortisone results in increased expression of SREBF1 mRNA]; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of CEBPA mRNA]; Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]; Rosmarinic Acid affects the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]
Hydrocortisone results in increased expression of CEBPA mRNA; Hydrocortisone results in increased expression of CEBPA protein 		CTD PMID:30528684 PMID:30776459 PMID:32535229 PMID:33476690 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta affects expression
multiple interactions 		ISO Hydrocortisone affects the expression of CEBPB mRNA
Mifepristone affects the reaction [Hydrocortisone affects the expression of CEBPB mRNA] 		CTD PMID:30528684 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cidec cell death-inducing DFFA-like effector c multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of CIDEC mRNA CTD PMID:34480604 NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:148,124,925...148,137,806 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions EXP Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein] CTD PMID:17434272 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col3a1 collagen type III alpha 1 chain multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of COL3A1 mRNA CTD PMID:34480604 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col7a1 collagen type VII alpha 1 chain decreases expression ISO Hydrocortisone results in decreased expression of COL7A1 mRNA CTD PMID:21267416 NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A decreases expression ISO Hydrocortisone results in decreased expression of CPT1A mRNA CTD PMID:30776459 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326 		JBrowse link
G Crh corticotropin releasing hormone increases abundance ISO CRH protein results in increased abundance of Hydrocortisone CTD PMID:8888355 PMID:20570051 NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386 		JBrowse link
G Cry1 cryptochrome circadian regulator 1 increases expression ISO Hydrocortisone results in increased expression of CRY1 mRNA CTD PMID:21980503 NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822 		JBrowse link
G Cryab crystallin, alpha B multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of CRYAB mRNA CTD PMID:34480604 NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528 		JBrowse link
G Cs citrate synthase decreases activity
multiple interactions 		EXP Hydrocortisone results in decreased activity of CS protein
Dactinomycin inhibits the reaction [Hydrocortisone results in decreased activity of CS protein] 		CTD PMID:6476976 NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938 		JBrowse link
G Csf2 colony stimulating factor 2 decreases secretion
multiple interactions 		ISO Hydrocortisone results in decreased secretion of CSF2 protein
Glycyrrhetinic Acid promotes the reaction [Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]]; Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] 		CTD PMID:10460758 PMID:15086553 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Ctnnb1 catenin beta 1 increases localization
multiple interactions 		ISO Hydrocortisone results in increased localization of CTNNB1 protein
GGTI 298 inhibits the reaction [Hydrocortisone results in increased localization of CTNNB1 protein] 		CTD PMID:25763180 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 decreases expression
multiple interactions
affects expression 		ISO Hydrocortisone results in decreased expression of CYP11A1 mRNA; Hydrocortisone results in decreased expression of CYP11A1 protein
HDAC1 protein affects the reaction [Hydrocortisone results in decreased expression of CYP11A1 mRNA]; Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of CYP11A1 mRNA]
Hydrocortisone affects the expression of CYP11A1 mRNA 		CTD PMID:30528684 PMID:34454011 NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196 		JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 increases chemical synthesis
multiple interactions
affects metabolic processing 		ISO CYP11B1 protein results in increased chemical synthesis of Hydrocortisone
3',4'-dimethoxyflavone promotes the reaction [CYP11B1 protein results in increased chemical synthesis of Hydrocortisone]; alpha-naphthoflavone promotes the reaction [CYP11B1 protein results in increased chemical synthesis of Hydrocortisone]; beta-Naphthoflavone promotes the reaction [CYP11B1 protein results in increased chemical synthesis of Hydrocortisone]
CYP11B1 protein affects the metabolism of Hydrocortisone 		CTD PMID:16030167 PMID:16054388 PMID:19900470 PMID:22172629 NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions EXP [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benz(a)anthracene results in increased expression of CYP1A1 protein] CTD PMID:8674863 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
decreases expression 		EXP [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 protein]; Hydrocortisone inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 mRNA]; Hydrocortisone inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 protein]
Hydrocortisone results in decreased expression of CYP1B1 protein 		CTD PMID:8674863 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CYP24A1 mRNA CTD PMID:34480604 NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:179,694,647...179,709,083 		JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CYP26B1 mRNA CTD PMID:34480604 NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases expression EXP Hydrocortisone results in increased expression of CYP2B1 mRNA; Hydrocortisone results in increased expression of CYP2B1 protein CTD PMID:10476907 NCBI chr 1:90,646,098...90,669,762 JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 multiple interactions ISO CYP2D6 gene SNP affects the reaction [Ethylenethiourea affects the abundance of Hydrocortisone] CTD PMID:33771511 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 increases expression EXP Hydrocortisone results in increased expression of CYP2E1 mRNA; Hydrocortisone results in increased expression of CYP2E1 protein CTD PMID:10476907 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 decreases expression ISO Hydrocortisone results in decreased expression of CYP2S1 mRNA CTD PMID:22155357 NCBI chr 1:90,437,741...90,453,073
Ensembl chr 1:90,438,224...90,453,073 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
affects metabolic processing
multiple interactions
affects hydroxylation
increases metabolic processing 		EXP
ISO 		Hydrocortisone results in increased expression of CYP3A2 mRNA
CYP3A4 protein affects the metabolism of Hydrocortisone
CYP3A4 promoter mutant form inhibits the reaction [Hydrocortisone results in increased expression of CYP3A4 mRNA]; kaempferol inhibits the reaction [CYP3A4 protein results in increased degradation of Hydrocortisone]; Quercetin inhibits the reaction [CYP3A4 protein results in increased degradation of Hydrocortisone]
CYP3A4 protein affects the hydroxylation of Hydrocortisone
CYP3A4 protein results in increased metabolism of Hydrocortisone 		CTD PMID:2271712 PMID:10476907 PMID:11907490 PMID:12505310 PMID:15025748 More... NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 increases expression EXP Hydrocortisone results in increased expression of CYP3A23-3A1 mRNA; Hydrocortisone results in increased expression of CYP3A23-3A1 protein CTD PMID:10476907 NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases expression
multiple interactions 		ISO Hydrocortisone results in increased expression of CYP3A5 mRNA
[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CYP3A5 mRNA 		CTD PMID:23223499 PMID:34480604 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Cyp4a1 cytochrome P450, family 4, subfamily a, polypeptide 1 increases expression EXP Hydrocortisone results in increased expression of CYP4A1 mRNA CTD PMID:10476907 NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:134,360,111...134,374,231 		JBrowse link
G Dcc DCC netrin 1 receptor multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DCC mRNA CTD PMID:34480604 NCBI chr18:67,144,272...68,248,159
Ensembl chr18:67,149,179...68,247,541 		JBrowse link
G Dcn decorin multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DCN mRNA CTD PMID:34480604 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926 		JBrowse link
G Dcx doublecortin multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DCX mRNA CTD PMID:34480604 NCBI chr  X:112,227,455...112,370,291
Ensembl chr  X:112,227,455...112,304,161 		JBrowse link
G Dhrs9 dehydrogenase/reductase 9 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DHRS9 mRNA CTD PMID:34480604 NCBI chr 3:74,553,357...74,579,535
Ensembl chr 3:74,555,606...74,581,376 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DNAJB1 mRNA CTD PMID:34480604 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416 		JBrowse link
G Dsg1 desmoglein 1 multiple interactions ISO Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; Hydrocortisone inhibits the reaction [[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of DSG1 mRNA] CTD PMID:32076005 NCBI chr18:11,948,098...11,980,455
Ensembl chr18:11,949,488...11,980,451 		JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression ISO Hydrocortisone results in increased expression of DUSP1 mRNA CTD PMID:21980503 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644 		JBrowse link
G Ebf1 EBF transcription factor 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EBF1 mRNA CTD PMID:34480604 NCBI chr10:29,597,221...29,990,571
Ensembl chr10:29,601,351...29,988,702 		JBrowse link
G Ebf3 EBF transcription factor 3 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EBF3 mRNA CTD PMID:34480604 NCBI chr 1:201,426,446...201,544,444
Ensembl chr 1:201,426,450...201,544,305 		JBrowse link
G Ecscr endothelial cell surface expressed chemotaxis and apoptosis regulator multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ECSCR mRNA CTD PMID:34480604 NCBI chr18:27,583,791...27,593,184
Ensembl chr18:27,583,195...27,593,195 		JBrowse link
G Egf epidermal growth factor multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]]; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ABCC1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ACTN2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of AFP mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ALB mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ALDOA mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of APOA1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of CDC20 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of CIDEC mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of CRYAB mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ECSCR mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of EGLN3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ELAVL3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ELAVL4 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ESRG mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FGB mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FLT1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FOXD3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FOXG1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GCLC mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GPX2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GSTA1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GSTA2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GSTP1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of H2BC14 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of HES5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of HMOX1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of LCK mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of MAFG mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of MMP1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of MYL4 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of NQO1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of PLN mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of POU5F1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SCARB1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SERPINA1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SFRP2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SOX1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SOX2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SPTSSB mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SRXN1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of TM4SF4 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of TTR mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of UGT2A3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of A2M mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ACSL5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of AMHR2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ANXA1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ASCL1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of BMP5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CAMK2B mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CDH10 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CEACAM6 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of COL3A1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CYP24A1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CYP26B1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CYP3A5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DCC mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DCN mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DCX mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DHRS9 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DNAJB1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EBF1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EBF3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EMX2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FABP1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FAH mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FBXO32 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FGF7 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FLRT3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GADD45A mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GATA6 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GCLM mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GPR183 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GRIA2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GRIA3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GSTO1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GUCY1A1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HAND2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HAVCR1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXB3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXD4 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXD8 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IFI44 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IGFBP7 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IGHV3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IL1R1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ISL1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of KEAP1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of KRT6A mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of LEF1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of LUM mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of MLIP mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of MPZL1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of NR2F1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of NR2F2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of PDE1A mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of RARA mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of RBM20 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of RRAD mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of SEMA3C mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of SH3BP5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of SQSTM1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of STMN2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TBX2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TF mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TFAP2A mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TFAP2B mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TXNRD1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of VCAM1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of VGLL1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ZFAND2A mRNA; Gefitinib promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]]; Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]; Hydrocortisone inhibits the reaction [EGF protein results in increased expression of PTGS2 mRNA]; Indomethacin promotes the reaction [Hydrocortisone inhibits the reaction [EGF protein results in increased abundance of Dinoprostone]] CTD PMID:17805209 PMID:34480604 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egln3 egl-9 family hypoxia-inducible factor 3 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of EGLN3 mRNA CTD PMID:34480604 NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015 		JBrowse link
G Elavl3 ELAV like RNA binding protein 3 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ELAVL3 mRNA CTD PMID:34480604 NCBI chr 8:28,823,120...28,859,395
Ensembl chr 8:28,825,707...28,859,659 		JBrowse link
G Elavl4 ELAV like RNA binding protein 4 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ELAVL4 mRNA CTD PMID:34480604 NCBI chr 5:130,285,418...130,429,106
Ensembl chr 5:130,285,418...130,429,096 		JBrowse link
G Emx2 empty spiracles homeobox 2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EMX2 mRNA CTD PMID:34480604 NCBI chr 1:268,612,663...268,619,671
Ensembl chr 1:268,612,663...268,619,671 		JBrowse link
G Epo erythropoietin increases expression ISO Hydrocortisone results in increased expression of EPO protein CTD PMID:10694834 NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725 		JBrowse link
G Errfi1 ERBB receptor feedback inhibitor 1 increases expression EXP Hydrocortisone results in increased expression of ERRFI1 mRNA CTD PMID:1472065 NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO Hydrocortisone binds to and results in increased activity of ESR1 protein CTD PMID:12676605 NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Fabp1 fatty acid binding protein 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FABP1 mRNA CTD PMID:34480604 NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions ISO [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FABP4 mRNA; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FABP4 mRNA] CTD PMID:33476690 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Fah fumarylacetoacetate hydrolase multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FAH mRNA CTD PMID:34480604 NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:147,957,935...147,981,046 		JBrowse link
G Fas Fas cell surface death receptor multiple interactions
increases expression 		ISO [HIV Envelope Protein gp120 co-treated with Hydrocortisone] results in increased expression of FAS mRNA; Hydrocortisone promotes the reaction [Mitoxantrone results in increased expression of FAS]
Hydrocortisone results in increased expression of FAS protein 		CTD PMID:9676859 PMID:11075952 PMID:15086553 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Fasn fatty acid synthase multiple interactions
increases expression 		ISO [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA; CEBPA protein affects the reaction [Hydrocortisone results in increased expression of FASN mRNA]; NR3C1 protein affects the reaction [Hydrocortisone results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Resveratrol inhibits the reaction [Hydrocortisone results in increased expression of FASN mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA] CTD PMID:30776459 PMID:33476690 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fbxo32 F-box protein 32 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FBXO32 mRNA CTD PMID:34480604 NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491 		JBrowse link
G Fgb fibrinogen beta chain multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FGB mRNA CTD PMID:34480604 NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434 		JBrowse link
G Fgf7 fibroblast growth factor 7 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FGF7 mRNA CTD PMID:34480604 NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328 		JBrowse link
G Fgf9 fibroblast growth factor 9 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ABCC1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ACTN2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of AFP mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ALB mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ALDOA mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of APOA1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of CDC20 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of CIDEC mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of CRYAB mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ECSCR mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of EGLN3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ELAVL3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ELAVL4 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of ESRG mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FGB mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FLT1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FOXD3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FOXG1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GCLC mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GPX2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GSTA1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GSTA2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GSTP1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of H2BC14 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of HES5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of HMOX1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of LCK mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of MAFG mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of MMP1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of MYL4 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of NQO1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of PLN mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of POU5F1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SCARB1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SERPINA1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SFRP2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SOX1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SOX2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SPTSSB mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SRXN1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of TM4SF4 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of TTR mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of UGT2A3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of A2M mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ACSL5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of AMHR2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ANXA1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ASCL1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of BMP5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CAMK2B mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CDH10 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CEACAM6 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of COL3A1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CYP24A1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CYP26B1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of CYP3A5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DCC mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DCN mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DCX mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DHRS9 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DNAJB1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EBF1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EBF3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of EMX2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FABP1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FAH mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FBXO32 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FGF7 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FLRT3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GADD45A mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GATA6 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GCLM mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GPR183 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GRIA2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GRIA3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GSTO1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GUCY1A1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HAND2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HAVCR1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXB3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXD4 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXD8 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IFI44 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IGFBP7 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IGHV3 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IL1R1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ISL1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of KEAP1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of KRT6A mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of LEF1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of LUM mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of MLIP mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of MPZL1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of NR2F1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of NR2F2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of PDE1A mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of RARA mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of RBM20 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of RRAD mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of SEMA3C mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of SH3BP5 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of SQSTM1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of STMN2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TBX2 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TF mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TFAP2A mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TFAP2B mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TXNRD1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of VCAM1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of VGLL1 mRNA; [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ZFAND2A mRNA CTD PMID:34480604 NCBI chr15:36,325,552...36,369,995
Ensembl chr15:36,325,599...36,367,926 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 increases expression ISO Hydrocortisone results in increased expression of FKBP5 mRNA CTD PMID:21267416 NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118 		JBrowse link
G Flg filaggrin decreases expression
multiple interactions 		ISO Hydrocortisone results in decreased expression of FLG mRNA
Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA] 		CTD PMID:32076005 NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968 		JBrowse link
G Flrt3 fibronectin leucine rich transmembrane protein 3 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of FLRT3 mRNA CTD PMID:34480604 NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:148,439,354...148,461,650 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FLT1 mRNA CTD PMID:34480604 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750 		JBrowse link
G Foxd3 forkhead box D3 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FOXD3 mRNA CTD PMID:34480604 NCBI chr 5:119,450,532...119,452,898
Ensembl chr 5:119,450,394...119,452,786 		JBrowse link
G Foxg1 forkhead box G1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of FOXG1 mRNA CTD PMID:34480604 NCBI chr 6:72,401,582...72,404,392
Ensembl chr 6:72,394,239...72,427,392 		JBrowse link
G Foxo1 forkhead box O1 increases expression ISO Hydrocortisone results in increased expression of FOXO1 mRNA CTD PMID:21267416 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GADD45A mRNA CTD PMID:34480604 NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Gata6 GATA binding protein 6 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GATA6 mRNA CTD PMID:34480604 NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,458,253...2,492,322 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression
multiple interactions 		EXP
ISO 		Hydrocortisone results in increased expression of GCLC mRNA
[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GCLC mRNA 		CTD PMID:10978506 PMID:34480604 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GCLM mRNA CTD PMID:34480604 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003 		JBrowse link
G Gh1 growth hormone 1 increases expression ISO Hydrocortisone results in increased expression of GH1 protein CTD PMID:15833589 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859 		JBrowse link
G Gnpat glyceronephosphate O-acyltransferase multiple interactions
increases expression 		ISO Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of GNPAT mRNA] CTD PMID:25763180 NCBI chr19:69,719,707...69,746,244
Ensembl chr19:69,719,394...69,746,244 		JBrowse link
G Gpr183 G protein-coupled receptor 183 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GPR183 mRNA CTD PMID:34480604 NCBI chr15:105,445,129...105,457,192
Ensembl chr15:105,437,561...105,466,977 		JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GPX2 mRNA CTD PMID:34480604 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862 		JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GRIA2 mRNA CTD PMID:34480604 NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616 		JBrowse link
G Gria3 glutamate ionotropic receptor AMPA type subunit 3 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GRIA3 mRNA CTD PMID:34480604 NCBI chr  X:125,103,975...125,369,690
Ensembl chr  X:125,103,782...125,369,679 		JBrowse link
G Gsta1 glutathione S-transferase alpha 1 increases expression
multiple interactions 		ISO Hydrocortisone results in increased expression of GSTA1 mRNA
[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GSTA1 mRNA; Hydrocortisone results in increased expression of and results in increased activity of GSTA1 protein 		CTD PMID:11297599 PMID:34480604 NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528 		JBrowse link
G Gsta2 glutathione S-transferase alpha 2 multiple interactions
decreases expression
increases expression 		EXP
ISO 		Hydrocortisone inhibits the reaction [sulforaphane results in increased expression of GSTA2 mRNA]
[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GSTA2 mRNA
Hydrocortisone results in decreased expression of GSTA2 mRNA
Hydrocortisone results in increased expression of GSTA2 mRNA 		CTD PMID:10476907 PMID:11502894 PMID:22606287 PMID:34480604 NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092 		JBrowse link
G Gsto1 glutathione S-transferase omega 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GSTO1 mRNA CTD PMID:34480604 NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of GSTP1 mRNA CTD PMID:34480604 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gucy1a1 guanylate cyclase 1 soluble subunit alpha 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of GUCY1A1 mRNA CTD PMID:34480604 NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737 		JBrowse link
G H6pd hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) increases expression ISO Hydrocortisone results in increased expression of H6PD mRNA CTD PMID:20410225 NCBI chr 5:165,717,456...165,753,158
Ensembl chr 5:165,721,654...165,753,125 		JBrowse link
G Hand2 heart and neural crest derivatives expressed 2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HAND2 mRNA CTD PMID:34480604 NCBI chr16:37,928,145...37,931,488
Ensembl chr16:37,928,145...37,931,488 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HAVCR1 mRNA CTD PMID:34480604 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268 		JBrowse link
G Hdac1 histone deacetylase 1 multiple interactions
increases expression 		ISO HDAC1 protein affects the reaction [Hydrocortisone results in decreased expression of CYP11A1 mRNA]; SF1 protein inhibits the reaction [Hydrocortisone results in increased expression of HDAC1 mRNA] CTD PMID:34454011 NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387 		JBrowse link
G Hes5 hes family bHLH transcription factor 5 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of HES5 mRNA CTD PMID:34480604 NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:170,803,940...170,806,021 		JBrowse link
G Hgf hepatocyte growth factor decreases expression ISO Hydrocortisone results in decreased expression of HGF protein CTD PMID:1459995 NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase multiple interactions
decreases expression 		ISO IGF1 protein inhibits the reaction [Hydrocortisone results in decreased expression of HMGCR mRNA]; Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of HMGCR mRNA] CTD PMID:31075344 NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of HMOX1 mRNA CTD PMID:34480604 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hoxa1 homeobox A1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA1 mRNA CTD PMID:34480604 NCBI chr 4:82,586,505...82,589,209
Ensembl chr 4:82,586,505...82,589,209 		JBrowse link
G Hoxa2 homeobox A2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA2 mRNA CTD PMID:34480604 NCBI chr 4:82,593,389...82,597,589
Ensembl chr 4:82,593,389...82,595,692 		JBrowse link
G Hoxa5 homeo box A5 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA5 mRNA CTD PMID:34480604 NCBI chr 4:82,632,958...82,636,851
Ensembl chr 4:82,632,306...82,639,038 		JBrowse link
G Hoxb3 homeo box B3 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXB3 mRNA CTD PMID:34480604 NCBI chr10:81,786,001...81,810,655
Ensembl chr10:81,795,882...81,809,628 		JBrowse link
G Hoxd4 homeo box D4 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXD4 mRNA CTD PMID:34480604 NCBI chr 3:80,021,886...80,041,462
Ensembl chr 3:80,036,900...80,038,948 		JBrowse link
G Hoxd8 homeobox D8 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXD8 mRNA CTD PMID:34480604 NCBI chr 3:80,015,223...80,017,789
Ensembl chr 3:80,014,735...80,018,765 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 multiple interactions
affects expression
increases oxidation
affects response to substance
increases chemical synthesis
increases expression
increases activity
affects oxidation 		ISO
EXP 		[HSD11B1 protein results in increased metabolism of Ketosteroids] which results in increased chemical synthesis of Hydrocortisone; [HSD11B1 protein results in increased oxidation of Hydrocortisone] which results in increased chemical synthesis of Cortisone; [HSD11B1 protein results in increased reduction of Cortisone] which results in increased chemical synthesis of Hydrocortisone; Dinoprostone promotes the reaction [HSD11B1 protein affects the oxidation of Hydrocortisone]; Hydrocortisone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA]; Mifepristone affects the reaction [Hydrocortisone affects the expression of HSD11B1 mRNA]; perfluorooctane sulfonic acid inhibits the reaction [Hydrocortisone results in increased expression of HSD11B1]
[HSD11B1 protein affects the susceptibility to Hydrocortisone] which results in decreased activity of NFE2L2 protein
HSD11B1 protein results in increased chemical synthesis of Hydrocortisone
Hydrocortisone results in increased expression of HSD11B1; Hydrocortisone results in increased expression of HSD11B1 mRNA; Hydrocortisone results in increased expression of HSD11B1 protein
Hydrocortisone results in increased activity of HSD11B1 protein 		CTD PMID:16054388 PMID:16751407 PMID:17761898 PMID:20410225 PMID:22178014 More... NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 affects binding
decreases expression
increases oxidation
multiple interactions
increases metabolic processing 		ISO HSD11B2 protein binds to Hydrocortisone
Hydrocortisone results in decreased expression of HSD11B2 mRNA; Hydrocortisone results in decreased expression of HSD11B2 protein
HSD11B2 protein results in increased oxidation of Hydrocortisone
[HSD11B2 protein results in increased oxidation of Hydrocortisone] which results in increased chemical synthesis of Cortisone; Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of HSD11B2 mRNA]; Ziram inhibits the reaction [[HSD11B2 protein results in increased oxidation of Hydrocortisone] which results in increased chemical synthesis of Cortisone]; Ziram inhibits the reaction [HSD11B2 protein results in increased oxidation of Hydrocortisone]
HSD11B2 protein results in increased metabolism of Hydrocortisone 		CTD PMID:22273746 PMID:22796344 PMID:26859423 PMID:30528684 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 affects binding ISO Hydrocortisone binds to HSD3B1 protein CTD PMID:25526675 NCBI chr 2:188,858,574...188,864,694 JBrowse link
G Hsd3b2 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 multiple interactions ISO [galaxolide results in decreased expression of [HSD3B2 co-treated with CYP21A2]] which results in decreased chemical synthesis of Hydrocortisone CTD PMID:23084589 NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:188,784,614...188,790,569 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions
decreases expression 		ISO Hydrocortisone inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]; Hydrocortisone inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Medroxyprogesterone Acetate inhibits the reaction [Hydrocortisone inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]]
Hydrocortisone results in decreased expression of ICAM1 protein 		CTD PMID:9150321 PMID:15086553 PMID:15358673 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Ifi44 interferon-induced protein 44 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IFI44 mRNA CTD PMID:34480604 NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877 		JBrowse link
G Ifnb1 interferon beta 1 multiple interactions
decreases secretion 		ISO IFNB1 protein inhibits the reaction [IGF2 protein results in increased secretion of Hydrocortisone]; Mitotane promotes the reaction [IFNB1 protein results in decreased secretion of Hydrocortisone] CTD PMID:23507702 NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487 		JBrowse link
G Ifng interferon gamma multiple interactions ISO [Hydrocortisone co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG mRNA; Hydrocortisone inhibits the reaction [nickel sulfate results in increased secretion of IFNG protein] CTD PMID:15663561 PMID:29594315 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions
decreases expression 		ISO IGF1 protein inhibits the reaction [Hydrocortisone results in decreased expression of APOB mRNA]; IGF1 protein inhibits the reaction [Hydrocortisone results in decreased expression of HMGCR mRNA]; Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of IGF1 mRNA]; NR3C1 protein affects the reaction [Hydrocortisone results in decreased expression of IGF1 mRNA]; NR3C1 protein affects the reaction [Hydrocortisone results in decreased expression of IGF1 protein]
Hydrocortisone results in decreased expression of IGF1 mRNA; Hydrocortisone results in decreased expression of IGF1 protein 		CTD PMID:30528684 PMID:31075344 PMID:32535229 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor affects expression
multiple interactions 		ISO Hydrocortisone affects the expression of IGF1R mRNA
Mifepristone affects the reaction [Hydrocortisone affects the expression of IGF1R mRNA] 		CTD PMID:30528684 NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664 		JBrowse link
G Igf2 insulin-like growth factor 2 multiple interactions
increases secretion 		ISO IFNB1 protein inhibits the reaction [IGF2 protein results in increased secretion of Hydrocortisone] CTD PMID:23507702 NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 multiple interactions ISO Hydrocortisone promotes the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]] CTD PMID:23275455 NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 decreases expression ISO Hydrocortisone results in decreased expression of IGFBP5 mRNA CTD PMID:21267416 NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390 		JBrowse link
G Igfbp7 insulin-like growth factor binding protein 7 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IGFBP7 mRNA CTD PMID:34480604 NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620 		JBrowse link
G Il10 interleukin 10 multiple interactions ISO [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL10 mRNA; Hydrocortisone affects the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL10 protein]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL10 mRNA] CTD PMID:29777833 PMID:33476690 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il17a interleukin 17A multiple interactions ISO [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL17A mRNA; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL17A mRNA] CTD PMID:33476690 NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331 		JBrowse link
G Il1a interleukin 1 alpha decreases expression
multiple interactions 		ISO Hydrocortisone results in decreased expression of IL1A mRNA
Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]; Hydrocortisone inhibits the reaction [IL1A protein results in increased expression of MMP9 mRNA]; Mifepristone inhibits the reaction [Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]]; NR3C1 protein promotes the reaction [Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]] 		CTD PMID:18722610 PMID:21980503 NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013 		JBrowse link
G Il1b interleukin 1 beta increases abundance
decreases expression
multiple interactions 		ISO
EXP 		IL1B protein results in increased abundance of Hydrocortisone
Hydrocortisone results in decreased expression of IL1B mRNA
Hydrocortisone inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]
[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of IL1B mRNA; Glycyrrhetinic Acid promotes the reaction [Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]]; Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of IL1B mRNA] 		CTD PMID:10460758 PMID:12548226 PMID:25851902 PMID:29594315 PMID:33476690 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1r1 interleukin 1 receptor type 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IL1R1 mRNA CTD PMID:34480604 NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579 		JBrowse link
G Il2 interleukin 2 multiple interactions ISO [Hydrocortisone co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA; Hydrocortisone affects the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2 protein] CTD PMID:29594315 PMID:29777833 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Il2ra interleukin 2 receptor subunit alpha decreases expression ISO Hydrocortisone results in decreased expression of IL2RA protein CTD PMID:15086553 NCBI chr17:71,759,802...71,808,475
Ensembl chr17:71,759,802...71,808,507 		JBrowse link
G Il4 interleukin 4 decreases expression ISO Hydrocortisone results in decreased expression of IL4 protein CTD PMID:7988651 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il5 interleukin 5 multiple interactions
decreases expression 		ISO Hydrocortisone inhibits the reaction [nickel sulfate results in increased secretion of IL5 protein]
Hydrocortisone results in decreased expression of IL5 protein 		CTD PMID:7988651 PMID:15663561 NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003 		JBrowse link
G Il6 interleukin 6 decreases secretion
decreases expression 		ISO Hydrocortisone results in decreased secretion of IL6 protein
Hydrocortisone results in decreased expression of IL6 protein 		CTD PMID:12682474 PMID:16255036 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Ins1 insulin 1 multiple interactions EXP Hydrocortisone inhibits the reaction [Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]] CTD PMID:25851902 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682 		JBrowse link
G Ins2 insulin 2 multiple interactions
increases expression 		ISO [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA; [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL10 mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL17A mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FABP4 mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of IL1B mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARA mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARGC1A mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of SREBF1 mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA; [Rosmarinic Acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA; [Rosmarinic Acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA; [Rosmarinic Acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of NFKBIA mRNA; Octreotide inhibits the reaction [Hydrocortisone results in increased expression of INS protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA]; Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]; Rosmarinic Acid affects the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA]; Rosmarinic Acid affects the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARGC1A mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL10 mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL17A mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FABP4 mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of IL1B mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARA mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of SREBF1 mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA] CTD PMID:7473517 PMID:7792821 PMID:7917157 PMID:33476690 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805 		JBrowse link
G Isl1 ISL LIM homeobox 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ISL1 mRNA CTD PMID:34480604 NCBI chr 2:49,813,618...49,823,442
Ensembl chr 2:49,813,618...49,823,442 		JBrowse link
G Itga10 integrin subunit alpha 10 increases expression ISO Hydrocortisone results in increased expression of ITGA10 mRNA CTD PMID:21267416 NCBI chr 2:186,871,711...186,891,012
Ensembl chr 2:186,871,711...186,891,012 		JBrowse link
G Itga5 integrin subunit alpha 5 increases expression ISO Hydrocortisone results in increased expression of ITGA5 mRNA CTD PMID:21267416 NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305 		JBrowse link
G Ivl involucrin decreases expression ISO Hydrocortisone results in decreased expression of IVL mRNA CTD PMID:32076005 NCBI chr 2:180,842,307...180,854,646
Ensembl chr 2:180,842,307...180,846,578 		JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of KEAP1 mRNA CTD PMID:34480604 NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042 		JBrowse link
G Klk1 kallikrein 1 increases export ISO Hydrocortisone results in increased export of KLK1 protein CTD PMID:7473517 NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:103,779,164...103,783,270 		JBrowse link
G Klk1c10 kallikrein 1-related peptidase C10 increases expression ISO Hydrocortisone results in increased expression of KLK3 protein CTD PMID:11956172 NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586 		JBrowse link
G Krt1 keratin 1 multiple interactions ISO Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; Hydrocortisone inhibits the reaction [[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of KRT1 mRNA] CTD PMID:32076005 NCBI chr 7:134,855,311...134,860,537
Ensembl chr 7:134,855,313...134,860,537 		JBrowse link
G Krt10 keratin 10 multiple interactions ISO Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; Hydrocortisone inhibits the reaction [[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of KRT10 mRNA] CTD PMID:32076005 NCBI chr10:84,834,865...84,839,160
Ensembl chr10:84,834,840...84,839,160 		JBrowse link
G Lck LCK proto-oncogene, Src family tyrosine kinase multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of LCK mRNA CTD PMID:34480604 NCBI chr 5:147,172,642...147,201,267
Ensembl chr 5:147,172,642...147,201,267 		JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions
decreases expression 		ISO Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of LDLR mRNA] CTD PMID:31075344 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675 		JBrowse link
G Lef1 lymphoid enhancer binding factor 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of LEF1 mRNA CTD PMID:34480604 NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929 		JBrowse link
G Loricrin loricrin cornified envelope precursor protein decreases expression ISO Hydrocortisone results in decreased expression of LORICRIN mRNA CTD PMID:32076005 NCBI chr 2:180,253,674...180,256,572
Ensembl chr 2:180,253,674...180,256,572 		JBrowse link
G Lpl lipoprotein lipase multiple interactions ISO Hydrocortisone results in decreased activity of and results in decreased expression of LPL protein CTD PMID:17549480 NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107 		JBrowse link
G Lum lumican multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of LUM mRNA CTD PMID:34480604 NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508 		JBrowse link
G Ly75 lymphocyte antigen 75 decreases expression ISO Hydrocortisone results in decreased expression of LY75 protein CTD PMID:15086553 NCBI chr 3:65,173,395...65,260,878
Ensembl chr 3:65,173,395...65,260,878 		JBrowse link
G Mafg MAF bZIP transcription factor G multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of MAFG mRNA CTD PMID:34480604 NCBI chr10:106,401,633...106,410,159 JBrowse link
G Maoa monoamine oxidase A increases expression ISO Hydrocortisone results in increased expression of MAOA mRNA CTD PMID:21267416 NCBI chr  X:8,615,239...8,681,372
Ensembl chr  X:8,615,239...8,682,631 		JBrowse link
G Map3k7 mitogen activated protein kinase kinase kinase 7 decreases expression ISO Hydrocortisone results in decreased expression of MAP3K7 mRNA CTD PMID:21267416 NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012 		JBrowse link
G Mlip muscular LMNA-interacting protein multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of MLIP mRNA CTD PMID:34480604 NCBI chr 8:86,815,491...87,085,117
Ensembl chr 8:86,814,798...87,082,408 		JBrowse link
G Mmp1 matrix metallopeptidase 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of MMP1 mRNA CTD PMID:34480604 NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions ISO Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]; Hydrocortisone inhibits the reaction [IL1A protein results in increased expression of MMP9 mRNA]; Mifepristone inhibits the reaction [Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]]; NR3C1 protein promotes the reaction [Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]] CTD PMID:18722610 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mpzl1 myelin protein zero-like 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of MPZL1 mRNA CTD PMID:34480604 NCBI chr13:80,385,454...80,422,315
Ensembl chr13:80,385,456...80,422,390 		JBrowse link
G Mt1a metallothionein 1A increases expression EXP Hydrocortisone results in increased expression of MT1A mRNA CTD PMID:6687866 NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Myl4 myosin, light chain 4 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of MYL4 mRNA CTD PMID:34480604 NCBI chr10:89,949,733...89,985,308
Ensembl chr10:89,949,404...89,985,308 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions ISO
EXP 		[Hydrocortisone results in increased activity of NR3C1 protein] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA; [Rosmarinic Acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA
[HSD11B1 protein affects the susceptibility to Hydrocortisone] which results in decreased activity of NFE2L2 protein; Hydrocortisone inhibits the reaction [Hydrogen Peroxide promotes the reaction [sulforaphane results in increased expression of NFE2L2 protein]]; Hydrocortisone inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; Hydrocortisone inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein] 		CTD PMID:22606287 PMID:33476690 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
increases expression 		ISO [Rosmarinic Acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of NFKBIA mRNA; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of NFKBIA mRNA] CTD PMID:25763180 PMID:33476690 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions EXP Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of NOS2 mRNA]; Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of NOS2 protein] CTD PMID:17434272 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nppa natriuretic peptide A increases expression
decreases secretion 		ISO Hydrocortisone results in increased expression of NPPA protein
NPPA protein results in decreased secretion of Hydrocortisone 		CTD PMID:2434734 PMID:2931268 PMID:7473517 NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493 		JBrowse link
G Npy neuropeptide Y affects expression ISO Hydrocortisone affects the expression of NPY protein CTD PMID:7955553 NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions EXP
ISO 		Hydrocortisone inhibits the reaction [Hydrogen Peroxide promotes the reaction [sulforaphane results in increased expression of NQO1 protein]]; Hydrocortisone inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Hydrocortisone inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]
[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of NQO1 mRNA 		CTD PMID:22606287 PMID:34480604 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of NR2F1 mRNA CTD PMID:34480604 NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:9,776,179...9,785,924 		JBrowse link
G Nr2f2 nuclear receptor subfamily 2, group F, member 2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of NR2F2 mRNA CTD PMID:34480604 NCBI chr 1:133,419,161...133,434,290
Ensembl chr 1:133,420,227...133,431,975 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions
affects localization
increases activity
affects binding
increases phosphorylation
decreases expression
affects abundance
increases expression 		ISO
EXP 		2,2',4,4',5-brominated diphenyl ether inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; 3-phenoxybenzoic acid inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; [Hydrocortisone co-treated with Progesterone] results in increased expression of NR3C1 mRNA; [Hydrocortisone results in increased activity of NR3C1 protein] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; Atrazine inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; bifenthrin inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; bisphenol A analog inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; bisphenol A inhibits the reaction [Hydrocortisone binds to NR3C1 protein]; bisphenol A inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; bisphenol AF inhibits the reaction [Hydrocortisone binds to NR3C1 protein]; bisphenol AF inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; bisphenol B inhibits the reaction [Hydrocortisone binds to NR3C1 protein]; bisphenol B inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; bisphenol Z inhibits the reaction [Hydrocortisone binds to NR3C1 protein]; bisphenol Z inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; croneton inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; cyhalothrin inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; cypermethrin inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; DDT inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; Hydrocortisone binds to and affects the activity of NR3C1 protein; Hydrocortisone binds to and results in increased activity of NR3C1 protein; Hydrocortisone results in increased expression of and affects the localization of NR3C1 protein; Methoxychlor inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; Mifepristone inhibits the reaction [Hydrocortisone affects the localization of NR3C1 protein]; Mifepristone inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; NR3C1 protein affects the reaction [Hydrocortisone results in decreased expression of IGF1 mRNA]; NR3C1 protein affects the reaction [Hydrocortisone results in decreased expression of IGF1 protein]; NR3C1 protein affects the reaction [Hydrocortisone results in decreased expression of SIRT1 mRNA]; NR3C1 protein affects the reaction [Hydrocortisone results in increased expression of FASN mRNA]; NR3C1 protein affects the reaction [Hydrocortisone results in increased expression of SREBF1 mRNA]; NR3C1 protein alternative form inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein alternative form]; NR3C1 protein promotes the reaction [Hydrocortisone inhibits the reaction [IL1A protein results in increased activity of MMP9 protein]]; o,p'-DDT inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; pentabrominated diphenyl ether 100 inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; Pesticides inhibits the reaction [Hydrocortisone results in increased expression of NR3C1 mRNA]; Polybrominated Biphenyls metabolite inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; resmethrin inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; Soil Pollutants inhibits the reaction [Hydrocortisone results in increased expression of NR3C1 mRNA]; Thiram inhibits the reaction [Hydrocortisone binds to NR3C1 protein]; tributyl phosphate inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; triphenyl phosphate inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; triphenyl phosphate metabolite inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; tris(1,3-dichloro-2-propyl)phosphate inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]
NR3C1 protein binds to Hydrocortisone
Hydrocortisone promotes the reaction [[NR3C1 protein binds to TAT promoter] which results in increased expression of TAT mRNA]
Hydrocortisone results in increased phosphorylation of NR3C1 protein
Hydrocortisone results in decreased expression of NR3C1 mRNA; Hydrocortisone results in decreased expression of NR3C1 protein
Fluoxetine promotes the reaction [Hydrocortisone results in increased activity of NR3C1 protein]
Hydrocortisone analog binds to NR3C1 protein
NR3C1 gene polymorphism affects the abundance of Hydrocortisone
Hydrocortisone results in increased expression of NR3C1; Hydrocortisone results in increased expression of NR3C1 mRNA 		CTD PMID:926113 PMID:1597467 PMID:11956172 PMID:12871829 PMID:15362971 More... NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 multiple interactions
increases activity 		ISO [Fludrocortisone binds to and results in increased activity of NR3C2 protein] which results in decreased abundance of Hydrocortisone
Hydrocortisone results in increased activity of NR3C2 protein 		CTD PMID:15362971 PMID:15780662 PMID:16566900 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Nr6a1 nuclear receptor subfamily 6, group A, member 1 decreases expression ISO Hydrocortisone results in decreased expression of NR6A1 mRNA CTD PMID:21267416 NCBI chr 3:42,904,832...43,094,622
Ensembl chr 3:42,904,832...43,092,951 		JBrowse link
G Ocln occludin increases expression ISO Hydrocortisone results in increased expression of OCLN mRNA CTD PMID:25763180 NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411 		JBrowse link
G Oxt oxytocin/neurophysin I prepropeptide affects abundance ISO OXT protein affects the abundance of Hydrocortisone CTD PMID:16554389 NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:138,235,754...138,236,594 		JBrowse link
G Paep progestagen associated endometrial protein increases metabolic processing ISO PAEP protein modified form results in increased metabolism of Hydrocortisone CTD PMID:17649829 NCBI chr 3:28,929,252...28,932,592 JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 multiple interactions
increases activity
increases expression 		EXP 3-phenoxybenzoic acid inhibits the reaction [Hydrocortisone results in increased expression of PCK1 mRNA]; bifenthrin inhibits the reaction [Hydrocortisone results in increased expression of PCK1 mRNA]; Dactinomycin inhibits the reaction [Hydrocortisone results in increased activity of PCK1 protein]; DDT inhibits the reaction [Hydrocortisone results in increased expression of PCK1 mRNA]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Hydrocortisone results in increased expression of PCK1 mRNA]; Methoxychlor inhibits the reaction [Hydrocortisone results in increased expression of PCK1 mRNA]; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of PCK1 mRNA]; o,p'-DDT inhibits the reaction [Hydrocortisone results in increased expression of PCK1 mRNA] CTD PMID:6476976 PMID:26647222 NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO Hydrocortisone results in decreased expression of PCNA protein CTD PMID:17549480 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pde1a phosphodiesterase 1A multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of PDE1A mRNA CTD PMID:34480604 NCBI chr 3:85,152,053...85,432,289
Ensembl chr 3:85,154,184...85,519,212 		JBrowse link
G Per1 period circadian regulator 1 increases expression ISO Hydrocortisone results in increased expression of PER1 mRNA CTD PMID:21980503 NCBI chr10:54,299,002...54,313,804
Ensembl chr10:54,302,641...54,314,211 		JBrowse link
G Pln phospholamban multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of PLN mRNA CTD PMID:34480604 NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241 		JBrowse link
G Pnpla2 patatin-like phospholipase domain containing 2 decreases expression ISO Hydrocortisone results in decreased expression of PNPLA2 mRNA CTD PMID:30776459 NCBI chr 1:205,982,279...205,987,361
Ensembl chr 1:205,982,258...205,987,359 		JBrowse link
G Pomc proopiomelanocortin increases response to substance
multiple interactions
increases abundance
increases secretion 		ISO POMC protein results in increased susceptibility to Hydrocortisone
Lead inhibits the reaction [POMC protein modified form results in increased secretion of Hydrocortisone]; Melatonin inhibits the reaction [POMC protein results in increased abundance of Hydrocortisone]
POMC protein results in increased secretion of Hydrocortisone 		CTD PMID:1321309 PMID:3015460 PMID:9881897 PMID:11082157 PMID:21332028 More... NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173 		JBrowse link
G Pou5f1 POU class 5 homeobox 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of POU5F1 mRNA CTD PMID:34480604 NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,227,837...3,232,598 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARA mRNA; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARA mRNA] CTD PMID:33476690 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714 		JBrowse link
G Ppard peroxisome proliferator-activated receptor delta multiple interactions ISO [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA] CTD PMID:33476690 NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein] CTD PMID:33476690 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions ISO [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARGC1A mRNA; Rosmarinic Acid affects the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARGC1A mRNA] CTD PMID:33476690 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213 		JBrowse link
G Prl prolactin multiple interactions EXP [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] affects the metabolism of 9,10-Dimethyl-1,2-benzanthracene; [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benz(a)anthracene results in increased expression of CYP1A1 protein]; [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 protein] CTD PMID:8674863 NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217 		JBrowse link
G Prune2 prune homolog 2 with BCH domain decreases expression ISO Hydrocortisone results in decreased expression of PRUNE2 mRNA CTD PMID:21267416 NCBI chr 1:223,779,617...224,130,058
Ensembl chr 1:223,969,102...224,051,592 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression 		ISO
EXP 		Hydrocortisone inhibits the reaction [EGF protein results in increased expression of PTGS2 mRNA]
Hydrocortisone results in increased expression of PTGS2 protein
Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of PTGS2 protein] 		CTD PMID:17805209 PMID:18650268 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Rap1a RAP1A, member of RAS oncogene family increases expression
multiple interactions 		ISO Hydrocortisone results in increased expression of RAP1A mRNA
Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of RAP1A mRNA] 		CTD PMID:25763180 NCBI chr 2:195,896,967...195,974,851
Ensembl chr 2:195,896,971...195,974,808 		JBrowse link
G Rapgef3 Rap guanine nucleotide exchange factor 3 multiple interactions
increases expression 		ISO Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of RAPGEF3 mRNA] CTD PMID:25763180 NCBI chr 7:130,754,883...130,777,303
Ensembl chr 7:130,754,871...130,777,668 		JBrowse link
G Rara retinoic acid receptor, alpha multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of RARA mRNA CTD PMID:34480604 NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160 		JBrowse link
G Rbbp7 RB binding protein 7, chromatin remodeling factor affects response to substance ISO RBBP7 protein affects the susceptibility to Hydrocortisone CTD PMID:12767060 NCBI chr  X:35,544,873...35,563,030
Ensembl chr  X:35,544,873...35,563,030 		JBrowse link
G Rbm20 RNA binding motif protein 20 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of RBM20 mRNA CTD PMID:34480604 NCBI chr 1:262,671,311...262,912,551
Ensembl chr 1:262,688,978...262,891,364 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO Hydrocortisone inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]; Medroxyprogesterone Acetate inhibits the reaction [Hydrocortisone inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]] CTD PMID:15358673 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Ren renin decreases expression ISO Hydrocortisone results in decreased expression of REN protein CTD PMID:7473517 PMID:15743397 NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543 		JBrowse link
G Rora RAR-related orphan receptor A increases expression ISO Hydrocortisone results in increased expression of RORA mRNA CTD PMID:21980503 NCBI chr 8:78,182,710...78,915,730
Ensembl chr 8:78,182,620...78,915,730 		JBrowse link
G Rrad RRAD, Ras related glycolysis inhibitor and calcium channel regulator multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of RRAD mRNA CTD PMID:34480604 NCBI chr19:360,581...363,874
Ensembl chr19:360,973...363,871 		JBrowse link
G Scarb1 scavenger receptor class B, member 1 multiple interactions
decreases expression 		ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SCARB1 mRNA; Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of SCARB1 mRNA] CTD PMID:31075344 PMID:34480604 NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980 		JBrowse link
G Scnn1a sodium channel epithelial 1 subunit alpha increases expression ISO Hydrocortisone results in increased expression of SCNN1A mRNA CTD PMID:17715387 NCBI chr 4:159,809,187...159,832,409
Ensembl chr 4:159,809,170...159,832,405 		JBrowse link
G Scnn1b sodium channel epithelial 1 subunit beta increases expression ISO Hydrocortisone results in increased expression of SCNN1B mRNA CTD PMID:17715387 NCBI chr 1:185,861,326...185,915,717
Ensembl chr 1:185,854,733...185,916,049 		JBrowse link
G Scnn1g sodium channel epithelial 1 subunit gamma increases expression ISO Hydrocortisone results in increased expression of SCNN1G mRNA CTD PMID:17715387 NCBI chr 1:185,736,225...185,770,099
Ensembl chr 1:185,736,191...185,770,097 		JBrowse link
G Sema3c semaphorin 3C multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of SEMA3C mRNA CTD PMID:34480604 NCBI chr 4:18,538,452...18,702,453
Ensembl chr 4:18,538,454...18,701,740 		JBrowse link
G Serpina1 serpin family A member 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SERPINA1 mRNA CTD PMID:34480604 NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:128,619,382...128,660,703 		JBrowse link
G Serpinb1a serpin family B member 1A multiple interactions EXP
ISO 		Hydrocortisone results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1A protein modified form
Hydrocortisone results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form 		CTD PMID:25447644 NCBI chr17:31,799,446...31,807,853
Ensembl chr17:31,799,415...31,808,166 		JBrowse link
G Serpinc1 serpin family C member 1 increases expression ISO Hydrocortisone results in increased expression of SERPINC1 protein CTD PMID:12682474 NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643 		JBrowse link
G Sf1 splicing factor 1 multiple interactions
decreases expression 		ISO Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of SF1 mRNA]; SF1 protein inhibits the reaction [Hydrocortisone results in increased expression of HDAC1 mRNA] CTD PMID:34454011 NCBI chr 1:213,090,256...213,112,688
Ensembl chr 1:213,099,260...213,113,590 		JBrowse link
G Sfrp2 secreted frizzled-related protein 2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SFRP2 mRNA CTD PMID:34480604 NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:171,387,385...171,395,079 		JBrowse link
G Sftpb surfactant protein B increases expression ISO Hydrocortisone results in increased expression of SFTPB mRNA CTD PMID:2539393 NCBI chr 4:105,917,495...105,926,631
Ensembl chr 4:105,917,578...105,927,646 		JBrowse link
G Sftpc surfactant protein C increases expression ISO Hydrocortisone results in increased expression of SFTPC mRNA CTD PMID:2539393 NCBI chr15:52,006,274...52,009,324
Ensembl chr15:52,006,283...52,009,475 		JBrowse link
G Sh3bp5 SH3-domain binding protein 5 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of SH3BP5 mRNA CTD PMID:34480604 NCBI chr16:6,589,877...6,676,524
Ensembl chr16:6,589,877...6,655,211 		JBrowse link
G Sirt1 sirtuin 1 decreases expression
multiple interactions 		ISO Hydrocortisone results in decreased expression of SIRT1 mRNA
NR3C1 protein affects the reaction [Hydrocortisone results in decreased expression of SIRT1 mRNA] 		CTD PMID:30776459 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Hydrocortisone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Slc23a2 solute carrier family 23 member 2 multiple interactions ISO Hydrocortisone inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid] CTD PMID:17092984 NCBI chr 3:139,755,583...139,913,304
Ensembl chr 3:139,755,584...139,847,343 		JBrowse link
G Slc5a5 solute carrier family 5 member 5 multiple interactions ISO 1-Methyl-3-isobutylxanthine promotes the reaction [[Tretinoin co-treated with Hydrocortisone] affects the localization of SLC5A5 protein]; 1-Methyl-3-isobutylxanthine promotes the reaction [[Tretinoin co-treated with Hydrocortisone] results in increased expression of SLC5A5 protein]; Colforsin inhibits the reaction [[Tretinoin co-treated with Hydrocortisone] results in increased activity of SLC5A5 protein]; Hydrocortisone promotes the reaction [Tretinoin affects the localization of SLC5A5 protein]; Hydrocortisone promotes the reaction [Tretinoin results in increased expression of SLC5A5 protein] CTD PMID:16439463 NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,580,705...18,590,691 		JBrowse link
G Sox1 SRY-box transcription factor 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SOX1 mRNA CTD PMID:34480604 NCBI chr16:83,837,689...83,841,703
Ensembl chr16:83,802,160...83,841,775 		JBrowse link
G Sox2 SRY-box transcription factor 2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SOX2 mRNA CTD PMID:34480604 NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:119,454,541...119,496,350 		JBrowse link
G Sptssb serine palmitoyltransferase, small subunit B multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SPTSSB mRNA CTD PMID:34480604 NCBI chr 2:156,432,509...156,461,936
Ensembl chr 2:156,432,512...156,460,909 		JBrowse link
G Sqstm1 sequestosome 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of SQSTM1 mRNA CTD PMID:34480604 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750 		JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 increases expression
multiple interactions 		ISO Hydrocortisone results in increased expression of SREBF1 mRNA
[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of SREBF1 mRNA; CEBPA protein affects the reaction [Hydrocortisone results in increased expression of SREBF1 mRNA]; NR3C1 protein affects the reaction [Hydrocortisone results in increased expression of SREBF1 mRNA]; Resveratrol inhibits the reaction [Hydrocortisone results in increased expression of SREBF1 mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of SREBF1 mRNA] 		CTD PMID:30776459 PMID:33476690 NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164 		JBrowse link
G Srxn1 sulfiredoxin 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of SRXN1 mRNA CTD PMID:34480604 NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765 		JBrowse link
G Star steroidogenic acute regulatory protein decreases expression
multiple interactions 		ISO Hydrocortisone results in decreased expression of STAR mRNA; Hydrocortisone results in decreased expression of STAR protein
Mifepristone inhibits the reaction [Hydrocortisone results in decreased expression of STAR mRNA] 		CTD PMID:30528684 NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447 		JBrowse link
G Stmn2 stathmin 2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of STMN2 mRNA CTD PMID:34480604 NCBI chr 2:95,112,017...95,159,642
Ensembl chr 2:95,112,019...95,159,335 		JBrowse link
G Tat tyrosine aminotransferase multiple interactions
increases expression
increases activity 		ISO
EXP 		Diethylnitrosamine inhibits the reaction [Hydrocortisone results in increased activity of TAT protein]; o-Aminoazotoluene inhibits the reaction [Hydrocortisone results in increased activity of TAT protein]
Hydrocortisone results in increased expression of TAT mRNA
beryllium sulfate inhibits the reaction [Hydrocortisone results in increased expression of TAT protein]; cypermethrin inhibits the reaction [Hydrocortisone results in increased expression of TAT mRNA]; Diethylnitrosamine inhibits the reaction [Hydrocortisone results in increased activity of TAT protein]; Hydrocortisone promotes the reaction [[NR3C1 protein binds to TAT promoter] which results in increased expression of TAT mRNA]; Methoxychlor inhibits the reaction [Hydrocortisone results in increased expression of TAT mRNA]; Methyldimethylaminoazobenzene inhibits the reaction [Hydrocortisone results in increased activity of TAT protein]; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of TAT mRNA]; N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide inhibits the reaction [Hydrocortisone results in increased expression of TAT mRNA]; o,p'-DDT inhibits the reaction [Hydrocortisone results in increased expression of TAT mRNA] 		CTD PMID:6120038 PMID:16267830 PMID:22465009 PMID:26647222 NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482 		JBrowse link
G Tbx19 T-box transcription factor 19 decreases abundance ISO TBX19 gene mutant form results in decreased abundance of Hydrocortisone CTD PMID:16390921 NCBI chr13:79,983,935...80,016,219
Ensembl chr13:79,983,935...80,007,023 		JBrowse link
G Tbx2 T-box transcription factor 2 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TBX2 mRNA CTD PMID:34480604 NCBI chr10:71,177,082...71,186,275
Ensembl chr10:71,177,082...71,186,275 		JBrowse link
G Tf transferrin multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TF mRNA; [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA; [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL10 mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL17A mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FABP4 mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of IL1B mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARA mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARGC1A mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of SREBF1 mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA; [Rosmarinic Acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA; [Rosmarinic Acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA; [Rosmarinic Acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of NFKBIA mRNA; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA]; Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]; Rosmarinic Acid affects the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA]; Rosmarinic Acid affects the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARGC1A mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL10 mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of IL17A mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FABP4 mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of FASN mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of IL1B mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARA mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARG protein]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of SREBF1 mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA] CTD PMID:33476690 PMID:34480604 NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400 		JBrowse link
G Tfap2a transcription factor AP-2 alpha multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TFAP2A mRNA CTD PMID:34480604 NCBI chr17:24,230,064...24,253,219
Ensembl chr17:24,229,910...24,253,219 		JBrowse link
G Tfap2b transcription factor AP-2 beta multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TFAP2B mRNA CTD PMID:34480604 NCBI chr 9:29,282,703...29,312,568
Ensembl chr 9:29,282,825...29,312,568 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP
ISO 		Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of TGFB1 mRNA]; Hydrocortisone inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]
[Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA; [Rosmarinic Acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of TGFB1 mRNA 		CTD PMID:17434272 PMID:33476690 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Tgm1 transglutaminase 1 multiple interactions
increases expression 		ISO [Hydrocortisone co-treated with sodium arsenate] results in increased expression of TGM1 mRNA; [Hydrocortisone co-treated with sodium arsenite] results in increased expression of TGM1 mRNA; sodium arsenate inhibits the reaction [Hydrocortisone results in increased expression of TGM1 mRNA]; sodium arsenite inhibits the reaction [Hydrocortisone results in increased expression of TGM1 mRNA] CTD PMID:11485391 NCBI chr15:33,160,985...33,175,632
Ensembl chr15:33,160,987...33,174,463 		JBrowse link
G Tjp1 tight junction protein 1 increases localization
multiple interactions 		ISO Hydrocortisone results in increased localization of TJP1 protein
GGTI 298 inhibits the reaction [Hydrocortisone results in increased localization of TJP1 protein] 		CTD PMID:25763180 NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158 		JBrowse link
G Tlr2 toll-like receptor 2 increases expression ISO Hydrocortisone results in increased expression of TLR2 mRNA CTD PMID:17033190 NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194 		JBrowse link
G Tlr4 toll-like receptor 4 decreases expression ISO Hydrocortisone results in decreased expression of TLR4 mRNA CTD PMID:17033190 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007 		JBrowse link
G Tm4sf4 transmembrane 4 L six family member 4 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of TM4SF4 mRNA CTD PMID:34480604 NCBI chr 2:143,720,220...143,771,283
Ensembl chr 2:143,720,267...143,771,227 		JBrowse link
G Tnf tumor necrosis factor decreases secretion
multiple interactions
decreases expression 		ISO Hydrocortisone results in decreased secretion of TNF protein
Hydrocortisone affects the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; Hydrocortisone inhibits the reaction [Lipopolysaccharides affects the expression of TNF mRNA]; Hydrocortisone inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Hydrocortisone inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]
Hydrocortisone results in decreased expression of TNF mRNA 		CTD PMID:9150321 PMID:10100995 PMID:15086553 PMID:21980503 PMID:26481333 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Treh trehalase decreases activity ISO Hydrocortisone results in decreased activity of TREH protein CTD PMID:2751871 NCBI chr 8:53,886,946...53,901,113
Ensembl chr 8:53,886,946...53,900,335 		JBrowse link
G Tsc22d3 TSC22 domain family, member 3 multiple interactions
increases expression 		ISO Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]
3-phenoxybenzoic acid inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; [barium chloride results in increased abundance of Barium] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; [cobaltous chloride results in increased abundance of Cobalt] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; [cupric chloride results in increased abundance of Copper] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; [lead nitrate results in increased abundance of Lead] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; [Lithium Chloride results in increased abundance of Lithium] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; [stannous chloride results in increased abundance of Tin] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; [zinc chloride results in increased abundance of Zinc] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; cyhalothrin inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; DDT inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; Methoxychlor inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; o,p'-DDT inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA]; resmethrin inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA] 		CTD PMID:25763180 PMID:26647222 PMID:29957541 NCBI chr  X:109,006,410...109,066,389
Ensembl chr  X:109,006,420...109,015,519 		JBrowse link
G Ttr transthyretin multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of TTR mRNA CTD PMID:34480604 NCBI chr18:12,216,684...12,225,972
Ensembl chr18:12,216,732...12,225,969 		JBrowse link
G Txnrd1 thioredoxin reductase 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TXNRD1 mRNA CTD PMID:34480604 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817 		JBrowse link
G Ucn2 urocortin 2 increases abundance ISO UCN2 protein results in increased abundance of Hydrocortisone CTD PMID:16330704 NCBI chr 8:118,516,111...118,517,660
Ensembl chr 8:118,483,364...118,517,439 		JBrowse link
G Ucp1 uncoupling protein 1 multiple interactions ISO [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of UCP1 mRNA] CTD PMID:33476690 NCBI chr19:41,713,350...41,721,421
Ensembl chr19:41,713,351...41,721,420 		JBrowse link
G Ugt2a3 UDP glucuronosyltransferase family 2 member A3 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in decreased expression of UGT2A3 mRNA CTD PMID:34480604 NCBI chr14:20,851,970...20,869,974
Ensembl chr14:20,851,969...20,869,973 		JBrowse link
G Ugt2b1 UDP glucuronosyltransferase 2 family, polypeptide B1 increases expression EXP Hydrocortisone results in increased expression of UGT2B1 mRNA CTD PMID:10476907 NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,378,853...21,392,331 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of VCAM1 mRNA; Hydrocortisone inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein]; Hydrocortisone inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Medroxyprogesterone Acetate inhibits the reaction [Hydrocortisone inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 protein]] CTD PMID:10100995 PMID:15358673 PMID:34480604 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions
decreases expression 		ISO Hydrocortisone inhibits the reaction [Nickel results in increased expression of VEGFA protein]
Hydrocortisone results in decreased expression of VEGFA protein 		CTD PMID:9390328 PMID:17549480 PMID:20116850 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
G Vgll1 vestigial-like family member 1 multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of VGLL1 mRNA CTD PMID:34480604 NCBI chr  X:140,016,938...140,036,348 JBrowse link
G Vwf von Willebrand factor multiple interactions
increases expression 		ISO Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of VWF mRNA] CTD PMID:25763180 NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757 		JBrowse link
G Zfand2a zinc finger AN1-type containing 2A multiple interactions ISO [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of ZFAND2A mRNA CTD PMID:34480604 NCBI chr12:20,275,435...20,286,513
Ensembl chr12:20,275,450...20,286,513 		JBrowse link
G Zfp36 zinc finger protein 36 increases expression ISO Hydrocortisone results in increased expression of ZFP36 mRNA CTD PMID:21980503 NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108 		JBrowse link
cortisone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions ISO [Calcitriol co-treated with Cortisone] results in decreased expression of ADIPOQ mRNA CTD PMID:19918113 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Akr1d1 aldo-keto reductase family 1, member D1 multiple interactions ISO [AKR1D1 protein co-treated with NADP] results in increased reduction of Cortisone CTD PMID:25500266 NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540 		JBrowse link
G Casp3 caspase 3 multiple interactions EXP Cortisone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] CTD PMID:15755911 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression ISO Cortisone results in increased expression of CCL2 mRNA CTD PMID:24135201 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Dhrs7 dehydrogenase/reductase 7 increases reduction ISO DHRS7 protein results in increased reduction of Cortisone CTD PMID:24246760 NCBI chr 6:97,068,149...97,083,744
Ensembl chr 6:97,068,149...97,083,744 		JBrowse link
G Fabp4 fatty acid binding protein 4 increases expression
multiple interactions 		ISO Cortisone results in increased expression of FABP4 mRNA
2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of FABP4 mRNA] 		CTD PMID:21315688 NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972 		JBrowse link
G Glul glutamate-ammonia ligase increases activity EXP Cortisone results in increased activity of GLUL protein CTD PMID:30993381 NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 multiple interactions
increases expression
increases reduction
affects response to substance
increases metabolic processing
affects metabolic processing 		ISO
EXP 		[Calcitriol co-treated with Cortisone] results in increased expression of HSD11B1 mRNA; [HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; [HSD11B1 protein results in increased oxidation of Hydrocortisone] which results in increased chemical synthesis of Cortisone; [HSD11B1 protein results in increased reduction of Cortisone] which results in increased chemical synthesis of Hydrocortisone; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]]
Cortisone results in increased expression of HSD11B1 mRNA
2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of and results in increased activity of HSD11B1 protein]; Cortisone results in increased expression of and results in increased activity of HSD11B1 protein
[HSD11B1 protein affects the susceptibility to Cortisone] which results in decreased activity of NFE2L2 protein; [HSD11B1 protein co-treated with Cortisone] results in decreased expression of NQO1 mRNA; Cortisone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]
HSD11B1 protein results in increased metabolism of Cortisone
HSD11B1 protein affects the metabolism of Cortisone 		CTD PMID:16054388 PMID:16751407 PMID:19918113 PMID:21315688 PMID:22606287 More... NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 increases chemical synthesis
multiple interactions 		ISO HSD11B2 protein results in increased chemical synthesis of Cortisone
[HSD11B2 protein results in increased oxidation of Hydrocortisone] which results in increased chemical synthesis of Cortisone; Ziram inhibits the reaction [[HSD11B2 protein results in increased oxidation of Hydrocortisone] which results in increased chemical synthesis of Cortisone] 		CTD PMID:22796344 PMID:26859423 NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812 		JBrowse link
G Il1b interleukin 1 beta multiple interactions
decreases expression 		ISO perfluorooctane sulfonic acid inhibits the reaction [Cortisone results in decreased expression of IL1B] CTD PMID:27288094 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il6 interleukin 6 decreases expression
multiple interactions 		ISO Cortisone results in decreased expression of IL6
perfluorooctane sulfonic acid inhibits the reaction [Cortisone results in decreased expression of IL6] 		CTD PMID:27288094 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases phosphorylation ISO Cortisone results in increased phosphorylation of MAPK1 protein CTD PMID:24135201 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases phosphorylation ISO Cortisone results in increased phosphorylation of MAPK3 protein CTD PMID:24135201 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions ISO
EXP 		[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]]
[HSD11B1 protein affects the susceptibility to Cortisone] which results in decreased activity of NFE2L2 protein 		CTD PMID:22606287 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nos2 nitric oxide synthase 2 increases expression ISO Cortisone results in increased expression of NOS2 protein CTD PMID:24135201 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions EXP [HSD11B1 protein co-treated with Cortisone] results in decreased expression of NQO1 mRNA CTD PMID:22606287 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 affects binding
multiple interactions
increases activity 		ISO Cortisone binds to NR3C1 protein
[Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]]
Cortisone results in increased activity of NR3C1 protein 		CTD PMID:15705660 PMID:15780662 PMID:22606287 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 increases activity ISO Cortisone results in increased activity of NR3C2 protein CTD PMID:15780662 NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions
increases expression 		ISO 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of PPARG mRNA] CTD PMID:21315688 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha increases expression ISO Cortisone results in increased expression of PPARGC1A mRNA CTD PMID:23056435 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit increases phosphorylation ISO Cortisone results in increased phosphorylation of RELA protein CTD PMID:24135201 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression
multiple interactions 		EXP Cortisone results in increased expression of SGK1 mRNA
Phenylephrine promotes the reaction [Cortisone results in increased expression of SGK1 mRNA]; Tetradecanoylphorbol Acetate promotes the reaction [Cortisone results in increased expression of SGK1 mRNA] 		CTD PMID:16533503 NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Cortisone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Slc2a4 solute carrier family 2 member 4 increases expression
multiple interactions 		ISO Cortisone results in increased expression of SLC2A4 mRNA
2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of SLC2A4 mRNA] 		CTD PMID:21315688 NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270 		JBrowse link
G Tnf tumor necrosis factor increases expression ISO Cortisone results in increased expression of TNF mRNA CTD PMID:24135201 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
deflazacort term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 increases activity ISO deflazacort results in increased activity of NR3C1 protein CTD PMID:15362971 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
Deoxycorticosterone acetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions
decreases expression 		EXP chromium mesoporphyrin inhibits the reaction [heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in decreased expression of ADIPOQ protein]]; chromium mesoporphyrin promotes the reaction [Desoxycorticosterone Acetate results in decreased expression of ADIPOQ protein]; heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in decreased expression of ADIPOQ protein] CTD PMID:23089228 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Alox15 arachidonate 15-lipoxygenase multiple interactions ISO ALOX15 protein affects the susceptibility to [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] CTD PMID:22467300 NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723 		JBrowse link
G Anxa1 annexin A1 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in increased expression of ANXA1 mRNA CTD PMID:22228705 NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831 		JBrowse link
G Apoe apolipoprotein E multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in increased expression of APOE mRNA CTD PMID:22228705 NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855 		JBrowse link
G Aqp1 aquaporin 1 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of AQP1 mRNA CTD PMID:22228705 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in decreased expression of ATP2A2 protein; Metformin inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in decreased expression of ATP2A2 protein] CTD PMID:30290168 NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934 		JBrowse link
G Cat catalase multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of CAT mRNA CTD PMID:22228705 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression
multiple interactions 		EXP Desoxycorticosterone Acetate results in increased expression of CCL2 protein
heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of CCL2 protein] 		CTD PMID:23089228 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Cd38 CD38 molecule multiple interactions ISO CD38 gene mutant form promotes the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with CDH3 protein]]; CD38 gene mutant form promotes the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with TJP1 protein]] CTD PMID:21992601 NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505 		JBrowse link
G Cd68 Cd68 molecule multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CD68 mRNA; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CD68 mRNA] CTD PMID:27678262 NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540 		JBrowse link
G Cdh3 cadherin 3 multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with CDH3 protein]; CD38 gene mutant form promotes the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with CDH3 protein]] CTD PMID:21992601 NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases expression
affects localization
multiple interactions 		EXP Desoxycorticosterone Acetate results in increased expression of CDKN2A mRNA; Desoxycorticosterone Acetate results in increased expression of CDKN2A protein
Desoxycorticosterone Acetate affects the localization of CDKN2A protein
[Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate affects the localization of CDKN2A protein]; [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of CDKN2A mRNA]; Spironolactone inhibits the reaction [Desoxycorticosterone Acetate affects the localization of CDKN2A protein]; Spironolactone inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of CDKN2A mRNA] 		CTD PMID:18504326 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cs citrate synthase multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride co-treated with cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester] results in increased expression of CS protein CTD PMID:29621749 NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938 		JBrowse link
G Cxcr2 C-X-C motif chemokine receptor 2 multiple interactions ISO CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CD68 mRNA]; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CYBA mRNA]; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CYBB mRNA]; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of IL1B mRNA]; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of IL6 mRNA]; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of NOX1 mRNA]; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of NOX4 mRNA]; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of TNF mRNA]; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of VCAM1 mRNA] CTD PMID:27678262 NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:83,183,808...83,188,602 		JBrowse link
G Cyba cytochrome b-245 alpha chain multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CYBA mRNA; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CYBA mRNA] CTD PMID:27678262 NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214 		JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CYBB mRNA; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CYBB mRNA]; CYBB protein affects the susceptibility to [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] CTD PMID:21368743 PMID:27678262 NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:16,030,596...16,065,065 		JBrowse link
G Des desmin multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of DES protein CTD PMID:21992601 NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347 		JBrowse link
G Edn1 endothelin 1 multiple interactions
increases expression 		EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in increased expression of EDN1 protein; [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDN1 mRNA; [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDN1 protein; [Ozone co-treated with Oxygen] inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDN1 mRNA]; [Ozone co-treated with Oxygen] inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDN1 protein]; chromium mesoporphyrin inhibits the reaction [heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of EDN1 protein]]; chromium mesoporphyrin promotes the reaction [Desoxycorticosterone Acetate results in increased expression of EDN1 protein]; heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of EDN1 protein] CTD PMID:7721389 PMID:23089228 PMID:26550192 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Ednra endothelin receptor type A multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDNRA mRNA; [Ozone co-treated with Oxygen] inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of EDNRA mRNA] CTD PMID:26550192 NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284 		JBrowse link
G Ednrb endothelin receptor type B multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in decreased expression of EDNRB mRNA; [Ozone co-treated with Oxygen] inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in decreased expression of EDNRB mRNA] CTD PMID:26550192 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Fxyd2 FXYD domain-containing ion transport regulator 2 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of FXYD2 mRNA CTD PMID:22228705 NCBI chr 8:54,609,658...54,616,788
Ensembl chr 8:54,609,658...54,616,957 		JBrowse link
G Gcg glucagon multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GCG mRNA CTD PMID:22228705 NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:67,522,489...67,531,533 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GCLC mRNA CTD PMID:22228705 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Glp1r glucagon-like peptide 1 receptor multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GLP1R mRNA CTD PMID:22228705 NCBI chr20:8,973,393...9,011,622
Ensembl chr20:8,973,352...9,011,654 		JBrowse link
G Gsta5 glutathione S-transferase alpha 5 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GSTA5 mRNA CTD PMID:22228705 NCBI chr 8:87,985,768...87,997,766
Ensembl chr 8:87,985,258...87,997,765 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GSTT1 mRNA CTD PMID:22228705 NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019 		JBrowse link
G Gstt2 glutathione S-transferase theta 2 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of GSTT2 mRNA CTD PMID:22228705 NCBI chr20:12,819,053...12,822,724
Ensembl chr20:12,818,540...12,822,718 		JBrowse link
G Hdac8 histone deacetylase 8 increases activity EXP Deoxycorticosterone acetate increases activity of Hdac8 protein in the heart RGD PMID:23868068 RGD:9681716 NCBI chr  X:71,425,240...71,632,865
Ensembl chr  X:71,394,928...71,632,865 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions EXP [chromium mesoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [Desoxycorticosterone Acetate results in decreased susceptibility to Acetylcholine]; Desoxycorticosterone Acetate results in increased expression of and results in increased activity of HMOX1 protein CTD PMID:14693679 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions
increases expression 		EXP heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of ICAM1 protein] CTD PMID:23089228 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of IGF1 mRNA CTD PMID:22228705 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of IL1B mRNA; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of IL1B mRNA] CTD PMID:27678262 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of IL6 mRNA; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of IL6 mRNA] CTD PMID:27678262 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Ins1 insulin 1 multiple interactions
decreases expression 		EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in decreased expression of INS1 protein; chromium mesoporphyrin inhibits the reaction [heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in decreased expression of INS1 protein]]; chromium mesoporphyrin promotes the reaction [Desoxycorticosterone Acetate results in decreased expression of INS1 protein]; cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in decreased expression of INS1 protein]; heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in decreased expression of INS1 protein] CTD PMID:23089228 PMID:29621749 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682 		JBrowse link
G Itm2b integral membrane protein 2B multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of ITM2B mRNA CTD PMID:22228705 NCBI chr15:54,955,549...54,978,455
Ensembl chr15:54,955,552...54,978,455 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression 		EXP chromium mesoporphyrin inhibits the reaction [heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of JUN mRNA]]; chromium mesoporphyrin promotes the reaction [Desoxycorticosterone Acetate results in increased expression of JUN mRNA]; heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of JUN mRNA]; heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of JUN protein]
Desoxycorticosterone Acetate results in increased expression of JUN mRNA; Desoxycorticosterone Acetate results in increased expression of JUN protein 		CTD PMID:23089228 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of KCNJ1 mRNA CTD PMID:22228705 NCBI chr 8:39,014,822...39,066,716
Ensembl chr 8:39,037,992...39,066,715 		JBrowse link
G Lpl lipoprotein lipase multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of LPL mRNA CTD PMID:22228705 NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 multiple interactions
increases expression 		EXP chromium mesoporphyrin inhibits the reaction [heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of MAPK9 mRNA]]; chromium mesoporphyrin promotes the reaction [Desoxycorticosterone Acetate results in increased expression of MAPK9 mRNA]; heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of MAPK9 mRNA] CTD PMID:23089228 NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228 		JBrowse link
G Mdh1 malate dehydrogenase 1 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of MDH1 mRNA CTD PMID:22228705 NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232 		JBrowse link
G Mir146a microRNA 146a multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in decreased expression of MIR146A mRNA; Metformin inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in decreased expression of MIR146A mRNA] CTD PMID:30290168 NCBI chr10:28,349,996...28,350,090 JBrowse link
G Mir155 microRNA 155 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in increased expression of MIR155 mRNA; Metformin inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in increased expression of MIR155 mRNA] CTD PMID:30290168 NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178 		JBrowse link
G Mir99b microRNA 99b multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in decreased expression of MIR99B mRNA; Metformin inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in decreased expression of MIR99B mRNA] CTD PMID:30290168 NCBI chr 1:67,350,064...67,350,133
Ensembl chr 1:67,350,060...67,350,139 		JBrowse link
G Ncf1 neutrophil cytosolic factor 1 multiple interactions ISO NCF1 protein affects the susceptibility to [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] CTD PMID:21368743 NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079 		JBrowse link
G Nfkb2 nuclear factor kappa B subunit 2 increases expression
multiple interactions 		EXP Desoxycorticosterone Acetate results in increased expression of NFKB2 protein
heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of NFKB2 protein] 		CTD PMID:23089228 NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637 		JBrowse link
G Nherf2 NHERF family PDZ scaffold protein 2 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of NHERF2 mRNA CTD PMID:22228705 NCBI chr10:14,167,005...14,177,519
Ensembl chr10:14,167,005...14,177,593 		JBrowse link
G Nox1 NADPH oxidase 1 multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of NOX1 mRNA; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of NOX1 mRNA] CTD PMID:27678262 NCBI chr  X:101,572,338...101,625,571
Ensembl chr  X:101,572,340...101,595,520 		JBrowse link
G Nox4 NADPH oxidase 4 multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of NOX4 mRNA; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of NOX4 mRNA] CTD PMID:27678262 NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483 		JBrowse link
G Nphs2 NPHS2 stomatin family member, podocin multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with CDH3 protein]; [Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with TJP1 protein]; [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of NPHS2 protein; CD38 gene mutant form promotes the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with CDH3 protein]]; CD38 gene mutant form promotes the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with TJP1 protein]] CTD PMID:21992601 NCBI chr13:70,993,622...71,011,585
Ensembl chr13:70,999,186...71,011,572 		JBrowse link
G Nptn neuroplastin multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of NPTN mRNA CTD PMID:22228705 NCBI chr 8:67,892,678...67,959,231
Ensembl chr 8:67,892,702...67,959,236 		JBrowse link
G Pdhx pyruvate dehydrogenase complex, component X multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride co-treated with cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester] results in increased expression of PDHX protein; [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of PDHX protein CTD PMID:29621749 NCBI chr 3:109,826,579...109,886,869
Ensembl chr 3:109,827,209...109,886,905 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
increases expression 		EXP chromium mesoporphyrin inhibits the reaction [heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of RELA mRNA]]; chromium mesoporphyrin promotes the reaction [Desoxycorticosterone Acetate results in increased expression of RELA mRNA]; heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of RELA mRNA] CTD PMID:23089228 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Ren renin multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in decreased expression of REN protein; [Ozone co-treated with Oxygen] inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in decreased expression of REN protein] CTD PMID:26550192 NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543 		JBrowse link
G Slc2a1 solute carrier family 2 member 1 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride co-treated with cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester] results in increased expression of SLC2A1 protein CTD PMID:29621749 NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742 		JBrowse link
G Slc2a4 solute carrier family 2 member 4 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride co-treated with cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester] results in increased expression of SLC2A4 protein CTD PMID:29621749 NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270 		JBrowse link
G Tjp1 tight junction protein 1 multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with TJP1 protein]; CD38 gene mutant form promotes the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with TJP1 protein]] CTD PMID:21992601 NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of TNF mRNA; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of TNF mRNA] CTD PMID:27678262 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tp53 tumor protein p53 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in increased expression of TP53 mRNA CTD PMID:22228705 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tpm1 tropomyosin 1 multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in increased expression of TPM1 mRNA CTD PMID:22228705 NCBI chr 8:76,516,654...76,543,661
Ensembl chr 8:76,511,871...76,543,468 		JBrowse link
G Umod uromodulin multiple interactions EXP [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary co-treated with Potassium Chloride] results in decreased expression of UMOD mRNA CTD PMID:22228705 NCBI chr 1:183,247,676...183,261,665
Ensembl chr 1:183,247,674...183,261,030 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO [Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of VCAM1 mRNA; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of VCAM1 mRNA] CTD PMID:27678262 NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801 		JBrowse link
desoximetasone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Desoximetasone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
dexamethasone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin decreases expression
multiple interactions
increases expression 		EXP
ISO 		Dexamethasone results in decreased expression of A2M mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of A2M mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of A2M mRNA
Dexamethasone results in increased expression of A2M mRNA 		CTD PMID:12971794 PMID:25047013 PMID:28628672 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G Aadac arylacetamide deacetylase decreases expression ISO Dexamethasone results in decreased expression of AADAC mRNA CTD PMID:22429928 NCBI chr 2:146,293,449...146,351,061
Ensembl chr 2:146,313,279...146,324,525 		JBrowse link
G Aamdc adipogenesis associated, Mth938 domain containing multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AAMDC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of AAMDC mRNA CTD PMID:28628672 NCBI chr 1:161,273,205...161,303,253
Ensembl chr 1:161,262,347...161,299,340 		JBrowse link
G Aamp angio-associated, migratory cell protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AAMP mRNA CTD PMID:28628672 NCBI chr 9:83,312,519...83,318,325
Ensembl chr 9:83,312,519...83,318,325 		JBrowse link
G Aars1 alanyl-tRNA synthetase 1 decreases expression ISO Dexamethasone results in decreased expression of AARS1 mRNA CTD PMID:22733784 NCBI chr19:55,906,694...55,930,499
Ensembl chr19:55,906,702...55,930,497 		JBrowse link
G Abat 4-aminobutyrate aminotransferase increases expression ISO Dexamethasone results in increased expression of ABAT mRNA CTD PMID:25047013 NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474 		JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of ABCA1 mRNA
[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ABCA1 mRNA; [Bexarotene co-treated with [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein; [diazepinylbenzoic acid co-treated with [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein]] results in decreased expression of ABCA1 mRNA; [LG 100268 co-treated with [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mRNA; [Rosiglitazone co-treated with [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein; [T0901317 co-treated with [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mRNA; [tributyltin co-treated with [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mRNA; [tributyltin co-treated with [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein; diazepinylbenzoic acid inhibits the reaction [[LG 100268 co-treated with [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mRNA]; diazepinylbenzoic acid inhibits the reaction [[tributyltin co-treated with [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mRNA]
Testosterone inhibits the reaction [Dexamethasone results in increased expression of ABCA1 mRNA]
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ABCA1 mRNA 		CTD PMID:16054899 PMID:20032058 PMID:25932594 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473 		JBrowse link
G Abca6 ATP binding cassette subfamily A member 6 increases expression ISO Dexamethasone results in increased expression of ABCA6 mRNA CTD PMID:25047013 NCBI chr10:95,642,026...95,711,535
Ensembl chr10:95,641,900...95,710,899 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 increases expression
multiple interactions 		ISO
EXP 		Dexamethasone results in increased expression of ABCB11 mRNA
[Dexamethasone co-treated with Ibuprofen] results in increased expression of ABCB11 mRNA 		CTD PMID:19118567 PMID:20888898 PMID:29222744 PMID:32599024 NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
increases expression
decreases expression
decreases activity
increases secretion
affects response to substance 		ISO
EXP 		[Tacrolimus results in decreased activity of ABCB1 protein] which results in decreased export of Dexamethasone; ABCB1 gene polymorphism affects the reaction [Dexamethasone results in decreased secretion of IFNG protein]; ABCB1 gene polymorphism affects the reaction [Dexamethasone results in decreased secretion of IL2 protein]; ABCB1 gene polymorphism affects the reaction [Dexamethasone results in decreased secretion of IL4 protein]; ABCB1 gene polymorphism affects the reaction [Dexamethasone results in decreased secretion of TNF protein]; Elacridar inhibits the reaction [ABCB1 protein results in increased secretion of Dexamethasone]; valspodar inhibits the reaction [ABCB1 protein results in increased secretion of Dexamethasone]
Dexamethasone inhibits the reaction [Lipopolysaccharides results in decreased expression of ABCB1A mRNA]
Dexamethasone results in increased expression of ABCB1 protein; Dexamethasone results in increased expression of ABCB1A mRNA; Dexamethasone results in increased expression of ABCB1A protein
Dexamethasone results in decreased expression of ABCB1 mRNA; Dexamethasone results in decreased expression of ABCB1A mRNA
Dexamethasone results in increased expression of ABCB1 mRNA
Dexamethasone results in decreased activity of ABCB1 protein
ABCB1 gene polymorphism affects the susceptibility to Dexamethasone 		CTD PMID:12387747 PMID:15205389 PMID:16321374 PMID:17015168 PMID:17324141 More... NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcb1b ATP-binding cassette, sub-family B member 1B increases expression
multiple interactions 		ISO
EXP 		Dexamethasone results in increased expression of ABCB1B mRNA
Dexamethasone results in increased expression of ABCB1B mRNA; Dexamethasone results in increased expression of ABCB1B protein
Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of ABCB1B mRNA] 		CTD PMID:15205389 PMID:17324141 PMID:19958760 PMID:22733784 NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 increases expression EXP Dexamethasone results in increased expression of ABCB4 mRNA CTD PMID:12429353 PMID:19118567 NCBI chr 4:26,106,895...26,164,440 JBrowse link
G Abcb9 ATP binding cassette subfamily B member 9 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ABCB9 mRNA CTD PMID:28628672 NCBI chr12:38,146,659...38,192,862
Ensembl chr12:38,159,904...38,192,860 		JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 multiple interactions
increases expression 		EXP
ISO 		Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of ABCC1 mRNA]
Dexamethasone results in increased expression of ABCC1 mRNA 		CTD PMID:15205389 PMID:22185406 NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions
decreases expression
increases expression 		EXP
ISO 		Testosterone inhibits the reaction [Dexamethasone results in increased expression of ABCC2 mRNA]
Dexamethasone results in decreased expression of ABCC2 mRNA
Dexamethasone results in increased expression of ABCC2 mRNA; Dexamethasone results in increased expression of ABCC2 protein 		CTD PMID:12429353 PMID:15102944 PMID:15258109 PMID:15908472 PMID:19118567 More... NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 multiple interactions
increases expression
decreases expression
affects expression
increases activity 		ISO
EXP 		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABCC3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABCC3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ABCC3 mRNA; Dexamethasone promotes the reaction [ABCC3 protein affects the transport of calcein AM]
Dexamethasone results in increased expression of ABCC3 mRNA; Dexamethasone results in increased expression of ABCC3 protein
Dexamethasone results in decreased expression of ABCC3 mRNA; Dexamethasone results in decreased expression of ABCC3 protein
Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of ABCC3 mRNA]
Dexamethasone affects the expression of ABCC3 mRNA
Dexamethasone results in increased activity of ABCC3 protein 		CTD PMID:15102944 PMID:15205389 PMID:15908472 PMID:15979871 PMID:17522070 More... NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 decreases expression EXP Dexamethasone results in decreased expression of ABCC4 mRNA; Dexamethasone results in decreased expression of ABCC4 protein CTD PMID:19922765 NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375 		JBrowse link
G Abcc5 ATP binding cassette subfamily C member 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ABCC5 mRNA CTD PMID:28628672 NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655 		JBrowse link
G Abcc6 ATP binding cassette subfamily C member 6 affects expression
decreases expression 		EXP Dexamethasone affects the expression of ABCC6 mRNA
Dexamethasone results in decreased expression of ABCC6 mRNA 		CTD PMID:15102944 PMID:16260000 NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895 		JBrowse link
G Abcd2 ATP binding cassette subfamily D member 2 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ABCD2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ABCD2 mRNA
Dexamethasone inhibits the reaction [Lipopolysaccharides results in decreased expression of ABCD2 mRNA] 		CTD PMID:22185406 PMID:25047013 PMID:28628672 NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:124,142,595...124,191,202 		JBrowse link
G Abcf1 ATP binding cassette subfamily F member 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABCF1 mRNA CTD PMID:28628672 NCBI chr20:2,807,315...2,820,240
Ensembl chr20:2,807,106...2,820,240 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 multiple interactions
decreases expression 		ISO
EXP 		Dexamethasone inhibits the reaction [ABCG2 protein affects the transport of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]
Dexamethasone results in decreased expression of ABCG2 mRNA 		CTD PMID:15365089 PMID:20607812 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Abhd1 abhydrolase domain containing 1 increases expression
multiple interactions 		EXP Dexamethasone results in increased expression of ABHD1 mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of ABHD1 mRNA] 		CTD PMID:20032058 NCBI chr 6:31,142,476...31,147,464
Ensembl chr 6:31,142,476...31,147,464 		JBrowse link
G Abhd11 abhydrolase domain containing 11 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABHD11 mRNA CTD PMID:28628672 NCBI chr12:27,318,739...27,322,016
Ensembl chr12:27,318,749...27,321,970 		JBrowse link
G Abhd14a abhydrolase domain containing 14A increases expression ISO Dexamethasone results in increased expression of ABHD14A mRNA CTD PMID:25047013 NCBI chr 8:115,957,853...115,965,697
Ensembl chr 8:115,957,858...115,965,697 		JBrowse link
G Abhd17c abhydrolase domain containing 17C, depalmitoylase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ABHD17C mRNA CTD PMID:28628672 NCBI chr 1:147,493,755...147,534,715
Ensembl chr 1:147,493,753...147,534,715 		JBrowse link
G Abhd2 abhydrolase domain containing 2, acylglycerol lipase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABHD2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ABHD2 mRNA CTD PMID:28628672 NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:142,626,732...142,712,674 		JBrowse link
G Abhd5 abhydrolase domain containing 5, lysophosphatidic acid acyltransferase increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ABHD5 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ABHD5 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 8:130,877,834...130,903,947
Ensembl chr 8:130,877,703...130,903,947 		JBrowse link
G Abi2 abl-interactor 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABI2 mRNA CTD PMID:28628672 NCBI chr 9:69,321,072...69,490,630
Ensembl chr 9:69,321,150...69,490,597 		JBrowse link
G Abi3 ABI family, member 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ABI3 mRNA CTD PMID:28628672 NCBI chr10:81,266,571...81,277,561
Ensembl chr10:81,266,571...81,277,561 		JBrowse link
G Abi3bp ABI family member 3 binding protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ABI3BP mRNA CTD PMID:28628672 NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120 		JBrowse link
G Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA CTD PMID:28628672 NCBI chr13:71,223,902...71,319,770
Ensembl chr13:71,224,019...71,389,775 		JBrowse link
G Ablim2 actin binding LIM protein family, member 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABLIM2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ABLIM2 mRNA CTD PMID:28628672 NCBI chr14:79,090,046...79,214,986
Ensembl chr14:79,090,923...79,214,972 		JBrowse link
G Abra actin-binding Rho activating protein affects expression ISO Dexamethasone affects the expression of ABRA mRNA CTD PMID:22733784 NCBI chr 7:74,855,008...74,859,076
Ensembl chr 7:74,855,007...74,859,076 		JBrowse link
G Abracl ABRA C-terminal like multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ABRACL mRNA CTD PMID:28628672 NCBI chr 1:14,474,802...14,484,992
Ensembl chr 1:14,474,803...14,485,055 		JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 multiple interactions ISO [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACAA2 mRNA; [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACAA2 mRNA; [Roscovitine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACAA2 mRNA; [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACAA2 mRNA CTD PMID:23428407 PMID:34323617 NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha multiple interactions
increases expression 		ISO [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ACACA mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased phosphorylation of ACACA protein; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACACA mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACACA protein; [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased phosphorylation of ACACA protein; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein co-treated with Quercetin] results in increased phosphorylation of ACACA protein; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased phosphorylation of ACACA protein; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of ACACA mRNA]; Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACACA protein]; pentagalloylglucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ACACA mRNA]; rotenoisin A promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased phosphorylation of ACACA protein]; Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased phosphorylation of ACACA protein]; thermozymocidin inhibits the reaction [Dexamethasone results in increased expression of ACACA mRNA]
[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ACACA mRNA] 		CTD PMID:18586010 PMID:23428407 PMID:25559859 PMID:30409764 PMID:30446312 More... NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888 		JBrowse link
G Acacb acetyl-CoA carboxylase beta increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ACACB mRNA
[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ACACB mRNA; [bisphenol A metabolite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ACACB mRNA; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of ACACB mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACACB mRNA 		CTD PMID:25047013 PMID:28628672 PMID:30665118 PMID:31053639 NCBI chr12:48,026,394...48,138,214
Ensembl chr12:48,026,394...48,138,214 		JBrowse link
G Acad8 acyl-CoA dehydrogenase family, member 8 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ACAD8 mRNA CTD PMID:28628672 NCBI chr 8:33,641,420...33,665,542
Ensembl chr 8:33,641,420...33,665,542 		JBrowse link
G Acad9 acyl-CoA dehydrogenase family, member 9 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACAD9 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACAD9 mRNA CTD PMID:28628672 NCBI chr 2:120,871,329...120,894,306
Ensembl chr 2:120,871,227...120,894,709 		JBrowse link
G Acadl acyl-CoA dehydrogenase, long chain decreases expression ISO Dexamethasone results in decreased expression of ACADL protein CTD PMID:33567340 NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164 		JBrowse link
G Acadm acyl-CoA dehydrogenase medium chain decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of ACADM mRNA
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ACADM mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACADM mRNA
Dexamethasone results in decreased expression of ACADM protein 		CTD PMID:17522070 PMID:23428407 PMID:24848799 PMID:33567340 NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864 		JBrowse link
G Acadvl acyl-CoA dehydrogenase, very long chain multiple interactions ISO [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACADVL mRNA CTD PMID:23428407 NCBI chr10:55,231,558...55,236,786
Ensembl chr10:55,231,440...55,236,750 		JBrowse link
G Acan aggrecan multiple interactions
decreases expression
increases expression 		ISO
EXP 		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACAN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACAN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ACAN mRNA; [TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ACAN mRNA; Dexamethasone inhibits the reaction [BMP2 protein results in increased expression of ACAN mRNA]; IL1B protein inhibits the reaction [[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ACAN mRNA]; Resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of ACAN mRNA]]
Dexamethasone results in decreased expression of ACAN mRNA; Dexamethasone results in decreased expression of ACAN protein
Dexamethasone results in increased expression of ACAN mRNA 		CTD PMID:17502159 PMID:21351055 PMID:25047013 PMID:26526931 PMID:27608943 More... NCBI chr 1:142,390,951...142,453,779
Ensembl chr 1:142,390,951...142,453,779 		JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACAT1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ACAT1 mRNA CTD PMID:28628672 NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:62,876,003...62,905,042 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 increases expression ISO Dexamethasone results in increased expression of ACAT2 mRNA CTD PMID:25047013 NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095 		JBrowse link
G Acbd5 acyl-CoA binding domain containing 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACBD5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ACBD5 mRNA CTD PMID:28628672 NCBI chr17:90,114,250...90,156,286
Ensembl chr17:90,114,375...90,156,286 		JBrowse link
G Acbd7 acyl-CoA binding domain containing 7 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ACBD7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACBD7 mRNA CTD PMID:28628672 NCBI chr17:79,813,106...79,821,254
Ensembl chr17:79,813,106...79,818,448 		JBrowse link
G Ace angiotensin I converting enzyme increases expression
multiple interactions
decreases activity 		EXP
ISO 		Dexamethasone results in increased expression of ACE mRNA; Dexamethasone results in increased expression of ACE protein
diisononyl phthalate promotes the reaction [Dexamethasone results in increased expression of ACE protein]; Enalapril inhibits the reaction [Dexamethasone results in increased expression of ACE protein]; Enalapril inhibits the reaction [diisononyl phthalate promotes the reaction [Dexamethasone results in increased expression of ACE protein]]
Dexamethasone results in decreased activity of ACE protein
[Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of ACE mRNA]; [Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of ACE protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of ACE mRNA] 		CTD PMID:1659346 PMID:9498404 PMID:15932931 PMID:22733784 PMID:30940551 More... NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942 		JBrowse link
G Ace2 angiotensin converting enzyme 2 decreases expression ISO Dexamethasone results in decreased expression of ACE2 mRNA CTD PMID:32808185 NCBI chr  X:33,925,458...33,972,851
Ensembl chr  X:33,925,458...33,971,596 		JBrowse link
G Ache acetylcholinesterase increases activity
multiple interactions 		EXP Dexamethasone results in increased activity of ACHE protein
[Dexamethasone co-treated with Ascorbic Acid] results in increased expression of ACHE mRNA; [Dexamethasone co-treated with Ascorbic Acid] results in increased expression of and results in increased activity of ACHE protein; Acetylcarnitine inhibits the reaction [Dexamethasone results in decreased activity of ACHE protein]; Acetylcarnitine inhibits the reaction [Dexamethasone results in increased activity of ACHE protein]; Melatonin inhibits the reaction [Dexamethasone results in decreased activity of ACHE protein]; Melatonin inhibits the reaction [Dexamethasone results in increased activity of ACHE protein] 		CTD PMID:21986892 PMID:27019979 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410 		JBrowse link
G Acin1 apoptotic chromatin condensation inducer 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACIN1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACIN1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ACIN1 mRNA CTD PMID:28628672 NCBI chr15:32,072,121...32,117,004
Ensembl chr15:32,072,123...32,117,166 		JBrowse link
G Ackr3 atypical chemokine receptor 3 decreases expression ISO Dexamethasone results in decreased expression of ACKR3 mRNA CTD PMID:17998272 NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214 		JBrowse link
G Acly ATP citrate lyase decreases expression EXP Dexamethasone results in decreased expression of ACLY mRNA CTD PMID:17522070 NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631 		JBrowse link
G Aco1 aconitase 1 increases expression ISO Dexamethasone results in increased expression of ACO1 mRNA CTD PMID:25047013 NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600 		JBrowse link
G Aco2 aconitase 2 decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of ACO2 mRNA
Dexamethasone results in decreased expression of ACO2 protein
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ACO2 mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACO2 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of ACO2 mRNA] 		CTD PMID:20032058 PMID:23428407 PMID:24848799 PMID:33567340 NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892 		JBrowse link
G Acot1 acyl-CoA thioesterase 1 increases expression ISO Dexamethasone results in increased expression of ACOT1 mRNA CTD PMID:25047013 NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749 		JBrowse link
G Acot11 acyl-CoA thioesterase 11 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACOT11 mRNA CTD PMID:28628672 NCBI chr 5:126,756,255...126,804,526
Ensembl chr 5:126,756,255...126,804,507 		JBrowse link
G Acot7 acyl-CoA thioesterase 7 multiple interactions
decreases expression 		ISO
EXP 		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACOT7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACOT7 mRNA
Dexamethasone results in decreased expression of ACOT7 mRNA 		CTD PMID:14618091 PMID:28628672 NCBI chr 5:167,969,284...168,062,033
Ensembl chr 5:167,968,895...168,062,033 		JBrowse link
G Acox1 acyl-CoA oxidase 1 decreases expression
multiple interactions
increases expression 		EXP
ISO 		Dexamethasone results in decreased expression of ACOX1 mRNA
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACOX1 mRNA; [Dexamethasone co-treated with Ibuprofen] results in increased expression of ACOX1 mRNA
Dexamethasone results in increased expression of ACOX1 mRNA 		CTD PMID:12971794 PMID:21041162 PMID:23428407 PMID:29222744 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136 		JBrowse link
G Acox2 acyl-CoA oxidase 2 decreases expression ISO Dexamethasone results in decreased expression of ACOX2 mRNA CTD PMID:22733784 NCBI chr15:19,090,820...19,122,392
Ensembl chr15:19,090,926...19,122,392 		JBrowse link
G Acp4 acid phosphatase 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACP4 mRNA CTD PMID:28628672 NCBI chr 1:103,872,922...103,888,418
Ensembl chr 1:103,872,922...103,881,156 		JBrowse link
G Acp5 acid phosphatase 5, tartrate resistant multiple interactions
increases activity
increases expression 		ISO
EXP 		[Thalidomide co-treated with Dexamethasone] results in decreased expression of ACP5 protein
Dexamethasone results in increased activity of ACP5 protein
Alendronate inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]; caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]; ginsenoside Rg3 inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]
Dexamethasone results in increased expression of ACP5 mRNA 		CTD PMID:16079895 PMID:21041162 PMID:27387537 PMID:28363435 NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929 		JBrowse link
G Acsf2 acyl-CoA synthetase family member 2 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ACSF2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSF2 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr10:80,001,389...80,043,796
Ensembl chr10:80,001,389...80,045,050 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 multiple interactions
decreases expression
increases expression 		ISO
EXP 		[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACSL1 mRNA; [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACSL1 mRNA; EGF protein inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACSL1 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACSL1 mRNA]
Dexamethasone results in decreased expression of ACSL1 mRNA
Dexamethasone results in increased expression of ACSL1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACSL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACSL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSL1 mRNA 		CTD PMID:16054899 PMID:17522070 PMID:23428407 PMID:25047013 PMID:28628672 NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 multiple interactions
increases expression 		ISO
EXP 		[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACSL4 mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of ACSL4 mRNA] 		CTD PMID:16054899 PMID:20032058 NCBI chr  X:110,739,633...110,803,416
Ensembl chr  X:110,739,648...110,803,261 		JBrowse link
G Acsl5 acyl-CoA synthetase long-chain family member 5 increases expression ISO Dexamethasone results in increased expression of ACSL5 mRNA CTD PMID:25047013 NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:264,294,864...264,341,943 		JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ACSS2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSS2 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830 		JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions
decreases expression 		ISO
EXP 		[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTA2 mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of ACTA2 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of and results in increased phosphorylation of ACTA2 protein]; Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTA2 mRNA]
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]]; PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; SENP2 protein promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; NLRC5 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]]; NLRC5 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; SIRT1 protein promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]
Dexamethasone results in decreased expression of ACTA2 mRNA 		CTD PMID:14618091 PMID:16054899 PMID:26435214 PMID:26739621 PMID:26806094 More... NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Actb actin, beta multiple interactions ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTB mRNA; Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTB mRNA] CTD PMID:16054899 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Actc1 actin, alpha, cardiac muscle 1 multiple interactions ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTC1 mRNA; Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTC1 mRNA] CTD PMID:16054899 NCBI chr 3:121,266,291...121,271,827
Ensembl chr 3:121,266,291...121,271,827 		JBrowse link
G Actg2 actin gamma 2, smooth muscle multiple interactions
increases expression 		ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTG2 mRNA
Dexamethasone results in increased expression of ACTG2 mRNA 		CTD PMID:16054899 PMID:22733784 NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295 		JBrowse link
G Actn1 actinin, alpha 1 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ACTN1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACTN1 mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172 		JBrowse link
G Actn2 actinin alpha 2 increases expression ISO Dexamethasone results in increased expression of ACTN2 mRNA CTD PMID:22733784 NCBI chr17:62,835,055...62,902,331
Ensembl chr17:62,812,988...62,903,552 		JBrowse link
G Actr1a actin related protein 1A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACTR1A mRNA CTD PMID:28628672 NCBI chr 1:255,179,241...255,199,009
Ensembl chr 1:255,179,242...255,199,459 		JBrowse link
G Actr2 actin related protein 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACTR2 mRNA CTD PMID:28628672 NCBI chr14:98,500,119...98,535,092
Ensembl chr14:98,500,138...98,541,998 		JBrowse link
G Actr3 actin related protein 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACTR3 mRNA CTD PMID:28628672 NCBI chr13:39,353,413...39,396,509
Ensembl chr13:39,353,079...39,396,711 		JBrowse link
G Actr6 actin related protein 6 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACTR6 mRNA CTD PMID:28628672 NCBI chr 7:26,037,574...26,058,362
Ensembl chr 7:26,037,574...26,060,604 		JBrowse link
G Acvr1c activin A receptor type 1C increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ACVR1C mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACVR1C mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACVR1C mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 3:63,224,322...63,301,252
Ensembl chr 3:63,227,559...63,301,205 		JBrowse link
G Acvrl1 activin A receptor like type 1 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ACVRL1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ACVRL1 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 7:134,117,917...134,135,306
Ensembl chr 7:134,118,024...134,135,305 		JBrowse link
G Ada adenosine deaminase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADA mRNA CTD PMID:28628672 NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293 		JBrowse link
G Adam10 ADAM metallopeptidase domain 10 multiple interactions EXP [APP protein alternative form co-treated with Dexamethasone] results in decreased expression of ADAM10 mRNA; ginsenoside Rg1 inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in decreased expression of ADAM10 mRNA]; Huang Qi inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in decreased expression of ADAM10 mRNA] CTD PMID:22484447 NCBI chr 8:80,226,862...80,358,728
Ensembl chr 8:80,226,674...80,361,600 		JBrowse link
G Adam12 ADAM metallopeptidase domain 12 multiple interactions ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADAM12 mRNA CTD PMID:16054899 NCBI chr 1:198,116,968...198,443,680
Ensembl chr 1:198,116,975...198,447,552 		JBrowse link
G Adam15 ADAM metallopeptidase domain 15 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADAM15 mRNA CTD PMID:28628672 NCBI chr 2:177,052,363...177,062,879
Ensembl chr 2:177,052,363...177,062,849 		JBrowse link
G Adam17 ADAM metallopeptidase domain 17 decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of ADAM17 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADAM17 mRNA 		CTD PMID:14618091 PMID:28628672 NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344 		JBrowse link
G Adam19 ADAM metallopeptidase domain 19 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ADAM19 mRNA CTD PMID:28628672 NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,992,754...31,084,455 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 multiple interactions
increases expression 		ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADAMTS1 mRNA
Dexamethasone results in increased expression of ADAMTS1 mRNA 		CTD PMID:16054899 PMID:22733784 PMID:25047013 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 decreases expression ISO Dexamethasone results in decreased expression of ADAMTS16 mRNA CTD PMID:22733784 NCBI chr 1:34,258,899...34,388,952
Ensembl chr 1:34,258,899...34,388,952 		JBrowse link
G Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif, 4 decreases expression ISO Dexamethasone results in decreased expression of ADAMTS4 mRNA CTD PMID:22733784 NCBI chr13:86,203,011...86,212,500
Ensembl chr13:86,202,642...86,212,514 		JBrowse link
G Adamts6 ADAM metallopeptidase with thrombospondin type 1 motif, 6 decreases expression ISO Dexamethasone results in decreased expression of ADAMTS6 mRNA CTD PMID:25047013 NCBI chr 2:37,155,260...37,367,077
Ensembl chr 2:37,155,288...37,367,070 		JBrowse link
G Adamts9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ADAMTS9 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ADAMTS9 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADAMTS9 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 4:126,847,726...127,019,924
Ensembl chr 4:126,847,729...127,019,876 		JBrowse link
G Adamtsl1 ADAMTS-like 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADAMTSL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADAMTSL1 mRNA CTD PMID:28628672 NCBI chr 5:105,010,471...105,965,792
Ensembl chr 5:105,010,464...105,964,394 		JBrowse link
G Adarb1 adenosine deaminase, RNA-specific, B1 increases expression ISO Dexamethasone results in increased expression of ADARB1 mRNA CTD PMID:22733784 NCBI chr20:11,222,171...11,350,416
Ensembl chr20:11,222,164...11,350,415 		JBrowse link
G Adcy1 adenylate cyclase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ADCY1 mRNA CTD PMID:28628672 NCBI chr14:86,125,119...86,234,459
Ensembl chr14:86,124,850...86,261,075 		JBrowse link
G Adcy3 adenylate cyclase 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ADCY3 mRNA
[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of ADCY3 mRNA; [rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of ADCY3 mRNA 		CTD PMID:28628672 PMID:29288687 NCBI chr 6:32,819,602...32,923,174
Ensembl chr 6:32,843,961...32,923,173 		JBrowse link
G Adcy4 adenylate cyclase 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADCY4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADCY4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADCY4 mRNA CTD PMID:28628672 NCBI chr15:33,236,201...33,252,070
Ensembl chr15:33,236,208...33,252,026 		JBrowse link
G Adcy6 adenylate cyclase 6 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADCY6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADCY6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADCY6 mRNA
[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of ADCY6 mRNA 		CTD PMID:28628672 PMID:29288687 NCBI chr 7:131,621,860...131,642,923
Ensembl chr 7:131,621,860...131,642,770 		JBrowse link
G Adcy7 adenylate cyclase 7 decreases expression ISO Dexamethasone results in decreased expression of ADCY7 mRNA CTD PMID:22733784 NCBI chr19:34,913,154...34,972,366
Ensembl chr19:34,914,322...34,936,743 		JBrowse link
G Adcy8 adenylate cyclase 8 multiple interactions ISO [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of ADCY8 mRNA CTD PMID:29288687 NCBI chr 7:98,306,434...98,555,687
Ensembl chr 7:98,306,464...98,555,038 		JBrowse link
G Add3 adducin 3 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ADD3 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ADD3 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504 		JBrowse link
G Adgra3 adhesion G protein-coupled receptor A3 decreases expression ISO Dexamethasone results in decreased expression of ADGRA3 mRNA CTD PMID:22733784 NCBI chr14:65,085,418...65,188,949
Ensembl chr14:65,087,380...65,188,959 		JBrowse link
G Adgrd1 adhesion G protein-coupled receptor D1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ADGRD1 mRNA CTD PMID:28628672 NCBI chr12:33,124,981...33,239,778
Ensembl chr12:33,125,915...33,272,509 		JBrowse link
G Adgrf5 adhesion G protein-coupled receptor F5 multiple interactions ISO [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADGRF5 mRNA CTD PMID:16997883 NCBI chr 9:25,014,861...25,128,045
Ensembl chr 9:25,018,277...25,121,237 		JBrowse link
G Adgrl2 adhesion G protein-coupled receptor L2 decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of ADGRL2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADGRL2 mRNA 		CTD PMID:14618091 PMID:28628672 NCBI chr 2:240,356,176...240,987,246
Ensembl chr 2:240,356,177...240,855,933 		JBrowse link
G Adh1c alcohol dehydrogenase 1C (class I), gamma polypeptide increases expression
multiple interactions 		ISO
EXP 		Dexamethasone results in increased expression of ADH1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADH1C mRNA
Dexamethasone results in increased expression of ADH1C mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of ADH1 mRNA] 		CTD PMID:20032058 PMID:22733784 PMID:25047013 PMID:28628672 NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291 		JBrowse link
G Adh4 alcohol dehydrogenase 4 (class II), pi polypeptide multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADH4 mRNA CTD PMID:28628672 NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:229,622,095...229,641,879 		JBrowse link
G Adhfe1 alcohol dehydrogenase, iron containing, 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ADHFE1 mRNA CTD PMID:28628672 NCBI chr 5:14,488,784...14,515,405
Ensembl chr 5:14,488,788...14,515,835 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions
increases expression 		ISO
EXP 		2,2',4,4',5-brominated diphenyl ether promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of ADIPOQ mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of ADIPOQ protein; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [2-ethylhexyldiphenylphosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased secretion of ADIPOQ protein; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA; [quinoxyfen co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased secretion of ADIPOQ protein; [Roscovitine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased secretion of ADIPOQ protein; [sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of ADIPOQ mRNA; [sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of and results in decreased secretion of ADIPOQ protein; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of ADIPOQ mRNA; [sodium arsenite co-treated with Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of ADIPOQ protein; [tetrabromobisphenol A co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [tetrabromobisphenol A co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased secretion of ADIPOQ protein; [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased secretion of ADIPOQ protein; bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]; butylparaben promotes the reaction [Dexamethasone results in increased expression of ADIPOQ mRNA]; Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]; Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]]; dibutyldichlorotin inhibits the reaction [Dexamethasone results in increased expression of ADIPOQ protein]; Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]; Ethanol inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased secretion of ADIPOQ protein]; GHRL protein inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased secretion of ADIPOQ protein]; hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of ADIPOQ mRNA]; hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of ADIPOQ protein]; Palmitic Acid inhibits the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased secretion of ADIPOQ protein]; Rosiglitazone promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]; sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]; triphenyltin chloride inhibits the reaction [Dexamethasone results in increased expression of ADIPOQ protein]
Dexamethasone results in increased expression of ADIPOQ mRNA; Dexamethasone results in increased expression of ADIPOQ protein
17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; 17-alpha-Hydroxyprogesterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]; 2-chloro-5-nitrobenzanilide promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA; [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of ADIPOQ mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of ADIPOQ protein; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADIPOQ mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of ADIPOQ mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein; [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of ADIPOQ mRNA; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; bisphenol A promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; BQ 610 affects the reaction [sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]]; butylbenzyl phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; butylbenzyl phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; butylbenzyl phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; butylparaben promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; Cyproterone Acetate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Dicamba inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; diethyl sulfate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Diethylhexyl Phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; Diethylhexyl Phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Diethylhexyl Phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; Diethylhexyl Phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Equilin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Melengestrol Acetate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Mifepristone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Norethindrone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; octocrylene inhibits the reaction [Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]; octocrylene promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; octocrylene promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; oxybenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ protein]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Pertussis Toxin promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; Pioglitazone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; RES 701-1 affects the reaction [sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]]; Rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of ADIPOQ protein]; sodium arsenite affects the reaction [Pertussis Toxin promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]]; sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]; Spironolactone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; T 0070907 affects the reaction [avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]; T 0070907 inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; T 0070907 inhibits the reaction [Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]]; thiocarbohydrazide inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; tributyltin promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ protein]; tributyltin promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]; tributyltin promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein] 		CTD PMID:16054899 PMID:19186324 PMID:19853017 PMID:22197818 PMID:22956630 More... NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Adipor2 adiponectin receptor 2 multiple interactions ISO Dexamethasone promotes the reaction [rosiglitazone results in increased activity of ADIPOR2 promoter]
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADIPOR2 mRNA 		CTD PMID:16609881 PMID:23428407 NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:154,172,567...154,231,666 		JBrowse link
G Adm adrenomedullin increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ADM mRNA
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ADM mRNA 		CTD PMID:16054899 PMID:19853017 PMID:22733784 PMID:25047013 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Ado 2-aminoethanethiol dioxygenase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADO mRNA CTD PMID:28628672 NCBI chr20:21,043,694...21,044,862
Ensembl chr20:21,043,317...21,048,483 		JBrowse link
G Adora2b adenosine A2B receptor multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADORA2B mRNA CTD PMID:28628672 NCBI chr10:47,439,712...47,456,092
Ensembl chr10:47,439,701...47,456,091 		JBrowse link
G Adora3 adenosine A3 receptor increases expression EXP Dexamethasone results in increased expression of ADORA3 mRNA; Dexamethasone results in increased expression of ADORA3 protein CTD PMID:7730645 NCBI chr 2:196,077,042...196,080,686
Ensembl chr 2:196,077,042...196,080,686 		JBrowse link
G Adpgk ADP-dependent glucokinase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADPGK mRNA CTD PMID:28628672 NCBI chr 8:68,595,194...68,623,179
Ensembl chr 8:68,595,248...68,623,178 		JBrowse link
G Adra1b adrenoceptor alpha 1B increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ADRA1B mRNA; Dexamethasone results in increased expression of ADRA1B protein
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ADRA1B mRNA 		CTD PMID:10229127 PMID:28628672 NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,756,461...28,814,347 		JBrowse link
G Adra1d adrenoceptor alpha 1D increases expression ISO Dexamethasone results in increased expression of ADRA1D mRNA; Dexamethasone results in increased expression of ADRA1D protein CTD PMID:10229127 NCBI chr 3:139,246,333...139,262,331
Ensembl chr 3:139,246,323...139,262,331 		JBrowse link
G Adra2a adrenoceptor alpha 2A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADRA2A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADRA2A mRNA CTD PMID:28628672 NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:263,065,278...263,069,871 		JBrowse link
G Adra2c adrenoceptor alpha 2C increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ADRA2C mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADRA2C mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr14:79,695,514...79,697,476
Ensembl chr14:79,694,995...79,706,656 		JBrowse link
G Adrb2 adrenoceptor beta 2 decreases expression
increases expression
increases activity
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of ADRB2 mRNA
Dexamethasone results in increased expression of ADRB2 mRNA
Dexamethasone results in increased activity of ADRB2 protein
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADRB2 mRNA
Mifepristone inhibits the reaction [Dexamethasone results in increased expression of ADRB2 mRNA] 		CTD PMID:9032216 PMID:9074950 PMID:16054899 PMID:21804312 NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803 		JBrowse link
G Adrb3 adrenoceptor beta 3 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of ADRB3 mRNA
[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of ADRB3 mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADRB3 protein; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADRB3 mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADRB3 protein 		CTD PMID:10725275 PMID:29288687 PMID:32417366 NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420 		JBrowse link
G Adss1 adenylosuccinate synthase 1 decreases expression ISO Dexamethasone results in decreased expression of ADSS1 protein CTD PMID:33567340 NCBI chr 6:137,500,549...137,523,087
Ensembl chr 6:137,501,001...137,523,086 		JBrowse link
G Afap1l1 actin filament associated protein 1-like 1 increases expression ISO Dexamethasone results in increased expression of AFAP1L1 mRNA CTD PMID:25047013 NCBI chr18:57,454,120...57,514,584
Ensembl chr18:57,454,121...57,514,480 		JBrowse link
G Aff1 ALF transcription elongation factor 1 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of AFF1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AFF1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AFF1 mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr14:6,165,864...6,328,848
Ensembl chr14:6,169,562...6,328,879 		JBrowse link
G Aff4 ALF transcription elongation factor 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AFF4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AFF4 mRNA CTD PMID:28628672 NCBI chr10:37,998,319...38,080,580
Ensembl chr10:37,999,579...38,080,580 		JBrowse link
G Afg3l2 AFG3 like matrix AAA peptidase subunit 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AFG3L2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AFG3L2 mRNA CTD PMID:28628672 NCBI chr18:63,224,163...63,269,000
Ensembl chr18:63,224,163...63,269,000 		JBrowse link
G Aftph aftiphilin multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AFTPH mRNA CTD PMID:28628672 NCBI chr14:99,072,761...99,127,006
Ensembl chr14:99,072,761...99,126,727 		JBrowse link
G Aga aspartylglucosaminidase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of AGA mRNA CTD PMID:28628672 NCBI chr16:45,191,215...45,249,537
Ensembl chr16:45,223,339...45,249,551 		JBrowse link
G Agfg2 ArfGAP with FG repeats 2 increases expression ISO Dexamethasone results in increased expression of AGFG2 mRNA CTD PMID:22733784 NCBI chr12:24,649,008...24,692,069
Ensembl chr12:24,649,038...24,685,197 		JBrowse link
G Ago2 argonaute RISC catalytic component 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AGO2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AGO2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AGO2 mRNA CTD PMID:28628672 NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980 		JBrowse link
G Ago3 argonaute RISC catalytic component 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AGO3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AGO3 mRNA CTD PMID:28628672 NCBI chr 5:143,913,957...143,998,746
Ensembl chr 5:143,926,501...143,998,737 		JBrowse link
G Agpat1 1-acylglycerol-3-phosphate O-acyltransferase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AGPAT1 mRNA CTD PMID:28628672 NCBI chr20:4,140,565...4,149,531
Ensembl chr20:4,140,565...4,150,445 		JBrowse link
G Agpat2 1-acylglycerol-3-phosphate O-acyltransferase 2 multiple interactions
increases expression 		ISO [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of AGPAT2 mRNA
Dexamethasone results in increased expression of AGPAT2 mRNA 		CTD PMID:23428407 PMID:25047013 NCBI chr 3:29,814,924...29,826,569
Ensembl chr 3:29,814,924...29,826,581 		JBrowse link
G Agpat3 1-acylglycerol-3-phosphate O-acyltransferase 3 multiple interactions
increases expression 		ISO [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of AGPAT3 mRNA; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of AGPAT3 mRNA]
Dexamethasone results in increased expression of AGPAT3 mRNA 		CTD PMID:23428407 PMID:31053639 NCBI chr20:10,330,650...10,415,026
Ensembl chr20:10,394,465...10,410,632 		JBrowse link
G Agpat4 1-acylglycerol-3-phosphate O-acyltransferase 4 decreases expression ISO Dexamethasone results in decreased expression of AGPAT4 mRNA CTD PMID:25047013 NCBI chr 1:51,075,081...51,181,548
Ensembl chr 1:51,075,081...51,180,976 		JBrowse link
G Agps alkylglycerone phosphate synthase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AGPS mRNA CTD PMID:28628672 NCBI chr 3:81,154,599...81,253,099
Ensembl chr 3:81,154,604...81,258,277 		JBrowse link
G Agr2 anterior gradient 2, protein disulphide isomerase family member multiple interactions ISO [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA CTD PMID:16997883 NCBI chr 6:58,435,908...58,456,678
Ensembl chr 6:58,435,908...58,456,677 		JBrowse link
G Agrn agrin decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of AGRN mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AGRN mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539 		JBrowse link
G Agt angiotensinogen multiple interactions
increases expression 		ISO
EXP 		[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of AGT mRNA; [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of AGT mRNA; adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [Isoproterenol promotes the reaction [Dexamethasone results in increased expression of AGT protein]]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of AGT mRNA]; ICI 118551 inhibits the reaction [Isoproterenol promotes the reaction [Dexamethasone results in increased expression of AGT protein]]; Isoproterenol promotes the reaction [Dexamethasone results in increased expression of AGT protein]; Propranolol inhibits the reaction [Isoproterenol promotes the reaction [Dexamethasone results in increased expression of AGT protein]]; sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of AGT mRNA]
[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with bisphenol AF] results in increased expression of AGT mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of AGT mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AGT mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AGT mRNA
Dexamethasone results in increased expression of AGT mRNA
Dexamethasone inhibits the reaction [AGT protein alternative form results in increased abundance of 6-Ketoprostaglandin F1 alpha]; Dexamethasone inhibits the reaction [AGT protein alternative form results in increased abundance of Dinoprostone] 		CTD PMID:4030047 PMID:6421564 PMID:7843740 PMID:16054899 PMID:19853017 More... NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a multiple interactions
increases expression
affects expression 		ISO
EXP 		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AGTR1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AGTR1 mRNA
Dexamethasone results in increased expression of AGTR1A mRNA; Dexamethasone results in increased expression of AGTR1A protein
[Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of AGTR1A protein]
diisononyl phthalate promotes the reaction [Dexamethasone results in increased expression of AGTR1 protein]; Enalapril inhibits the reaction [Dexamethasone results in increased expression of AGTR1 protein]; Enalapril inhibits the reaction [diisononyl phthalate promotes the reaction [Dexamethasone results in increased expression of AGTR1 protein]]
Dexamethasone affects the expression of AGTR1 mRNA
Dexamethasone results in increased expression of AGTR1 protein; Dexamethasone results in increased expression of AGTR1A mRNA 		CTD PMID:23935943 PMID:28628672 PMID:30359671 PMID:30940551 PMID:32494933 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Agtr2 angiotensin II receptor, type 2 decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of AGTR2 mRNA; Dexamethasone results in decreased expression of AGTR2 protein
[Dexamethasone co-treated with Lithium Chloride co-treated with Pilocarpine] affects the expression of AGTR2 mRNA; AGTR2 protein inhibits the reaction [Dexamethasone results in decreased expression of GDNF mRNA]; AGTR2 protein inhibits the reaction [Dexamethasone results in decreased expression of INS1 mRNA]; AGTR2 protein inhibits the reaction [Dexamethasone results in decreased expression of INS2 mRNA]; AGTR2 protein inhibits the reaction [Dexamethasone results in decreased expression of NPHS1 mRNA]; AGTR2 protein inhibits the reaction [Dexamethasone results in decreased expression of NPHS2 mRNA]; AGTR2 protein inhibits the reaction [Dexamethasone results in decreased expression of RET mRNA]; Dexamethasone promotes the reaction [NR3C1 protein binds to AGTR2 promoter]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of AGTR2 mRNA]; trichostatin A inhibits the reaction [Dexamethasone results in decreased expression of AGTR2 mRNA] 		CTD PMID:30359671 PMID:32494933 PMID:32791177 NCBI chr  X:116,914,320...116,918,504
Ensembl chr  X:116,913,656...116,918,745 		JBrowse link
G Ahcyl1 adenosylhomocysteinase-like 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AHCYL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AHCYL1 mRNA CTD PMID:28628672 NCBI chr 2:197,982,335...198,016,770
Ensembl chr 2:197,982,344...198,033,930 		JBrowse link
G Ahnak AHNAK nucleoprotein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AHNAK mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AHNAK mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AHNAK mRNA CTD PMID:28628672 NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:215,321,931...215,400,675 		JBrowse link
G Ahnak2 AHNAK nucleoprotein 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AHNAK2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AHNAK2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AHNAK2 mRNA CTD PMID:28628672 NCBI chr 6:137,648,867...137,697,580
Ensembl chr 6:137,652,537...137,675,546 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions
affects localization
increases degradation
affects binding
decreases expression
increases expression 		ISO
EXP 		[2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide co-treated with Dexamethasone] affects the localization of AHR protein; Dexamethasone inhibits the reaction [AHR protein results in increased expression of CYP1A1]; Dexamethasone inhibits the reaction [Benzo(a)pyrene results in increased expression of AHR mRNA]; Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of AHR protein]; Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR mRNA]; Dexamethasone promotes the reaction [IL1B protein affects the localization of AHR protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of AHR mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of AHR protein]
Dexamethasone affects the localization of AHR protein
Dexamethasone results in increased degradation of AHR protein
Dexamethasone binds to AHR protein
Dexamethasone results in increased expression of AHR mRNA
Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR mRNA]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR mRNA]]
Dexamethasone results in increased expression of AHR mRNA; Dexamethasone results in increased expression of AHR protein
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AHR mRNA; [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AHR mRNA]; Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin binds to AHR protein]]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of AHR mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AHR mRNA]
Dexamethasone results in decreased expression of AHR mRNA; Dexamethasone results in decreased expression of AHR protein 		CTD PMID:9804617 PMID:10478797 PMID:16054899 PMID:17552871 PMID:17690134 More... NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahsa1 activator of Hsp90 ATPase activity 1 increases expression ISO Dexamethasone results in increased expression of AHSA1 mRNA CTD PMID:17998272 NCBI chr 6:112,644,287...112,652,290
Ensembl chr 6:112,644,479...112,655,595 		JBrowse link
G Ahsa2 activator of HSP90 ATPase homolog 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AHSA2 mRNA CTD PMID:28628672 NCBI chr14:101,677,447...101,688,706
Ensembl chr14:101,677,447...101,686,923 		JBrowse link
G Ahsg alpha-2-HS-glycoprotein increases response to substance ISO AHSG gene polymorphism results in increased susceptibility to Dexamethasone CTD PMID:20400291 NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039 		JBrowse link
G Aida axin interactor, dorsalization associated multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AIDA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AIDA mRNA CTD PMID:28628672 NCBI chr13:97,471,931...97,499,531
Ensembl chr13:97,471,604...97,499,535 		JBrowse link
G Aif1l allograft inflammatory factor 1-like increases expression ISO Dexamethasone results in increased expression of AIF1L mRNA CTD PMID:22733784 NCBI chr 3:35,627,239...35,651,793
Ensembl chr 3:35,627,239...35,651,793 		JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 multiple interactions
increases activity 		ISO
EXP 		Dexamethasone inhibits the reaction [Puromycin Aminonucleoside affects the localization of AIFM1 protein]
Dexamethasone results in increased activity of AIFM1 protein 		CTD PMID:15987750 PMID:16403471 NCBI chr  X:132,528,107...132,567,237
Ensembl chr  X:132,528,107...132,567,237 		JBrowse link
G Aifm2 AIF family member 2 multiple interactions
increases expression 		ISO [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of AIFM2 mRNA
Dexamethasone results in increased expression of AIFM2 mRNA 		CTD PMID:24848799 PMID:25047013 NCBI chr20:30,195,781...30,222,014
Ensembl chr20:30,193,829...30,220,957 		JBrowse link
G Aig1 androgen-induced 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of AIG1 mRNA CTD PMID:28628672 NCBI chr 1:9,866,546...10,089,454
Ensembl chr 1:9,866,548...10,089,155 		JBrowse link
G Aip aryl-hydrocarbon receptor-interacting protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AIP mRNA CTD PMID:28628672 NCBI chr 1:210,837,473...210,848,691
Ensembl chr 1:210,836,755...210,848,634 		JBrowse link
G Ak1 adenylate kinase 1 multiple interactions
decreases expression 		ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AK1 mRNA
Dexamethasone results in decreased expression of AK1 protein 		CTD PMID:28628672 PMID:33567340 NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757 		JBrowse link
G Ak2 adenylate kinase 2 increases expression ISO Dexamethasone results in increased expression of AK2 mRNA CTD PMID:22733784 NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:146,630,445...146,650,610 		JBrowse link
G Ak3 adenylate kinase 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AK3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AK3 mRNA CTD PMID:28628672 NCBI chr 1:236,151,012...236,178,689
Ensembl chr 1:236,151,012...236,178,183 		JBrowse link
G Ak4 adenylate kinase 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AK4 mRNA CTD PMID:28628672 NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401 		JBrowse link
G Akap10 A-kinase anchoring protein 10 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AKAP10 mRNA CTD PMID:28628672 NCBI chr10:47,044,819...47,108,153
Ensembl chr10:47,044,819...47,108,203 		JBrowse link
G Akap11 A-kinase anchoring protein 11 decreases expression ISO Dexamethasone results in decreased expression of AKAP11 mRNA CTD PMID:25047013 NCBI chr15:60,320,839...60,365,480
Ensembl chr15:60,320,839...60,365,335 		JBrowse link
G Akap12 A-kinase anchoring protein 12 multiple interactions ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of AKAP12 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AKAP12 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AKAP12 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AKAP12 mRNA 		CTD PMID:16054899 PMID:28628672 NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557 		JBrowse link
G Akap7 A-kinase anchoring protein 7 multiple interactions ISO [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AKAP7 mRNA CTD PMID:16997883 NCBI chr 1:21,906,503...22,168,663
Ensembl chr 1:21,906,676...22,037,090 		JBrowse link
G Akirin1 akirin 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AKIRIN1 mRNA CTD PMID:28628672 NCBI chr 5:141,274,174...141,289,617
Ensembl chr 5:141,274,175...141,289,575 		JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AKR1A1 mRNA CTD PMID:28628672 NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:135,329,606...135,367,035 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 multiple interactions
decreases expression 		ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AKR1B1 mRNA
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of AKR1B1 mRNA
Dexamethasone results in decreased expression of AKR1B1 protein 		CTD PMID:24848799 PMID:28628672 PMID:33567340 NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315 		JBrowse link
G Akr1b7 aldo-keto reductase family 1, member B7 multiple interactions EXP Dexamethasone inhibits the reaction [Freund's Adjuvant results in increased expression of AKR1B7 mRNA] CTD PMID:21149847 NCBI chr 4:64,043,901...64,083,751
Ensembl chr 4:64,020,686...64,064,909 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 multiple interactions
increases expression 		ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AKR1C1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AKR1C1 mRNA
Dexamethasone results in increased expression of AKR1C1 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of AKR1C3 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AKR1C3 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Akr1c8 aldo-keto reductase family 1 member C8 increases expression
multiple interactions 		EXP Dexamethasone results in increased expression of AKR1CL mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of AKR1CL mRNA] 		CTD PMID:20032058 NCBI chr17:71,091,398...71,117,985
Ensembl chr17:71,083,080...71,117,957 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 decreases phosphorylation
decreases expression
multiple interactions
increases expression 		ISO
EXP 		Dexamethasone results in decreased phosphorylation of AKT1 protein
Dexamethasone results in decreased expression of AKT1 mRNA
[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased phosphorylation of AKT1 protein; dorsomorphin inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased phosphorylation of AKT1 protein]
Dexamethasone results in increased expression of AKT1 mRNA
Dexamethasone results in decreased expression of AKT1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [echinacoside inhibits the reaction [Dexamethasone results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Dexamethasone results in decreased phosphorylation of AKT1 protein]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of AKT1 protein; [bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of AKT1 mRNA; [bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased phosphorylation of AKT1 protein; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased phosphorylation of AKT1 protein; Dexamethasone affects the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; Dexamethasone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of AKT1 protein]; Dexamethasone inhibits the reaction [Ovalbumin results in increased expression of and results in increased phosphorylation of AKT1 protein]; echinacoside inhibits the reaction [Dexamethasone results in decreased phosphorylation of AKT1 protein]; IGF1 protein inhibits the reaction [Dexamethasone results in decreased phosphorylation of AKT1 protein]; naringin inhibits the reaction [Dexamethasone results in decreased phosphorylation of AKT1 protein]; naringin inhibits the reaction [Dexamethasone results in increased expression of AKT1 mRNA]; PIK3R1 mutant form inhibits the reaction [Dexamethasone results in decreased phosphorylation of AKT1 protein]; PIK3R1 protein affects the reaction [Dexamethasone affects the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]]; PIK3R1 protein affects the reaction [Dexamethasone results in decreased expression of AKT1 protein]; Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of AKT1 protein]
[Dexamethasone co-treated with beta-hydroxyisovaleric acid] results in increased phosphorylation of AKT1 protein; Dexamethasone inhibits the reaction [Hydrogen Sulfide results in decreased phosphorylation of AKT1 protein]; INS1 protein inhibits the reaction [Dexamethasone results in decreased phosphorylation of AKT1 protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased phosphorylation of AKT1 protein] 		CTD PMID:15187100 PMID:15576458 PMID:18467435 PMID:20181797 PMID:22733784 More... NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 multiple interactions
decreases expression 		ISO
EXP 		Berberine inhibits the reaction [Dexamethasone results in decreased expression of AKT2 mRNA]
Dexamethasone inhibits the reaction [SMAD5 protein binds to AKT2 gene] 		CTD PMID:20079400 PMID:20462044 PMID:35148621 NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420 		JBrowse link
G Alas1 5'-aminolevulinate synthase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ALAS1 mRNA CTD PMID:28628672 NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:115,755,238...115,768,642 		JBrowse link
G Alb albumin multiple interactions
increases expression
decreases expression
increases secretion 		ISO
EXP 		Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein]; Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein]; Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CXCL8 protein]
Dexamethasone results in increased expression of ALB mRNA; Dexamethasone results in increased expression of ALB protein
Dexamethasone results in decreased expression of ALB protein
Dexamethasone results in increased secretion of ALB protein 		CTD PMID:10380089 PMID:14676436 PMID:15965953 PMID:16908450 PMID:27427493 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule increases expression ISO Dexamethasone results in increased expression of ALCAM mRNA CTD PMID:21041162 NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876 		JBrowse link
G Aldh16a1 aldehyde dehydrogenase 16 family, member A1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ALDH16A1 mRNA CTD PMID:28628672 NCBI chr 1:104,763,200...104,776,270
Ensembl chr 1:104,763,055...104,776,270 		JBrowse link
G Aldh18a1 aldehyde dehydrogenase 18 family, member A1 decreases expression ISO Dexamethasone results in decreased expression of ALDH18A1 mRNA CTD PMID:22733784 NCBI chr 1:249,325,082...249,357,383
Ensembl chr 1:249,325,082...249,357,383 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 affects expression EXP Dexamethasone affects the expression of ALDH1A1 mRNA CTD PMID:15102944 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Aldh1a2 aldehyde dehydrogenase 1 family, member A2 increases expression ISO Dexamethasone results in increased expression of ALDH1A2 mRNA CTD PMID:34464682 NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ALDH1A3 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALDH1A3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ALDH1A3 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777 		JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 affects expression
increases expression 		EXP
ISO 		Dexamethasone affects the expression of ALDH1B1 mRNA
Dexamethasone results in increased expression of ALDH1B1 mRNA 		CTD PMID:15102944 PMID:17998271 NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365 		JBrowse link
G Aldh1l1 aldehyde dehydrogenase 1 family, member L1 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ALDH1L1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ALDH1L1 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 4:124,617,182...124,663,674
Ensembl chr 4:124,617,217...124,664,704 		JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 decreases expression ISO Dexamethasone results in decreased expression of ALDH1L2 mRNA CTD PMID:22733784 NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398 		JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member increases expression ISO Dexamethasone results in increased expression of ALDH2 mRNA CTD PMID:21041162 NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 decreases expression ISO Dexamethasone results in decreased expression of ALDH3A1 mRNA CTD PMID:22733784 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Aldh4a1 aldehyde dehydrogenase 4 family, member A1 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ALDH4A1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALDH4A1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ALDH4A1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ALDH4A1 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:157,162,945...157,188,673 		JBrowse link
G Aldh8a1 aldehyde dehydrogenase 8 family, member A1 increases expression ISO Dexamethasone results in increased expression of ALDH8A1 mRNA CTD PMID:17998271 NCBI chr 1:18,003,507...18,022,952
Ensembl chr 1:18,003,514...18,023,883 		JBrowse link
G Aldoa aldolase, fructose-bisphosphate A multiple interactions
increases expression 		ISO
EXP 		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ALDOA mRNA
Dexamethasone results in increased expression of ALDOA mRNA 		CTD PMID:17522070 PMID:28628672 NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211 		JBrowse link
G Aldoc aldolase, fructose-bisphosphate C multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ALDOC mRNA CTD PMID:28628672 NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,715,489...63,719,133 		JBrowse link
G Alg14 ALG14, UDP-N-acetylglucosaminyltransferase subunit multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ALG14 mRNA CTD PMID:28628672 NCBI chr 2:212,053,008...212,130,136
Ensembl chr 2:212,044,969...212,130,140 		JBrowse link
G Alg3 ALG3, alpha-1,3- mannosyltransferase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ALG3 mRNA CTD PMID:28628672 NCBI chr11:93,804,859...93,810,403
Ensembl chr11:93,804,891...93,812,060 		JBrowse link
G Alox12b arachidonate 12-lipoxygenase, 12R type multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALOX12B mRNA CTD PMID:28628672 NCBI chr10:54,361,898...54,373,776
Ensembl chr10:54,361,898...54,373,776 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions EXP Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] CTD PMID:18083043 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126 		JBrowse link
G Alox5ap arachidonate 5-lipoxygenase activating protein increases expression ISO Dexamethasone results in increased expression of ALOX5AP mRNA CTD PMID:22733784 NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038 		JBrowse link
G Alpk1 alpha-kinase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ALPK1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ALPK1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ALPK1 mRNA CTD PMID:28628672 NCBI chr 2:218,801,425...218,924,013
Ensembl chr 2:218,780,189...218,921,646 		JBrowse link
G Alpk2 alpha-kinase 2 increases expression ISO Dexamethasone results in increased expression of ALPK2 mRNA CTD PMID:22733784 NCBI chr18:61,045,717...61,161,703
Ensembl chr18:61,045,380...61,175,985 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions
decreases expression
increases expression 		ISO
EXP 		[Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of ALPL mRNA; [Dexamethasone co-treated with 1,25-dihydroxyvitamin D] inhibits the reaction [WNT3A protein results in increased expression of ALPL protein]; [Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the expression of ALPL mRNA; Diethylhexyl Phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the expression of ALPL mRNA]; mono-(2-ethylhexyl)phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the expression of ALPL mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of ALPL mRNA]
Dexamethasone results in decreased expression of ALPL mRNA; Dexamethasone results in decreased expression of ALPL protein
Atorvastatin inhibits the reaction [Dexamethasone results in decreased expression of ALPL mRNA]; Atorvastatin inhibits the reaction [Dexamethasone results in decreased expression of ALPL protein]; caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in decreased expression of ALPL protein]
Dexamethasone results in increased expression of ALPL mRNA
[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA; [Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased activity of ALPL protein; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ALPL mRNA; cordycepin inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased activity of ALPL protein]]; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased activity of ALPL protein] 		CTD PMID:15270777 PMID:26424790 PMID:26492236 PMID:27608943 PMID:28363435 More... NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Als2cl ALS2 C-terminal like multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ALS2CL mRNA CTD PMID:28628672 NCBI chr 8:119,746,498...119,762,824
Ensembl chr 8:119,743,248...119,762,843 		JBrowse link
G Alyref Aly/REF export factor decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of ALYREF mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ALYREF mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ALYREF mRNA 		CTD PMID:21041162 PMID:28628672 NCBI chr10:106,369,750...106,373,395
Ensembl chr10:106,369,750...106,373,395 		JBrowse link
G Amh anti-Mullerian hormone decreases secretion EXP Dexamethasone results in decreased secretion of AMH protein CTD PMID:34537908 NCBI chr 7:9,557,451...9,559,867
Ensembl chr 7:9,557,451...9,559,867 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of AMIGO2 mRNA CTD PMID:28628672 NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218 		JBrowse link
G Amigo3 adhesion molecule with Ig like domain 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AMIGO3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AMIGO3 mRNA CTD PMID:28628672 NCBI chr 8:117,620,499...117,622,025
Ensembl chr 8:117,616,629...117,626,577 		JBrowse link
G Amotl2 angiomotin like 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AMOTL2 mRNA CTD PMID:28628672 NCBI chr 8:112,182,060...112,198,032
Ensembl chr 8:112,181,863...112,198,030 		JBrowse link
G Ampd2 adenosine monophosphate deaminase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AMPD2 mRNA CTD PMID:28628672 NCBI chr 2:198,395,767...198,408,514
Ensembl chr 2:198,395,768...198,408,796 		JBrowse link
G Ampd3 adenosine monophosphate deaminase 3 increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of AMPD3 mRNA
apicidin inhibits the reaction [Dexamethasone results in increased expression of AMPD3 mRNA]; trichostatin A inhibits the reaction [Dexamethasone results in increased expression of AMPD3 mRNA]; Valproic Acid inhibits the reaction [Dexamethasone results in increased expression of AMPD3 mRNA]
Testosterone inhibits the reaction [Dexamethasone results in increased expression of AMPD3 mRNA] 		CTD PMID:14618091 PMID:20032058 PMID:22733784 PMID:23946490 PMID:29229235 NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608 		JBrowse link
G Amph amphiphysin increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of AMPH mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AMPH mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr17:50,435,018...50,678,583
Ensembl chr17:50,435,018...50,678,501 		JBrowse link
G Amt aminomethyltransferase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AMT mRNA CTD PMID:28628672 NCBI chr 8:117,859,700...117,866,692
Ensembl chr 8:117,860,345...117,866,803 		JBrowse link
G Amy2a3 amylase 2a3 decreases expression EXP Dexamethasone results in decreased expression of AMY2A3 mRNA CTD PMID:27427493 NCBI chr 2:204,005,840...204,014,412
Ensembl chr 2:204,005,840...204,014,413 		JBrowse link
G Amy2a5 amylase 2a5 increases expression ISO Dexamethasone results in increased expression of AMY2A5 mRNA CTD PMID:22733784 NCBI chr 2:203,949,578...203,958,111 JBrowse link
G Anapc1 anaphase promoting complex subunit 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] affects the expression of ANAPC1 mRNA CTD PMID:28628672 NCBI chr 3:136,303,350...136,383,464
Ensembl chr 3:136,303,413...136,383,464 		JBrowse link
G Anapc10 anaphase promoting complex subunit 10 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ANAPC10 mRNA CTD PMID:28628672 NCBI chr19:45,057,278...45,109,882
Ensembl chr19:45,029,546...45,109,882 		JBrowse link
G Angpt1 angiopoietin 1 multiple interactions ISO [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ANGPT1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ANGPT1 mRNA CTD PMID:16997883 PMID:28628672 NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696 		JBrowse link
G Angptl1 angiopoietin-like 1 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ANGPTL1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ANGPTL1 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr13:71,463,913...71,531,810
Ensembl chr13:71,511,727...71,531,818 		JBrowse link
G Angptl4 angiopoietin-like 4 increases expression
increases response to substance
decreases expression
multiple interactions
affects response to substance 		ISO
EXP 		Dexamethasone results in increased expression of ANGPTL4 mRNA
ANGPTL4 gene mutant form results in increased susceptibility to Dexamethasone
Dexamethasone results in decreased expression of ANGPTL4 mRNA
Dexamethasone inhibits the reaction [Freund's Adjuvant results in decreased expression of ANGPTL4 mRNA]; Testosterone inhibits the reaction [Dexamethasone results in increased expression of ANGPTL4 mRNA]
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA; [ANGPTL4 gene mutant form results in increased susceptibility to Dexamethasone] which results in decreased expression of FASN mRNA; [ANGPTL4 gene mutant form results in increased susceptibility to Dexamethasone] which results in decreased expression of MLXIPL mRNA; [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA; [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of ACACA mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of ACACB mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of AGPAT3 mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of CD36 mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of LPIN1 mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of MLXIPL mRNA alternative form]; ANGPTL4 gene mutant form promotes the reaction [Dexamethasone results in decreased expression of SREBF1 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA]
ANGPTL4 affects the susceptibility to Dexamethasone 		CTD PMID:16054899 PMID:19628874 PMID:20032058 PMID:21149847 PMID:22733784 More... NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681 		JBrowse link
G Angptl7 angiopoietin like 7 increases expression ISO Dexamethasone results in increased expression of ANGPTL7 mRNA CTD PMID:22733784 NCBI chr 5:164,215,223...164,220,408
Ensembl chr 5:164,215,223...164,220,584 		JBrowse link
G Ank1 ankyrin 1 decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of ANK1 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of ANK1 mRNA] 		CTD PMID:20032058 NCBI chr16:75,578,824...75,757,464
Ensembl chr16:75,578,824...75,757,464 		JBrowse link
G Ank3 ankyrin 3 increases expression ISO Dexamethasone results in increased expression of ANK3 mRNA CTD PMID:22733784 NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879 		JBrowse link
G Ankfy1 ankyrin repeat and FYVE domain containing 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ANKFY1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ANKFY1 mRNA CTD PMID:28628672 NCBI chr10:57,810,781...57,882,495
Ensembl chr10:57,810,781...57,882,495 		JBrowse link
G Ankmy2 ankyrin repeat and MYND domain containing 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKMY2 mRNA CTD PMID:28628672 NCBI chr 6:58,616,251...58,657,634
Ensembl chr 6:58,615,243...58,657,685 		JBrowse link
G Ankrd1 ankyrin repeat domain 1 decreases expression ISO Dexamethasone results in decreased expression of ANKRD1 mRNA CTD PMID:22733784 NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751 		JBrowse link
G Ankrd11 ankyrin repeat domain containing 11 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ANKRD11 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKRD11 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ANKRD11 mRNA CTD PMID:28628672 NCBI chr19:67,848,836...68,007,491
Ensembl chr19:67,848,844...68,007,491 		JBrowse link
G Ankrd12 ankyrin repeat domain 12 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ANKRD12 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKRD12 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ANKRD12 mRNA CTD PMID:28628672 NCBI chr 9:113,030,127...113,134,816
Ensembl chr 9:113,030,919...113,134,762 		JBrowse link
G Ankrd13a ankyrin repeat domain 13a multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ANKRD13A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ANKRD13A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ANKRD13A mRNA CTD PMID:28628672 NCBI chr12:47,458,828...47,488,959
Ensembl chr12:47,458,831...47,489,312 		JBrowse link
G Ankrd13b ankyrin repeat domain 13B multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ANKRD13B mRNA CTD PMID:28628672 NCBI chr10:62,817,791...62,836,456
Ensembl chr10:62,817,778...62,836,635 		JBrowse link
G Ankrd24 ankyrin repeat domain 24 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ANKRD24 mRNA CTD PMID:28628672 NCBI chr 7:8,712,720...8,731,910
Ensembl chr 7:8,712,722...8,731,910 		JBrowse link
G Ankrd37 ankyrin repeat domain 37 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ANKRD37 mRNA CTD PMID:28628672 NCBI chr16:53,001,487...53,004,545
Ensembl chr16:52,994,740...53,004,545 		JBrowse link
G Ankrd49 ankyrin repeat domain 49 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ANKRD49 mRNA CTD PMID:28628672 NCBI chr 8:19,908,968...19,913,656
Ensembl chr 8:19,908,973...19,913,656 		JBrowse link
G Ankrd53 ankyrin repeat domain 53 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ANKRD53 mRNA CTD PMID:28628672 NCBI chr 4:117,804,702...117,810,650
Ensembl chr 4:117,804,548...117,810,645 		JBrowse link
G Anks1a ankyrin repeat and sterile alpha motif domain containing 1A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ANKS1A mRNA CTD PMID:28628672 NCBI chr20:5,965,421...6,118,875
Ensembl chr20:5,965,028...6,118,875 		JBrowse link
G Ankzf1 ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKZF1 mRNA CTD PMID:28628672 NCBI chr 9:84,136,862...84,143,830
Ensembl chr 9:84,136,862...84,145,091 		JBrowse link
G Antxr1 ANTXR cell adhesion molecule 1 decreases expression ISO Dexamethasone results in decreased expression of ANTXR1 mRNA CTD PMID:25047013 NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892 		JBrowse link
G Antxr2 ANTXR cell adhesion molecule 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ANTXR2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ANTXR2 mRNA CTD PMID:28628672 NCBI chr14:11,845,774...11,986,166
Ensembl chr14:11,845,700...11,986,168 		JBrowse link
G Anxa1 annexin A1 multiple interactions
affects response to substance
increases phosphorylation
increases localization
increases expression 		ISO
EXP 		4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Dexamethasone results in increased phosphorylation of ANXA1 protein]; ANXA1 protein inhibits the reaction [Dexamethasone results in decreased susceptibility to CXCL8 protein]; Dexamethasone promotes the reaction [EGFR protein binds to ANXA1 protein modified form]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [EGFR protein binds to ANXA1 protein modified form]]; Mifepristone inhibits the reaction [Dexamethasone results in increased localization of ANXA1 protein modified form]; Mifepristone inhibits the reaction [Dexamethasone results in increased phosphorylation of and results in increased expression of ANXA1 protein]
ANXA1 protein affects the susceptibility to Dexamethasone
ANXA1 protein affects the susceptibility to [Dexamethasone co-treated with Carrageenan]
Dexamethasone results in increased expression of ANXA1 protein 		CTD PMID:7522859 PMID:10807665 PMID:12475898 PMID:15472012 NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831 		JBrowse link
G Anxa10 annexin A10 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ANXA10 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANXA10 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ANXA10 mRNA CTD PMID:28628672 NCBI chr16:32,505,025...32,571,961
Ensembl chr16:32,467,126...32,571,961 		JBrowse link
G Anxa11 annexin A11 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANXA11 mRNA CTD PMID:28628672 NCBI chr16:1,419,627...1,464,590
Ensembl chr16:1,418,351...1,464,839 		JBrowse link
G Anxa3 annexin A3 multiple interactions ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ANXA3 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ANXA3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ANXA3 mRNA 		CTD PMID:16054899 PMID:28628672 NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849 		JBrowse link
G Anxa4 annexin A4 increases expression ISO Dexamethasone results in increased expression of ANXA4 mRNA CTD PMID:22733784 PMID:25047013 NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:120,741,750...120,798,513 		JBrowse link
G Anxa6 annexin A6 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ANXA6 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ANXA6 mRNA
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ANXA6 mRNA 		CTD PMID:16054899 PMID:25047013 PMID:28628672 NCBI chr10:39,602,106...39,657,183
Ensembl chr10:39,602,106...39,657,359 		JBrowse link
G Anxa8 annexin A8 multiple interactions ISO [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of ANXA8 mRNA CTD PMID:16997883 NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,403,353...9,418,310 		JBrowse link
G Aoc3 amine oxidase, copper containing 3 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of AOC3 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AOC3 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr10:86,773,018...86,780,961 JBrowse link
G Aox1 aldehyde oxidase 1 increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of AOX1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AOX1 mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of AOX1 mRNA] 		CTD PMID:20032058 PMID:25047013 PMID:28628672 NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980 		JBrowse link
G Ap1b1 adaptor related protein complex 1 subunit beta 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AP1B1 mRNA CTD PMID:28628672 NCBI chr14:84,093,529...84,144,835
Ensembl chr14:84,093,559...84,144,892 		JBrowse link
G Ap1g1 adaptor related protein complex 1 subunit gamma 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP1G1 mRNA CTD PMID:28628672 NCBI chr19:54,654,101...54,740,586
Ensembl chr19:54,620,807...54,740,586 		JBrowse link
G Ap1g2 adaptor related protein complex 1 subunit gamma 2 increases expression ISO Dexamethasone results in increased expression of AP1G2 mRNA CTD PMID:12782123 NCBI chr15:32,541,528...32,549,392
Ensembl chr15:32,541,528...32,549,280 		JBrowse link
G Ap1s2 adaptor related protein complex 1 subunit sigma 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of AP1S2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of AP1S2 mRNA CTD PMID:28628672 NCBI chr  X:34,204,601...34,230,819
Ensembl chr  X:34,204,603...34,228,529 		JBrowse link
G Ap2a1 adaptor related protein complex 2 subunit alpha 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP2A1 mRNA CTD PMID:28628672 NCBI chr 1:104,520,789...104,550,655
Ensembl chr 1:104,520,792...104,550,655 		JBrowse link
G Ap3b2 adaptor related protein complex 3 subunit beta 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AP3B2 mRNA CTD PMID:28628672 NCBI chr 1:144,821,819...144,854,533
Ensembl chr 1:144,821,819...144,854,432 		JBrowse link
G Ap3m2 adaptor related protein complex 3 subunit mu 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of AP3M2 mRNA CTD PMID:28628672 NCBI chr16:75,908,459...75,937,915
Ensembl chr16:75,920,084...75,937,923 		JBrowse link
G Ap3s1 adaptor related protein complex 3 subunit sigma 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP3S1 mRNA CTD PMID:28628672 NCBI chr18:41,649,321...41,718,221
Ensembl chr18:41,648,796...41,767,641 		JBrowse link
G Ap3s2 adaptor related protein complex 3 subunit sigma 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP3S2 mRNA CTD PMID:28628672 NCBI chr 1:143,228,131...143,268,573
Ensembl chr 1:143,228,135...143,268,573 		JBrowse link
G Ap5b1 adaptor related protein complex 5 subunit beta 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AP5B1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AP5B1 mRNA CTD PMID:28628672 NCBI chr 1:212,305,612...212,309,643
Ensembl chr 1:212,305,604...212,309,629 		JBrowse link
G Apcdd1 APC down-regulated 1 multiple interactions
increases expression 		ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of APCDD1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of APCDD1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of APCDD1 protein; APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT1 protein]; APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B protein]; APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT3A protein]; APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA protein]; APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of APCDD1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of APCDD1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of APCDD1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of APCDD1 mRNA
Dexamethasone results in increased expression of APCDD1 mRNA 		CTD PMID:16054899 PMID:25047013 PMID:28242765 PMID:28628672 NCBI chr18:58,655,696...58,686,359
Ensembl chr18:58,655,919...58,686,356 		JBrowse link
G Apcdd1l APC down-regulated 1 like decreases expression ISO Dexamethasone results in decreased expression of APCDD1L mRNA CTD PMID:25047013 NCBI chr 3:183,000,504...183,076,628
Ensembl chr 3:183,000,521...183,076,339 		JBrowse link
G Apeh acylaminoacyl-peptide hydrolase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of APEH mRNA CTD PMID:28628672 NCBI chr 8:117,652,390...117,661,502
Ensembl chr 8:117,652,393...117,661,711 		JBrowse link
G Apln apelin decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of APLN mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of APLN mRNA] 		CTD PMID:19853017 PMID:20032058 NCBI chr  X:132,058,739...132,091,518
Ensembl chr  X:132,081,759...132,091,246 		JBrowse link
G Apmap adipocyte plasma membrane associated protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of APMAP mRNA CTD PMID:28628672 NCBI chr 3:159,869,451...159,897,727
Ensembl chr 3:159,869,451...159,897,726 		JBrowse link
G Apoa1 apolipoprotein A1 affects expression
multiple interactions
increases expression 		EXP Dexamethasone affects the expression of APOA1 mRNA
[fenofibric acid co-treated with Dexamethasone] results in increased expression of APOA1 mRNA; fenofibric acid inhibits the reaction [Dexamethasone results in increased expression of APOA1 mRNA] 		CTD PMID:7556148 PMID:11328961 PMID:15102944 NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729 		JBrowse link
G Apoa4 apolipoprotein A4 affects expression
increases expression 		EXP Dexamethasone affects the expression of APOA4 mRNA
Dexamethasone results in increased expression of APOA4 mRNA 		CTD PMID:11328961 PMID:15102944 NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164 		JBrowse link
G Apob apolipoprotein B increases expression
affects expression 		EXP Dexamethasone results in increased expression of APOB protein
Dexamethasone affects the expression of APOB mRNA; Dexamethasone affects the expression of APOB protein 		CTD PMID:15965953 PMID:32234517 NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814 		JBrowse link
G Apobec1 apolipoprotein B mRNA editing enzyme catalytic subunit 1 increases expression ISO Dexamethasone results in increased expression of APOBEC1 mRNA CTD PMID:22733784 NCBI chr 4:157,472,879...157,500,496
Ensembl chr 4:157,472,868...157,498,909 		JBrowse link
G Apoc1 apolipoprotein C1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of APOC1 mRNA CTD PMID:28628672 NCBI chr 1:88,475,018...88,479,052
Ensembl chr 1:88,474,663...88,478,155 		JBrowse link
G Apoc3 apolipoprotein C3 increases expression
multiple interactions 		ISO
EXP 		Dexamethasone results in increased expression of APOC3 mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of APOC3 mRNA]
pirinixic acid inhibits the reaction [Dexamethasone results in increased expression of APOC3 mRNA] 		CTD PMID:11162775 PMID:20032058 NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:55,428,024...55,458,679 		JBrowse link
G Apod apolipoprotein D multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of APOD mRNA CTD PMID:28628672 NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263 		JBrowse link
G Apoe apolipoprotein E increases expression ISO Dexamethasone results in increased expression of APOE mRNA CTD PMID:21041162 PMID:25047013 NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855 		JBrowse link
G Apol9a apolipoprotein L9a decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of APOL9A mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of APOL4 mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr 7:111,021,452...111,030,380
Ensembl chr 7:111,021,453...111,028,213 		JBrowse link
G Apoo apolipoprotein O multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of APOO mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of APOO mRNA CTD PMID:28628672 NCBI chr  X:63,151,736...63,256,696
Ensembl chr  X:63,151,814...63,256,690 		JBrowse link
G App amyloid beta precursor protein multiple interactions EXP [APP protein alternative form co-treated with Dexamethasone] results in decreased expression of ADAM10 mRNA; [APP protein alternative form co-treated with Dexamethasone] results in increased expression of APP mRNA; [APP protein alternative form co-treated with Dexamethasone] results in increased expression of APP protein; [APP protein alternative form co-treated with Dexamethasone] results in increased expression of APP protein alternative form; [APP protein alternative form co-treated with Dexamethasone] results in increased expression of BACE1 mRNA; ginsenoside Rg1 inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in decreased expression of ADAM10 mRNA]; ginsenoside Rg1 inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in increased expression of APP mRNA]; ginsenoside Rg1 inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in increased expression of APP protein alternative form]; ginsenoside Rg1 inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in increased expression of APP protein]; ginsenoside Rg1 inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in increased expression of BACE1 mRNA]; ginsenoside Rg1 results in decreased susceptibility to [APP protein alternative form co-treated with Dexamethasone]; Huang Qi inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in decreased expression of ADAM10 mRNA]; Huang Qi inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in increased expression of APP mRNA]; Huang Qi inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in increased expression of APP protein alternative form]; Huang Qi inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in increased expression of APP protein]; Huang Qi inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in increased expression of BACE1 mRNA]; Huang Qi results in decreased susceptibility to [APP protein alternative form co-treated with Dexamethasone] CTD PMID:22484447 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971 		JBrowse link
G Appl1 adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of APPL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of APPL1 mRNA CTD PMID:28628672 NCBI chr16:2,125,234...2,173,457
Ensembl chr16:2,125,234...2,173,421 		JBrowse link
G Aqp1 aquaporin 1 decreases expression ISO Dexamethasone results in decreased expression of AQP1 mRNA CTD PMID:22733784 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions
increases expression 		ISO Dexamethasone promotes the reaction [AQP3 protein results in increased transport of Water]; Mercuric Chloride inhibits the reaction [Dexamethasone promotes the reaction [AQP3 protein results in increased transport of Water]]
Dexamethasone results in increased expression of AQP3 mRNA; Dexamethasone results in increased expression of AQP3 protein 		CTD PMID:9374739 NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685 		JBrowse link
G Aqp5 aquaporin 5 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of AQP5 mRNA
Dexamethasone inhibits the reaction [bisphenol A results in decreased expression of AQP5 protein] 		CTD PMID:22733784 PMID:26283537 NCBI chr 7:132,601,528...132,605,060
Ensembl chr 7:132,601,059...132,605,062 		JBrowse link
G Aqp7 aquaporin 7 increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of AQP7 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AQP7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AQP7 mRNA 		CTD PMID:14618091 PMID:19853017 PMID:25047013 PMID:28628672 NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618 		JBrowse link
G Ar androgen receptor affects activity
multiple interactions
affects binding
decreases expression 		ISO
EXP 		Dexamethasone affects the activity of AR protein
Dexamethasone inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; Dexamethasone inhibits the reaction [Metribolone results in increased activity of AR protein]
Dexamethasone binds to AR protein
Dexamethasone results in decreased expression of AR mRNA
[Testosterone binds to AR protein] inhibits the reaction [Dexamethasone results in increased expression of DDIT4 mRNA]; bicalutamide inhibits the reaction [[Testosterone binds to AR protein] inhibits the reaction [Dexamethasone results in increased expression of DDIT4 mRNA]]
Dexamethasone binds to AR protein mutant form 		CTD PMID:11956172 PMID:14565775 PMID:15084347 PMID:18324785 PMID:19681914 More... NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Araf A-Raf proto-oncogene, serine/threonine kinase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARAF mRNA; Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to ARAF protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [EGF protein promotes the reaction [EGFR protein binds to ARAF protein]]] CTD PMID:10807665 PMID:28628672 NCBI chr  X:3,780,932...3,845,919
Ensembl chr  X:3,780,932...3,792,611 		JBrowse link
G Areg amphiregulin multiple interactions
decreases expression 		ISO
EXP 		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AREG mRNA
Dexamethasone results in decreased expression of AREG mRNA 		CTD PMID:12837037 PMID:28628672 NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641 		JBrowse link
G Arf1 ARF GTPase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ARF1 mRNA CTD PMID:28628672 NCBI chr10:44,497,543...44,513,994 JBrowse link
G Arf2 ADP-ribosylation factor 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARL17B mRNA CTD PMID:28628672 NCBI chr10:89,367,843...89,389,644
Ensembl chr10:89,368,044...89,389,651 		JBrowse link
G Arf3 ARF GTPase 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ARF3 mRNA CTD PMID:28628672 NCBI chr 7:131,765,039...131,792,075
Ensembl chr 7:131,750,672...131,770,123 		JBrowse link
G Arg2 arginase 2 increases expression
multiple interactions 		EXP Dexamethasone results in increased expression of ARG2 mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of ARG2 mRNA] 		CTD PMID:14618091 PMID:20032058 NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375 		JBrowse link
G Arglu1 arginine and glutamate rich 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARGLU1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARGLU1 mRNA CTD PMID:28628672 NCBI chr16:87,455,097...87,479,148
Ensembl chr16:87,455,113...87,479,148 		JBrowse link
G Arhgap10 Rho GTPase activating protein 10 increases expression ISO Dexamethasone results in increased expression of ARHGAP10 mRNA CTD PMID:17998272 PMID:22733784 NCBI chr19:47,352,783...47,614,532
Ensembl chr19:47,352,276...47,614,531 		JBrowse link
G Arhgap20 Rho GTPase activating protein 20 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ARHGAP20 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARHGAP20 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 8:60,970,480...61,055,199
Ensembl chr 8:60,970,475...61,055,198 		JBrowse link
G Arhgap22 Rho GTPase activating protein 22 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of ARHGAP22 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARHGAP22 mRNA 		CTD PMID:22733784 PMID:25047013 PMID:28628672 NCBI chr16:8,480,222...8,637,823
Ensembl chr16:8,479,956...8,637,822 		JBrowse link
G Arhgap29 Rho GTPase activating protein 29 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARHGAP29 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ARHGAP29 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARHGAP29 mRNA CTD PMID:28628672 NCBI chr 2:212,744,626...212,816,710
Ensembl chr 2:212,755,803...212,986,729 		JBrowse link
G Arhgap30 Rho GTPase activating protein 30 increases expression ISO Dexamethasone results in increased expression of ARHGAP30 mRNA CTD PMID:17998272 NCBI chr13:86,354,448...86,376,552
Ensembl chr13:86,354,547...86,376,888 		JBrowse link
G Arhgap39 Rho GTPase activating protein 39 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGAP39 mRNA CTD PMID:28628672 NCBI chr 7:110,326,918...110,419,500
Ensembl chr 7:110,326,918...110,419,460 		JBrowse link
G Arhgap45 Rho GTPase activating protein 45 decreases expression ISO Dexamethasone results in decreased expression of ARHGAP45 mRNA CTD PMID:21621594 NCBI chr 7:10,325,515...10,340,955
Ensembl chr 7:10,325,539...10,341,890 		JBrowse link
G Arhgap5 Rho GTPase activating protein 5 multiple interactions ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ARHGAP5 mRNA; EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ARHGAP5 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ARHGAP5 mRNA] CTD PMID:16054899 NCBI chr 6:75,711,199...75,774,636
Ensembl chr 6:75,711,515...75,774,636 		JBrowse link
G Arhgap6 Rho GTPase activating protein 6 increases expression ISO Dexamethasone results in increased expression of ARHGAP6 mRNA CTD PMID:25047013 NCBI chr  X:28,525,912...29,062,344
Ensembl chr  X:28,525,917...29,061,244 		JBrowse link
G Arhgef1 Rho guanine nucleotide exchange factor 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ARHGEF1 mRNA CTD PMID:28628672 NCBI chr 1:89,626,884...89,648,823
Ensembl chr 1:89,628,266...89,649,067 		JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of ARHGEF2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGEF2 mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646 		JBrowse link
G Arhgef28 Rho guanine nucleotide exchange factor 28 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ARHGEF28 mRNA CTD PMID:28628672 NCBI chr 2:30,998,292...31,294,757
Ensembl chr 2:30,998,295...31,294,853 		JBrowse link
G Arhgef9 Cdc42 guanine nucleotide exchange factor 9 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARHGEF9 mRNA CTD PMID:28628672 NCBI chr  X:63,929,168...64,087,267
Ensembl chr  X:63,929,176...64,087,104 		JBrowse link
G Arid2 AT-rich interaction domain 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ARID2 mRNA CTD PMID:28628672 NCBI chr 7:129,326,371...129,443,813
Ensembl chr 7:129,324,137...129,443,187 		JBrowse link
G Arid5a AT-rich interaction domain 5A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARID5A mRNA CTD PMID:28628672 NCBI chr 9:46,030,513...46,058,729
Ensembl chr 9:46,030,548...46,045,363 		JBrowse link
G Arid5b AT-rich interaction domain 5B increases expression ISO Dexamethasone results in increased expression of ARID5B mRNA CTD PMID:22733784 NCBI chr20:20,305,693...20,489,689
Ensembl chr20:20,306,712...20,489,686 		JBrowse link
G Arih2 ariadne RBR E3 ubiquitin protein ligase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARIH2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA CTD PMID:28628672 NCBI chr 8:118,175,267...118,234,425
Ensembl chr 8:118,175,267...118,234,284 		JBrowse link
G Arl2bp ARF like GTPase 2 binding protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ARL2BP mRNA CTD PMID:28628672 NCBI chr19:10,342,895...10,352,529
Ensembl chr19:10,342,895...10,352,514 		JBrowse link
G Arl4c ARF like GTPase 4C decreases expression ISO Dexamethasone results in decreased expression of ARL4C mRNA CTD PMID:22733784 NCBI chr 9:96,748,075...96,751,510
Ensembl chr 9:96,745,069...96,752,772 		JBrowse link
G Arl6ip4 ARF like GTPase 6 interacting protein 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ARL6IP4 mRNA CTD PMID:28628672 NCBI chr12:38,140,566...38,142,711
Ensembl chr12:38,140,550...38,142,724 		JBrowse link
G Arl8a ARF like GTPase 8A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ARL8A mRNA CTD PMID:28628672 NCBI chr13:49,137,632...49,146,633
Ensembl chr13:49,137,632...49,146,633 		JBrowse link
G Armc9 armadillo repeat containing 9 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ARMC9 mRNA CTD PMID:28628672 NCBI chr 9:94,250,492...94,376,589
Ensembl chr 9:94,250,859...94,376,589 		JBrowse link
G Armcx1 armadillo repeat containing, X-linked 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARMCX1 mRNA CTD PMID:28628672 NCBI chr  X:102,192,225...102,196,130
Ensembl chr  X:102,192,015...102,199,115 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator increases expression EXP Dexamethasone results in increased expression of ARNT mRNA CTD PMID:19615983 NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546 		JBrowse link
G Arnt2 aryl hydrocarbon receptor nuclear translocator 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARNT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ARNT2 mRNA CTD PMID:28628672 NCBI chr 1:147,645,354...147,801,986
Ensembl chr 1:147,599,058...147,801,997 		JBrowse link
G Arpc1b actin related protein 2/3 complex, subunit 1B multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ARPC1B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARPC1B mRNA CTD PMID:28628672 NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504 		JBrowse link
G Arpc3 actin related protein 2/3 complex, subunit 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ARPC3 mRNA CTD PMID:28628672 NCBI chr12:39,833,569...39,847,436
Ensembl chr12:39,833,569...39,847,436 		JBrowse link
G Arpc5 actin related protein 2/3 complex, subunit 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARPC5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARPC5 mRNA CTD PMID:28628672 NCBI chr13:67,454,379...67,463,288
Ensembl chr13:67,437,027...67,463,283 		JBrowse link
G Arpc5l actin related protein 2/3 complex, subunit 5-like multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARPC5L mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ARPC5L mRNA CTD PMID:28628672 NCBI chr 3:43,169,518...43,177,224
Ensembl chr 3:43,169,462...43,177,240
Ensembl chr 9:43,169,462...43,177,240 		JBrowse link
G Arpp21 cAMP regulated phosphoprotein 21 decreases expression ISO Dexamethasone results in decreased expression of ARPP21 mRNA CTD PMID:22733784 NCBI chr 8:120,912,964...121,077,586
Ensembl chr 8:120,912,970...121,031,357 		JBrowse link
G Arrdc2 arrestin domain containing 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARRDC2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ARRDC2 mRNA CTD PMID:28628672 NCBI chr16:18,635,883...18,640,019
Ensembl chr16:18,635,883...18,640,158 		JBrowse link
G Arsg arylsulfatase G multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ARSG mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARSG mRNA CTD PMID:28628672 NCBI chr10:94,912,094...95,063,021
Ensembl chr10:94,913,152...95,042,447 		JBrowse link
G Art1 ADP-ribosyltransferase 1 multiple interactions
increases expression 		EXP
ISO 		Testosterone inhibits the reaction [Dexamethasone results in increased expression of ART1 mRNA] CTD PMID:20032058 PMID:22733784 NCBI chr 1:165,890,032...165,899,154
Ensembl chr 1:165,890,086...165,899,146 		JBrowse link
G Art3 ADP-ribosyltransferase 3 increases expression ISO Dexamethasone results in increased expression of ART3 mRNA CTD PMID:22733784 NCBI chr14:15,921,540...16,003,764
Ensembl chr14:15,921,395...15,949,806 		JBrowse link
G Art5 ADP-ribosyltransferase 5 increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of ART5 mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of ART5 mRNA] 		CTD PMID:20032058 PMID:22733784 NCBI chr 1:165,885,344...165,895,306
Ensembl chr 1:165,885,280...165,895,306 		JBrowse link
G Artn artemin decreases expression ISO Dexamethasone results in decreased expression of ARTN mRNA CTD PMID:22733784 NCBI chr 5:136,750,188...136,755,645
Ensembl chr 5:136,750,188...136,753,457 		JBrowse link
G Asah2 N-acylsphingosine amidohydrolase 2 decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of ASAH2 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of ASAH2 mRNA] 		CTD PMID:20032058 NCBI chr 1:239,278,994...239,386,598
Ensembl chr 1:239,278,994...239,382,024 		JBrowse link
G Asb1 ankyrin repeat and SOCS box-containing 1 decreases expression ISO Dexamethasone results in decreased expression of ASB1 mRNA CTD PMID:25047013 NCBI chr 9:99,566,852...99,588,321
Ensembl chr 9:99,567,867...99,583,907 		JBrowse link
G Asb2 ankyrin repeat and SOCS box-containing 2 increases expression ISO Dexamethasone results in increased expression of ASB2 mRNA CTD PMID:22733784 NCBI chr 6:128,239,550...128,275,833
Ensembl chr 6:128,239,552...128,266,321 		JBrowse link
G Asb7 ankyrin repeat and SOCS box-containing 7 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASB7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASB7 mRNA CTD PMID:28628672 NCBI chr 1:129,621,462...129,677,788
Ensembl chr 1:129,635,330...129,677,505 		JBrowse link
G Ascc3 activating signal cointegrator 1 complex subunit 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ASCC3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASCC3 mRNA CTD PMID:28628672 NCBI chr20:55,089,430...55,372,374
Ensembl chr20:55,255,503...55,372,374 		JBrowse link
G Asic1 acid sensing ion channel subunit 1 decreases expression EXP Dexamethasone results in decreased expression of ASIC1 mRNA CTD PMID:11588175 NCBI chr 7:132,677,158...132,707,379
Ensembl chr 7:132,698,723...132,707,832 		JBrowse link
G Asic2 acid sensing ion channel subunit 2 decreases expression EXP Dexamethasone results in decreased expression of ASIC2 mRNA CTD PMID:11588175 NCBI chr10:66,368,308...67,438,237
Ensembl chr10:66,368,310...66,636,245 		JBrowse link
G Asic3 acid sensing ion channel subunit 3 decreases expression EXP Dexamethasone results in decreased expression of ASIC3 mRNA CTD PMID:11588175 NCBI chr 4:11,652,946...11,657,415
Ensembl chr 4:11,652,946...11,657,367 		JBrowse link
G Asl argininosuccinate lyase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ASL mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASL mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASL mRNA CTD PMID:28628672 NCBI chr12:32,295,779...32,313,257
Ensembl chr12:32,295,633...32,317,261 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) decreases expression ISO Dexamethasone results in decreased expression of ASNS mRNA CTD PMID:22733784 PMID:25047013 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Aspa aspartoacylase multiple interactions
increases expression 		ISO [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ASPA mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ASPA mRNA
Dexamethasone results in increased expression of ASPA mRNA 		CTD PMID:24848799 PMID:25047013 PMID:28628672 NCBI chr10:58,390,204...58,443,790
Ensembl chr10:58,379,410...58,443,769 		JBrowse link
G Asph aspartate-beta-hydroxylase increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of ASPH mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASPH mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr 5:27,398,933...27,611,519
Ensembl chr 5:27,398,949...27,611,215 		JBrowse link
G Aspn asporin multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ASPN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ASPN mRNA CTD PMID:28628672 NCBI chr17:15,286,338...15,310,567
Ensembl chr17:15,287,065...15,310,632 		JBrowse link
G Asprv1 aspartic peptidase, retroviral-like 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ASPRV1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ASPRV1 mRNA CTD PMID:28628672 NCBI chr 4:120,634,793...120,636,265
Ensembl chr 4:120,634,793...120,636,260 		JBrowse link
G Aspscr1 ASPSCR1 tether for SLC2A4, UBX domain containing multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ASPSCR1 mRNA CTD PMID:28628672 NCBI chr10:106,450,600...106,488,231
Ensembl chr10:106,450,567...106,488,579 		JBrowse link
G Asrgl1 asparaginase and isoaspartyl peptidase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ASRGL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASRGL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASRGL1 mRNA CTD PMID:28628672 NCBI chr 1:215,436,180...215,456,188
Ensembl chr 1:215,435,218...215,456,198 		JBrowse link
G Ass1 argininosuccinate synthase 1 increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of ASS1 mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of ASS1 mRNA] 		CTD PMID:20032058 PMID:25047013 NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627 		JBrowse link
G Asxl2 ASXL transcriptional regulator 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA CTD PMID:28628672 NCBI chr 6:32,090,497...32,234,487
Ensembl chr 6:32,145,607...32,227,851 		JBrowse link
G Atad2 ATPase family, AAA domain containing 2 multiple interactions ISO [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA CTD PMID:26424790 NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:91,523,626...91,566,238 		JBrowse link
G Atad2b ATPase family, AAA domain containing 2B multiple interactions ISO [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of ATAD2B mRNA CTD PMID:26424790 NCBI chr 6:33,646,075...33,789,532
Ensembl chr 6:33,646,075...33,789,532 		JBrowse link
G Atcay ATCAY kinesin light chain interacting caytaxin decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of ATCAY mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of ATCAY mRNA] 		CTD PMID:20032058 NCBI chr 7:9,138,485...9,162,249
Ensembl chr 7:9,138,587...9,163,370 		JBrowse link
G Atf3 activating transcription factor 3 decreases expression ISO Dexamethasone results in decreased expression of ATF3 mRNA CTD PMID:22733784 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atf4 activating transcription factor 4 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of ATF4 mRNA
Dexamethasone inhibits the reaction [[Ovalbumin co-treated with aluminum sulfate] results in increased expression of ATF4 mRNA] 		CTD PMID:22733784 PMID:27660012 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atf5 activating transcription factor 5 decreases expression ISO Dexamethasone results in decreased expression of ATF5 mRNA CTD PMID:22733784 PMID:25047013 NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183 		JBrowse link
G Atf6 activating transcription factor 6 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATF6 mRNA CTD PMID:28628672 NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033 		JBrowse link
G Atg14 autophagy related 14 increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of ATG14 protein
5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid inhibits the reaction [Dexamethasone results in increased expression of ATG14 protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of ATG14 protein] 		CTD PMID:33359579 NCBI chr15:23,275,457...23,306,817
Ensembl chr15:23,275,457...23,306,815 		JBrowse link
G Atg5 autophagy related 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ATG5 mRNA CTD PMID:28628672 NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821 		JBrowse link
G Atg7 autophagy related 7 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATG7 mRNA CTD PMID:28628672 NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:149,391,390...149,598,319 		JBrowse link
G Atl3 atlastin GTPase 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATL3 mRNA CTD PMID:28628672 NCBI chr 1:214,110,127...214,151,098
Ensembl chr 1:214,109,702...214,152,510 		JBrowse link
G Atosa atos homolog A multiple interactions
increases expression 		ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATOSA mRNA
Dexamethasone results in increased expression of ATOSA mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr 8:84,575,360...84,653,103
Ensembl chr 8:84,575,370...84,653,091 		JBrowse link
G Atp13a3 ATPase 13A3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ATP13A3 mRNA CTD PMID:28628672 NCBI chr11:83,860,725...83,946,899
Ensembl chr11:83,870,218...83,944,662 		JBrowse link
G Atp1a2 ATPase Na+/K+ transporting subunit alpha 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ATP1A2 mRNA CTD PMID:28628672 NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911 		JBrowse link
G Atp1b2 ATPase Na+/K+ transporting subunit beta 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP1B2 mRNA CTD PMID:28628672 NCBI chr10:54,817,473...54,823,708
Ensembl chr10:54,817,476...54,823,708 		JBrowse link
G Atp1b3 ATPase Na+/K+ transporting subunit beta 3 increases expression ISO Dexamethasone results in increased expression of ATP1B3 mRNA CTD PMID:25047013 NCBI chr 8:105,789,824...105,821,151
Ensembl chr 8:65,253,361...65,254,304
Ensembl chr 8:65,253,361...65,254,304 		JBrowse link
G Atp2a1 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 increases expression
decreases expression 		EXP
ISO 		Dexamethasone results in increased expression of ATP2A1 mRNA
Dexamethasone results in decreased expression of ATP2A1 protein 		CTD PMID:14618091 PMID:33567340 NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:190,457,198...190,475,423 		JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 multiple interactions
increases expression 		ISO Dexamethasone promotes the reaction [Lipopolysaccharides results in increased expression of ATP2A2 mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP2A2 mRNA
Dexamethasone results in increased expression of ATP2A2 mRNA 		CTD PMID:22185406 PMID:28628672 NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934 		JBrowse link
G Atp2b4 ATPase plasma membrane Ca2+ transporting 4 increases expression ISO Dexamethasone results in increased expression of ATP2B4 mRNA CTD PMID:25047013 NCBI chr13:47,708,157...47,807,389
Ensembl chr13:47,711,121...47,758,876 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha increases expression
multiple interactions
decreases expression 		ISO Dexamethasone results in increased expression of ATP5F1A mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP5F1A mRNA
Dexamethasone results in decreased expression of ATP5F1A protein 		CTD PMID:25047013 PMID:28628672 PMID:33567340 NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922 		JBrowse link
G Atp5f1b ATP synthase F1 subunit beta decreases expression ISO Dexamethasone results in decreased expression of ATP5F1B protein CTD PMID:33567340 NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462 		JBrowse link
G Atp5f1d ATP synthase F1 subunit delta multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATP5F1D mRNA CTD PMID:28628672 NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583 		JBrowse link
G Atp5mf ATP synthase membrane subunit f multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP5MF mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ATP5MF mRNA CTD PMID:28628672 NCBI chr12:14,535,435...14,542,007
Ensembl chr12:14,522,832...14,542,709 		JBrowse link
G Atp6ap1 ATPase H+ transporting accessory protein 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP6AP1 mRNA CTD PMID:28628672 NCBI chr  X:157,231,243...157,238,323
Ensembl chr  X:157,225,327...157,238,323 		JBrowse link
G Atp6ap1l ATPase H+ transporting accessory protein 1 like multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATP6AP1L mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP6AP1L mRNA CTD PMID:28628672 NCBI chr 2:23,772,724...23,814,913
Ensembl chr 2:23,772,745...23,814,618 		JBrowse link
G Atp6ap2 ATPase H+ transporting accessory protein 2 decreases expression ISO Dexamethasone results in decreased expression of ATP6AP2 mRNA CTD PMID:19853017 NCBI chr  X:12,856,708...12,883,670
Ensembl chr  X:12,855,859...12,905,875 		JBrowse link
G Atp6v0a1 ATPase H+ transporting V0 subunit a1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP6V0A1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATP6V0A1 mRNA CTD PMID:28628672 NCBI chr10:86,436,089...86,490,185
Ensembl chr10:86,436,141...86,490,181 		JBrowse link
G Atp6v0b ATPase H+ transporting V0 subunit B multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP6V0B mRNA CTD PMID:28628672 NCBI chr 5:136,708,823...136,710,339
Ensembl chr 5:136,708,823...136,716,828 		JBrowse link
G Atp6v0d1 ATPase H+ transporting V0 subunit D1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP6V0D1 mRNA CTD PMID:28628672 NCBI chr19:50,313,268...50,357,248
Ensembl chr19:50,313,273...50,357,395 		JBrowse link
G Atp6v1h ATPase H+ transporting V1 subunit H decreases expression ISO Dexamethasone results in decreased expression of ATP6V1H mRNA CTD PMID:22185406 NCBI chr 5:19,176,849...19,282,516
Ensembl chr 5:19,176,849...19,282,516 		JBrowse link
G Atxn2 ataxin 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATXN2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATXN2 mRNA CTD PMID:28628672 NCBI chr12:40,413,657...40,509,895
Ensembl chr12:40,414,904...40,510,473 		JBrowse link
G Atxn7l1 ataxin 7-like 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATXN7L1 mRNA CTD PMID:28628672 NCBI chr 6:55,487,309...55,709,751
Ensembl chr 6:55,649,362...55,701,996 		JBrowse link
G Avp arginine vasopressin multiple interactions
decreases expression
increases activity 		EXP Dexamethasone inhibits the reaction [AVP protein results in increased abundance of 6-Ketoprostaglandin F1 alpha]; Dexamethasone inhibits the reaction [AVP protein results in increased abundance of Dinoprostone]; Dexamethasone inhibits the reaction [Phenylephrine results in increased secretion of AVP protein]; Enalapril promotes the reaction [Dexamethasone results in increased activity of AVP protein]; Hexamethonium promotes the reaction [Dexamethasone results in increased activity of AVP protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of AVP mRNA] CTD PMID:2271928 PMID:3346065 PMID:4030047 PMID:32445661 NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:138,246,554...138,248,522 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of AZGP1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of AZGP1 mRNA 		CTD PMID:19853017 PMID:28628672 NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020 		JBrowse link
G Azin2 antizyme inhibitor 2 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of AZIN2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AZIN2 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 5:146,568,187...146,594,777
Ensembl chr 5:146,565,437...146,594,777 		JBrowse link
G B2m beta-2 microglobulin decreases expression
increases expression 		ISO Dexamethasone results in decreased expression of B2M protein
Dexamethasone results in increased expression of B2M mRNA 		CTD PMID:3047540 PMID:21041162 NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356 		JBrowse link
G B3galnt2 beta-1,3-N-acetylgalactosaminyltransferase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of B3GALNT2 mRNA CTD PMID:28628672 NCBI chr17:56,030,409...56,072,952
Ensembl chr17:56,030,409...56,072,952 		JBrowse link
G B3galt4 Beta-1,3-galactosyltransferase 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B3GALT4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B3GALT4 mRNA CTD PMID:28628672 NCBI chr20:4,937,974...4,939,549
Ensembl chr20:4,937,674...4,939,885 		JBrowse link
G B3gnt2 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B3GNT2 mRNA CTD PMID:28628672 NCBI chr14:101,009,682...101,034,507
Ensembl chr14:100,967,131...101,043,412 		JBrowse link
G B3gnt5 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of B3GNT5 mRNA CTD PMID:28628672 NCBI chr11:94,645,480...94,657,584
Ensembl chr11:94,645,480...94,660,514 		JBrowse link
G B3gnt9 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of B3GNT9 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B3GNT9 mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr19:50,039,649...50,042,206
Ensembl chr19:50,030,866...50,043,339 		JBrowse link
G B4galt1 beta-1,4-galactosyltransferase 1 decreases expression ISO Dexamethasone results in decreased expression of B4GALT1 mRNA CTD PMID:25047013 NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:60,731,602...60,778,445 		JBrowse link
G B4galt5 beta-1,4-galactosyltransferase 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of B4GALT5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B4GALT5 mRNA CTD PMID:28628672 NCBI chr 3:176,437,073...176,453,001
Ensembl chr 3:176,437,073...176,488,978 		JBrowse link
G B4galt6 beta-1,4-galactosyltransferase 6 decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of B4GALT6 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of B4GALT6 mRNA] 		CTD PMID:20032058 NCBI chr18:12,233,350...12,290,204
Ensembl chr18:12,233,351...12,290,204 		JBrowse link
G B4galt7 beta-1,4-galactosyltransferase 7 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of B4GALT7 mRNA CTD PMID:28628672 NCBI chr17:9,023,667...9,032,742
Ensembl chr17:9,023,618...9,032,745 		JBrowse link
G Bacc1 BPTF associated chromatin complex component 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BACC1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BACC1 mRNA CTD PMID:28628672 NCBI chr10:55,450,648...55,453,409
Ensembl chr10:55,450,250...55,453,311 		JBrowse link
G Bace1 beta-secretase 1 multiple interactions EXP [APP protein alternative form co-treated with Dexamethasone] results in increased expression of BACE1 mRNA; ginsenoside Rg1 inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in increased expression of BACE1 mRNA]; Huang Qi inhibits the reaction [[APP protein alternative form co-treated with Dexamethasone] results in increased expression of BACE1 mRNA] CTD PMID:22484447 NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918 		JBrowse link
G Bad BCL2-associated agonist of cell death decreases phosphorylation
increases phosphorylation
multiple interactions
increases expression 		ISO Dexamethasone results in decreased phosphorylation of BAD protein
Dexamethasone results in increased phosphorylation of BAD protein
Mifepristone inhibits the reaction [Dexamethasone results in decreased phosphorylation of BAD protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BAD mRNA]; MK 2206 inhibits the reaction [Dexamethasone results in increased phosphorylation of BAD protein]; naringin inhibits the reaction [Dexamethasone results in increased phosphorylation of BAD protein] 		CTD PMID:16644695 PMID:30878453 NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bag2 BAG cochaperone 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BAG2 mRNA CTD PMID:28628672 NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752 		JBrowse link
G Bag4 BAG cochaperone 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BAG4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BAG4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BAG4 mRNA CTD PMID:28628672 NCBI chr16:72,991,407...73,008,620
Ensembl chr16:72,991,362...73,013,273 		JBrowse link
G Bag5 BAG cochaperone 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BAG5 mRNA CTD PMID:28628672 NCBI chr 6:136,589,623...136,593,278
Ensembl chr 6:136,584,741...136,598,492 		JBrowse link
G Bag6 BAG cochaperone 6 decreases expression ISO Dexamethasone results in decreased expression of BAG6 mRNA CTD PMID:25047013 NCBI chr20:3,680,607...3,693,329
Ensembl chr20:3,680,607...3,693,329 		JBrowse link
G Baiap2l2 BAR/IMD domain containing adaptor protein 2 like 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BAIAP2L2 mRNA CTD PMID:28628672 NCBI chr 7:112,704,798...112,731,691
Ensembl chr 7:112,704,682...112,731,127 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 increases expression
multiple interactions 		ISO
EXP 		Dexamethasone results in increased expression of BAK1 mRNA; Dexamethasone results in increased expression of BAK1 protein
fludarabine inhibits the reaction [Dexamethasone results in increased expression of BAK1 protein] 		CTD PMID:19428934 PMID:30506661 NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974 		JBrowse link
G Bambi BMP and activin membrane-bound inhibitor decreases expression ISO Dexamethasone results in decreased expression of BAMBI mRNA CTD PMID:17998272 NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247 		JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 multiple interactions
decreases expression 		EXP Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BASP1 mRNA] CTD PMID:20032058 NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
increases expression 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [echinacoside inhibits the reaction [Dexamethasone results in increased expression of BAX protein]]; [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with [Dexamethasone co-treated with INS protein co-treated with PRL protein]] results in decreased expression of BAX protein; Dexamethasone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of BAX mRNA]; Dexamethasone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of BAX protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of BAX protein]; Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of BAX protein]; echinacoside inhibits the reaction [Dexamethasone results in increased expression of BAX protein]; naringin inhibits the reaction [Dexamethasone results in increased expression of BAX protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BAX mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BAX mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BAX mRNA
Dexamethasone results in increased expression of BAX mRNA; Dexamethasone results in increased expression of BAX protein
Dexamethasone inhibits the reaction [TGFB1 protein results in increased expression of BAX protein]; fludarabine inhibits the reaction [Dexamethasone results in increased expression of BAX protein] 		CTD PMID:9790906 PMID:11751460 PMID:15987750 PMID:19080409 PMID:23935943 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Baz2a bromodomain adjacent to zinc finger domain, 2A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BAZ2A mRNA CTD PMID:28628672 NCBI chr 7:1,107,377...1,145,507
Ensembl chr 7:1,107,796...1,145,507 		JBrowse link
G Bbc3 Bcl-2 binding component 3 increases expression
decreases expression 		ISO Dexamethasone results in increased expression of BBC3 mRNA
Dexamethasone results in decreased expression of BBC3 mRNA 		CTD PMID:22733784 PMID:25047013 NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666 		JBrowse link
G Bbip1 BBSome interacting protein 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BBIP1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BBIP1 mRNA CTD PMID:28628672 NCBI chr 1:262,950,459...262,964,410
Ensembl chr 1:262,950,462...262,964,394 		JBrowse link
G Bbln bublin coiled coil protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BBLN mRNA CTD PMID:28628672 NCBI chr 3:36,072,325...36,075,070
Ensembl chr 3:36,072,328...36,075,093 		JBrowse link
G Bbof1 basal body orientation factor 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BBOF1 mRNA CTD PMID:28628672 NCBI chr 6:109,786,363...109,812,153
Ensembl chr 6:109,786,363...109,812,147 		JBrowse link
G Bbs1 Bardet-Biedl syndrome 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BBS1 mRNA CTD PMID:28628672 NCBI chr 1:211,614,195...211,633,504
Ensembl chr 1:211,615,533...211,633,468 		JBrowse link
G Bbs7 Bardet-Biedl syndrome 7 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BBS7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BBS7 mRNA CTD PMID:28628672 NCBI chr 2:121,362,884...121,402,473
Ensembl chr 2:121,362,885...121,402,473 		JBrowse link
G Bcap31 B-cell receptor-associated protein 31 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCAP31 mRNA CTD PMID:28628672 NCBI chr  X:156,548,911...156,581,002
Ensembl chr  X:156,548,911...156,579,371 		JBrowse link
G Bcas3 BCAS3, microtubule associated cell migration factor multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCAS3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCAS3 mRNA CTD PMID:28628672 NCBI chr10:70,711,084...71,170,492
Ensembl chr10:70,711,525...71,170,803 		JBrowse link
G Bcat1 branched chain amino acid transaminase 1 decreases expression ISO Dexamethasone results in decreased expression of BCAT1 mRNA CTD PMID:22733784 NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288 		JBrowse link
G Bcat2 branched chain amino acid transaminase 2 increases expression ISO Dexamethasone results in increased expression of BCAT2 mRNA CTD PMID:22733784 NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463 		JBrowse link
G Bcdin3d BCDIN3 domain containing RNA methyltransferase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCDIN3D mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BCDIN3D mRNA CTD PMID:28628672 NCBI chr 7:132,484,404...132,488,998
Ensembl chr 7:132,484,431...132,488,998 		JBrowse link
G Bche butyrylcholinesterase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCHE mRNA CTD PMID:28628672 NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
decreases response to substance
increases expression
decreases expression
increases response to substance 		ISO
EXP 		[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BCL2 mRNA; [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 mRNA; [oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 protein; Dexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA]; Dexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]; Dexamethasone inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BCL2]; Mycophenolic Acid inhibits the reaction [BCL2 protein results in decreased susceptibility to Dexamethasone]
Dexamethasone results in increased expression of BCL2 mRNA
Dexamethasone results in decreased expression of BCL2 mRNA; Dexamethasone results in decreased expression of BCL2 protein
Dexamethasone results in increased expression of BCL2 protein
Dexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein]; fludarabine inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [echinacoside inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein]]; [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with [Dexamethasone co-treated with INS protein co-treated with PRL protein]] results in increased expression of BCL2 protein; BCL2 gene inhibits the reaction [Dexamethasone results in decreased activity of CAT protein]; BCL2 gene inhibits the reaction [Dexamethasone results in decreased activity of NQO1 protein]; Dexamethasone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of BCL2 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]; echinacoside inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein]; naringin inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein]
Dexamethasone results in increased expression of BCL2; Dexamethasone results in increased expression of BCL2 protein
BCL2 protein results in increased susceptibility to Dexamethasone 		CTD PMID:7517174 PMID:10200551 PMID:11319611 PMID:11751460 PMID:15867202 More... NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2a1 BCL2-related protein A1 increases expression ISO Dexamethasone results in increased expression of BCL2A1B mRNA CTD PMID:21041162 NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890 		JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions
decreases expression
increases expression
increases stability 		ISO
EXP 		Dexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2L1 mRNA]; Dexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2L1 protein]; Dexamethasone inhibits the reaction [Cycloheximide results in increased expression of BCL2L1 protein]; Dexamethasone inhibits the reaction [Dactinomycin results in increased expression of BCL2L1 protein]; Dexamethasone inhibits the reaction [Dichlororibofuranosylbenzimidazole results in increased expression of BCL2L1 protein]
Dexamethasone results in decreased expression of BCL2L1 protein
Dexamethasone results in increased expression of BCL2L1 mRNA
Dexamethasone results in increased expression of BCL2L1 mRNA alternative form; Dexamethasone results in increased expression of BCL2L1 protein alternative form
Dexamethasone results in increased expression of BCL2L1 mRNA alternative form; Dexamethasone results in increased expression of BCL2L1 protein; Dexamethasone results in increased expression of BCL2L1 protein alternative form
2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of BCL2L1 protein]; [Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of BCL2L1 protein; Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein]
Dexamethasone inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 protein alternative form]; Dexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2L1 protein]; Doxorubicin inhibits the reaction [Dexamethasone results in increased expression of BCL2L1 protein]; fludarabine inhibits the reaction [Dexamethasone results in decreased expression of BCL2L1 protein]; Mifepristone affects the reaction [Dexamethasone inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 protein alternative form]]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BCL2L1 protein]
Dexamethasone results in increased stability of BCL2L1 mRNA 		CTD PMID:9326359 PMID:10200566 PMID:11319611 PMID:15388240 PMID:15804364 More... NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bcl2l11 Bcl2-like 11 increases response to substance
increases expression
multiple interactions
increases phosphorylation 		ISO BCL2L11 protein results in increased susceptibility to Dexamethasone
Dexamethasone results in increased expression of BCL2L11 mRNA alternative form; Dexamethasone results in increased expression of BCL2L11 protein
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA; GSTM1 protein inhibits the reaction [Dexamethasone results in increased phosphorylation of BCL2L11 protein]; NR3C1 protein affects the reaction [Dexamethasone results in increased expression of BCL2L11 protein] 		CTD PMID:12782123 PMID:14996839 PMID:17953376 PMID:18515658 PMID:20067466 More... NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695 		JBrowse link
G Bcl2l13 Bcl2-like 13 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCL2L13 mRNA CTD PMID:28628672 NCBI chr 4:155,728,284...155,785,058
Ensembl chr 4:155,728,284...155,781,158 		JBrowse link
G Bcl2l2 Bcl2-like 2 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of BCL2L2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L2 mRNA 		CTD PMID:21041162 PMID:28628672 NCBI chr15:32,326,686...32,337,834
Ensembl chr15:32,326,020...32,335,379 		JBrowse link
G Bcl3 BCL3, transcription coactivator decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of BCL3 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BCL3 mRNA] 		CTD PMID:20032058 PMID:25047013 NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368 		JBrowse link
G Bcl6 BCL6, transcription repressor decreases expression ISO Dexamethasone results in decreased expression of BCL6 mRNA CTD PMID:21041162 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047 		JBrowse link
G Bcl7a BAF chromatin remodeling complex subunit BCL7A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCL7A mRNA CTD PMID:28628672 NCBI chr12:38,872,851...38,904,770
Ensembl chr12:38,872,851...38,904,770 		JBrowse link
G Bcl7b BAF chromatin remodeling complex subunit BCL7B multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL7B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCL7B mRNA CTD PMID:28628672 NCBI chr12:27,133,412...27,146,631
Ensembl chr12:27,133,412...27,146,636 		JBrowse link
G Bclaf1 BCL2-associated transcription factor 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BCLAF1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BCLAF1 mRNA CTD PMID:28628672 NCBI chr 1:16,904,572...16,937,106
Ensembl chr 1:16,914,118...16,936,801 		JBrowse link
G Bcr BCR activator of RhoGEF and GTPase decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of BCR mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BCR mRNA] 		CTD PMID:20032058 NCBI chr20:13,468,732...13,596,333
Ensembl chr20:13,468,732...13,596,333 		JBrowse link
G Bdh1 3-hydroxybutyrate dehydrogenase 1 increases expression ISO Dexamethasone results in increased expression of BDH1 mRNA CTD PMID:25047013 NCBI chr11:82,806,125...82,848,133
Ensembl chr11:82,807,503...82,842,636 		JBrowse link
G Bdh2 3-hydroxybutyrate dehydrogenase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BDH2 mRNA CTD PMID:28628672 NCBI chr 2:226,376,346...226,397,010
Ensembl chr 2:226,376,356...226,397,006 		JBrowse link
G Bdkrb1 bradykinin receptor B1 multiple interactions
decreases expression 		EXP
ISO 		Dexamethasone inhibits the reaction [KNG1 protein binds to and results in increased activity of BDKRB1 protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BDKRB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BDKRB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of BDKRB1 mRNA
Dexamethasone results in decreased expression of BDKRB1 mRNA 		CTD PMID:11159707 PMID:25047013 PMID:28628672 NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973 		JBrowse link
G Bdnf brain-derived neurotrophic factor decreases expression
multiple interactions
decreases acetylation 		ISO
EXP 		Dexamethasone results in decreased expression of BDNF mRNA; Dexamethasone results in decreased expression of BDNF protein
BDNF protein inhibits the reaction [Dexamethasone results in decreased expression of SLC17A7 mRNA]; BDNF protein inhibits the reaction [Dexamethasone results in decreased expression of SLC1A1 mRNA]; BDNF protein inhibits the reaction [Dexamethasone results in increased expression of GAD1 mRNA]; Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF mRNA]; Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF protein]; Dexamethasone promotes the reaction [HDAC2 protein binds to BDNF promoter]; Dexamethasone promotes the reaction [NR3C1 protein binds to BDNF promoter]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in decreased expression of BDNF protein]]; Mifepristone inhibits the reaction [Dexamethasone results in decreased acetylation of BDNF exon]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BDNF mRNA]; romidepsin inhibits the reaction [Dexamethasone results in decreased acetylation of BDNF exon]; romidepsin inhibits the reaction [Dexamethasone results in decreased expression of BDNF mRNA] 		CTD PMID:15215491 PMID:25047013 PMID:29111458 PMID:30628712 PMID:31518422 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Becn1 beclin 1 multiple interactions ISO [Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BECN1 protein
Dexamethasone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of BECN1 protein] 		CTD PMID:23111315 PMID:38729284 NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Best1 bestrophin 1 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of BEST1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BEST1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BEST1 mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr 1:216,054,395...216,071,012
Ensembl chr 1:216,054,395...216,070,974 		JBrowse link
G Best2 bestrophin 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BEST2 mRNA CTD PMID:28628672 NCBI chr19:40,047,191...40,053,216
Ensembl chr19:40,047,191...40,053,216 		JBrowse link
G Bex2 brain expressed X-linked 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BEX1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BEX1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BEX1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of BEX1 mRNA CTD PMID:28628672 NCBI chr  X:103,811,458...103,812,986
Ensembl chr  X:103,808,935...103,812,092 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein multiple interactions
decreases expression 		ISO
EXP 		[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA; [Ascorbic Acid co-treated with Dexamethasone] results in increased expression of BGLAP mRNA; [Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA; [Rutin co-treated with Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased secretion of BGLAP protein; Ammonium Chloride inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA]; bafilomycin A1 inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA]; Bexarotene inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; Chloroquine inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA]; cordycepin inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA]]; dorsomorphin inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA]; Rosiglitazone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; Sirolimus inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA]; tributyltin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]
Dexamethasone results in decreased expression of BGLAP mRNA; Dexamethasone results in decreased expression of BGLAP protein
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP protein]; [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP mRNA; [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of BGLAP protein; [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA; [Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA; [Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP protein; [Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the expression of BGLAP mRNA; Allethrins inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; bisphenol A diglycidyl ether inhibits the reaction [Dexamethasone results in decreased expression of BGLAP mRNA]; bisphenol A diglycidyl ether inhibits the reaction [Dexamethasone results in decreased expression of BGLAP protein]; d,d-T80-prallethrin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; Diethylhexyl Phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the expression of BGLAP mRNA]; mono-(2-ethylhexyl)phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the expression of BGLAP mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP protein]; Pioglitazone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; protosappanin B inhibits the reaction [Dexamethasone results in decreased expression of BGLAP mRNA]; protosappanin B inhibits the reaction [Dexamethasone results in decreased expression of BGLAP protein]; quinoxyfen inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; Rosiglitazone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; Tretinoin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; triphenyltin hydroxide inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; XAV939 inhibits the reaction [protosappanin B inhibits the reaction [Dexamethasone results in decreased expression of BGLAP mRNA]]; XAV939 inhibits the reaction [protosappanin B inhibits the reaction [Dexamethasone results in decreased expression of BGLAP protein]]
[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of BGLAP mRNA; [Simvastatin co-treated with Dexamethasone] results in increased expression of BGLAP; ginsenoside Rg3 inhibits the reaction [Dexamethasone results in decreased expression of BGLAP protein]; Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of BGLAP mRNA]; Quercetin affects the reaction [Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of BGLAP mRNA]] 		CTD PMID:12510807 PMID:19216230 PMID:23111315 PMID:25932594 PMID:26492236 More... NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Bgn biglycan decreases expression ISO Dexamethasone results in decreased expression of BGN mRNA CTD PMID:25047013 NCBI chr  X:156,348,633...156,360,797
Ensembl chr  X:156,348,615...156,360,799 		JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of BHLHE40 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BHLHE40 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BHLHE40 mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783 		JBrowse link
G Bhlhe41 basic helix-loop-helix family, member e41 multiple interactions
decreases expression 		EXP Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BHLHE41 mRNA] CTD PMID:20032058 NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:180,565,003...180,569,355 		JBrowse link
G Bhmt2 betaine-homocysteine S-methyltransferase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BHMT2 mRNA CTD PMID:28628672 NCBI chr 2:26,630,502...26,647,450
Ensembl chr 2:26,630,510...26,651,326 		JBrowse link
G Bicc1 BicC family RNA binding protein 1 decreases expression ISO Dexamethasone results in decreased expression of BICC1 mRNA CTD PMID:22733784 NCBI chr20:17,448,745...17,685,887
Ensembl chr20:17,448,765...17,685,885 		JBrowse link
G Bicral BICRA like chromatin remodeling complex associated protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BICRAL mRNA CTD PMID:28628672 NCBI chr 9:21,597,886...21,682,985
Ensembl chr 9:21,597,855...21,682,983 		JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BIRC2 mRNA; Dexamethasone inhibits the reaction [TNF protein results in decreased expression of BIRC2 protein] CTD PMID:11399663 PMID:28628672 NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 multiple interactions
increases expression 		ISO
EXP 		Dexamethasone inhibits the reaction [TNF protein results in decreased expression of BIRC3 protein]
Dexamethasone results in increased expression of BIRC3 mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of BIRC3 mRNA]
Dexamethasone results in increased expression of BIRC3 mRNA; Dexamethasone results in increased expression of BIRC3 protein 		CTD PMID:9374718 PMID:11399663 PMID:12782123 PMID:16144937 PMID:20032058 NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 affects expression
multiple interactions 		ISO Dexamethasone affects the expression of BIRC5
2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of BIRC5 protein]; [Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of BIRC5 protein
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BIRC5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BIRC5 mRNA; [PDCD5 protein co-treated with Dexamethasone] results in decreased expression of BIRC5; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BIRC5] 		CTD PMID:20693715 PMID:21244764 PMID:28628672 PMID:29704545 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Bivm basic, immunoglobulin-like variable motif containing multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BIVM mRNA CTD PMID:28628672 NCBI chr 9:53,760,885...53,797,125
Ensembl chr 9:53,761,331...53,797,118 		JBrowse link
G Blnk B-cell linker increases expression ISO Dexamethasone results in increased expression of BLNK mRNA CTD PMID:21041162 NCBI chr 1:249,703,064...249,770,533
Ensembl chr 1:249,703,072...249,770,533 		JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 affects expression
multiple interactions 		ISO Dexamethasone affects the expression of BMAL1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BMAL1 mRNA 		CTD PMID:23251369 PMID:28628672 PMID:29040059 NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739 		JBrowse link
G Bmf Bcl2 modifying factor decreases expression ISO Dexamethasone results in decreased expression of BMF mRNA CTD PMID:25047013 NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258 		JBrowse link
G Bmi1 BMI1 proto-oncogene, polycomb ring finger multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BMI1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BMI1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BMI1 mRNA CTD PMID:28628672 NCBI chr17:86,240,683...86,250,044
Ensembl chr17:86,243,491...86,250,024 		JBrowse link
G Bmp1 bone morphogenetic protein 1 increases expression EXP Dexamethasone results in increased expression of BMP1 mRNA CTD PMID:38971901 NCBI chr15:51,961,310...52,005,597
Ensembl chr15:51,961,310...52,005,485 		JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions
decreases expression 		ISO
EXP 		[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with Cholecalciferol] results in increased expression of BMP2 mRNA; [Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA; Dexamethasone inhibits the reaction [BMP2 protein results in increased expression of ACAN mRNA]; Dexamethasone inhibits the reaction [BMP2 protein results in increased expression of COL2A1 mRNA]; Dexamethasone inhibits the reaction [BMP2 protein results in increased expression of GREM1 mRNA]; Dexamethasone inhibits the reaction [BMP2 protein results in increased expression of SOST mRNA]; Dexamethasone promotes the reaction [BMP2 protein results in increased expression of SOX9 mRNA]; MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA]; PARG mRNA promotes the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid co-treated with Cholecalciferol] results in increased expression of BMP2 mRNA]; Sirolimus inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA]
[Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA; [Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]
Dexamethasone results in decreased expression of BMP2 mRNA; Dexamethasone results in decreased expression of BMP2 protein
Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]; ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]]; ginsenoside Rg3 inhibits the reaction [Dexamethasone results in decreased expression of BMP2 mRNA]; ginsenoside Rg3 inhibits the reaction [Dexamethasone results in decreased expression of BMP2 protein]; NOG protein inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]]] 		CTD PMID:15268896 PMID:17502159 PMID:22940495 PMID:23111315 PMID:26492236 More... NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760 		JBrowse link
G Bmp2k BMP-2 inducible kinase multiple interactions
decreases expression 		ISO
EXP 		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BMP2K mRNA
Dexamethasone results in decreased expression of BMP2K mRNA 		CTD PMID:28628672 PMID:38971901 NCBI chr14:12,785,169...12,882,676
Ensembl chr14:12,785,169...12,882,657 		JBrowse link
G Bmp4 bone morphogenetic protein 4 multiple interactions
affects expression 		ISO Dexamethasone inhibits the reaction [BMP4 protein results in increased expression of GREM1 mRNA]; Dexamethasone inhibits the reaction [BMP4 protein results in increased expression of SOST mRNA]
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of BMP4 mRNA
Dexamethasone affects the expression of BMP4 mRNA 		CTD PMID:15268896 PMID:16054899 PMID:21277400 NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172 		JBrowse link
G Bmp6 bone morphogenetic protein 6 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BMP6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BMP6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BMP6 mRNA; Dexamethasone inhibits the reaction [BMP6 protein results in increased expression of GREM1 mRNA]; Dexamethasone inhibits the reaction [BMP6 protein results in increased expression of SOST mRNA] CTD PMID:15268896 PMID:28628672 NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261 		JBrowse link
G Bmp7 bone morphogenetic protein 7 multiple interactions ISO [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of CS mRNA; [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of HGF mRNA; [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of MMP2 mRNA; [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of PPARGC1A mRNA; [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of PPARGC1A protein; [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of PRDM16 mRNA; [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of UCP1 mRNA; [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of UCP1 protein; [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of VEGFA mRNA; [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of BMP7 mRNA CTD PMID:29288687 PMID:33091441 NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137 		JBrowse link
G Bmp8a bone morphogenetic protein 8a decreases response to substance
increases expression 		ISO BMP8A results in decreased susceptibility to Dexamethasone
Dexamethasone results in increased expression of BMP8A mRNA; Dexamethasone results in increased expression of BMP8A protein 		CTD PMID:21277400 PMID:22733784 NCBI chr 5:140,874,942...140,902,881
Ensembl chr 5:140,874,503...140,902,881 		JBrowse link
G Bmper BMP-binding endothelial regulator increases expression
decreases expression 		ISO
EXP 		Dexamethasone results in increased expression of BMPER mRNA
Dexamethasone results in decreased expression of BMPER mRNA 		CTD PMID:22733784 PMID:38971901 NCBI chr 8:30,008,049...30,253,201
Ensembl chr 8:30,008,148...30,434,359 		JBrowse link
G Bmpr1a bone morphogenetic protein receptor type 1A multiple interactions
decreases expression 		EXP
ISO 		Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein]; ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein]]; ginsenoside Rg3 inhibits the reaction [Dexamethasone results in decreased expression of BMPR1A mRNA]; ginsenoside Rg3 inhibits the reaction [Dexamethasone results in decreased expression of BMPR1A protein]; NOG protein inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Dexamethasone inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein]]]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BMPR1A mRNA
Dexamethasone results in decreased expression of BMPR1A mRNA; Dexamethasone results in decreased expression of BMPR1A protein 		CTD PMID:27387537 PMID:28628672 PMID:38971901 NCBI chr16:9,740,751...9,786,861
Ensembl chr16:9,742,875...9,786,861 		JBrowse link
G Bmpr1b bone morphogenetic protein receptor type 1B decreases expression EXP Dexamethasone results in decreased expression of BMPR1B mRNA CTD PMID:38971901 NCBI chr 2:233,211,525...233,544,344
Ensembl chr 2:233,211,525...233,544,311 		JBrowse link
G Bmpr2 bone morphogenetic protein receptor type 2 decreases expression EXP Dexamethasone results in decreased expression of BMPR2 mRNA CTD PMID:38971901 NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350 		JBrowse link
G Bms1 BMS1 ribosome biogenesis factor multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BMS1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BMS1 mRNA CTD PMID:28628672 NCBI chr 4:153,230,471...153,267,437
Ensembl chr 4:153,230,471...153,267,429 		JBrowse link
G Bnc1 basonuclin zinc finger protein 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BNC1 mRNA CTD PMID:28628672 NCBI chr 1:145,326,881...145,352,534
Ensembl chr 1:145,326,892...145,353,510 		JBrowse link
G Bnc2 basonuclin zinc finger protein 2 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of BNC2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BNC2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BNC2 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 5:103,724,934...104,061,890
Ensembl chr 5:103,724,934...104,125,428 		JBrowse link
G Bnip3 BCL2 interacting protein 3 increases expression
decreases expression 		ISO Dexamethasone results in increased expression of BNIP3 mRNA
Dexamethasone results in decreased expression of BNIP3 mRNA 		CTD PMID:21041162 PMID:25047013 NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962 		JBrowse link
G Bod1l1 biorientation of chromosomes in cell division 1-like 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BOD1L1 mRNA CTD PMID:28628672 NCBI chr14:73,320,880...73,375,662
Ensembl chr14:73,320,832...73,375,658 		JBrowse link
G Bok BCL2 family apoptosis regulator BOK increases expression ISO Dexamethasone results in increased expression of BOK mRNA CTD PMID:21041162 NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833 		JBrowse link
G Bola3 bolA family member 3 increases expression ISO Dexamethasone results in increased expression of BOLA3 mRNA CTD PMID:25047013 NCBI chr 4:117,411,044...117,420,491
Ensembl chr 4:117,410,680...117,420,491 		JBrowse link
G Borcs5 BLOC-1 related complex subunit 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BORCS5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BORCS5 mRNA CTD PMID:28628672 NCBI chr 4:169,190,025...169,272,335
Ensembl chr 4:169,204,528...169,271,819 		JBrowse link
G Borcs6 BLOC-1 related complex subunit 6 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BORCS6 mRNA CTD PMID:28628672 NCBI chr10:54,259,349...54,261,203
Ensembl chr10:54,256,949...54,261,387 		JBrowse link
G Bpnt2 3'(2'), 5'-bisphosphate nucleotidase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BPNT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BPNT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BPNT2 mRNA CTD PMID:28628672 NCBI chr 5:22,573,241...22,600,126
Ensembl chr 5:22,570,165...22,600,126 		JBrowse link
G Brd10 bromodomain containing 10 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BRD10 mRNA CTD PMID:28628672 NCBI chr 1:236,904,520...236,984,414
Ensembl chr 1:236,904,520...236,983,923 		JBrowse link
G Brd3 bromodomain containing 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BRD3 mRNA CTD PMID:28628672 NCBI chr 3:31,173,332...31,227,749
Ensembl chr 3:31,173,332...31,227,629 		JBrowse link
G Brd7 bromodomain containing 7 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BRD7 mRNA CTD PMID:28628672 NCBI chr19:34,882,238...34,910,944
Ensembl chr19:34,882,304...34,910,944 		JBrowse link
G Brd9 bromodomain containing 9 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BRD9 mRNA CTD PMID:28628672 NCBI chr 1:31,158,546...31,185,812
Ensembl chr 1:31,158,546...31,186,125 		JBrowse link
G Brix1 biogenesis of ribosomes BRX1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BRIX1 mRNA CTD PMID:28628672 NCBI chr 2:61,177,769...61,188,647
Ensembl chr 2:61,177,771...61,188,647 		JBrowse link
G Brox BRO1 domain and CAAX motif containing multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BROX mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BROX mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BROX mRNA CTD PMID:28628672 NCBI chr13:97,451,736...97,471,598
Ensembl chr13:97,451,737...97,471,519 		JBrowse link
G Bst1 bone marrow stromal cell antigen 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BST1 mRNA CTD PMID:28628672 NCBI chr14:71,466,179...71,482,671
Ensembl chr14:71,466,180...71,482,647 		JBrowse link
G Btaf1 B-TFIID TATA-box binding protein associated factor 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BTAF1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BTAF1 mRNA CTD PMID:28628672 NCBI chr 1:244,065,728...244,156,457
Ensembl chr 1:244,065,743...244,156,457 		JBrowse link
G Btbd6 BTB domain containing 6 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BTBD6 mRNA CTD PMID:28628672 NCBI chr 6:137,879,202...137,881,662
Ensembl chr 6:137,879,162...137,881,652 		JBrowse link
G Btbd7 BTB domain containing 7 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BTBD7 mRNA CTD PMID:28628672 NCBI chr 6:127,685,185...127,774,947
Ensembl chr 6:127,688,421...127,737,222 		JBrowse link
G Btd biotinidase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BTD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BTD mRNA CTD PMID:28628672 NCBI chr16:6,869,448...6,900,711
Ensembl chr16:6,869,291...6,901,410 		JBrowse link
G Btg1 BTG anti-proliferation factor 1 increases expression
multiple interactions
decreases expression 		ISO Dexamethasone results in increased expression of BTG1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BTG1 mRNA
Dexamethasone results in decreased expression of BTG1 mRNA 		CTD PMID:12782123 PMID:21041162 PMID:28628672 NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of BTG2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BTG2 mRNA 		CTD PMID:12782123 PMID:28628672 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G Btnl2 butyrophilin-like 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BTNL2 mRNA CTD PMID:28628672 NCBI chr20:4,492,100...4,505,932
Ensembl chr20:4,492,111...4,505,932 		JBrowse link
G Btrc beta-transducin repeat containing E3 ubiquitin protein ligase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BTRC mRNA CTD PMID:28628672 NCBI chr 1:254,159,085...254,324,819
Ensembl chr 1:254,159,124...254,328,357 		JBrowse link
G Bub3 BUB3 mitotic checkpoint protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BUB3 mRNA CTD PMID:28628672 NCBI chr 1:195,760,532...195,771,140
Ensembl chr 1:195,758,105...195,791,028 		JBrowse link
G C10h5orf15 similar to human chromosome 5 open reading frame 15 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C5ORF15 mRNA CTD PMID:28628672 NCBI chr10:37,064,889...37,077,493
Ensembl chr10:37,064,728...37,077,493 		JBrowse link
G C11h22orf39 similar to human chromosome 22 open reading frame 39 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C22ORF39 mRNA CTD PMID:28628672 NCBI chr11:95,660,135...95,665,750
Ensembl chr11:95,663,881...95,664,588 		JBrowse link
G C11h3orf38 similar to human chromosome 3 open reading frame 38 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of C3ORF38 mRNA CTD PMID:28628672 NCBI chr11:15,930,504...15,935,152
Ensembl chr11:15,783,138...15,935,152 		JBrowse link
G C13h1orf21 similar to human chromosome 1 open reading frame 21 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of C1ORF21 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C1ORF21 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr13:66,540,245...66,749,631
Ensembl chr13:66,540,245...66,659,684 		JBrowse link
G C13h2orf76 similar to chromosome 2 open reading frame 76 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of C2ORF76 mRNA CTD PMID:28628672 NCBI chr13:33,801,523...33,889,430
Ensembl chr13:33,802,243...33,877,384 		JBrowse link
G C15h14orf93 similar to human chromosome 14 open reading frame 93 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C14ORF93 mRNA CTD PMID:28628672 NCBI chr15:32,007,591...32,034,337
Ensembl chr15:32,007,595...32,034,289 		JBrowse link
G C1galt1c1 C1GALT1-specific chaperone 1 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of C1GALT1C1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C1GALT1C1 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr  X:122,243,736...122,248,217
Ensembl chr  X:122,234,454...122,248,422 		JBrowse link
G C1h19orf12 similar to human chromosome 19 open reading frame 12 increases expression ISO Dexamethasone results in increased expression of C19ORF12 mRNA CTD PMID:25047013 NCBI chr 1:100,010,280...100,023,907
Ensembl chr 1:100,010,323...100,023,903 		JBrowse link
G C1h19orf18 similar to human chromosome 19 open reading frame 18 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of C19ORF18 mRNA CTD PMID:28628672 NCBI chr 1:82,094,513...82,122,109
Ensembl chr 1:82,098,305...82,122,119 		JBrowse link
G C1h9orf85 similar to human chromosome 9 open reading frame 85 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of C9ORF85 mRNA CTD PMID:28628672 NCBI chr 1:228,562,621...228,624,472
Ensembl chr 1:228,564,731...228,624,278 		JBrowse link
G C1qa complement C1q A chain increases expression ISO Dexamethasone results in increased expression of C1QA mRNA CTD PMID:21041162 NCBI chr 5:154,417,086...154,419,933
Ensembl chr 5:154,417,087...154,427,732 		JBrowse link
G C1qtnf1 C1q and TNF related 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C1QTNF1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C1QTNF1 mRNA CTD PMID:28628672 NCBI chr10:104,159,021...104,180,253
Ensembl chr10:104,158,886...104,180,251 		JBrowse link
G C1qtnf3 C1q and TNF related 3 decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of C1QTNF3 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of C1QTNF3 mRNA] 		CTD PMID:20032058 NCBI chr 2:61,644,225...61,666,640
Ensembl chr 2:61,644,276...61,666,559 		JBrowse link
G C1qtnf5 C1q and TNF related 5 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of C1QTNF5 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C1QTNF5 mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr 8:53,347,754...53,349,912
Ensembl chr 8:53,347,711...53,349,912 		JBrowse link
G C1qtnf6 C1q and TNF related 6 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C1QTNF6 mRNA CTD PMID:28628672 NCBI chr 7:111,958,348...111,964,948
Ensembl chr 7:111,958,350...111,966,871 		JBrowse link
G C1r complement C1r multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C1R mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C1R mRNA CTD PMID:28628672 NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714 		JBrowse link
G C1s complement C1s multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C1S mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C1S mRNA CTD PMID:28628672 NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736 		JBrowse link
G C20h6orf136 similar to human chromosome 6 open reading frame 136 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C6ORF136 mRNA CTD PMID:28628672 NCBI chr20:2,862,567...2,866,756
Ensembl chr20:2,862,478...2,866,754 		JBrowse link
G C20h6orf89 similar to human chromosome 6 open reading frame 89 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C6ORF89 mRNA CTD PMID:28628672 NCBI chr20:7,324,105...7,368,482
Ensembl chr20:7,324,129...7,363,666 		JBrowse link
G C2cd2 C2 calcium-dependent domain containing 2 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of C2CD2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of C2CD2 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr11:50,694,680...50,759,096
Ensembl chr11:50,694,563...50,759,016 		JBrowse link
G C2h1orf54 similar to human chromosome 1 open reading frame 54 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C1ORF54 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C1ORF54 mRNA CTD PMID:28628672 NCBI chr 2:186,113,922...186,124,637
Ensembl chr 2:186,113,922...186,124,335 		JBrowse link
G C3 complement C3 multiple interactions
increases expression 		EXP
ISO 		Dexamethasone promotes the reaction [Ethinyl Estradiol results in increased expression of C3 mRNA]
Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of C3 protein]
Dexamethasone results in increased expression of C3 mRNA 		CTD PMID:11566438 PMID:21041162 PMID:22733784 PMID:33140555 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G C3h9orf50 similar to human chromosome 9 open reading frame 50 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of C9ORF50 mRNA CTD PMID:28628672 NCBI chr 3:34,477,535...34,484,791
Ensembl chr 3:34,478,508...34,484,805 		JBrowse link
G C4a complement C4A (Rodgers blood group) multiple interactions
increases expression 		EXP Testosterone inhibits the reaction [Dexamethasone results in increased expression of C4A mRNA] CTD PMID:20032058 NCBI chr20:4,010,306...4,024,707 JBrowse link
G C4h2orf68 similar to human chromosome 2 open reading frame 68 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C2ORF68 mRNA CTD PMID:28628672 NCBI chr 4:105,960,543...105,966,509
Ensembl chr 4:105,960,751...105,966,508 		JBrowse link
G C5 complement C5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C5 mRNA; Dexamethasone analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein] CTD PMID:18776917 PMID:28628672 NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468 		JBrowse link
G C5h1orf159 similar to human chromosome 1 open reading frame 159 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C1ORF159 mRNA CTD PMID:28628672 NCBI chr 5:171,983,700...172,001,373
Ensembl chr 5:171,983,936...172,001,373 		JBrowse link
G C5h1orf167 similar to human chromosome 1 open reading frame 167 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C1ORF167 mRNA CTD PMID:28628672 NCBI chr 5:163,770,495...163,788,791 JBrowse link
G C5h8orf34 similar to human chromosome 8 open reading frame 34 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of C8ORF34 mRNA CTD PMID:28628672 NCBI chr 5:12,021,000...12,560,212
Ensembl chr 5:12,021,007...12,559,772 		JBrowse link
G C6 complement C6 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of C6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of C6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of C6 mRNA CTD PMID:28628672 NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:55,573,653...55,649,120 		JBrowse link
G C8h11orf54 similar to human chromosome 11 open reading frame 54 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BKGD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BKGD mRNA CTD PMID:28628672 NCBI chr 8:20,405,240...20,427,811
Ensembl chr 8:20,405,241...20,427,811 		JBrowse link
G C8h11orf71 similar to human chromosome 11 open reading frame 71 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of C11ORF71 mRNA CTD PMID:28628672 NCBI chr 8:57,735,075...57,735,489
Ensembl chr 8:57,734,900...57,738,597 		JBrowse link
G C8h15orf39 similar to human chromosome 15 open reading frame 39 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of C15ORF39 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of C15ORF39 mRNA CTD PMID:28628672 NCBI chr 8:66,542,269...66,551,835
Ensembl chr 8:66,542,269...66,554,782 		JBrowse link
G C9h6orf132 similar to human chromosome 6 open reading frame 132 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of C6ORF132 mRNA CTD PMID:28628672 NCBI chr 9:21,022,482...21,058,942
Ensembl chr 9:21,023,092...21,059,125 		JBrowse link
G Ca12 carbonic anhydrase 12 multiple interactions
increases expression 		ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CA12 mRNA; Dexamethasone inhibits the reaction [Genistein results in increased expression of CA12 mRNA]; fulvestrant promotes the reaction [Dexamethasone inhibits the reaction [Genistein results in increased expression of CA12 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Genistein results in increased expression of CA12 mRNA]]; NR3C1 mutant form inhibits the reaction [Dexamethasone inhibits the reaction [Genistein results in increased expression of CA12 mRNA]]
Dexamethasone results in increased expression of CA12 mRNA 		CTD PMID:25136773 PMID:28628672 NCBI chr 8:76,169,723...76,225,465
Ensembl chr 8:76,169,815...76,225,465 		JBrowse link
G Ca3 carbonic anhydrase 3 decreases expression ISO Dexamethasone results in decreased expression of CA3 protein; Dexamethasone results in decreased expression of CAR3 mRNA CTD PMID:22733784 PMID:33567340 NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524 		JBrowse link
G Ca4 carbonic anhydrase 4 decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of CA4 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CA4 mRNA] 		CTD PMID:20032058 NCBI chr10:70,325,102...70,333,916
Ensembl chr10:70,325,358...70,333,916 		JBrowse link
G Cables1 Cdk5 and Abl enzyme substrate 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CABLES1 mRNA CTD PMID:28628672 NCBI chr18:3,349,681...3,455,956
Ensembl chr18:3,351,652...3,455,956 		JBrowse link
G Cabp4 calcium binding protein 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CABP4 mRNA CTD PMID:28628672 NCBI chr 1:210,857,223...210,872,431
Ensembl chr 1:210,858,133...210,862,632 		JBrowse link
G Cacna1i calcium voltage-gated channel subunit alpha1 I multiple interactions ISO [Dexamethasone co-treated with Genistein] results in increased expression of CACNA1I mRNA CTD PMID:25136773 NCBI chr 7:113,716,266...113,827,670
Ensembl chr 7:113,716,266...113,827,670 		JBrowse link
G Cacna2d1 calcium voltage-gated channel auxiliary subunit alpha2delta 1 multiple interactions ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CACNA2D1 mRNA CTD PMID:16054899 NCBI chr 4:19,902,324...20,330,287
Ensembl chr 4:19,905,764...20,330,147 		JBrowse link
G Cacna2d4 calcium voltage-gated channel auxiliary subunit alpha2delta 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CACNA2D4 mRNA CTD PMID:28628672 NCBI chr 4:154,080,877...154,197,369
Ensembl chr 4:154,080,877...154,193,778 		JBrowse link
G Cacnb3 calcium voltage-gated channel auxiliary subunit beta 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CACNB3 mRNA CTD PMID:28628672 NCBI chr 7:131,663,810...131,676,085
Ensembl chr 7:131,662,545...131,676,085 		JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CAD mRNA CTD PMID:28628672 NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:31,012,091...31,035,297 		JBrowse link
G Calb1 calbindin 1 decreases expression EXP Dexamethasone results in decreased expression of CALB1 mRNA CTD PMID:14978156 NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:34,172,664...34,200,160 		JBrowse link
G Calb2 calbindin 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CALB2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CALB2 mRNA CTD PMID:28628672 NCBI chr19:55,023,849...55,050,858
Ensembl chr19:55,023,838...55,057,952 		JBrowse link
G Calca calcitonin-related polypeptide alpha decreases response to substance
decreases expression
multiple interactions 		ISO
EXP 		CALCA protein results in decreased susceptibility to Dexamethasone
Dexamethasone results in decreased expression of CALCA mRNA
Dexamethasone inhibits the reaction [Nitroglycerin results in increased expression of CALCA mRNA] 		CTD PMID:11588175 PMID:14729435 PMID:16222118 NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529 		JBrowse link
G Calhm5 calcium homeostasis modulator family member 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CALHM5 mRNA CTD PMID:28628672 NCBI chr20:26,609,400...26,615,478
Ensembl chr20:26,609,400...26,615,478 		JBrowse link
G Calml4 calmodulin-like 4 multiple interactions ISO [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CALML4 mRNA; EGF protein inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CALML4 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CALML4 mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CALML4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CALML4 mRNA 		CTD PMID:16054899 PMID:28628672 NCBI chr 8:72,218,870...72,230,650
Ensembl chr 8:72,218,613...72,230,650 		JBrowse link
G Calu calumenin increases expression EXP Dexamethasone results in increased expression of CALU mRNA CTD PMID:17522070 NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:58,914,421...58,941,956 		JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II delta multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CAMK2D mRNA CTD PMID:28628672 NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276 		JBrowse link
G Camk4 calcium/calmodulin-dependent protein kinase IV decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of CAMK4 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CAMK4 mRNA] 		CTD PMID:20032058 NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,857,146...25,077,193 		JBrowse link
G Camp cathelicidin antimicrobial peptide multiple interactions ISO [Dexamethasone co-treated with Genistein] results in increased expression of CAMP mRNA CTD PMID:25136773 NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998 		JBrowse link
G Camsap1 calmodulin regulated spectrin-associated protein 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CAMSAP1 mRNA CTD PMID:28628672 NCBI chr 3:29,144,318...29,206,382
Ensembl chr 3:29,144,318...29,204,184 		JBrowse link
G Camsap2 calmodulin regulated spectrin-associated protein family, member 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CAMSAP2 mRNA CTD PMID:28628672 NCBI chr13:50,274,950...50,354,298
Ensembl chr13:50,274,950...50,354,298 		JBrowse link
G Cant1 calcium activated nucleotidase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CANT1 mRNA CTD PMID:28628672 NCBI chr10:104,135,676...104,148,854
Ensembl chr10:104,135,682...104,148,698 		JBrowse link
G Capn1 calpain 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] affects the expression of CAPN1 mRNA CTD PMID:28628672 NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:212,705,222...212,729,445 		JBrowse link
G Capn2 calpain 2 increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of CAPN2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CAPN2 mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of CAPN2 mRNA] 		CTD PMID:20032058 PMID:21041162 PMID:28628672 NCBI chr13:96,681,902...96,732,625
Ensembl chr13:96,681,848...96,732,625 		JBrowse link
G Capn3 calpain 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CAPN3 mRNA CTD PMID:28628672 NCBI chr 3:127,860,002...127,913,677
Ensembl chr 3:127,861,589...127,911,638 		JBrowse link
G Capn6 calpain 6 decreases expression ISO Dexamethasone results in decreased expression of CAPN6 mRNA CTD PMID:22733784 NCBI chr  X:112,177,467...112,202,178
Ensembl chr  X:112,177,467...112,202,178 		JBrowse link
G Capns1 calpain, small subunit 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CAPNS1 mRNA CTD PMID:28628672 NCBI chr 1:94,572,083...94,582,332
Ensembl chr 1:94,572,083...94,583,368 		JBrowse link
G Capns2 calpain, small subunit 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CAPNS2 mRNA CTD PMID:28628672 NCBI chr19:30,277,324...30,278,266 JBrowse link
G Caprin2 caprin family member 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CAPRIN2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CAPRIN2 mRNA CTD PMID:28628672 NCBI chr 4:183,537,935...183,592,162
Ensembl chr 4:183,537,430...183,592,809 		JBrowse link
G Caps2 calcyphosine 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CAPS2 mRNA CTD PMID:28628672 NCBI chr 7:49,467,320...49,525,465
Ensembl chr 7:49,464,885...49,525,465 		JBrowse link
G Car2 carbonic anhydrase 2 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CA2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CA2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CA2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CA2 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064 		JBrowse link
G Card10 caspase recruitment domain family, member 10 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CARD10 mRNA CTD PMID:28628672 NCBI chr 7:112,210,944...112,252,044
Ensembl chr 7:112,210,776...112,239,806 		JBrowse link
G Card14 caspase recruitment domain family, member 14 increases expression ISO Dexamethasone results in increased expression of CARD14 mRNA CTD PMID:22733784 NCBI chr10:105,064,941...105,100,132
Ensembl chr10:105,064,941...105,100,132 		JBrowse link
G Card6 caspase recruitment domain family, member 6 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CARD6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CARD6 mRNA CTD PMID:28628672 NCBI chr 2:55,921,832...55,934,388
Ensembl chr 2:55,921,832...55,934,363 		JBrowse link
G Carhsp1 calcium regulated heat stable protein 1 decreases expression ISO Dexamethasone results in decreased expression of CARHSP1 mRNA CTD PMID:25047013 NCBI chr10:7,453,602...7,467,218
Ensembl chr10:7,452,978...7,467,770 		JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CARS1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CARS1 mRNA CTD PMID:28628672 NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407 		JBrowse link
G Cars2 cysteinyl-tRNA synthetase 2, mitochondrial multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CARS2 mRNA CTD PMID:28628672 NCBI chr16:84,649,617...84,689,254
Ensembl chr16:84,645,627...84,690,192 		JBrowse link
G Casp1 caspase 1 multiple interactions
increases cleavage
increases expression 		ISO
EXP 		Dexamethasone inhibits the reaction [TNF protein results in increased expression of CASP1 mRNA]
Dexamethasone results in increased cleavage of CASP1 protein
PPARG protein inhibits the reaction [Dexamethasone results in increased cleavage of CASP1 protein]
[Dexamethasone co-treated with Curcumin] inhibits the reaction [[Ovalbumin co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased cleavage of CASP1 protein]; [Dexamethasone co-treated with Curcumin] inhibits the reaction [[Ovalbumin co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of CASP1 mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP1 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CASP1 protein]
Dexamethasone results in increased expression of CASP1 mRNA 		CTD PMID:11397893 PMID:21041162 PMID:22733784 PMID:30102002 PMID:32687258 More... NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275 		JBrowse link
G Casp2 caspase 2 decreases expression EXP
ISO 		Dexamethasone results in decreased expression of CASP2 mRNA CTD PMID:14618091 PMID:21041162 NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022 		JBrowse link
G Casp3 caspase 3 decreases activity
increases cleavage
increases activity
multiple interactions
decreases expression
increases expression 		ISO
EXP 		Dexamethasone results in decreased activity of CASP3 protein
Dexamethasone results in increased cleavage of CASP3 protein
Dexamethasone results in increased activity of CASP3 protein
[afuresertib co-treated with pomalidomide co-treated with Dexamethasone] results in increased cleavage of CASP3 protein; [Dexamethasone co-treated with Bortezomib] results in increased activity of CASP3 protein; [GCS-100 co-treated with Dexamethasone] results in increased activity of CASP3 protein; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CASP3 mRNA; [PDCD5 protein co-treated with Dexamethasone] results in increased expression of CASP3; Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]; Dexamethasone promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in increased cleavage of CASP3 protein]; Dexamethasone promotes the reaction [Gold results in increased activity of CASP3 protein]; Dexamethasone promotes the reaction [Nanotubes, Carbon results in increased activity of CASP3 protein]; Dexamethasone promotes the reaction [Silver results in increased activity of CASP3 protein]; Dexamethasone results in increased cleavage of and results in increased activity of CASP3 protein; FAS protein inhibits the reaction [Dexamethasone results in increased activity of CASP3 protein]; Ginkgo biloba extract inhibits the reaction [Dexamethasone results in increased expression of CASP3 protein]; isocoumarin NM-3 promotes the reaction [Dexamethasone results in increased activity of CASP3 protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]]
Dexamethasone results in decreased expression of CASP3 mRNA
Active Hexose Correlated Compound inhibits the reaction [Dexamethasone results in increased activity of CASP3 protein]; caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in increased activity of CASP3 protein]; Dexamethasone inhibits the reaction [Arsanilic Acid results in increased cleavage of CASP3 protein]; Dexamethasone inhibits the reaction [Arsanilic Acid results in increased expression of CASP3 mRNA]; Dexamethasone inhibits the reaction [Camptothecin results in increased activity of CASP3 protein]; Dexamethasone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Dexamethasone inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP3 protein]; Dexamethasone inhibits the reaction [TGFB1 protein results in increased activity of CASP3 protein]; Dexamethasone results in increased cleavage of and results in increased activity of CASP3 protein; Dexamethasone results in increased expression of and results in increased cleavage of CASP3 protein; fludarabine inhibits the reaction [Dexamethasone results in increased cleavage of CASP3 protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in increased cleavage of CASP3 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Arsanilic Acid results in increased expression of CASP3 mRNA]]; Ubiquinone inhibits the reaction [Dexamethasone results in increased activity of CASP3 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [echinacoside inhibits the reaction [Dexamethasone results in increased cleavage of CASP3 protein]]; aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Dexamethasone results in increased activity of CASP3 protein]; CDKN1A protein affects the reaction [Dexamethasone results in increased cleavage of CASP3 protein]; Dexamethasone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CASP3 mRNA]; Dexamethasone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CASP3 protein]; Dexamethasone inhibits the reaction [TNF protein results in increased activity of CASP3 protein]; echinacoside inhibits the reaction [Dexamethasone results in increased cleavage of CASP3 protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased activity of CASP3 protein]; MK 2206 inhibits the reaction [Dexamethasone results in increased cleavage of CASP3 protein]; naringin inhibits the reaction [Dexamethasone results in increased cleavage of CASP3 protein]; Spermine inhibits the reaction [Dexamethasone results in increased activity of CASP3 protein] 		CTD PMID:10200566 PMID:10919278 PMID:11137978 PMID:11319611 PMID:11399061 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp4 caspase 4 increases expression ISO Dexamethasone results in increased expression of CASP4 mRNA CTD PMID:21041162 PMID:22733784 NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727 		JBrowse link
G Casp6 caspase 6 multiple interactions
decreases expression 		ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CASP6 mRNA
Dexamethasone results in decreased expression of CASP6 mRNA 		CTD PMID:21041162 PMID:28628672 NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726 		JBrowse link
G Casp7 caspase 7 multiple interactions EXP
ISO 		Dexamethasone inhibits the reaction [TGFB1 protein results in increased activity of CASP7 protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CASP7 mRNA 		CTD PMID:15388240 PMID:28628672 NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512 		JBrowse link
G Casp8 caspase 8 multiple interactions
increases response to substance
increases activity 		ISO
EXP 		[afuresertib co-treated with pomalidomide co-treated with Dexamethasone] results in increased cleavage of CASP8 protein; [Methotrexate results in increased expression of CASP8 protein] which results in increased susceptibility to Dexamethasone; Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]]
CASP8 protein results in increased susceptibility to Dexamethasone
[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 mRNA]; [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 protein]]; CASP8 protein promotes the reaction [Dexamethasone results in increased expression of TSC22D3 protein]; lactacystin inhibits the reaction [[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 protein]]; Spermine inhibits the reaction [Dexamethasone results in increased activity of CASP8 protein]
Dexamethasone inhibits the reaction [TGFB1 protein results in increased activity of CASP8 protein] 		CTD PMID:11399061 PMID:15388240 PMID:15576458 PMID:17070682 PMID:20671745 More... NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp8ap2 caspase 8 associated protein 2 decreases expression ISO Dexamethasone results in decreased expression of CASP8AP2 mRNA CTD PMID:21041162 NCBI chr 5:51,809,366...51,848,633
Ensembl chr 5:51,810,972...51,848,632 		JBrowse link
G Casp9 caspase 9 increases cleavage
increases activity
multiple interactions
decreases expression 		ISO
EXP 		Dexamethasone results in increased cleavage of CASP9 protein
Dexamethasone results in increased activity of CASP9 protein
Dexamethasone inhibits the reaction [TGFB1 protein results in increased activity of CASP9 protein]; fludarabine inhibits the reaction [Dexamethasone results in increased cleavage of CASP9 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [echinacoside inhibits the reaction [Dexamethasone results in increased cleavage of CASP9 protein]]; echinacoside inhibits the reaction [Dexamethasone results in increased cleavage of CASP9 protein]; Spermine inhibits the reaction [Dexamethasone results in increased activity of CASP9 protein]
isocoumarin NM-3 promotes the reaction [Dexamethasone results in increased activity of CASP9 protein]
Dexamethasone results in decreased expression of CASP9 mRNA 		CTD PMID:11399061 PMID:11734450 PMID:15388240 PMID:15574755 PMID:15576458 More... Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Casq2 calsequestrin 2 affects expression ISO Dexamethasone affects the expression of CASQ2 mRNA CTD PMID:34742744 NCBI chr 2:192,214,556...192,270,821
Ensembl chr 2:192,214,537...192,270,820 		JBrowse link
G Cat catalase multiple interactions
increases expression
decreases activity
increases activity
decreases expression 		ISO
EXP 		[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CAT mRNA; BCL2 gene inhibits the reaction [Dexamethasone results in decreased activity of CAT protein]; Dexamethasone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of CAT protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in decreased activity of CAT protein]; Dexamethasone inhibits the reaction [Paraquat results in increased activity of CAT protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CAT mRNA
Dexamethasone results in increased expression of CAT mRNA
Dexamethasone results in increased expression of CAT protein
[Dexamethasone co-treated with ciprofibrate] results in increased expression of CAT protein; Dexamethasone inhibits the reaction [Lipopolysaccharides results in decreased expression of CAT protein]; Dexamethasone inhibits the reaction [Oleic Acid results in increased activity of CAT protein]
Dexamethasone results in increased activity of CAT protein
Dexamethasone results in decreased expression of CAT mRNA 		CTD PMID:10590836 PMID:11114198 PMID:15353912 PMID:15895680 PMID:15965953 More... NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Cav1 caveolin 1 multiple interactions
increases expression 		ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA; [octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein; [SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein]
[Dexamethasone results in increased expression of CAV1 protein] which results in decreased susceptibility to VEGFA protein
Dexamethasone results in increased expression of CAV1 mRNA; Dexamethasone results in increased expression of CAV1 protein 		CTD PMID:14984747 PMID:16054899 PMID:23426970 PMID:25047013 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Cav2 caveolin 2 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CAV2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CAV2 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425 		JBrowse link
G Cavin1 caveolae associated protein 1 increases expression ISO Dexamethasone results in increased expression of CAVIN1 mRNA CTD PMID:25047013 NCBI chr10:86,384,401...86,398,240
Ensembl chr10:86,384,401...86,396,383 		JBrowse link
G Cavin2 caveolae associated protein 2 multiple interactions
increases expression 		ISO apicidin inhibits the reaction [Dexamethasone results in increased expression of CAVIN2 mRNA]; Valproic Acid inhibits the reaction [Dexamethasone results in increased expression of CAVIN2 mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CAVIN2 mRNA 		CTD PMID:23946490 PMID:28628672 NCBI chr 9:57,794,007...57,806,024
Ensembl chr 9:57,794,019...57,806,024 		JBrowse link
G Cbarp CACN subunit beta associated regulatory protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CBARP mRNA CTD PMID:28628672 NCBI chr 7:10,217,314...10,225,855
Ensembl chr 7:10,217,328...10,225,854 		JBrowse link
G Cblb Cbl proto-oncogene B increases expression ISO Dexamethasone results in increased expression of CBLB; Dexamethasone results in increased expression of CBLB mRNA CTD PMID:22733784 NCBI chr11:62,058,829...62,225,904
Ensembl chr11:62,061,653...62,225,778 		JBrowse link
G Cbll1 Cbl proto-oncogene like 1 decreases expression ISO Dexamethasone results in decreased expression of CBLL1 mRNA CTD PMID:21621594 NCBI chr 6:53,798,712...53,812,890
Ensembl chr 6:53,798,712...53,813,880 		JBrowse link
G Cbr1 carbonyl reductase 1 decreases expression ISO Dexamethasone results in decreased expression of CBR1 mRNA CTD PMID:22733784 NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104
Ensembl chr11:46,378,411...46,381,104 		JBrowse link
G Cbx1 chromobox 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CBX1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CBX1 mRNA CTD PMID:28628672 NCBI chr10:82,266,746...82,286,431
Ensembl chr10:82,266,759...82,287,242 		JBrowse link
G Cbx7 chromobox 7 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CBX7 mRNA CTD PMID:28628672 NCBI chr 7:113,341,030...113,358,716
Ensembl chr 7:113,341,030...113,358,346 		JBrowse link
G Cbx8 chromobox 8 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CBX8 mRNA CTD PMID:28628672 NCBI chr10:104,793,062...104,795,500
Ensembl chr10:104,793,062...104,795,500 		JBrowse link
G Cc2d1a coiled-coil and C2 domain containing 1A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CC2D1A mRNA CTD PMID:28628672 NCBI chr19:40,916,587...40,931,702
Ensembl chr19:40,916,532...40,931,701 		JBrowse link
G Ccar1 cell division cycle and apoptosis regulator 1 increases expression ISO Dexamethasone results in increased expression of CCAR1 mRNA CTD PMID:17998272 NCBI chr20:31,228,624...31,271,233
Ensembl chr20:31,228,624...31,271,227 		JBrowse link
G Ccdc107 coiled-coil domain containing 107 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CCDC107 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC107 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CCDC107 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 5:62,545,273...62,548,711
Ensembl chr 5:62,544,714...62,548,709 		JBrowse link
G Ccdc117 coiled-coil domain containing 117 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC117 mRNA CTD PMID:28628672 NCBI chr14:84,614,282...84,623,648
Ensembl chr14:84,614,283...84,624,087 		JBrowse link
G Ccdc120 coiled-coil domain containing 120 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC120 mRNA CTD PMID:28628672 NCBI chr  X:17,437,219...17,443,716
Ensembl chr  X:17,425,624...17,444,717 		JBrowse link
G Ccdc121 coiled-coil domain containing 121 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC121 mRNA CTD PMID:28628672 NCBI chr 6:30,690,831...30,693,437
Ensembl chr 6:30,690,831...30,693,437 		JBrowse link
G Ccdc127 coiled-coil domain containing 127 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC127 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC127 mRNA CTD PMID:28628672 NCBI chr 1:30,757,010...30,764,473
Ensembl chr 1:30,757,010...30,764,473 		JBrowse link
G Ccdc136 coiled-coil domain containing 136 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CCDC136 mRNA CTD PMID:28628672 NCBI chr 4:58,963,196...58,992,962
Ensembl chr 4:58,962,908...58,992,975 		JBrowse link
G Ccdc137 coiled-coil domain containing 137 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CCDC137 mRNA CTD PMID:28628672 NCBI chr10:106,229,099...106,235,502
Ensembl chr10:106,229,099...106,235,502 		JBrowse link
G Ccdc146 coiled-coil domain containing 146 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CCDC146 mRNA CTD PMID:28628672 NCBI chr 4:14,554,966...14,703,801
Ensembl chr 4:14,554,966...14,703,799 		JBrowse link
G Ccdc167 coiled-coil domain containing 167 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC167 mRNA CTD PMID:28628672 NCBI chr20:7,768,425...7,783,181
Ensembl chr20:7,753,072...7,783,181 		JBrowse link
G Ccdc177 coiled-coil domain containing 177 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC177 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC177 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CCDC177 mRNA CTD PMID:28628672 NCBI chr 6:106,135,827...106,142,413
Ensembl chr 6:106,134,333...106,144,441 		JBrowse link
G Ccdc28b coiled coil domain containing 28B multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC28B mRNA CTD PMID:28628672 NCBI chr 5:147,246,627...147,251,629
Ensembl chr 5:147,246,628...147,251,629 		JBrowse link
G Ccdc47 coiled-coil domain containing 47 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CCDC47 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CCDC47 mRNA CTD PMID:28628672 NCBI chr10:91,630,101...91,648,626
Ensembl chr10:91,630,106...91,648,626 		JBrowse link
G Ccdc59 coiled-coil domain containing 59 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC59 mRNA CTD PMID:28628672 NCBI chr 7:43,029,272...43,035,655
Ensembl chr 7:43,029,272...43,035,655 		JBrowse link
G Ccdc61 coiled-coil domain containing 61 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CCDC61 mRNA CTD PMID:28628672 NCBI chr 1:87,665,541...87,685,732
Ensembl chr 1:87,665,541...87,685,732 		JBrowse link
G Ccdc69 coiled-coil domain containing 69 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CCDC69 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC69 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CCDC69 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr10:39,673,984...39,701,080
Ensembl chr10:39,673,985...39,700,579 		JBrowse link
G Ccdc71l coiled-coil domain containing 71-like multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CCDC71L mRNA CTD PMID:28628672 NCBI chr 6:54,687,474...54,691,566
Ensembl chr 6:54,617,540...55,014,344 		JBrowse link
G Ccdc77 coiled-coil domain containing 77 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC77 mRNA CTD PMID:28628672 NCBI chr 4:155,206,402...155,238,235
Ensembl chr 4:155,193,275...155,239,207 		JBrowse link
G Ccdc85a coiled-coil domain containing 85A increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CCDC85A mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCDC85A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC85A mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr14:106,327,580...106,560,205
Ensembl chr14:106,327,580...106,560,165 		JBrowse link
G Ccdc86 coiled-coil domain containing 86 decreases expression ISO Dexamethasone results in decreased expression of CCDC86 mRNA CTD PMID:12782123 NCBI chr 1:217,015,059...217,021,439
Ensembl chr 1:217,014,848...217,021,468 		JBrowse link
G Ccdc88c coiled-coil domain containing 88C multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CCDC88C mRNA CTD PMID:28628672 NCBI chr 6:125,899,337...126,019,162
Ensembl chr 6:125,899,526...126,018,865 		JBrowse link
G Cckbr cholecystokinin B receptor decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of CCKBR mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CCKBR mRNA] 		CTD PMID:20032058 NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:169,183,194...169,193,745 		JBrowse link
G Ccl11 C-C motif chemokine ligand 11 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CCL11 mRNA
Dexamethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CCL11 mRNA]
Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL11 protein] 		CTD PMID:21041162 PMID:27568862 PMID:31751647 NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575 		JBrowse link
G Ccl12 C-C motif chemokine ligand 12 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CCL12 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CCL13 mRNA 		CTD PMID:21041162 PMID:28628672 NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,567,876...67,569,426 		JBrowse link
G Ccl17 C-C motif chemokine ligand 17 multiple interactions
increases expression 		ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CCL17 mRNA; [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL17 mRNA; TNF protein inhibits the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL17 mRNA]
Dexamethasone results in increased expression of CCL17 mRNA 		CTD PMID:16054899 PMID:21041162 PMID:23503329 NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,208,120...10,209,895 		JBrowse link
G Ccl19 C-C motif chemokine ligand 19 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CCL19 mRNA
[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL19 mRNA; TNF protein inhibits the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL19 mRNA] 		CTD PMID:21041162 PMID:23503329 NCBI chr 5:61,759,220...61,761,164
Ensembl chr 5:61,759,220...61,772,022 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression 		ISO
EXP 		15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein]; [Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein; [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CCL2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CCL2 mRNA; Dexamethasone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Dexamethasone inhibits the reaction [Mitomycin results in increased expression of CCL2 mRNA]; Dexamethasone inhibits the reaction [Mitomycin results in increased secretion of CCL2 protein]; Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]
15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein]; [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the susceptibility to Ethanol] which results in increased secretion of CCL2 protein; [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the susceptibility to GHRL protein] which results in increased secretion of CCL2 protein; [Amiodarone co-treated with Dexamethasone] results in increased expression of CCL2 mRNA; [Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein; [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA; [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA]; [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA; Dexamethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CCL2 mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA]; TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA]
Dexamethasone inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]; Dexamethasone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]
Dexamethasone results in increased expression of CCL2 mRNA 		CTD PMID:15187150 PMID:16054899 PMID:16997883 PMID:18234956 PMID:19255438 More... NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 multiple interactions ISO
EXP 		[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL20 mRNA; TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL20 mRNA]
Dexamethasone inhibits the reaction [IL1B protein results in increased expression of CCL20 mRNA]; Dexamethasone inhibits the reaction [IL1B protein results in increased secretion of CCL20 protein] 		CTD PMID:23503329 PMID:25851902 NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736 		JBrowse link
G Ccl24 C-C motif chemokine ligand 24 multiple interactions ISO [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL24 mRNA CTD PMID:23503329 NCBI chr12:26,737,423...26,741,420
Ensembl chr12:26,737,439...26,750,924 		JBrowse link
G Ccl25 C-C motif chemokine ligand 25 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of CCL25 mRNA
[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA 		CTD PMID:21041162 PMID:23503329 NCBI chr12:7,505,231...7,514,402
Ensembl chr12:7,505,235...7,514,385 		JBrowse link
G Ccl26 C-C motif chemokine ligand 26 multiple interactions ISO Dexamethasone inhibits the reaction [IL4 protein results in increased expression of CCL26 protein] CTD PMID:16045735 NCBI chr12:26,745,972...26,750,924 JBrowse link
G Ccl27 C-C motif chemokine ligand 27 multiple interactions ISO [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA CTD PMID:23503329 NCBI chr 5:61,737,261...61,744,375
Ensembl chr 5:61,737,261...61,743,522 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions
decreases expression 		ISO Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; DUSP1 gene mutant form inhibits the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]]
Dexamethasone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]
Dexamethasone results in decreased expression of CCL3 protein 		CTD PMID:16880258 PMID:21880982 PMID:27568862 PMID:36416909 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 multiple interactions ISO Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL4 protein] CTD PMID:27568862 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions
increases expression 		ISO
EXP 		Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein]
Dexamethasone results in increased expression of CCL5 mRNA
Dexamethasone inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4]; Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]
[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL5 mRNA; Dexamethasone inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CCL5 mRNA]; Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCL5 protein] 		CTD PMID:10495789 PMID:16908450 PMID:18083043 PMID:21041162 PMID:23503329 More... NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 multiple interactions
decreases expression 		ISO [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL7 mRNA; [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mRNA; TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL7 mRNA]
Dexamethasone results in decreased expression of CCL7 mRNA 		CTD PMID:16054899 PMID:22733784 PMID:23503329 NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947 		JBrowse link
G Ccl9 C-C motif chemokine ligand 9 increases expression ISO Dexamethasone results in increased expression of CCL6 mRNA CTD PMID:21041162 NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Dexamethasone results in increased expression of CCN1 mRNA CTD PMID:22733784 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 increases expression ISO Dexamethasone results in increased expression of CCN2 mRNA CTD PMID:22733784 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn3 cellular communication network factor 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CCN3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CCN3 mRNA CTD PMID:28628672 NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:87,982,216...87,994,581 		JBrowse link
G Ccn4 cellular communication network factor 4 decreases expression ISO Dexamethasone results in decreased expression of CCN4 mRNA CTD PMID:22733784 NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094 		JBrowse link
G Ccn5 cellular communication network factor 5 multiple interactions ISO [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCN5 mRNA; [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCN5 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCN5 mRNA] CTD PMID:16054899 NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062 		JBrowse link
G Ccna2 cyclin A2 decreases expression
multiple interactions
increases expression 		ISO Dexamethasone results in decreased expression of CCNA2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CCNA2 mRNA
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNA2 protein; silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNA2 protein]
Dexamethasone results in increased expression of CCNA2 mRNA 		CTD PMID:21041162 PMID:23137833 PMID:25559859 PMID:28628672 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnb1 cyclin B1 decreases expression
increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of CCNB1 mRNA
Dexamethasone results in increased expression of CCNB1 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CCNB1 mRNA] 		CTD PMID:20032058 PMID:23137833 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnb2 cyclin B2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CCNB2 mRNA CTD PMID:28628672 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682 		JBrowse link
G Ccnc cyclin C multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CCNC mRNA CTD PMID:28628672 NCBI chr 5:40,063,589...40,081,731
Ensembl chr 5:40,063,623...40,093,370 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
decreases expression
increases expression
increases ubiquitination
increases degradation 		ISO
EXP 		bafilomycin A1 inhibits the reaction [Dexamethasone results in decreased expression of CCND1 protein]; Dexamethasone inhibits the reaction [EGF protein results in increased expression of CCND1 protein]; Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCND1 protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of CCND1 protein]
Dexamethasone results in decreased expression of CCND1 mRNA; Dexamethasone results in decreased expression of CCND1 protein
Dexamethasone results in increased expression of CCND1 mRNA
Dexamethasone results in increased ubiquitination of CCND1 protein
Dexamethasone results in increased degradation of CCND1 protein
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of CCND1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dexamethasone results in increased degradation of CCND1 protein]; Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CCND1 mRNA]
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCND1 protein]; 5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CCND1 protein]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCND1 protein; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CCND1 protein; [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCND1 mRNA; [INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CCND1 protein; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CCND1 protein]; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CCND1 protein]]; naringin inhibits the reaction [Dexamethasone results in increased expression of CCND1 mRNA]; protosappanin B inhibits the reaction [Dexamethasone results in decreased expression of CCND1 protein]; Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCND1 protein]; sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CCND1 protein] 		CTD PMID:12971794 PMID:14618091 PMID:15489888 PMID:16054899 PMID:16707792 More... NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnd2 cyclin D2 decreases expression
multiple interactions
increases expression 		EXP
ISO 		Dexamethasone results in decreased expression of CCND2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCND2 mRNA
Dexamethasone results in decreased expression of CCND2 mRNA; Dexamethasone results in decreased expression of CCND2 protein
Dexamethasone results in increased expression of CCND2 mRNA 		CTD PMID:14618091 PMID:19428934 PMID:21041162 PMID:28628672 NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301 		JBrowse link
G Ccnd3 cyclin D3 decreases expression ISO Dexamethasone results in decreased expression of CCND3 mRNA CTD PMID:21041162 NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033 		JBrowse link
G Ccne1 cyclin E1 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of CCNE1 mRNA
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNE1 protein]; 5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CCNE1 protein]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNE1 protein; [INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CCNE1 protein; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNE1 protein] 		CTD PMID:21041162 PMID:24646949 PMID:27475717 PMID:30248417 NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Ccng1 cyclin G1 increases expression EXP Dexamethasone results in increased expression of CCNG1 mRNA CTD PMID:17522070 NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766 		JBrowse link
G Ccni cyclin I multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CCNI mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CCNI mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CCNI mRNA CTD PMID:28628672 NCBI chr14:15,164,047...15,186,885
Ensembl chr14:15,164,095...15,186,885 		JBrowse link
G Ccnj cyclin J multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CCNJ mRNA CTD PMID:28628672 NCBI chr 1:249,608,991...249,626,798
Ensembl chr 1:249,608,969...249,626,794 		JBrowse link
G Ccnl2 cyclin L2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CCNL2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CCNL2 mRNA CTD PMID:28628672 NCBI chr 5:171,698,951...171,711,037
Ensembl chr 5:171,699,689...171,711,231 		JBrowse link
G Ccr3 C-C motif chemokine receptor 3 decreases expression ISO Dexamethasone results in decreased expression of CCR3 protein CTD PMID:15931867 NCBI chr 8:132,463,533...132,511,601
Ensembl chr 8:132,463,788...132,511,593 		JBrowse link
G Ccr4 C-C motif chemokine receptor 4 increases expression ISO Dexamethasone results in increased expression of CCR4 mRNA CTD PMID:12782123 NCBI chr 8:123,054,505...123,060,244
Ensembl chr 8:123,054,324...123,077,642 		JBrowse link
G Ccr7 C-C motif chemokine receptor 7 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CCR7 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CCR7 mRNA; Dexamethasone inhibits the reaction [Particulate Matter results in increased expression of CCR7 protein] 		CTD PMID:21041162 PMID:28463086 PMID:28628672 NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501 		JBrowse link
G Ccr9 C-C motif chemokine receptor 9 increases expression
decreases expression 		ISO Dexamethasone results in increased expression of CCR9 mRNA
Dexamethasone results in decreased expression of CCR9 mRNA 		CTD PMID:17998272 PMID:21041162 NCBI chr 8:132,273,581...132,287,651
Ensembl chr 8:132,273,544...132,287,883 		JBrowse link
G Cct4 chaperonin containing TCP1 subunit 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CCT4 mRNA CTD PMID:28628672 NCBI chr14:101,193,057...101,205,935
Ensembl chr14:101,192,772...101,205,770 		JBrowse link
G Cct8 chaperonin containing TCP1 subunit 8 decreases expression ISO Dexamethasone results in decreased expression of CCT8 mRNA CTD PMID:21041162 NCBI chr11:40,196,619...40,208,328
Ensembl chr11:40,196,619...40,208,328 		JBrowse link
G Cd14 CD14 molecule increases expression ISO Dexamethasone results in increased expression of CD14 protein CTD PMID:10614771 NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292 		JBrowse link
G Cd151 CD151 molecule (Raph blood group) increases expression ISO Dexamethasone results in increased expression of CD151 mRNA CTD PMID:21041162 NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784 		JBrowse link
G Cd163 CD163 molecule increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of CD163 protein
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CD163 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CD163 mRNA 		CTD PMID:17410599 PMID:28628672 NCBI chr 4:158,770,751...158,804,146
Ensembl chr 4:158,770,749...158,804,146 		JBrowse link
G Cd2 Cd2 molecule decreases expression ISO Dexamethasone results in decreased expression of CD2 mRNA CTD PMID:21041162 NCBI chr 2:191,399,510...191,412,659
Ensembl chr 2:191,399,510...191,413,665 		JBrowse link
G Cd22 CD22 molecule increases expression ISO Dexamethasone results in increased expression of CD22 mRNA CTD PMID:21041162 NCBI chr 1:95,243,785...95,270,430
Ensembl chr 1:95,244,868...95,259,730 		JBrowse link
G Cd24 CD24 molecule increases expression
decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of CD24 mRNA
Dexamethasone results in decreased expression of CD24A mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of CD24 mRNA] 		CTD PMID:14618091 PMID:20032058 PMID:21041162 NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785 		JBrowse link
G Cd27 CD27 molecule decreases expression ISO Dexamethasone results in decreased expression of CD27 mRNA CTD PMID:21041162 NCBI chr 4:159,716,932...159,721,823
Ensembl chr 4:159,716,935...159,721,823 		JBrowse link
G Cd274 CD274 molecule increases expression ISO Dexamethasone results in increased expression of CD274 mRNA CTD PMID:21041162 NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:236,496,463...236,549,951 		JBrowse link
G Cd28 Cd28 molecule multiple interactions
decreases expression 		ISO [Dexamethasone co-treated with CD28 protein] results in increased expression of NFKBIA mRNA; Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of IFNG protein]; Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of IL2 protein]; Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of TNF protein]; Mifepristone inhibits the reaction [[Dexamethasone co-treated with CD28 protein] results in increased expression of NFKBIA mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of IFNG protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of IL2 protein]]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [CD28 protein results in increased secretion of TNF protein]]
Dexamethasone results in decreased expression of CD28 mRNA 		CTD PMID:20363256 PMID:21041162 NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192 		JBrowse link
G Cd2bp2 Cd2 (cytoplasmic tail) binding protein 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CD2BP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CD2BP2 mRNA CTD PMID:28628672 NCBI chr 1:191,239,899...191,244,395
Ensembl chr 1:191,239,901...191,243,398 		JBrowse link
G Cd302 CD302 molecule increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CD302 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CD302 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CD302 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CD302 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 3:65,131,017...65,164,737
Ensembl chr 3:65,113,102...65,164,737 		JBrowse link
G Cd36 CD36 molecule increases expression
multiple interactions
affects expression 		ISO
EXP 		Dexamethasone results in increased expression of CD36 mRNA; Dexamethasone results in increased expression of CD36 protein
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CD36 mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CD36 mRNA; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of CD36 mRNA]; Dexamethasone promotes the reaction [NR3C1 protein binds to CD36 promoter]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CD36 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CD36 protein]; NR3C1 protein affects the reaction [Dexamethasone results in increased expression of CD36 mRNA]; NR3C1 protein affects the reaction [Dexamethasone results in increased expression of CD36 protein]
Dexamethasone inhibits the reaction [Freund's Adjuvant results in increased expression of CD36 mRNA]; Testosterone inhibits the reaction [Dexamethasone results in increased expression of CD36 mRNA]
Dexamethasone affects the expression of CD36 mRNA 		CTD PMID:10614771 PMID:14618091 PMID:15102944 PMID:20032058 PMID:21041162 More... NCBI chr 4:18,209,088...18,302,142 JBrowse link
G Cd38 CD38 molecule increases expression ISO Dexamethasone results in increased expression of CD38 mRNA CTD PMID:21041162 NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505 		JBrowse link
G Cd3d CD3 delta subunit of T-cell receptor complex decreases expression ISO Dexamethasone results in decreased expression of CD3D mRNA CTD PMID:21041162 NCBI chr 8:54,184,573...54,190,112
Ensembl chr 8:54,175,155...54,196,722 		JBrowse link
G Cd3e CD3 epsilon subunit of T-cell receptor complex decreases expression ISO Dexamethasone results in decreased expression of CD3E mRNA CTD PMID:21041162 NCBI chr 8:54,200,617...54,211,770
Ensembl chr 8:54,200,617...54,211,876 		JBrowse link
G Cd3g CD3 gamma subunit of T-cell receptor complex decreases expression ISO Dexamethasone results in decreased expression of CD3G mRNA CTD PMID:21041162 NCBI chr 8:54,177,572...54,184,087
Ensembl chr 8:54,177,977...54,183,918 		JBrowse link
G Cd4 Cd4 molecule multiple interactions
decreases expression 		ISO Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of CD4 protein]
Dexamethasone results in decreased expression of CD4 mRNA 		CTD PMID:11408767 PMID:20363256 PMID:21041162 NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:159,356,337...159,381,461 		JBrowse link
G Cd40 CD40 molecule increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CD40 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CD40 mRNA
Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 mRNA] 		CTD PMID:21041162 PMID:22185406 PMID:28628672 NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847 		JBrowse link
G Cd5 Cd5 molecule decreases expression ISO Dexamethasone results in decreased expression of CD5 mRNA CTD PMID:21041162 NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:216,790,245...216,811,209 		JBrowse link
G Cd52 CD52 molecule increases expression ISO Dexamethasone results in increased expression of CD52 mRNA CTD PMID:21041162 NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086 		JBrowse link
G Cd53 Cd53 molecule increases expression ISO Dexamethasone results in increased expression of CD53 mRNA CTD PMID:12782123 PMID:21041162 NCBI chr 2:197,040,369...197,087,925
Ensembl chr 2:197,040,369...197,218,593 		JBrowse link
G Cd55 CD55 molecule (Cromer blood group) multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CD55 mRNA CTD PMID:28628672 NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107 		JBrowse link
G Cd59b CD59b molecule multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CD59 mRNA CTD PMID:28628672 NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:110,914,091...110,935,310 		JBrowse link
G Cd6 Cd6 molecule decreases expression ISO Dexamethasone results in decreased expression of CD6 mRNA CTD PMID:21041162 NCBI chr 1:216,867,767...216,906,642
Ensembl chr 1:216,867,771...216,879,432 		JBrowse link
G Cd68 Cd68 molecule increases expression ISO Dexamethasone results in increased expression of CD68 protein
Dexamethasone results in increased expression of CD68 mRNA 		CTD PMID:10614771 PMID:21041162 NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540 		JBrowse link
G Cd69 Cd69 molecule increases expression
decreases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CD69 mRNA
Dexamethasone results in decreased expression of CD69 mRNA
Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CD69 mRNA] 		CTD PMID:12782123 PMID:21041162 PMID:22185406 NCBI chr 4:164,411,485...164,419,403
Ensembl chr 4:164,411,485...164,419,509 		JBrowse link
G Cd7 Cd7 molecule increases expression ISO Dexamethasone results in increased expression of CD7 mRNA CTD PMID:21041162 NCBI chr10:106,802,373...106,805,269
Ensembl chr10:106,802,383...106,805,294 		JBrowse link
G Cd72 Cd72 molecule increases expression ISO Dexamethasone results in increased expression of CD72 mRNA CTD PMID:21041162 NCBI chr 5:62,493,155...62,500,779
Ensembl chr 5:62,493,161...62,500,519 		JBrowse link
G Cd74 CD74 molecule increases expression ISO Dexamethasone results in increased expression of CD74 mRNA CTD PMID:21041162 NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410 		JBrowse link
G Cd81 Cd81 molecule increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CD81 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CD81 mRNA 		CTD PMID:21041162 PMID:28628672 NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092 		JBrowse link
G Cd83 CD83 molecule increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CD83 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CD83 mRNA; Dexamethasone inhibits the reaction [Particulate Matter results in increased expression of CD83 protein] 		CTD PMID:21041162 PMID:28463086 PMID:28628672 NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047 		JBrowse link
G Cd8a CD8 subunit alpha decreases expression ISO Dexamethasone results in decreased expression of CD8A mRNA CTD PMID:21041162 NCBI chr 4:104,924,116...104,928,353
Ensembl chr 4:104,900,833...104,928,358 		JBrowse link
G Cd8b CD8 subunit beta decreases expression ISO Dexamethasone results in decreased expression of CD8B1 mRNA CTD PMID:21041162 NCBI chr 4:104,870,911...104,886,838
Ensembl chr 4:104,870,893...104,886,868 		JBrowse link
G Cd9 CD9 molecule multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CD9 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CD9 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CD9 mRNA CTD PMID:28628672 NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444 		JBrowse link
G Cd93 CD93 molecule increases expression ISO Dexamethasone results in increased expression of CD93 mRNA CTD PMID:21041162 NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:156,345,019...156,351,537 		JBrowse link
G Cd99 CD99 molecule (Xg blood group) multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CD99 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] affects the expression of CD99 mRNA CTD PMID:28628672 NCBI chr20:56,000,494...56,005,140 JBrowse link
G Cda cytidine deaminase increases activity ISO Dexamethasone results in increased activity of CDA protein CTD PMID:6882797 NCBI chr 5:155,839,929...155,866,541
Ensembl chr 5:155,839,929...155,866,541 		JBrowse link
G Cdc34 cell division cycle 34, ubiquitin conjugating enzyme multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDC34 mRNA CTD PMID:28628672 NCBI chr 7:10,668,209...10,674,206
Ensembl chr 7:10,668,210...10,674,526 		JBrowse link
G Cdc37l1 cell division cycle 37-like 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDC37L1 mRNA CTD PMID:28628672 NCBI chr 1:236,118,630...236,147,527
Ensembl chr 1:236,118,555...236,207,079 		JBrowse link
G Cdc40 cell division cycle 40 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDC40 mRNA CTD PMID:28628672 NCBI chr20:45,855,739...45,908,239
Ensembl chr20:45,855,739...45,907,978 		JBrowse link
G Cdc42 cell division cycle 42 multiple interactions
decreases expression 		ISO
EXP 		[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDC42 mRNA
Dexamethasone results in decreased expression of CDC42 mRNA 		CTD PMID:16054899 PMID:29111458 NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627 		JBrowse link
G Cdc42bpb CDC42 binding protein kinase beta multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDC42BPB mRNA CTD PMID:28628672 NCBI chr 6:136,154,905...136,241,259
Ensembl chr 6:136,154,905...136,237,570 		JBrowse link
G Cdc42ep2 CDC42 effector protein 2 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CDC42EP2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDC42EP2 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 1:212,631,317...212,640,231
Ensembl chr 1:212,629,881...212,640,234 		JBrowse link
G Cdc42ep4 CDC42 effector protein 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDC42EP4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDC42EP4 mRNA CTD PMID:28628672 NCBI chr10:99,271,750...99,298,551
Ensembl chr10:99,267,540...99,300,168 		JBrowse link
G Cdc42se1 CDC42 small effector 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDC42SE1 mRNA CTD PMID:28628672 NCBI chr 2:185,494,692...185,502,519
Ensembl chr 2:185,496,547...185,502,514 		JBrowse link
G Cdca2 cell division cycle associated 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDCA2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDCA2 mRNA CTD PMID:28628672 NCBI chr15:46,071,360...46,117,524
Ensembl chr15:46,071,360...46,116,639 		JBrowse link
G Cdca4 cell division cycle associated 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDCA4 mRNA CTD PMID:28628672 NCBI chr 6:137,713,390...137,722,652
Ensembl chr 6:137,713,051...137,722,580 		JBrowse link
G Cdca5 cell division cycle associated 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDCA5 mRNA CTD PMID:28628672 NCBI chr 1:212,807,863...212,821,313
Ensembl chr 1:212,804,014...212,821,309 		JBrowse link
G Cdca7 cell division cycle associated 7 decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of CDCA7 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDCA7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDCA7 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CDCA7 mRNA] 		CTD PMID:20032058 PMID:28628672 NCBI chr 3:77,730,315...77,740,950
Ensembl chr 3:77,729,970...77,740,947 		JBrowse link
G Cdca7l cell division cycle associated 7 like increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CDCA7L mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDCA7L mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr 6:144,936,885...144,982,844
Ensembl chr 6:144,908,171...144,982,843 		JBrowse link
G Cdh1 cadherin 1 multiple interactions
decreases expression 		ISO
EXP 		Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Particulate Matter] results in decreased expression of CDH1 protein]; Dexamethasone inhibits the reaction [Bleomycin results in decreased expression of CDH1 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein]
Dexamethasone inhibits the reaction [Particulate Matter results in decreased expression of CDH1 protein]
Dexamethasone results in decreased expression of CDH1 mRNA 		CTD PMID:28300665 PMID:28694203 PMID:35335934 PMID:36790081 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh13 cadherin 13 multiple interactions
decreases expression 		ISO
EXP 		[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDH13 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDH13 mRNA]
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CDH13 mRNA] 		CTD PMID:16054899 PMID:20032058 NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119 		JBrowse link
G Cdh2 cadherin 2 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of CDH2 mRNA
Dexamethasone inhibits the reaction [Particulate Matter results in increased expression of CDH2 protein]
Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Particulate Matter] results in increased expression of CDH2 protein] 		CTD PMID:25047013 PMID:35335934 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cdhr1 cadherin-related family member 1 decreases expression ISO Dexamethasone results in decreased expression of CDHR1 mRNA CTD PMID:22733784 NCBI chr16:12,863,696...12,883,579
Ensembl chr16:12,863,696...12,883,579 		JBrowse link
G Cdipt CDP-diacylglycerol--inositol 3-phosphatidyltransferase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDIPT mRNA CTD PMID:28628672 NCBI chr 1:191,013,632...191,017,943
Ensembl chr 1:191,013,463...191,017,971 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 decreases expression
increases expression 		EXP
ISO 		Dexamethasone results in decreased expression of CDK1 mRNA
Dexamethasone results in increased expression of CDK1 mRNA 		CTD PMID:14618091 PMID:23137833 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk14 cyclin-dependent kinase 14 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDK14 mRNA CTD PMID:28628672 NCBI chr 4:29,619,237...30,213,651
Ensembl chr 4:29,621,217...30,213,651 		JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions
decreases expression
increases expression
decreases activity 		ISO
EXP 		Cycloheximide inhibits the reaction [Dexamethasone results in decreased expression of CDK2 mRNA]; Dexamethasone inhibits the reaction [CDK2 protein binds to CDKN1A protein]
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein]; 5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CDK2 protein]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein; [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein; [INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CDK2 protein; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK2 protein]; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CDK2 protein]]
Dexamethasone results in increased expression of CDK2 mRNA
Dexamethasone inhibits the reaction [CDK2 protein results in increased phosphorylation of RB1 protein]
Dexamethasone results in decreased expression of CDK2 mRNA; Dexamethasone results in decreased expression of CDK2 protein; Dexamethasone results in decreased expression of CDK2 protein modified form
Dexamethasone results in decreased activity of CDK2 protein 		CTD PMID:9442036 PMID:12800980 PMID:19428934 PMID:21041162 PMID:23137833 More... NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of CDK4 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDK4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CDK4 mRNA
5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CDK4 protein]; [INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CDK4 protein 		CTD PMID:21041162 PMID:24646949 PMID:28628672 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163 		JBrowse link
G Cdk5rap3 CDK5 regulatory subunit associated protein 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDK5RAP3 mRNA CTD PMID:28628672 NCBI chr10:82,390,845...82,402,814
Ensembl chr10:82,390,845...82,400,001 		JBrowse link
G Cdk6 cyclin-dependent kinase 6 multiple interactions ISO 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK6 protein]; 5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CDK6 protein]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CDK6 protein; [INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CDK6 protein; dorsomorphin inhibits the reaction [14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CDK6 protein]]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDK6 mRNA 		CTD PMID:24646949 PMID:28628672 PMID:30248417 NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701 		JBrowse link
G Cdk7 cyclin-dependent kinase 7 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDK7 mRNA CTD PMID:28628672 NCBI chr 2:33,574,623...33,599,485
Ensembl chr 2:33,574,623...33,599,485 		JBrowse link
G Cdk9 cyclin-dependent kinase 9 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDK9 mRNA CTD PMID:28628672 NCBI chr 3:36,394,168...36,399,016
Ensembl chr 3:36,394,169...36,399,528 		JBrowse link
G Cdkl3 cyclin-dependent kinase-like 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CDKL3 mRNA CTD PMID:28628672 NCBI chr10:36,755,413...36,850,197
Ensembl chr10:36,764,377...36,878,660 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions
decreases stability
increases expression 		ISO
EXP 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Dexamethasone results in decreased expression of and affects the localization of CDKN1A protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Dexamethasone results in decreased stability of CDKN1A protein]; [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1A protein; CDKN1A protein affects the reaction [Dexamethasone affects the expression of NFE2L2 protein]; CDKN1A protein affects the reaction [Dexamethasone results in increased cleavage of CASP3 protein]; CDKN1A protein affects the reaction [Dexamethasone results in increased expression of HMOX1 protein]; Cycloheximide promotes the reaction [Dexamethasone results in decreased expression of CDKN1A protein]; Dexamethasone results in decreased expression of and affects the localization of CDKN1A protein; IGF1 protein inhibits the reaction [Dexamethasone results in decreased expression of and affects the localization of CDKN1A protein]; IGF1 protein inhibits the reaction [Dexamethasone results in decreased stability of CDKN1A protein]
Dexamethasone results in increased expression of CDKN1A mRNA; Dexamethasone results in increased expression of CDKN1A protein
Testosterone inhibits the reaction [Dexamethasone results in increased expression of CDKN1A mRNA]
Dexamethasone inhibits the reaction [CDK2 protein binds to CDKN1A protein] 		CTD PMID:9442036 PMID:12800980 PMID:18395440 PMID:20032058 PMID:21041162 More... NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression
decreases expression
multiple interactions 		ISO
EXP 		Dexamethasone results in increased expression of CDKN1B mRNA; Dexamethasone results in increased expression of CDKN1B protein
Dexamethasone results in decreased expression of CDKN1B mRNA; Dexamethasone results in decreased expression of CDKN1B protein
[Polyribonucleotides results in decreased expression of MIR17 mRNA] inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B mRNA]; [Polyribonucleotides results in decreased expression of MIR17 mRNA] inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B protein]; Dexamethasone inhibits the reaction [FOXL2 protein binds to CDKN1B promoter]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDKN1B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CDKN1B mRNA; [Polyribonucleotides results in decreased expression of MIR17 mRNA] inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B mRNA]; [Polyribonucleotides results in decreased expression of MIR17 mRNA] inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B protein]; Dexamethasone inhibits the reaction [FOXL2 protein binds to CDKN1B promoter]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B protein]
5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in decreased expression of CDKN1B protein]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein; [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein; [INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in decreased expression of CDKN1B protein; Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein] 		CTD PMID:19428934 PMID:24646949 PMID:25559859 PMID:28628672 PMID:30409764 More... NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CDKN1C mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1C mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CDKN1C mRNA 		CTD PMID:21041162 PMID:22064387 PMID:28628672 NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498 		JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C increases expression ISO Dexamethasone results in increased expression of CDKN2C mRNA CTD PMID:25047013 NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891 		JBrowse link
G Cdkn2d cyclin dependent kinase inhibitor 2D multiple interactions
decreases expression 		ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN2D mRNA
Dexamethasone results in decreased expression of CDKN2D mRNA 		CTD PMID:21041162 PMID:28628672 NCBI chr 8:28,108,036...28,110,809
Ensembl chr 8:28,108,044...28,110,809 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 multiple interactions
decreases expression 		EXP Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CDKN3 mRNA] CTD PMID:20032058 NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722 		JBrowse link
G Cdo1 cysteine dioxygenase type 1 multiple interactions
increases expression 		ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDO1 mRNA; [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDO1 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDO1 mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CDO1 mRNA
Dexamethasone results in increased expression of CDO1 mRNA 		CTD PMID:16054899 PMID:25047013 PMID:28628672 NCBI chr18:41,619,076...41,633,719
Ensembl chr18:41,619,070...41,633,891 		JBrowse link
G Cdon cell adhesion associated, oncogene regulated decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of CDON mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDON mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDON mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CDON mRNA
[HDAC1 protein co-treated with HDAC2 protein] affects the reaction [Dexamethasone results in decreased expression of CDON mRNA]; apicidin inhibits the reaction [Dexamethasone results in decreased expression of CDON mRNA]; HDAC3 protein affects the reaction [Dexamethasone results in decreased expression of CDON mRNA]; Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of CDON mRNA] 		CTD PMID:22733784 PMID:27645313 PMID:28628672 NCBI chr 8:42,032,921...42,119,451
Ensembl chr 8:42,033,042...42,119,345 		JBrowse link
G Cdr2 cerebellar degeneration-related protein 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDR2 mRNA CTD PMID:28628672 NCBI chr 1:184,934,128...184,959,036
Ensembl chr 1:184,934,129...184,968,863 		JBrowse link
G Cds2 CDP-diacylglycerol synthase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDS2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDS2 mRNA CTD PMID:28628672 NCBI chr 3:139,967,870...140,006,459
Ensembl chr 3:139,967,742...140,009,201 		JBrowse link
G Cdsn corneodesmosin decreases expression ISO Dexamethasone results in decreased expression of CDSN mRNA CTD PMID:22733784 NCBI chr20:3,184,142...3,188,962
Ensembl chr20:3,183,808...3,188,962 		JBrowse link
G Cdv3 carnitine deficiency-associated gene expressed in ventricle 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDV3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CDV3 mRNA CTD PMID:28628672 NCBI chr 8:112,812,898...112,826,073
Ensembl chr 8:112,813,952...112,826,056 		JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 increases expression EXP Dexamethasone results in increased expression of CEACAM1 mRNA CTD PMID:17522070 NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798 		JBrowse link
G Ceacam20 CEA cell adhesion molecule 20 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEACAM20 mRNA CTD PMID:28628672 NCBI chr 1:88,750,010...88,771,679
Ensembl chr 1:88,750,000...88,772,779 		JBrowse link
G Ceacam6 CEA cell adhesion molecule 6 multiple interactions ISO [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEACAM6 mRNA CTD PMID:16997883 NCBI chr 1:89,544,415...89,562,552
Ensembl chr 1:89,544,400...89,562,552 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of CEBPA mRNA; Dexamethasone results in increased expression of CEBPA protein
[Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of CEBPA mRNA]
[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA; [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of CEBPA mRNA; [bisphenol F co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA; [bisphenol F co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein; [bisphenol S co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CEBPA protein; [bisphenol S co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA; [Dexamethasone co-treated with Insulin co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CEBPA mRNA; [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA; [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA; [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein; [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] affects the expression of CEBPA mRNA; cordycepin inhibits the reaction [[Dexamethasone co-treated with Insulin co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]; Rosmarinic Acid affects the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA]; Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein]; sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA]
(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein]; (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; (+)-JQ1 compound inhibits the reaction [Rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of CEBPA mRNA]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]; 3,5,6-trichloro-2-pyridinol promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA]; 3,5,6-trichloro-2-pyridinol promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA protein]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of CEBPA mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA protein; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPA mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein; [bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA; [bisphenol S co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] affects the expression of CEBPA protein; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA protein; [Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of CEBPA mRNA; [Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA mRNA; [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPA protein; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA protein; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA protein; [INS1 protein co-treated with Dexamethasone] results in increased expression of CEBPA mRNA; [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA; [sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA; [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA]; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA mRNA]; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]; andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPA mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]; APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]; butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; butylparaben promotes the reaction [Dexamethasone results in increased expression of CEBPA mRNA]; cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA]; Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA protein]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]]; CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]]; Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]]; Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA]; hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of CEBPA mRNA]; Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]; IWR-1 compound inhibits the reaction [Raloxifene Hydrochloride inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]]; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein]; Palmitic Acid promotes the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA]; pentagalloylglucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA]; pentagalloylglucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA protein]; Quercetin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA protein]; Raloxifene Hydrochloride inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPA mRNA]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPA protein]; Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPA protein]; Rosiglitazone promotes the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; Rosiglitazone promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; Rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA protein]; Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]; sodium arsenite inhibits the reaction [[INS1 protein co-treated with Dexamethasone] results in increased expression of CEBPA mRNA]; sodium arsenite promotes the reaction [[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA]; sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA]; sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA] 		CTD PMID:9543393 PMID:11101056 PMID:11812925 PMID:12837037 PMID:15965953 More... NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions
increases expression
decreases expression 		EXP
ISO 		2-amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine inhibits the reaction [Dexamethasone results in increased expression of CEBPB mRNA]; [Dexamethasone co-treated with oltipraz] results in increased activity of CEBPB protein; CEBPB protein inhibits the reaction [PPARA protein inhibits the reaction [Dexamethasone results in increased expression of ORM1 mRNA]]; Dexamethasone inhibits the reaction [CEBPB protein results in increased expression of GSTA2 mRNA]; Dexamethasone results in increased localization of and results in increased activity of CEBPB protein; Quercetin promotes the reaction [Dexamethasone results in increased expression of CEBPB protein]; Testosterone inhibits the reaction [Dexamethasone results in increased expression of CEBPB mRNA]
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] promotes the reaction [CREB1 protein binds to CEBPB promoter]]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPB mRNA]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CEBPB protein]; 2,2',4,4',5-brominated diphenyl ether promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPB mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPB mRNA]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPB mRNA]; 5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPB protein]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPB mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] promotes the reaction [CREB1 protein binds to CEBPB promoter]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of and results in increased phosphorylation of CEBPB protein; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPB mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CEBPB protein; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPB mRNA; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPB mRNA; [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPB mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPB mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPB protein; [INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPB protein; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPB mRNA; Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CEBPB protein]; andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPB mRNA]; andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of and results in increased phosphorylation of CEBPB protein]; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPB mRNA]; dorsomorphin inhibits the reaction [rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPB protein]]; Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPB mRNA]; ITGB1 protein promotes the reaction [ST6GAL1 protein inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPB mRNA]]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPB mRNA]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPB protein]; rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPB mRNA]; rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPB protein]; sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPB mRNA]; ST6GAL1 protein inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPB mRNA]
Dexamethasone results in increased expression of CEBPB mRNA; Dexamethasone results in increased expression of CEBPB protein
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CEBPB mRNA; [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPB mRNA
Dexamethasone results in decreased expression of CEBPB mRNA 		CTD PMID:14568882 PMID:15661831 PMID:15870285 PMID:15965953 PMID:16054899 More... NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta multiple interactions
increases expression 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPD mRNA]; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPD mRNA; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPD mRNA; [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPD protein; Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPD mRNA]; Rifampin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPD mRNA]
Testosterone inhibits the reaction [Dexamethasone results in increased expression of CEBPD mRNA] 		CTD PMID:16054899 PMID:20032058 PMID:30903904 PMID:33412187 PMID:34302803 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824 		JBrowse link
G Celf1 CUGBP, Elav-like family member 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CELF1 mRNA CTD PMID:28628672 NCBI chr 3:97,380,407...97,455,253
Ensembl chr 3:97,380,424...97,452,791 		JBrowse link
G Celf2 CUGBP, Elav-like family member 2 multiple interactions
increases expression 		ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CELF2 mRNA; [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CELF2 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CELF2 mRNA]
Dexamethasone results in increased expression of CELF2 mRNA 		CTD PMID:16054899 PMID:25047013 NCBI chr17:75,813,928...76,639,300
Ensembl chr17:75,813,704...76,636,362 		JBrowse link
G Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 decreases expression ISO Dexamethasone results in decreased expression of CELSR3 mRNA CTD PMID:12782123 NCBI chr 8:118,409,136...118,438,593
Ensembl chr 8:118,409,136...118,436,847 		JBrowse link
G Cemip cell migration inducing hyaluronidase 1 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of CEMIP mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEMIP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CEMIP mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 1:147,316,052...147,471,552
Ensembl chr 1:147,316,052...147,471,768 		JBrowse link
G Cemip2 cell migration inducing hyaluronidase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEMIP2 mRNA CTD PMID:28628672 NCBI chr 1:228,756,826...228,834,313
Ensembl chr 1:228,757,466...228,832,906 		JBrowse link
G Cenatac centrosomal AT-AC splicing factor multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CENATAC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CENATAC mRNA CTD PMID:28628672 NCBI chr 8:53,632,777...53,639,661
Ensembl chr 8:53,632,044...53,639,650 		JBrowse link
G Cend1 cell cycle exit and neuronal differentiation 1 increases expression ISO Dexamethasone results in increased expression of CEND1 mRNA CTD PMID:25047013 NCBI chr 1:205,954,713...205,957,710
Ensembl chr 1:205,953,197...205,957,944 		JBrowse link
G Cenpa centromere protein A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CENPA mRNA CTD PMID:28628672 NCBI chr 6:31,420,062...31,431,703 JBrowse link
G Cenpf centromere protein F multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CENPF mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CENPF mRNA CTD PMID:28628672 NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886 		JBrowse link
G Cenpo centromere protein O multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CENPO mRNA CTD PMID:28628672 NCBI chr 6:32,923,127...32,937,879
Ensembl chr 6:32,908,025...32,937,853 		JBrowse link
G Cenpt centromere protein T multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CENPT mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CENPT mRNA CTD PMID:28628672 NCBI chr19:50,644,548...50,651,048
Ensembl chr19:50,634,368...50,651,037 		JBrowse link
G Cenpu centromere protein U multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CENPU mRNA CTD PMID:28628672 NCBI chr16:52,448,446...52,471,662
Ensembl chr16:52,425,096...52,471,662 		JBrowse link
G Cenpw centromere protein W multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CENPW mRNA CTD PMID:28628672 NCBI chr 1:29,353,939...29,359,109
Ensembl chr 1:29,353,970...29,359,109 		JBrowse link
G Cenpx centromere protein X multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CENPX mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CENPX mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CENPX mRNA CTD PMID:28628672 NCBI chr10:106,489,796...106,492,637
Ensembl chr10:106,489,796...106,492,637 		JBrowse link
G Cep112 centrosomal protein 112 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CEP112 mRNA CTD PMID:28628672 NCBI chr10:93,865,630...94,332,679
Ensembl chr10:93,865,699...94,332,680 		JBrowse link
G Cep131 centrosomal protein 131 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CEP131 mRNA CTD PMID:28628672 NCBI chr10:105,844,433...105,868,811
Ensembl chr10:105,844,433...105,868,797 		JBrowse link
G Cep135 centrosomal protein 135 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CEP135 mRNA CTD PMID:28628672 NCBI chr14:31,884,774...31,950,050
Ensembl chr14:31,884,781...31,950,050 		JBrowse link
G Cep164 centrosomal protein 164 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CEP164 mRNA CTD PMID:28628672 NCBI chr 8:54,967,621...55,031,264
Ensembl chr 8:54,967,621...55,031,206 		JBrowse link
G Cep170b centrosomal protein 170B multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEP170B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CEP170B mRNA CTD PMID:28628672 NCBI chr 6:137,602,707...137,627,750
Ensembl chr 6:137,602,707...137,627,750 		JBrowse link
G Cep19 centrosomal protein 19 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CEP19 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CEP19 mRNA CTD PMID:28628672 NCBI chr11:82,182,868...82,192,134
Ensembl chr11:82,182,868...82,192,032 		JBrowse link
G Cep250 centrosomal protein 250 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CEP250 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CEP250 mRNA CTD PMID:28628672 NCBI chr 3:164,931,033...164,976,210
Ensembl chr 3:164,931,066...164,976,210 		JBrowse link
G Cep290 centrosomal protein 290 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEP290 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CEP290 mRNA CTD PMID:28628672 NCBI chr 7:37,196,765...37,285,955
Ensembl chr 7:37,196,783...37,285,955 		JBrowse link
G Cep41 centrosomal protein 41 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEP41 mRNA CTD PMID:28628672 NCBI chr 4:60,238,602...60,279,670
Ensembl chr 4:60,239,539...60,254,419 		JBrowse link
G Cep63 centrosomal protein 63 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CEP63 mRNA CTD PMID:28628672 NCBI chr 8:112,041,586...112,093,061
Ensembl chr 8:112,041,594...112,084,646 		JBrowse link
G Ces1d carboxylesterase 1D increases expression
multiple interactions
decreases expression 		ISO
EXP 		Dexamethasone results in increased expression of CES1 mRNA; Dexamethasone results in increased expression of CES1 protein
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CES1D mRNA
Dexamethasone results in decreased expression of CES1D mRNA
Dexamethasone results in decreased expression of CES1 mRNA; Dexamethasone results in decreased expression of CES1 protein 		CTD PMID:10640517 PMID:22429928 PMID:24848799 PMID:25047013 NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449 		JBrowse link
G Ces2h carboxylesterase 2H affects expression
increases expression
decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone affects the expression of CES2 mRNA
Dexamethasone results in increased expression of CES2 mRNA; Dexamethasone results in increased expression of CES2 protein
Dexamethasone results in decreased expression of CES2 mRNA; Dexamethasone results in decreased expression of CES2 protein
Dexamethasone promotes the reaction [CES2 protein results in increased hydrolysis of Methylprednisolone Hemisuccinate] 		CTD PMID:10640517 PMID:15102944 PMID:15794950 NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752 		JBrowse link
G Ces3a carboxylesterase 3a decreases expression EXP Dexamethasone results in decreased expression of CES3 mRNA; Dexamethasone results in decreased expression of CES3 protein CTD PMID:10640517 NCBI chr19:49,902,312...49,910,484 JBrowse link
G Cetn2 centrin 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CETN2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CETN2 mRNA CTD PMID:28628672 NCBI chr  X:155,812,212...155,817,186
Ensembl chr  X:155,812,003...155,817,744 		JBrowse link
G Cetn3 centrin 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CETN3 mRNA CTD PMID:28628672 NCBI chr 2:13,817,760...13,837,502
Ensembl chr 2:13,824,803...13,837,502 		JBrowse link
G Cfap410 cilia and flagella associated protein 410 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CFAP410 mRNA CTD PMID:28628672 NCBI chr20:10,687,506...10,694,366
Ensembl chr20:10,687,506...10,694,366 		JBrowse link
G Cfb complement factor B increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CFB mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CFB mRNA 		CTD PMID:21041162 PMID:28628672 NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740 		JBrowse link
G Cfd complement factor D decreases expression
multiple interactions
increases expression 		ISO Dexamethasone results in decreased expression of CFD mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CFD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CFD mRNA
Dexamethasone results in increased expression of CFD mRNA
(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CFD mRNA]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CFD mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CFD mRNA
Dexamethasone results in increased expression of CFD protein 		CTD PMID:17998272 PMID:19853017 PMID:23428407 PMID:24418828 PMID:25047013 More... NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572 		JBrowse link
G Cfl1 cofilin 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CFL1 mRNA CTD PMID:28628672 NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353 		JBrowse link
G Cfl2 cofilin 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CFL2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CFL2 mRNA CTD PMID:28628672 NCBI chr 6:78,090,843...78,094,888
Ensembl chr 6:78,090,843...78,094,888 		JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CFLAR; Dexamethasone results in increased expression of CFLAR mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CFLAR mRNA; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CFLAR] 		CTD PMID:21244764 PMID:25047013 PMID:28628672 NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434 		JBrowse link
G Ch25h cholesterol 25-hydroxylase decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of CH25H mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CH25H mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CH25H mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CH25H mRNA 		CTD PMID:22733784 PMID:25047013 PMID:28628672 NCBI chr 1:241,428,048...241,429,366
Ensembl chr 1:241,331,619...241,431,190 		JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 decreases expression ISO Dexamethasone results in decreased expression of CHAC1 mRNA CTD PMID:22733784 PMID:25047013 NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361 		JBrowse link
G Chaf1b chromatin assembly factor 1 subunit B multiple interactions ISO [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of CHAF1B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CHAF1B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CHAF1B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CHAF1B mRNA CTD PMID:26424790 PMID:28628672 NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733 		JBrowse link
G Chat choline O-acetyltransferase decreases expression EXP Dexamethasone results in decreased expression of CHAT protein CTD PMID:29524569 NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416 		JBrowse link
G Chchd10 coiled-coil-helix-coiled-coil-helix domain containing 10 increases expression ISO Dexamethasone results in increased expression of CHCHD10 mRNA CTD PMID:25047013 NCBI chr20:12,725,274...12,730,295
Ensembl chr20:12,725,277...12,745,677 		JBrowse link
G Chchd7 coiled-coil-helix-coiled-coil-helix domain containing 7 increases expression ISO Dexamethasone results in increased expression of CHCHD7 mRNA CTD PMID:25047013 NCBI chr 5:21,754,719...21,759,274
Ensembl chr 5:21,754,719...21,759,274 		JBrowse link
G Chd1 chromodomain helicase DNA binding protein 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CHD1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CHD1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CHD1 mRNA CTD PMID:28628672 NCBI chr 1:65,334,905...65,402,270
Ensembl chr 1:65,335,218...65,401,280 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CHD2 mRNA CTD PMID:28628672 NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335 		JBrowse link
G Chd4 chromodomain helicase DNA binding protein 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CHD4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CHD4 mRNA CTD PMID:28628672 NCBI chr 4:159,584,623...159,617,867
Ensembl chr 4:159,584,654...159,617,866 		JBrowse link
G Chd7 chromodomain helicase DNA binding protein 7 increases expression ISO Dexamethasone results in increased expression of CHD7 mRNA CTD PMID:22733784 NCBI chr 5:26,609,245...26,792,736
Ensembl chr 5:26,609,407...26,792,734 		JBrowse link
G Chd8 chromodomain helicase DNA binding protein 8 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CHD8 mRNA CTD PMID:28628672 NCBI chr15:27,379,285...27,438,959
Ensembl chr15:27,379,285...27,417,851 		JBrowse link
G Chd9 chromodomain helicase DNA binding protein 9 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CHD9 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CHD9 mRNA CTD PMID:28628672 NCBI chr19:32,114,379...32,337,488
Ensembl chr19:32,115,920...32,319,042 		JBrowse link
G Chi3l1 chitinase 3 like 1 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of CHI3L1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CHI3L1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CHI3L1 mRNA 		CTD PMID:16357325 PMID:25047013 PMID:28628672 NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825 		JBrowse link
G Chic2 cysteine-rich hydrophobic domain 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CHIC2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CHIC2 mRNA CTD PMID:28628672 NCBI chr14:33,511,839...33,546,181
Ensembl chr14:33,511,535...33,548,558 		JBrowse link
G Chid1 chitinase domain containing 1 multiple interactions
increases expression 		ISO [Dexamethasone co-treated with IL4 protein] results in increased expression of CHID1 mRNA; [Dexamethasone co-treated with IL4 protein] results in increased expression of CHID1 protein; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CHID1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CHID1 mRNA; IFNG protein inhibits the reaction [[Dexamethasone co-treated with IL4 protein] results in increased expression of CHID1 mRNA]
Dexamethasone results in increased expression of CHID1 mRNA 		CTD PMID:16357325 PMID:28628672 NCBI chr 1:206,024,059...206,059,259
Ensembl chr 1:205,998,801...206,059,227 		JBrowse link
G Chkb choline kinase beta multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CHKB mRNA CTD PMID:28628672 NCBI chr 7:122,380,592...122,385,102
Ensembl chr 7:122,380,594...122,383,949 		JBrowse link
G Chmp1a charged multivesicular body protein 1A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CHMP1A mRNA CTD PMID:28628672 NCBI chr19:68,146,672...68,154,952
Ensembl chr19:68,146,672...68,154,952 		JBrowse link
G Chmp4b charged multivesicular body protein 4B multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CHMP4B mRNA CTD PMID:28628672 NCBI chr 3:163,631,054...163,671,569
Ensembl chr 3:163,631,054...163,671,569 		JBrowse link
G Chrd chordin multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CHRD mRNA CTD PMID:28628672 NCBI chr11:93,676,400...93,685,584
Ensembl chr11:93,676,400...93,685,278 		JBrowse link
G Chrdl1 chordin-like 1 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CHRDL1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CHRDL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CHRDL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CHRDL1 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr  X:111,685,864...111,789,684
Ensembl chr  X:111,685,866...111,789,661 		JBrowse link
G Chrm4 cholinergic receptor, muscarinic 4 multiple interactions ISO Dexamethasone inhibits the reaction [Ovalbumin results in decreased expression of CHRM4 mRNA] CTD PMID:37004399 NCBI chr 3:98,349,080...98,356,821
Ensembl chr 3:98,348,650...98,358,771 		JBrowse link
G Chrnd cholinergic receptor nicotinic delta subunit increases expression
multiple interactions 		EXP Dexamethasone results in increased expression of CHRND mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of CHRND mRNA] 		CTD PMID:20032058 NCBI chr 9:95,310,316...95,318,734
Ensembl chr 9:95,310,298...95,318,745 		JBrowse link
G Chst14 carbohydrate sulfotransferase 14 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CHST14 mRNA CTD PMID:28628672 NCBI chr 3:126,370,348...126,372,405
Ensembl chr 3:126,370,348...126,372,777 		JBrowse link
G Chst15 carbohydrate sulfotransferase 15 increases expression ISO Dexamethasone results in increased expression of CHST15 mRNA CTD PMID:22733784 NCBI chr 1:196,458,978...196,540,088
Ensembl chr 1:196,460,425...196,491,444 		JBrowse link
G Chst2 carbohydrate sulfotransferase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CHST2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CHST2 mRNA CTD PMID:28628672 NCBI chr 8:104,839,716...104,845,961
Ensembl chr 8:104,831,292...104,860,301 		JBrowse link
G Chst6 carbohydrate sulfotransferase 6 decreases expression ISO Dexamethasone results in decreased expression of CHST6 mRNA CTD PMID:25047013 NCBI chr19:56,769,991...56,790,276
Ensembl chr19:56,769,967...56,790,306 		JBrowse link
G Chsy1 chondroitin sulfate synthase 1 decreases expression ISO Dexamethasone results in decreased expression of CHSY1 mRNA CTD PMID:25047013 NCBI chr 1:129,100,088...129,161,167
Ensembl chr 1:129,100,041...129,161,081 		JBrowse link
G Chuk component of inhibitor of nuclear factor kappa B kinase complex multiple interactions ISO Dexamethasone inhibits the reaction [TNF protein results in increased activity of CHUK protein] CTD PMID:15489888 NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273 		JBrowse link
G Ciao3 cytosolic iron-sulfur assembly component 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIAO3 mRNA CTD PMID:28628672 NCBI chr10:15,300,403...15,309,467
Ensembl chr10:15,300,471...15,309,468 		JBrowse link
G Cib2 calcium and integrin binding family member 2 multiple interactions
decreases expression 		EXP Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CIB2 mRNA] CTD PMID:20032058 NCBI chr 8:63,826,410...63,843,301
Ensembl chr 8:63,826,411...63,843,277 		JBrowse link
G Cidea cell death-inducing DFFA-like effector a increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of CIDEA mRNA
[acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in decreased expression of CIDEA mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with bisphenol AF] results in increased expression of CIDEA mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of CIDEA mRNA
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CIDEA mRNA; [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Roscovitine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEA mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of CIDEA mRNA] 		CTD PMID:19853017 PMID:20032058 PMID:24848799 PMID:29288687 PMID:31596606 More... NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382 		JBrowse link
G Cidec cell death-inducing DFFA-like effector c multiple interactions
increases expression 		ISO [acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in increased expression of CIDEC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CIDEC mRNA; [quinoxyfen co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in increased expression of CIDEC mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of CIDEC mRNA; [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of CIDEC mRNA
Dexamethasone results in increased expression of CIDEC mRNA
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEC mRNA; [quinoxyfen co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEC mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEC mRNA; [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEC mRNA; [tetrabromobisphenol A co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEC mRNA; [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEC mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEC mRNA 		CTD PMID:19853017 PMID:23086663 PMID:25047013 PMID:28628672 PMID:34323617 NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:148,124,925...148,137,806 		JBrowse link
G Cilp cartilage intermediate layer protein increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CILP mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CILP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CILP mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 8:74,671,696...74,687,420
Ensembl chr 8:74,671,534...74,687,409 		JBrowse link
G Cinp cyclin-dependent kinase 2-interacting protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CINP mRNA CTD PMID:28628672 NCBI chr 6:135,698,477...135,720,798
Ensembl chr 6:135,706,793...135,720,689 		JBrowse link
G Cirbp cold inducible RNA binding protein decreases expression ISO Dexamethasone results in decreased expression of CIRBP mRNA CTD PMID:17998272 NCBI chr 7:10,184,515...10,189,623 JBrowse link
G Cish cytokine inducible SH2-containing protein increases expression ISO Dexamethasone results in increased expression of CISH mRNA CTD PMID:22733784 NCBI chr 8:116,850,969...116,855,917
Ensembl chr 8:116,850,773...116,855,986 		JBrowse link
G Cited1 Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 multiple interactions
decreases expression 		ISO [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of CITED1 mRNA; cadmium sulfate inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of CITED1 mRNA]
Dexamethasone results in decreased expression of CITED1 mRNA 		CTD PMID:28189605 PMID:34742744 NCBI chr  X:71,390,328...71,395,023
Ensembl chr  X:71,390,331...71,393,649 		JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 multiple interactions ISO CITED2 protein inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA]; CITED2 protein inhibits the reaction [Dexamethasone results in increased expression of TRIM63 mRNA] CTD PMID:19032942 NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782 		JBrowse link
G Cited4 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CITED4 mRNA CTD PMID:28628672 NCBI chr 5:139,532,165...139,533,056
Ensembl chr 5:139,531,584...139,533,361 		JBrowse link
G Ciz1 CDKN1A interacting zinc finger protein 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIZ1 mRNA CTD PMID:28628672 NCBI chr 3:36,055,753...36,071,510
Ensembl chr 3:36,056,370...36,075,192 		JBrowse link
G Ckap4 cytoskeleton-associated protein 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CKAP4 mRNA CTD PMID:28628672 NCBI chr 7:21,118,527...21,126,624
Ensembl chr 7:21,118,085...21,126,624 		JBrowse link
G Ckap5 cytoskeleton associated protein 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CKAP5 mRNA CTD PMID:28628672 NCBI chr 3:97,946,966...98,049,050
Ensembl chr 3:97,947,031...98,049,049 		JBrowse link
G Ckb creatine kinase B increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of CKB mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CKB mRNA 		CTD PMID:14618091 PMID:28628672 NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478 		JBrowse link
G Cklf chemokine-like factor multiple interactions ISO [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CKLF mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CKLF mRNA 		CTD PMID:23503329 PMID:28628672 NCBI chr19:704,528...712,998
Ensembl chr19:697,451...712,998 		JBrowse link
G Ckm creatine kinase, M-type multiple interactions
increases expression
decreases expression 		ISO [Dexamethasone co-treated with IGF1 protein] results in decreased expression of CKM protein; Dexamethasone promotes the reaction [IGF1 protein results in increased expression of CKM mRNA]
Dexamethasone results in increased expression of CKM mRNA
Dexamethasone results in decreased expression of CKM protein 		CTD PMID:22936724 PMID:33567340 NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719 		JBrowse link
G Ckmt2 creatine kinase, mitochondrial 2 multiple interactions
decreases expression 		ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CKMT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CKMT2 mRNA
Dexamethasone results in decreased expression of CKMT2 protein 		CTD PMID:28628672 PMID:33567340 NCBI chr 2:24,815,008...24,845,511
Ensembl chr 2:24,815,008...24,845,511 		JBrowse link
G Cks1b CDC28 protein kinase regulatory subunit 1B multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CKS1B mRNA CTD PMID:28628672 NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365 		JBrowse link
G Clba1 clathrin binding box of aftiphilin containing 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLBA1 mRNA CTD PMID:28628672 NCBI chr 6:137,703,947...137,710,743
Ensembl chr 6:137,703,619...137,710,742 		JBrowse link
G Clcf1 cardiotrophin-like cytokine factor 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLCF1 mRNA CTD PMID:28628672 NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064 		JBrowse link
G Clcn1 chloride voltage-gated channel 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLCN1 mRNA CTD PMID:28628672 NCBI chr 4:72,138,739...72,168,113
Ensembl chr 4:72,139,162...72,168,128 		JBrowse link
G Clcn4 chloride voltage-gated channel 4 decreases expression EXP Dexamethasone results in decreased expression of CLCN4 mRNA CTD PMID:14618091 NCBI chr  X:27,290,769...27,356,967
Ensembl chr  X:27,290,868...27,356,939 		JBrowse link
G Clcn7 chloride voltage-gated channel 7 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLCN7 mRNA CTD PMID:28628672 NCBI chr10:14,656,261...14,681,632
Ensembl chr10:14,656,245...14,681,631 		JBrowse link
G Cldn1 claudin 1 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CLDN1 protein
Dexamethasone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CLDN1 protein] 		CTD PMID:32619553 PMID:38729284 NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529 		JBrowse link
G Cldn11 claudin 11 increases expression ISO Dexamethasone results in increased expression of CLDN11 mRNA CTD PMID:25047013 NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:114,136,234...114,149,539 		JBrowse link
G Cldn3 claudin 3 multiple interactions ISO Dexamethasone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of CLDN3 protein] CTD PMID:38729284 NCBI chr12:27,345,075...27,346,547
Ensembl chr12:27,345,076...27,348,841 		JBrowse link
G Cldn4 claudin 4 multiple interactions ISO Dexamethasone affects the reaction [IL1B protein affects the expression of CLDN4 mRNA] CTD PMID:35405071 NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958 		JBrowse link
G Cldn5 claudin 5 multiple interactions EXP
ISO 		Dexamethasone inhibits the reaction [Hydrogen Sulfide results in decreased expression of CLDN5 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in decreased expression of CLDN5 protein]]; Dexamethasone inhibits the reaction [[sodium bisulfide results in increased abundance of Hydrogen Sulfide] which results in decreased expression of CLDN5 protein]; Dexamethasone inhibits the reaction [sodium bisulfide results in decreased expression of CLDN5 protein] 		CTD PMID:28741371 PMID:32404561 NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322 		JBrowse link
G Cldn7 claudin 7 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLDN7 mRNA CTD PMID:28628672 NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905 		JBrowse link
G Cldnd2 claudin domain containing 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLDND2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CLDND2 mRNA CTD PMID:28628672 NCBI chr 1:102,985,122...102,988,010
Ensembl chr 1:102,985,122...102,987,808 		JBrowse link
G Clec3b C-type lectin domain family 3, member B multiple interactions
increases expression 		ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CLEC3B mRNA; EGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CLEC3B mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CLEC3B mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLEC3B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CLEC3B mRNA
Dexamethasone results in increased expression of CLEC3B mRNA 		CTD PMID:16054899 PMID:25047013 PMID:28628672 NCBI chr 8:131,687,575...131,693,292 JBrowse link
G Clec4a3 C-type lectin domain family 4, member A3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CLEC4A mRNA CTD PMID:28628672 NCBI chr 4:157,885,899...157,896,728
Ensembl chr 4:157,885,895...157,896,727 		JBrowse link
G Clgn calmegin decreases expression ISO Dexamethasone results in decreased expression of CLGN mRNA CTD PMID:25047013 NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325 		JBrowse link
G Clic3 chloride intracellular channel 3 multiple interactions ISO [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CLIC3 mRNA CTD PMID:16997883 NCBI chr 3:28,670,176...28,672,166
Ensembl chr 3:28,670,229...28,675,723 		JBrowse link
G Clic4 chloride intracellular channel 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLIC4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CLIC4 mRNA CTD PMID:28628672 NCBI chr 5:152,737,371...152,797,118
Ensembl chr 5:152,737,371...152,797,118 		JBrowse link
G Clip2 CAP-GLY domain containing linker protein 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CLIP2 mRNA CTD PMID:28628672 NCBI chr12:27,798,289...27,863,486
Ensembl chr12:27,799,524...27,863,484 		JBrowse link
G Clip4 CAP-GLY domain containing linker protein family, member 4 decreases expression ISO Dexamethasone results in decreased expression of CLIP4 mRNA CTD PMID:22733784 NCBI chr 6:29,359,628...29,449,365
NCBI chr 6:29,349,245...29,351,890
Ensembl chr 6:29,348,918...29,449,271 		JBrowse link
G Clk1 CDC-like kinase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CLK1 mRNA CTD PMID:28628672 NCBI chr 9:67,441,962...67,453,180
Ensembl chr 9:67,441,952...67,451,187 		JBrowse link
G Clmn calmin increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CLMN mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLMN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CLMN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CLMN mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 6:129,470,613...129,572,079
Ensembl chr 6:129,478,149...129,572,027 		JBrowse link
G Clmp CXADR-like membrane protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLMP mRNA CTD PMID:28628672 NCBI chr 8:49,957,639...50,065,959
Ensembl chr 8:49,957,720...50,065,959 		JBrowse link
G Cln6 CLN6, transmembrane ER protein decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of CLN6 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CLN6 mRNA] 		CTD PMID:20032058 NCBI chr 8:72,198,773...72,213,777
Ensembl chr 8:72,198,712...72,213,776 		JBrowse link
G Clock clock circadian regulator affects expression ISO Dexamethasone affects the expression of CLOCK mRNA CTD PMID:23251369 NCBI chr14:32,262,747...32,346,872
Ensembl chr14:32,262,750...32,346,872 		JBrowse link
G Clp1 cleavage factor polyribonucleotide kinase subunit 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CLP1 mRNA CTD PMID:28628672 NCBI chr 3:90,213,461...90,217,165
Ensembl chr 3:90,213,465...90,217,538 		JBrowse link
G Clstn1 calsyntenin 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLSTN1 mRNA CTD PMID:28628672 NCBI chr 5:165,314,128...165,377,627
Ensembl chr 5:165,314,309...165,377,625 		JBrowse link
G Clstn2 calsyntenin 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLSTN2 mRNA CTD PMID:28628672 NCBI chr 8:106,899,894...107,516,402
Ensembl chr 8:106,899,894...107,040,053 		JBrowse link
G Clstn3 calsyntenin 3 multiple interactions
decreases expression 		ISO [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CLSTN3 mRNA
Dexamethasone results in decreased expression of CLSTN3 mRNA 		CTD PMID:24848799 PMID:25047013 NCBI chr 4:159,017,795...159,051,069
Ensembl chr 4:159,017,795...159,051,069 		JBrowse link
G Clu clusterin decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of CLU mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CLU mRNA] 		CTD PMID:17522070 PMID:20032058 PMID:25047013 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860 		JBrowse link
G Cmklr2 chemerin chemokine-like receptor 2 increases expression ISO Dexamethasone results in increased expression of CMKLR2 mRNA CTD PMID:22733784 NCBI chr 9:72,077,164...72,111,979
Ensembl chr 9:72,078,608...72,116,257 		JBrowse link
G Cmss1 cms1 ribosomal small subunit homolog multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CMSS1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CMSS1 mRNA CTD PMID:28628672 NCBI chr11:56,403,620...56,701,751
Ensembl chr11:56,403,499...56,701,755 		JBrowse link
G Cmtm3 CKLF-like MARVEL transmembrane domain containing 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CMTM3 mRNA CTD PMID:28628672 NCBI chr19:629,000...637,152
Ensembl chr19:628,895...636,225 		JBrowse link
G Cnbp CCHC-type zinc finger, nucleic acid binding protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CNBP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CNBP mRNA CTD PMID:28628672 NCBI chr 4:121,860,102...121,868,976
Ensembl chr 4:121,860,105...121,869,010 		JBrowse link
G Cndp2 carnosine dipeptidase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CNDP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CNDP2 mRNA CTD PMID:28628672 NCBI chr18:80,314,799...80,331,900
Ensembl chr18:80,314,801...80,331,900 		JBrowse link
G Cnih3 cornichon family AMPA receptor auxiliary protein 3 decreases expression ISO Dexamethasone results in decreased expression of CNIH3 mRNA CTD PMID:25047013 NCBI chr13:95,548,440...95,739,500
Ensembl chr13:95,598,998...95,772,064 		JBrowse link
G Cnksr1 connector enhancer of kinase suppressor of Ras 1 increases expression
multiple interactions 		EXP Dexamethasone results in increased expression of CNKSR1 mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of CNKSR1 mRNA] 		CTD PMID:20032058 NCBI chr 5:151,731,222...151,742,049
Ensembl chr 5:151,731,224...151,742,203 		JBrowse link
G Cnksr3 Cnksr family member 3 increases expression ISO Dexamethasone results in increased expression of CNKSR3 mRNA CTD PMID:25047013 NCBI chr 1:45,904,581...45,996,921
Ensembl chr 1:45,904,581...45,996,921 		JBrowse link
G Cnn1 calponin 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CNN1 mRNA CTD PMID:28628672 NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:28,908,330...28,919,482 		JBrowse link
G Cnn2 calponin 2 multiple interactions ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CNN2 mRNA CTD PMID:16054899 NCBI chr 7:10,363,141...10,370,312
Ensembl chr 7:10,363,102...10,370,312 		JBrowse link
G Cnn3 calponin 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CNN3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CNN3 mRNA CTD PMID:28628672 NCBI chr 2:212,203,661...212,234,772
Ensembl chr 2:212,226,640...212,234,815 		JBrowse link
G Cnot11 CCR4-NOT transcription complex, subunit 11 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CNOT11 mRNA CTD PMID:28628672 NCBI chr 9:49,310,624...49,320,325
Ensembl chr 9:49,309,518...49,321,771 		JBrowse link
G Cnot4 CCR4-NOT transcription complex, subunit 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CNOT4 mRNA CTD PMID:28628672 NCBI chr 4:64,679,903...64,781,432
Ensembl chr 4:64,679,904...64,738,083 		JBrowse link
G Cnot8 CCR4-NOT transcription complex, subunit 8 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CNOT8 mRNA CTD PMID:28628672 NCBI chr10:42,782,042...42,795,207
Ensembl chr10:42,782,283...42,795,207 		JBrowse link
G Cnp 2',3'-cyclic nucleotide 3' phosphodiesterase decreases expression EXP Dexamethasone results in decreased expression of CNP mRNA CTD PMID:19853640 NCBI chr10:86,011,504...86,018,063
Ensembl chr10:86,011,495...86,018,063 		JBrowse link
G Cnpy3 canopy FGF signaling regulator 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CNPY3 mRNA CTD PMID:28628672 NCBI chr 9:21,731,088...21,745,448
Ensembl chr 9:21,730,791...21,745,505 		JBrowse link
G Cnpy4 canopy FGF signaling regulator 4 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CNPY4 mRNA CTD PMID:28628672 NCBI chr12:22,178,254...22,184,432
Ensembl chr12:22,178,160...22,184,425 		JBrowse link
G Cnr1 cannabinoid receptor 1 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CNR1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CNR1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CNR1 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252 		JBrowse link
G Cntn1 contactin 1 decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of CNTN1 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CNTN1 mRNA] 		CTD PMID:20032058 NCBI chr 7:125,142,638...125,440,397
Ensembl chr 7:125,142,696...125,440,391 		JBrowse link
G Coa3 cytochrome C oxidase assembly factor 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COA3 mRNA CTD PMID:28628672 NCBI chr10:86,720,454...86,721,435
Ensembl chr10:86,720,456...86,721,440 		JBrowse link
G Coa5 cytochrome C oxidase assembly factor 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COA5 mRNA CTD PMID:28628672 NCBI chr 9:47,147,267...47,160,724
Ensembl chr 9:47,147,267...47,160,672 		JBrowse link
G Coasy Coenzyme A synthase multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COASY mRNA CTD PMID:28628672 NCBI chr10:86,514,850...86,519,130
Ensembl chr10:86,514,874...86,519,130 		JBrowse link
G Cobll1 cordon-bleu WH2 repeat protein-like 1 increases expression ISO Dexamethasone results in increased expression of COBLL1 mRNA CTD PMID:25047013 NCBI chr 3:70,161,369...70,324,844
Ensembl chr 3:70,161,372...70,323,460 		JBrowse link
G Col10a1 collagen type X alpha 1 chain increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of COL10A1 mRNA; Dexamethasone results in increased expression of COL10A1 protein
PTH protein modified form inhibits the reaction [Dexamethasone results in increased expression of COL10A1 protein] 		CTD PMID:27608943 NCBI chr20:39,737,536...39,744,518
Ensembl chr20:39,716,822...39,751,440 		JBrowse link
G Col11a1 collagen type XI alpha 1 chain multiple interactions ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of COL11A1 mRNA CTD PMID:16054899 NCBI chr 2:204,509,136...204,702,264
Ensembl chr 2:204,509,136...204,702,264 		JBrowse link
G Col12a1 collagen type XII alpha 1 chain increases expression
multiple interactions
decreases expression 		ISO Dexamethasone results in increased expression of COL12A1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of COL12A1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of COL12A1 mRNA
Dexamethasone results in decreased expression of COL12A1 mRNA 		CTD PMID:22733784 PMID:25047013 PMID:28628672 NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711 		JBrowse link
G Col13a1 collagen type XIII alpha 1 chain decreases expression ISO Dexamethasone results in decreased expression of COL13A1 mRNA CTD PMID:25047013 NCBI chr20:30,326,744...30,466,800
Ensembl chr20:30,326,744...30,466,800 		JBrowse link
G Col14a1 collagen type XIV alpha 1 chain decreases expression ISO Dexamethasone results in decreased expression of COL14A1 mRNA CTD PMID:25047013 NCBI chr 7:88,611,827...88,826,939
Ensembl chr 7:88,611,828...88,826,938 		JBrowse link
G Col15a1 collagen type XV alpha 1 chain multiple interactions
decreases expression 		ISO
EXP 		[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of COL15A1 mRNA
Dexamethasone results in decreased expression of COL15A1 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COL15A1 mRNA] 		CTD PMID:16997883 PMID:20032058 PMID:25047013 NCBI chr 5:66,297,546...66,403,172
Ensembl chr 5:66,297,461...66,403,170 		JBrowse link
G Col18a1 collagen type XVIII alpha 1 chain multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of COL18A1 mRNA CTD PMID:28628672 NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112 		JBrowse link
G Col1a1 collagen type I alpha 1 chain decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of COL1A1 mRNA; Dexamethasone results in decreased expression of COL1A1 protein
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; [Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of COL1A1 mRNA; [Rutin co-treated with Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of COL1A1 mRNA; cordycepin inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of COL1A1 mRNA]]; Dexamethasone inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; NLRC5 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]]; NLRC5 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of COL1A1 mRNA]; SIRT1 protein promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]]; Theophylline promotes the reaction [Dexamethasone inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]]
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of COL1A1 mRNA]; [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid] co-treated with fasudil] results in increased expression of COL1A1 mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Particulate Matter] results in increased expression of COL1A1 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Dexamethasone inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; Atorvastatin inhibits the reaction [Dexamethasone results in decreased expression of COL1A1 mRNA]; PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]]; PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]]; SENP2 protein promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]] 		CTD PMID:14618091 PMID:16430859 PMID:26435214 PMID:26739621 PMID:26806094 More... NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain decreases expression ISO Dexamethasone results in decreased expression of COL1A2 mRNA CTD PMID:25047013 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col2a1 collagen type II alpha 1 chain multiple interactions
decreases expression
affects expression 		ISO
EXP 		[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL2A1 mRNA; Dexamethasone inhibits the reaction [BMP2 protein results in increased expression of COL2A1 mRNA]; IL1B protein inhibits the reaction [[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL2A1 mRNA]; PTH protein modified form inhibits the reaction [Dexamethasone results in decreased expression of COL2A1 protein]; resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of COL2A1 mRNA]]
Dexamethasone results in decreased expression of COL2A1 mRNA; Dexamethasone results in decreased expression of COL2A1 protein
Dexamethasone affects the reaction [[Freund's Adjuvant co-treated with COL2A1 protein] affects the activity of GSR protein]; Dexamethasone inhibits the reaction [[Freund's Adjuvant co-treated with COL2A1 protein] results in increased expression of IL1B protein]; Dexamethasone inhibits the reaction [[Freund's Adjuvant co-treated with COL2A1 protein] results in increased expression of IL6 protein]
Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in decreased abundance of Amino Acids]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in decreased abundance of Pantothenic Acid]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in decreased abundance of phenylpyruvic acid]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Amino Acids]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Carnitine]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Citric Acid]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatine]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Creatinine]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of phenylacetylglycine]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Succinic Acid]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Uric Acid]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Uridine]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased secretion of IL1B protein]
Dexamethasone affects the expression of COL2A1 mRNA 		CTD PMID:17299831 PMID:17502159 PMID:21277400 PMID:24709313 PMID:26526931 More... NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:130,977,561...131,006,627 		JBrowse link
G Col3a1 collagen type III alpha 1 chain decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of COL3A1 mRNA
Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Particulate Matter] results in increased expression of COL3A1 mRNA]
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COL3A1 mRNA] 		CTD PMID:20032058 PMID:25047013 PMID:35335934 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain multiple interactions
increases expression 		ISO
EXP 		[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of COL4A1 mRNA
Dexamethasone results in increased expression of COL4A1 mRNA 		CTD PMID:16054899 PMID:22733784 PMID:25047013 PMID:35143883 NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482 		JBrowse link
G Col4a2 collagen type IV alpha 2 chain increases expression ISO Dexamethasone results in increased expression of COL4A2 mRNA CTD PMID:22733784 NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520 		JBrowse link
G Col4a6 collagen type IV alpha 6 chain multiple interactions ISO [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of COL4A6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COL4A6 mRNA CTD PMID:16997883 PMID:28628672 NCBI chr  X:109,554,945...109,905,987
Ensembl chr  X:109,552,651...109,905,944 		JBrowse link
G Col5a1 collagen type V alpha 1 chain decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of COL5A1 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COL5A1 mRNA] 		CTD PMID:14618091 PMID:20032058 PMID:25047013 NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:31,606,486...31,753,020 		JBrowse link
G Col5a2 collagen type V alpha 2 chain decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of COL5A2 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COL5A2 mRNA] 		CTD PMID:20032058 PMID:25047013 NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150 		JBrowse link
G Col5a3 collagen type V alpha 3 chain multiple interactions
decreases expression 		EXP Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COL5A3 mRNA] CTD PMID:20032058 NCBI chr 8:27,580,768...27,626,002
Ensembl chr 8:27,580,768...27,626,122 		JBrowse link
G Col6a1 collagen type VI alpha 1 chain multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COL6A1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of COL6A1 mRNA CTD PMID:28628672 NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107 		JBrowse link
G Col6a2 collagen type VI alpha 2 chain decreases expression ISO Dexamethasone results in decreased expression of COL6A2 mRNA CTD PMID:25047013 NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042 		JBrowse link
G Col6a3 collagen type VI alpha 3 chain multiple interactions
decreases expression 		ISO
EXP 		[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of COL6A3 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of COL6A3 mRNA]
Dexamethasone results in decreased expression of COL6A3 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COL6A3 mRNA] 		CTD PMID:16054899 PMID:20032058 PMID:25047013 NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:98,809,171...98,886,990 		JBrowse link
G Col7a1 collagen type VII alpha 1 chain multiple interactions
decreases expression 		ISO [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of COL7A1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COL7A1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of COL7A1 mRNA
Dexamethasone results in decreased expression of COL7A1 mRNA 		CTD PMID:16997883 PMID:25047013 PMID:28628672 NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439 		JBrowse link
G Col8a1 collagen type VIII alpha 1 chain decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of COL8A1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of COL8A1 mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr11:56,245,998...56,378,586
Ensembl chr11:56,369,868...56,376,229 		JBrowse link
G Col8a2 collagen type VIII alpha 2 chain multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of COL8A2 mRNA CTD PMID:28628672 NCBI chr 5:143,870,754...143,897,372
Ensembl chr 5:143,870,742...143,897,884 		JBrowse link
G Col9a1 collagen type IX alpha 1 chain affects expression ISO Dexamethasone affects the expression of COL9A1 mRNA CTD PMID:21277400 NCBI chr 9:34,081,364...34,164,552
Ensembl chr 9:34,003,905...34,164,543 		JBrowse link
G Colec11 collectin sub-family member 11 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COLEC11 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COLEC11 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of COLEC11 mRNA CTD PMID:28628672 NCBI chr 6:50,952,357...50,984,845
Ensembl chr 6:50,952,357...50,999,493 		JBrowse link
G Colgalt2 collagen beta(1-O)galactosyltransferase 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COLGALT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COLGALT2 mRNA CTD PMID:28628672 NCBI chr13:67,073,551...67,178,194
Ensembl chr13:67,073,551...67,178,194 		JBrowse link
G Commd1 copper metabolism domain containing 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COMMD1 mRNA CTD PMID:28628672 NCBI chr14:101,081,667...101,185,738
Ensembl chr14:101,081,667...101,185,639 		JBrowse link
G Commd10 COMM domain containing 10 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COMMD10 mRNA CTD PMID:28628672 NCBI chr18:41,927,802...42,061,384
Ensembl chr18:41,921,694...42,086,729 		JBrowse link
G Commd2 COMM domain containing 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COMMD2 mRNA CTD PMID:28628672 NCBI chr 2:143,998,672...144,002,918
Ensembl chr 2:143,998,672...144,002,918 		JBrowse link
G Commd6 COMM domain containing 6 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COMMD6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of COMMD6 mRNA CTD PMID:28628672 NCBI chr15:84,882,069...84,889,124
Ensembl chr15:84,882,548...84,889,194 		JBrowse link
G Comt catechol-O-methyltransferase multiple interactions
increases expression 		EXP
ISO 		Testosterone inhibits the reaction [Dexamethasone results in increased expression of COMT mRNA] CTD PMID:16962226 PMID:20032058 PMID:21041162 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Copb2 COPI coat complex subunit beta 2 multiple interactions
decreases expression 		EXP Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COPB2 mRNA] CTD PMID:20032058 NCBI chr 8:108,040,687...108,062,810
Ensembl chr 8:108,040,693...108,064,550 		JBrowse link
G Copg1 COPI coat complex subunit gamma 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COPG1 mRNA CTD PMID:28628672 NCBI chr 4:121,923,644...121,949,819
Ensembl chr 4:121,923,873...121,949,812 		JBrowse link
G Cops7a COP9 signalosome subunit 7A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COPS7A mRNA CTD PMID:28628672 NCBI chr 4:159,452,878...159,478,878
Ensembl chr 4:159,452,897...159,460,315 		JBrowse link
G Cops9 COP9 signalosome subunit 9 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MYEOV2 mRNA CTD PMID:28628672 NCBI chr 9:100,657,276...100,662,206
Ensembl chr 9:100,657,276...100,662,206 		JBrowse link
G Copz1 COPI coat complex subunit zeta 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COPZ1 mRNA CTD PMID:28628672 NCBI chr 7:136,287,696...136,314,131
Ensembl chr 7:136,288,032...136,314,135 		JBrowse link
G Copz2 COPI coat complex subunit zeta 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COPZ2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COPZ2 mRNA CTD PMID:28628672 NCBI chr10:82,328,888...82,341,959
Ensembl chr10:82,328,660...82,341,959 		JBrowse link
G Coq8b coenzyme Q8B multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of COQ8B mRNA CTD PMID:28628672 NCBI chr 1:91,653,241...91,676,822
Ensembl chr 1:91,654,225...91,676,819 		JBrowse link
G Coro1c coronin 1C multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CORO1C mRNA CTD PMID:28628672 NCBI chr12:48,373,573...48,445,718
Ensembl chr12:48,373,597...48,445,716 		JBrowse link
G Coro2a coronin 2A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CORO2A mRNA CTD PMID:28628672 NCBI chr 5:65,623,820...65,677,483
Ensembl chr 5:65,623,823...65,654,602 		JBrowse link
G Coro2b coronin 2B multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CORO2B mRNA CTD PMID:28628672 NCBI chr 8:71,802,329...71,912,739
Ensembl chr 8:71,802,329...71,912,739 		JBrowse link
G Coro6 coronin 6 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CORO6 mRNA CTD PMID:28628672 NCBI chr10:62,808,172...62,817,788
Ensembl chr10:62,809,689...62,817,787 		JBrowse link
G Cotl1 coactosin-like F-actin binding protein 1 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of COTL1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COTL1 mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840 		JBrowse link
G Cox11 cytochrome c oxidase copper chaperone COX11 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of COX11 mRNA CTD PMID:28628672 NCBI chr10:75,955,825...75,962,398
Ensembl chr10:75,955,783...75,963,489 		JBrowse link
G Cox16 cytochrome c oxidase assembly factor COX16 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COX16 mRNA CTD PMID:28628672 NCBI chr 6:106,745,424...106,912,523
Ensembl chr 6:106,899,494...106,912,484 		JBrowse link
G Cox20 cytochrome c oxidase assembly factor COX20 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of COX20 mRNA CTD PMID:28628672 NCBI chr13:92,592,260...92,604,129
Ensembl chr14:6,872,315...6,872,638 		JBrowse link
G Cox6b2 cytochrome c oxidase subunit 6B2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COX6B2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COX6B2 mRNA CTD PMID:28628672 NCBI chr 1:78,122,871...78,124,096
Ensembl chr 1:78,122,453...78,124,094 		JBrowse link
G Cox7a1 cytochrome c oxidase subunit 7A1 multiple interactions
increases expression 		ISO [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of COX7A1 mRNA; [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of COX7A1 mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of COX7A mRNA
Dexamethasone results in increased expression of COX7A1 mRNA 		CTD PMID:24848799 PMID:25047013 PMID:29288687 PMID:32417366 NCBI chr 1:94,549,663...94,572,330
Ensembl chr 1:94,569,216...94,570,889 		JBrowse link
G Cox7b cytochrome c oxidase subunit 7B multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COX7B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of COX7B mRNA CTD PMID:28628672 NCBI chr  X:75,149,036...75,155,285
Ensembl chr  X:75,148,996...75,155,284 		JBrowse link
G Cox7b2 cytochrome c oxidase subunit 7B2 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of COX7B2 mRNA
Dexamethasone inhibits the reaction [Lipopolysaccharides results in decreased expression of COX7B2 mRNA] 		CTD PMID:22185406 NCBI chr14:37,047,081...37,159,288
Ensembl chr14:37,047,081...37,159,288 		JBrowse link
G Cp ceruloplasmin multiple interactions
increases expression 		ISO
EXP 		[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA; [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA]
Dexamethasone results in increased expression of CP mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of CP mRNA] 		CTD PMID:16054899 PMID:20032058 PMID:22733784 NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087 		JBrowse link
G Cpa1 carboxypeptidase A1 decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of CPA1 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CPA1 mRNA] 		CTD PMID:20032058 NCBI chr 4:60,224,801...60,230,928
Ensembl chr 4:60,224,801...60,230,928 		JBrowse link
G Cpap centrosome assembly and centriole elongation protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CPAP mRNA CTD PMID:28628672 NCBI chr15:34,742,838...34,806,020
Ensembl chr15:34,742,838...34,802,421 		JBrowse link
G Cpe carboxypeptidase E decreases expression
increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of CPE mRNA
dexamethasone increases expression of CPE mRNA in rat hippocampal neurons
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CPE mRNA
Dexamethasone results in increased expression of CPE mRNA alternative form
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CPE mRNA] 		CTD
RGD		 PMID:20032058 PMID:25426952 PMID:28628672 PMID:25426952 RGD:405650601 NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524 		JBrowse link
G Cpeb2 cytoplasmic polyadenylation element binding protein 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CPEB2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CPEB2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CPEB2 mRNA CTD PMID:28628672 NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263 		JBrowse link
G Cped1 cadherin-like and PC-esterase domain containing 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CPED1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CPED1 mRNA CTD PMID:28628672 NCBI chr 4:51,482,497...51,755,440
Ensembl chr 4:51,482,545...51,755,442 		JBrowse link
G Cpn1 carboxypeptidase N subunit 1 increases expression EXP Dexamethasone results in increased expression of CPN1 protein CTD PMID:10485340 NCBI chr 1:252,793,786...252,822,675
Ensembl chr 1:252,793,423...252,822,664 		JBrowse link
G Cpne7 copine 7 increases expression ISO Dexamethasone results in increased expression of CPNE7 mRNA CTD PMID:25047013 NCBI chr19:68,072,165...68,091,197
Ensembl chr19:68,074,545...68,091,197 		JBrowse link
G Cps1 carbamoyl-phosphate synthase 1 increases expression ISO
EXP 		Dexamethasone results in increased expression of CPS1 protein
Dexamethasone results in increased expression of CPS1 mRNA 		CTD PMID:12198645 PMID:15965953 NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:76,000,754...76,186,734 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CPT1A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CPT1A mRNA CTD PMID:28628672 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326 		JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 multiple interactions ISO [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CPT2 mRNA CTD PMID:23428407 NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:127,893,207...127,910,818 		JBrowse link
G Cptp ceramide-1-phosphate transfer protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CPTP mRNA CTD PMID:28628672 NCBI chr 5:171,757,181...171,761,271
Ensembl chr 5:171,757,181...171,761,266 		JBrowse link
G Cpz carboxypeptidase Z multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CPZ mRNA CTD PMID:28628672 NCBI chr14:79,448,242...79,471,557
Ensembl chr14:79,448,139...79,471,556 		JBrowse link
G Crabp2 cellular retinoic acid binding protein 2 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of CRABP2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CRABP2 mRNA 		CTD PMID:20228061 PMID:22733784 PMID:28628672 NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:175,707,312...175,728,385 		JBrowse link
G Cradd CASP2 and RIPK1 domain containing adaptor with death domain multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CRADD mRNA CTD PMID:28628672 NCBI chr 7:31,827,131...31,839,796
Ensembl chr 7:31,685,622...31,874,512 		JBrowse link
G Crbn cereblon multiple interactions ISO [pomalidomide co-treated with Dexamethasone co-treated with afuresertib] results in increased expression of CRBN protein; [pomalidomide co-treated with Dexamethasone] results in increased expression of CRBN protein CTD PMID:29928335 NCBI chr 4:141,255,400...141,276,722
Ensembl chr 4:141,257,243...141,276,038 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 increases phosphorylation
multiple interactions
decreases expression
affects expression 		ISO
EXP 		Dexamethasone results in increased phosphorylation of CREB1 protein
14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] promotes the reaction [CREB1 protein binds to CEBPB promoter]]; 14-deoxy-11,12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CREB1 protein]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] promotes the reaction [CREB1 protein binds to CEBPB promoter]; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CREB1 protein
Dexamethasone results in decreased expression of CREB1 mRNA
[Dexamethasone co-treated with Cyclic AMP] results in increased phosphorylation of CREB1 protein
Dexamethasone affects the expression of CREB1 mRNA 		CTD PMID:16239108 PMID:21041162 PMID:21804312 PMID:22676303 PMID:29111458 More... NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Crebrf CREB3 regulatory factor multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CREBRF mRNA CTD PMID:28628672 NCBI chr10:16,903,607...16,967,450
Ensembl chr10:16,903,547...16,966,430 		JBrowse link
G Creg1 cellular repressor of E1A-stimulated genes 1 increases expression
multiple interactions 		EXP Dexamethasone results in increased expression of CREG mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of CREG mRNA] 		CTD PMID:20032058 NCBI chr13:80,552,779...80,565,272
Ensembl chr13:80,549,933...80,565,272 		JBrowse link
G Crh corticotropin releasing hormone increases expression EXP Dexamethasone results in increased expression of CRH mRNA CTD PMID:18819432 NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386 		JBrowse link
G Crisp1 cysteine-rich secretory protein 1 decreases expression
multiple interactions 		EXP Dexamethasone results in decreased expression of CRISP1 mRNA
Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CRISP1 mRNA] 		CTD PMID:20032058 NCBI chr 9:28,238,326...28,265,344
Ensembl chr 9:28,238,328...28,265,344 		JBrowse link
G Crispld2 cysteine-rich secretory protein LCCL domain containing 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CRISPLD2 mRNA CTD PMID:28628672 NCBI chr19:64,961,764...65,020,099
Ensembl chr19:64,961,771...65,020,349 		JBrowse link
G Crk CRK proto-oncogene, adaptor protein multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CRK mRNA CTD PMID:28628672 NCBI chr10:61,028,736...61,054,971
Ensembl chr10:61,028,757...61,082,988 		JBrowse link
G Crkl CRK like proto-oncogene, adaptor protein multiple interactions ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CRKL mRNA CTD PMID:16054899 NCBI chr11:97,033,033...97,067,457
Ensembl chr11:97,024,782...97,067,457 		JBrowse link
G Crp C-reactive protein multiple interactions ISO
EXP 		Dexamethasone inhibits the reaction [[Lipopolysaccharides co-treated with IL10 protein] results in increased expression of CRP protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CRP protein]
Dexamethasone promotes the reaction [Losartan inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CRP protein]] 		CTD PMID:32812458 PMID:37177863 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Crtc2 CREB regulated transcription coactivator 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CRTC2 mRNA CTD PMID:28628672 NCBI chr 2:178,007,233...178,017,397
Ensembl chr 2:178,007,240...178,017,389 		JBrowse link
G Cry2 cryptochrome circadian regulator 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CRY2 mRNA CTD PMID:28628672 NCBI chr 3:98,830,479...98,860,437
Ensembl chr 3:98,830,483...98,860,447 		JBrowse link
G Cryab crystallin, alpha B multiple interactions
increases expression
decreases expression 		ISO Ginkgo biloba extract promotes the reaction [Dexamethasone results in increased expression of CRYAB mRNA]
Dexamethasone results in decreased expression of CRYAB protein 		CTD PMID:19064852 PMID:25047013 PMID:33567340 NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528 		JBrowse link
G Crybg1 crystallin beta-gamma domain containing 1 increases expression ISO Dexamethasone results in increased expression of CRYBG1 mRNA CTD PMID:12782123 NCBI chr20:49,007,673...49,204,040
Ensembl chr20:49,007,929...49,204,047 		JBrowse link
G Cs citrate synthase increases expression
multiple interactions
decreases expression 		ISO
EXP 		Dexamethasone results in increased expression of CS mRNA
[[Dexamethasone co-treated with Spironolactone] results in increased abundance of Glucocorticoids] which results in increased activity of CS protein
Dexamethasone results in decreased expression of CS protein
[BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of CS mRNA 		CTD PMID:1328298 PMID:25047013 PMID:33091441 PMID:33567340 NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938 		JBrowse link
G Csad cysteine sulfinic acid decarboxylase increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CSAD mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CSAD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CSAD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CSAD mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 7:135,187,175...135,216,495
Ensembl chr 7:135,187,175...135,215,581 		JBrowse link
G Csf1 colony stimulating factor 1 multiple interactions
decreases expression
increases expression 		ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CSF1 mRNA
Dexamethasone results in decreased expression of CSF1 mRNA
Dexamethasone results in increased expression of CSF1 mRNA 		CTD PMID:16054899 PMID:21041162 PMID:22733784 NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468 		JBrowse link
G Csf1r colony stimulating factor 1 receptor increases expression ISO Dexamethasone results in increased expression of CSF1R protein
Dexamethasone results in increased expression of CSF1R mRNA 		CTD PMID:15679045 PMID:21041162 NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806 		JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions
increases activity
decreases expression 		ISO [Theophylline co-treated with Dexamethasone] inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; [trichostatin A co-treated with Dexamethasone] inhibits the reaction [IL1B protein promotes the reaction [H4C16 protein modified form binds to CSF2 promoter]]; Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein]; Dexamethasone inhibits the reaction [IL13 protein results in increased secretion of CSF2 protein]; Dexamethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; Dexamethasone inhibits the reaction [IL4 protein results in increased secretion of CSF2 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein]; Dexamethasone inhibits the reaction [lipoteichoic acid results in increased secretion of CSF2 protein]; Dexamethasone inhibits the reaction [TNF protein results in increased expression of CSF2 mRNA]; Dexamethasone inhibits the reaction [TNF protein results in increased secretion of CSF2 protein]; Dexamethasone promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of CSF2 mRNA]]; trichostatin A inhibits the reaction [[Theophylline co-treated with Dexamethasone] inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]]; trichostatin A inhibits the reaction [Dexamethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]]
Dexamethasone results in increased activity of CSF2 protein
Dexamethasone results in decreased expression of CSF2 mRNA
Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 protein] 		CTD PMID:10596698 PMID:11730731 PMID:12070353 PMID:12077271 PMID:14998300 More... NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Csf3 colony stimulating factor 3 increases expression ISO Dexamethasone results in increased expression of CSF3 mRNA CTD PMID:16144937 NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860 		JBrowse link
G Csgalnact2 chondroitin sulfate N-acetylgalactosaminyltransferase 2 decreases expression ISO Dexamethasone results in decreased expression of CSGALNACT2 mRNA CTD PMID:25047013 NCBI chr 4:152,944,154...152,981,237
Ensembl chr 4:152,950,028...152,981,220 		JBrowse link
G Csk C-terminal Src kinase decreases expression ISO Dexamethasone results in decreased expression of CSK mRNA CTD PMID:21041162 NCBI chr 8:66,925,650...66,944,861
Ensembl chr 8:66,925,651...66,930,274 		JBrowse link
G Csn2 casein beta multiple interactions ISO [PRL protein co-treated with Dexamethasone] results in increased expression of CSN2 mRNA; beta-Naphthoflavone inhibits the reaction [[PRL protein co-treated with Dexamethasone] results in increased expression of CSN2 mRNA] CTD PMID:29521512 NCBI chr14:20,601,824...20,609,061
Ensembl chr14:20,601,824...20,609,060 		JBrowse link
G Csrp2 cysteine and glycine-rich protein 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CSRP2 mRNA CTD PMID:28628672 NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238 		JBrowse link
G Csrp3 cysteine and glycine rich protein 3 increases expression
multiple interactions 		EXP Dexamethasone results in increased expression of CSRP3 mRNA
Testosterone inhibits the reaction [Dexamethasone results in increased expression of CSRP3 mRNA] 		CTD PMID:20032058 NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916 		JBrowse link
G Cst3 cystatin C increases expression ISO Dexamethasone results in increased expression of CST3 mRNA CTD PMID:22733784 NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937 		JBrowse link
G Cst5 cystatin D multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CST5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CST5 mRNA CTD PMID:28628672 NCBI chr 3:158,033,791...158,038,345
Ensembl chr 3:158,033,791...158,038,345 		JBrowse link
G Cst6 cystatin E/M multiple interactions ISO [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CST6 mRNA CTD PMID:16997883 NCBI chr 1:212,084,676...212,086,384
Ensembl chr 1:212,084,676...212,086,384 		JBrowse link
G Csta cystatin A multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CSTA mRNA CTD PMID:28628672 NCBI chr11:78,125,813...78,136,818
Ensembl chr11:78,125,800...78,136,822 		JBrowse link
G Cstf1 cleavage stimulation factor subunit 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CSTF1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CSTF1 mRNA CTD PMID:28628672 NCBI chr 3:181,562,953...181,574,727
Ensembl chr 3:181,562,955...181,574,727 		JBrowse link
G Cstf3 cleavage stimulation factor subunit 3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CSTF3 mRNA CTD PMID:28628672 NCBI chr 3:111,421,291...111,492,539
Ensembl chr 3:111,421,234...111,497,046 		JBrowse link
G Ctbp2 C-terminal binding protein 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CTBP2 mRNA CTD PMID:28628672 NCBI chr 1:197,208,536...197,348,802
Ensembl chr 1:197,212,133...197,254,261 		JBrowse link
G Ctdspl CTD small phosphatase like multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CTDSPL mRNA CTD PMID:28628672 NCBI chr 8:127,520,478...127,644,999
Ensembl chr 8:127,520,499...127,644,999 		JBrowse link
G Cth cystathionine gamma-lyase decreases activity
decreases expression
multiple interactions 		ISO Dexamethasone results in decreased activity of CTH protein
Dexamethasone results in decreased expression of CTH mRNA
Ibuprofen promotes the reaction [Dexamethasone results in decreased activity of CTH protein]; Ibuprofen promotes the reaction [Dexamethasone results in decreased expression of CTH mRNA]; NR3C1 protein affects the reaction [Dexamethasone results in decreased expression of CTH mRNA]; NR3C1 protein affects the reaction [Ibuprofen promotes the reaction [Dexamethasone results in decreased expression of CTH mRNA]] 		CTD PMID:29222744 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066 		JBrowse link
G Ctnnb1 catenin beta 1 decreases expression
increases expression
multiple interactions
affects localization 		ISO
EXP 		Dexamethasone results in decreased expression of CTNNB1 protein
Dexamethasone results in increased expression of CTNNB1 mRNA
[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of CTNNB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CTNNB1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CTNNB1 mRNA; lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of CTNNB1 mRNA]
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CTNNB1 protein; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein; [Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the expression of CTNNB1 mRNA; [Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the phosphorylation of CTNNB1 protein; boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]]; CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]; CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA protein]]; CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]]; CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]; Diethylhexyl Phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the expression of CTNNB1 mRNA]; Diethylhexyl Phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the phosphorylation of CTNNB1 protein]; IWR-1 compound inhibits the reaction [Raloxifene Hydrochloride inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CTNNB1 protein]]; Lithium Chloride affects the reaction [Diethylhexyl Phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the phosphorylation of CTNNB1 protein]]; Lithium Chloride affects the reaction [mono-(2-ethylhexyl)phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the phosphorylation of CTNNB1 protein]]; mono-(2-ethylhexyl)phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the expression of CTNNB1 mRNA]; mono-(2-ethylhexyl)phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the phosphorylation of CTNNB1 protein]; protosappanin B inhibits the reaction [Dexamethasone results in decreased expression of CTNNB1 protein]; Raloxifene Hydrochloride inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CTNNB1 protein]; sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein]; T 0070907 affects the reaction [Diethylhexyl Phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the phosphorylation of CTNNB1 protein]]; T 0070907 affects the reaction [mono-(2-ethylhexyl)phthalate affects the reaction [[Dexamethasone co-treated with Ascorbic Acid co-treated with beta-glycerophosphoric acid] affects the phosphorylation of CTNNB1 protein]]
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of CTNNB1 protein]; Atorvastatin inhibits the reaction [Dexamethasone results in decreased expression of CTNNB1 mRNA]; Dexamethasone inhibits the reaction [2-amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine results in increased expression of CTNNB1 mRNA]; Dexamethasone results in decreased expression of and results in increased phosphorylation of CTNNB1 protein; Quercetin promotes the reaction [Dexamethasone results in decreased expression of CTNNB1 mRNA]; Quercetin promotes the reaction [Dexamethasone results in decreased expression of CTNNB1 protein]
Dexamethasone affects the localization of CTNNB1 protein
Dexamethasone results in decreased expression of CTNNB1 mRNA; Dexamethasone results in decreased expression of CTNNB1 protein 		CTD PMID:18467435 PMID:20501703 PMID:20578217 PMID:28285642 PMID:28628672 More... NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctnnbl1 catenin, beta like 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CTNNBL1 mRNA CTD PMID:28628672 NCBI chr 3:166,807,899...166,968,932
Ensembl chr 3:166,807,858...166,968,931 		JBrowse link
G Ctrl chymotrypsin-like increases expression ISO Dexamethasone results in increased expression of CTRB1 mRNA CTD PMID:22733784 NCBI chr19:50,737,078...50,740,659
Ensembl chr19:50,737,079...50,738,979 		JBrowse link
G Ctsb cathepsin B multiple interactions EXP dexamethasone decreases activity of Ctsb protein in heart and kidney; dexamethasone increases activity of Ctsb protein in serum RGD PMID:8717430 RGD:1625507 NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478 		JBrowse link
G Ctsc cathepsin C multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CTSC mRNA CTD PMID:28628672 NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082 		JBrowse link
G Ctsd cathepsin D increases expression
decreases expression 		ISO Dexamethasone results in increased expression of CTSD mRNA
Dexamethasone results in decreased expression of CTSD mRNA 		CTD PMID:21041162 PMID:25047013 NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821 		JBrowse link
G Ctsf cathepsin F multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CTSF mRNA CTD PMID:28628672 NCBI chr 1:211,582,169...211,587,917
Ensembl chr 1:211,582,098...211,587,916 		JBrowse link
G Ctsh cathepsin H multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CTSH mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CTSH mRNA CTD PMID:28628672 NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:99,488,874...99,509,181 		JBrowse link
G Ctsk cathepsin K increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CTSK mRNA
[Dexamethasone co-treated with TNFSF11 protein] results in increased expression of CTSK protein 		CTD PMID:25047013 PMID:39393751 NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582 		JBrowse link
G Ctsl cathepsin L increases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in increased expression of CTSL mRNA
Calcitriol inhibits the reaction [Dexamethasone results in increased expression of CTSL mRNA]
Testosterone inhibits the reaction [Dexamethasone results in increased expression of CTSL mRNA] 		CTD PMID:14618091 PMID:17522070 PMID:20032058 PMID:29962435 NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113 		JBrowse link
G Ctsz cathepsin Z decreases expression ISO Dexamethasone results in decreased expression of CTSZ mRNA CTD PMID:22733784 NCBI chr 3:183,643,077...183,653,847
Ensembl chr 3:183,643,077...183,657,012 		JBrowse link
G Cttnbp2nl CTTNBP2 N-terminal like multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CTTNBP2NL mRNA CTD PMID:28628672 NCBI chr 2:195,196,318...195,244,792
Ensembl chr 2:195,196,318...195,243,181 		JBrowse link
G Cul4b cullin 4B increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CUL4B mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CUL4B mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr  X:122,154,332...122,192,299
Ensembl chr  X:122,154,332...122,192,299 		JBrowse link
G Cul9 cullin 9 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of CUL9 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CUL9 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CUL9 mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 9:21,933,699...21,977,145
Ensembl chr 9:21,933,803...21,977,145 		JBrowse link
G Cutc cutC copper transporter increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CUTC mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CUTC mRNA 		CTD PMID:25047013 PMID:28628672 NCBI chr 1:252,571,489...252,586,269
Ensembl chr 1:252,571,521...252,597,272 		JBrowse link
G Cwc25 CWC25 spliceosome-associated protein homolog multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CWC25 mRNA CTD PMID:28628672 NCBI chr10:83,232,052...83,256,722
Ensembl chr10:83,232,052...83,256,722 		JBrowse link
G Cwc27 CWC27 spliceosome associated cyclophilin multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CWC27 mRNA CTD PMID:28628672 NCBI chr 2:37,498,462...37,709,691
Ensembl chr 2:37,498,468...37,709,355 		JBrowse link
G Cwf19l1 CWF19 like cell cycle control factor 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CWF19L1 mRNA CTD PMID:28628672 NCBI chr 1:252,946,934...252,970,194
Ensembl chr 1:252,946,934...252,970,168 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 multiple interactions
decreases expression
increases expression 		ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CX3CL1 mRNA; [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CX3CL1 mRNA; Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CX3CL1 mRNA]; TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CX3CL1 mRNA]
Dexamethasone results in decreased expression of CX3CL1 mRNA
Dexamethasone results in increased expression of CX3CL1 mRNA 		CTD PMID:16054899 PMID:21041162 PMID:22733784 PMID:23503329 NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 multiple interactions EXP Dexamethasone inhibits the reaction [Freund's Adjuvant results in increased expression of CXCL1 mRNA]; Dexamethasone inhibits the reaction [Ozone results in increased expression of CXCL1 mRNA]; Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL1 mRNA] CTD PMID:8603703 PMID:18590720 PMID:21149847 NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CXCL10 mRNA
[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL10 mRNA; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 protein]; TNF protein inhibits the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL10 mRNA] 		CTD PMID:21041162 PMID:23503329 PMID:27568862 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cxcl11 C-X-C motif chemokine ligand 11 multiple interactions ISO [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL11 mRNA CTD PMID:23503329 NCBI chr14:15,973,728...15,976,503
Ensembl chr14:15,973,720...15,976,567 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 multiple interactions
decreases expression
increases expression 		ISO [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL12 mRNA; [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL12 mRNA]; [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL12 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL12 mRNA]; TNF protein inhibits the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL12 mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CXCL12 mRNA
Dexamethasone results in decreased expression of CXCL12 mRNA
Dexamethasone results in increased expression of CXCL12 mRNA 		CTD PMID:16054899 PMID:21041162 PMID:22733784 PMID:23503329 PMID:28628672 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627 		JBrowse link
G Cxcl16 C-X-C motif chemokine ligand 16 multiple interactions ISO [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA; TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL16 mRNA] CTD PMID:23503329 NCBI chr10:55,665,355...55,669,950
Ensembl chr10:55,664,742...55,670,226 		JBrowse link
G Cxcl17 C-X-C motif chemokine ligand 17 multiple interactions ISO Dexamethasone inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CXCL17 mRNA] CTD PMID:32679548 NCBI chr 1:90,112,561...90,124,648
Ensembl chr 1:90,112,771...90,124,535 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions
increases expression
decreases expression 		EXP
ISO 		Dexamethasone inhibits the reaction [Ozone results in increased expression of CXCL2 mRNA]; Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CXCL2 mRNA]
Dexamethasone results in increased expression of CXCL2 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CXCL2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CXCL2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CXCL2 mRNA
Dexamethasone results in decreased expression of CXCL2 mRNA
[Cyclophosphamide co-treated with Dexamethasone] inhibits the reaction [Paraquat results in increased expression of CXCL2 mRNA]; [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL2 mRNA; Amiodarone inhibits the reaction [Dexamethasone results in increased expression of CXCL2 mRNA]; Dexamethasone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL2 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein]; Dexamethasone inhibits the reaction [Ozone results in increased expression of CXCL2 protein]; TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL2 mRNA] 		CTD PMID:7737418 PMID:14754758 PMID:18590720 PMID:22154906 PMID:23503329 More... NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression
multiple interactions 		ISO Dexamethasone results in decreased expression of CXCL1 mRNA
[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL1 mRNA; [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL1 mRNA]; [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL1 mRNA; Dexamethasone inhibits the reaction [[Ovalbumin co-treated with aluminum sulfate] results in increased secretion of CXCL1 protein]; Dexamethasone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL1 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 protein]; Dexamethasone inhibits the reaction [Silicon Dioxide results in increased expression of CXCL1 mRNA]; DUSP1 gene mutant form inhibits the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA]]; DUSP1 gene mutant form promotes the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 protein]]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL1 mRNA]; TNF protein inhibits the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL1 mRNA] 		CTD PMID:16054899 PMID:16880258 PMID:21414392 PMID:22733784 PMID:23503329 More... NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcl6 C-X-C motif chemokine ligand 6 decreases expression ISO Dexamethasone results in decreased expression of CXCL6 mRNA CTD PMID:25047013 NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,594,959...17,596,417 		JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 increases expression
decreases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CXCL9 mRNA
Dexamethasone results in decreased expression of CXCL9 protein
[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL9 protein]; TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL9 mRNA] 		CTD PMID:21041162 PMID:21880982 PMID:23503329 PMID:27568862 NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 multiple interactions
decreases expression
increases expression 		ISO Dexamethasone inhibits the reaction [TNF protein results in increased expression of CXCR4 mRNA]
Dexamethasone results in decreased expression of CXCR4 mRNA
Dexamethasone results in increased expression of CXCR4 mRNA; Dexamethasone results in increased expression of CXCR4 protein 		CTD PMID:11872090 PMID:12732289 PMID:21041162 PMID:21420233 PMID:22733784 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cxcr6 C-X-C motif chemokine receptor 6 increases expression ISO Dexamethasone results in increased expression of CXCR6 mRNA CTD PMID:21041162 NCBI chr 8:132,311,834...132,317,001
Ensembl chr 8:132,306,600...132,322,498 		JBrowse link
G Cxhxorf38 similar to human chromosome X open reading frame 38 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CXORF38 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CXORF38 mRNA CTD PMID:28628672 NCBI chr  X:12,800,935...12,823,632
Ensembl chr  X:12,802,377...12,814,198 		JBrowse link
G Cxxc1 CXXC finger protein 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CXXC1 mRNA CTD PMID:28628672 NCBI chr18:70,088,407...70,093,786
Ensembl chr18:70,088,460...70,093,778 		JBrowse link
G Cxxc5 CXXC finger protein 5 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CXXC5 mRNA CTD PMID:28628672 NCBI chr18:27,701,650...27,732,633
Ensembl chr18:27,701,188...27,732,635 		JBrowse link
G Cyb561 cytochrome b-561 increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CYB561 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CYB561 mRNA 		CTD PMID:22733784 PMID:28628672 NCBI chr10:91,377,866...91,388,548
Ensembl chr10:91,377,866...91,385,097 		JBrowse link
G Cyb561a3 cytochrome b561 family, member A3 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYB561A3 mRNA CTD PMID:28628672 NCBI chr 1:216,641,108...216,662,495
Ensembl chr 1:216,651,128...216,662,492 		JBrowse link
G Cyb5a cytochrome b5 type A increases expression
multiple interactions 		ISO Dexamethasone results in increased expression of CYB5A mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CYB5A mRNA 		CTD PMID:22733784 PMID:25047013 PMID:28628672 NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094 		JBrowse link
G Cyb5d2 cytochrome b5 domain containing 2 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CYB5D2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CYB5D2 mRNA CTD PMID:28628672 NCBI chr10:57,892,799...57,911,831
Ensembl chr10:57,895,296...57,912,030 		JBrowse link
G Cyb5r1 cytochrome b5 reductase 1 multiple interactions ISO [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CYB5R1 mRNA CTD PMID:28628672 NCBI chr13:48,401,061...48,407,466
Ensembl chr13:48,399,106...48,407,465 		JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 decreases expression
multiple interactions 		EXP
ISO 		Dexamethasone results in decreased expression of CYB5R3 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CYB5R3 mRNA 		CTD PMID:17522070 PMID:28628672 NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:116,186,729...116,204,306 		JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions ISO Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CYBB mRNA]
Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CYBB mRNA] 		CTD PMID:9794432 PMID:27568862 NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:16,030,596...16,065,065 		JBrowse link
G Cycs cytochrome c, somatic multiple interactions
decreases expression 		ISO [GCS-100 co-treated with Dexamethasone] affects the localization of CYCS protein; [IFNG protein co-treated with bisphenol AF] inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of CYCS protein]; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of CYCS protein
Dexamethasone results in decreased expression of CYCS protein
[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CYCS mRNA 		CTD PMID:16166312 PMID:24848799 PMID:31596606 PMID:33567340 NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions
decreases expression 		EXP [Dexamethasone co-treated with Dibutyl Phthalate] results in decreased expression of CYP11A1 mRNA
Dexamethasone results in decreased expression of CYP11A1 mRNA 		CTD PMID:22615892 PMID:29902490 PMID:33983380 PMID:35246761 NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196 		JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 decreases expression EXP Dexamethasone results in decreased expression of CYP11B1 mRNA CTD PMID:33983380 PMID:35246761 NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions
decreases expression
increases expression 		EXP
ISO 		[Dexamethasone co-treated with Dibutyl Phthalate] results in decreased expression of CYP17A1 mRNA
Dexamethasone results in decreased expression of CYP17A1 mRNA
Berberine inhibits the reaction [Dexamethasone results in increased expression of CYP17A1 mRNA] 		CTD PMID:20462044 PMID:22615892 PMID:29902490 PMID:33983380 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions
increases expression
decreases expression
increases activity 		ISO Calcitriol promotes the reaction [Dexamethasone results in increased activity of CYP19A1 protein]
Dexamethasone results in increased expression of CYP19A1 mRNA
Dexamethasone results in decreased expression of CYP19A1 mRNA 		CTD PMID:15525692 PMID:15862960 PMID:16691199 PMID:25047013 PMID:29701941 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
decreases expression
increases activity
decreases activity 		ISO
EXP 		[Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; [Dexamethasone co-treated with Mifepristone] results in increased activity of CYP1A1 protein; [NR3C1 protein co-treated with Dexamethasone] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Dexamethasone inhibits the reaction [AHR protein results in increased expression of CYP1A1]; Dexamethasone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; Dexamethasone inhibits the reaction [cyprodinil results in increased expression of CYP1A1 protein]; Dexamethasone inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of CYP1A1 protein]; Dexamethasone inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; Dexamethasone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Dexamethasone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
Dexamethasone results in increased expression of CYP1A1 mRNA
Dexamethasone results in decreased expression of CYP1A1 protein
Dexamethasone results in increased activity of CYP1A1 protein
Dexamethasone promotes the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; Dexamethasone promotes the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; Dexamethasone promotes the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]]; NR3C1 protein promotes the reaction [Dexamethasone promotes the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]]
[PRL protein co-treated with Dexamethasone] results in increased expression of CYP1A1 mRNA; beta-Naphthoflavone promotes the reaction [[PRL protein co-treated with Dexamethasone] results in increased expression of CYP1A1 mRNA]; Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]]
Dexamethasone results in decreased activity of CYP1A1 protein 		CTD PMID:2916850 PMID:7587946 PMID:11328961 PMID:14691211 PMID:15620718 More... NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
decreases expression
decreases activity
affects expression
increases expression 		ISO
EXP 		[Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein]; [Dexamethasone co-treated with Mifepristone] results in increased activity of CYP1A2 protein; Dexamethasone inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein]; Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]]
Dexamethasone results in decreased expression of CYP1A2 protein
Dexamethasone results in decreased activity of CYP1A2 protein
Dexamethasone affects the expression of CYP1A2 mRNA
Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]]
Dexamethasone results in increased expression of CYP1A2 mRNA
Dexamethasone results in decreased expression of CYP1A2 mRNA 		CTD PMID:11328961 PMID:15102944 PMID:15607757 PMID:17690134 PMID:19022236 More... NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions
increases expression 		ISO
EXP 		[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CYP1B1 mRNA; [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CYP1B1 protein
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CYP1B1 mRNA
Dexamethasone results in increased expression of CYP1B1 mRNA; Dexamethasone results in increased expression of CYP1B1 protein
Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]; Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein]; Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]; Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]] 		CTD PMID:9804617 PMID:15967407 PMID:17690134 PMID:21041162 PMID:28628672 More... NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp21a1 cytochrome P450, family 21, subfamily a, polypeptide 1 decreases expression EXP Dexamethasone results in decreased expression of CYP21A1 mRNA CTD PMID:35246761 NCBI chr20:4,028,323...4,031,549
Ensembl chr20:4,028,391...4,031,543 		JBrowse link
G Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1 affects activity
increases expression
affects expression 		ISO Dexamethasone affects the activity of CYP24A1 protein
Dexamethasone results in increased expression of CYP24A1 mRNA
Dexamethasone affects the expression of CYP24A1 mRNA 		CTD PMID:10694374 PMID:15630458 NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:179,694,647...179,709,083 		JBrowse link
G Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 decreases expression ISO Dexamethasone results in decreased expression of CYP26A1 mRNA CTD PMID:34464682 NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657 		JBrowse link